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Abstract 
Background 
In chronic obstructive pulmonary disease (COPD), understanding the problem of poor patient 
participation in evidence-based self-management (SM) and pulmonary rehabilitation (PR) 
programmes (together referred to as SM support programmes) is critical. This thesis aimed to 
improve understanding of poor patient participation and retention in these programmes; how 
participation might be improved; and how might patients be better supported with their SM. 
 
Methods 
Using the Medical Research Council guidance on complex interventions this thesis (1) 
quantified the ‘actual’ patient participation and completion rates; (2) explained, using theory, 
the factors that influenced participation in studies of SM support including the programmes 
among chronic disease and COPD patients; and (3) explored patient and expert stakeholders’ 
perspectives on the reasons for non-participation in SM support programmes, how 
participation might be improved, how might patients be supported with their SM. 
 
Results 
(1) Among 56 studies, high study participation rates and completion rates were seen however, 
the incomplete reporting of participant flow confused the problem of participation. (2) 
Among 31 studies, participation among patients with chronic disease including COPD was 
shown to be influenced by their ‘attitude’ and ‘perceived social influence/subjective norms’; 
‘illness’ and ‘intervention perceptions’. (3) From 38 interviewees, besides patients’ beliefs, 
non-participation was also influenced by resignation and denial of the illness; health systems; 
and programme organisational factors. Professionals building relationships and supporting 
patients with their SM alongside programme organisational improvements might encourage 
patient participation in SM and the programmes.  
 
Conclusions 
Patient participation is a complex behaviour, besides socio-behavioural factors, participation 
behaviour can by influenced by a mix of several health system and programme organisational 
factors. Changing the behaviour of health professionals and indeed the wider health system, 
towards normalising a patient partnership approach, with implementation of SM support in 
6 
 
routine care might help more patients to consider participation in their care and improve 
patient participation in COPD SM support programmes. 
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Glossary 
 
Definitions used in this thesis 
Uptake/Participation/Non-participation: patient taking part in a self-management (SM) 
intervention or in studies of SM interventions or not taking part; 
Attendance: number of sessions in a SM programme actually attended (e.g. 2 of 7 sessions); 
Non-attendance: no sessions of the programme attended; 
Completion: attendance at all sessions of a SM programme (or at sufficient to reach a pre-
determined “effective dose” of the intervention); 
Drop-out/Non-completion: patient who withdraws from the programme or leaves the study. 
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Chapter I. Uptake of self-management programmes by 
patients with chronic obstructive pulmonary disease 
Chapter I presents the: 
 Background section as follows  
o a brief description of COPD; burden of COPD on the individual, society and 
health services; 
o  the national and international guidelines on the non-pharmacological 
treatment/management of COPD with a particular focus on self-management 
(SM) interventions including pulmonary rehabilitation;  
o the definition and description of SM, the distinction and relationship between 
SM and the terms used synonymously with SM, the different methods of SM 
delivery to patients with COPD and role of SM in COPD is explained; 
o the existing evidence of benefit from studies of SM in COPD and existing 
participation and completion rates in studies of COPD SM is presented; and 
o the description of the current availability or delivery of SM for COPD in 
clinical practice 
 Summary of the rationale for this study. 
 Aims and objectives of the study. 
 Structure of the thesis. 
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1.1 Background 
1.1.1 Chronic obstructive pulmonary disease 
“Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease 
with some significant extrapulmonary effects that may contribute to the severity in individual 
patients. Its pulmonary component is characterized by airflow limitation that is not fully 
reversible. The airflow limitation is usually progressive and associated with an abnormal 
inflammatory response of the lung to noxious particles or gases”.15 
 
The chronic airflow limitation characteristic of COPD is caused by a mixture of small airway 
disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), the relative 
contributions of which vary from person to person. COPD is characterised by chronic and 
progressive dyspnoea, cough and sputum production. Chronic cough and sputum production 
may precede airflow limitation by many years. Conversely, significant airflow limitation may 
develop without chronic cough and sputum production. COPD is also associated with 
periodic exacerbations of symptoms. An exacerbation being defined as “an event in the 
natural course of the disease characterized by a change in the patient’s baseline dyspnoea, 
cough, and/or sputum that is beyond normal day-to-day variations, is acute in onset, and may 
warrant a change in regular medication in a patient with underlying COPD”.15 
 
1.1.1.1 Aetiology and pathology 
The main cause of COPD in high and middle income 
countries is tobacco smoking including second-hand smoke or passive exposure 
http://www.who.int/respiratory/copd/causes/en/index.html (accessed 5-1-14) Other factors 
associated with COPD are occupational exposure, alpha-1 antitrypsin deficiency (the most 
well documented genetic risk factor), indoor air pollution from biomass cooking, seen mostly 
in the developing countries, and childhood respiratory infections.15,16 The risk of developing 
COPD is also inversely related to socio-economic status.15  
The pathologic changes occur in the proximal airways, peripheral airways, lung parenchyma 
and pulmonary vessels of patients.15 The changes include chronic inflammation with 
increased numbers of specific inflammatory cell types and structural changes which increase 
with severity and persist on smoking cessation. In COPD patients the inflammatory response 
appears to be an amplification of the normal inflammatory response of the respiratory tract to 
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irritants such as cigarette smoke. Lung inflammation is further amplified by oxidative stress 
and an excess of proteinases in the lung.15 
Spirometry is vital for the clinical diagnosis of COPD and provides a useful description of its 
severity based on the pathological changes in COPD;15 this method of measurement is the 
most widely available reproducible test of lung function. The presence of a post-
bronchodilator Forced Expiratory Volume in 1 second (FEV1)/Forced Vital Capacity (FVC) 
<0.70 confirms the presence of persistent airflow limitation and thus of COPD.17  
 
1.1.1.2 Prevalence 
COPD is a public health problem worldwide.18 According to the World Health Organisation, 
an estimated 65 million people have moderate to severe COPD 
http://www.who.int/respiratory/copd/burden/en/index.html (accessed 4-1-13).  
COPD represents a global health burden and will change from ranked 12 as cause of 
disability adjusted-life years (DALY) lost to ranked fifth by the year 2020.19 One DALY can 
be one lost year of “healthy life”  
 http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/ (accessed 18-1-13). 
COPD is projected to rank third among all causes of death by 2020.20 The 2010 data from the 
Global Burden of Disease, Injuries and Risk factors Study showed that the UK, in 
comparison to the European Union countries, in all ages, had significantly higher rates of 
years of life lost from several diseases with COPD being the fourth cause of years of life lost 
behind ischaemic heart disease, lung cancer and stroke.21 In the UK, research by the British 
Lung Foundation (BLF) showed that an estimated 3.7 million people are suffering with 
COPD, yet only 900,000 are currently diagnosed, receiving treatment and care and an 
estimated 2.8 million are unaware that they have the condition.22 Patients’ might dismiss a 
cardinal symptom, breathlessness, and perceive it to be a sign of getting old 
or perceive it as smoker’s cough, http://www.lunguk.org/media-and-campaigning/media-
centre/latestpressreleases/British-Lung-Foundation-
victory?dm_i=FWX,H6XI,3L2RQO,1EGV0,1 (accessed 1-1-2011). 
The Quality and Outcomes Framework (QOF) data from UK general practice, estimates 
COPD prevalence to be 1.4%, but this proportion could be much higher.16  
Normally, COPD was more common in men, but because of the increased uptake of smoking 
among women in high income countries and exposure to indoor air pollution 
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in low income countries, the disease now affects men and women equally 
http://www.who.int/respiratory/copd/burden/en/index.html (accessed 4-1-13).  
 
1.1.1.3 Impact of COPD on patients, society and the National Health Service 
(NHS) 
COPD is the fifth biggest killer in the UK.23 The numbers of deaths from COPD increase 
with age as the condition is progressive and deteriorates over time. Persons living with COPD 
may suffer from both physical and psychological limitations.24,25 These are at an increased 
risk of comorbidities such as cerebrovascular and cardiovascular disease, and suffer from 
neurological and musculoskeletal symptoms26 which can disrupt their daily functioning. The 
physical limitations imposed by COPD may result in patients’ avoiding social participation 
and social isolation can negatively influence activities of daily living.25  
Mental health problems are three times more common amongst patients with COPD in 
comparison to the general population.27 Psychological limitations such as depression, anxiety 
(seen higher in women28), and panic disorder are commonly seen amongst patients living 
with COPD.29-31 In a review31 of mental health in COPD and chronic heart failure, the 
prevalence figures in COPD for depression ranged from 8-80% and for anxiety the range was 
6-74%. In a COPD patient suffering from anxiety and panic disorder, the sensation of 
breathlessness is more acute and may be out of proportion to disease severity.29 As a result, 
these patients’ experience problems with activities of daily living and rely on others for their 
care.29 Psychological factors including fear, frustration, regret and social isolation add to the 
emotional burden of COPD.32 Depression may prevent adherence to medications, a healthy 
dietary regime, exercise and smoking cessation all potentially worsening the course of the 
illness;24 Psychological distress also affects mood, motivation, health care utilisation and 
survival.30 Many patients with COPD accept that they are helpless – “a perception that 
whatever [they] do will make no difference in the future.”32 Help-seeking by patients with 
severe symptoms can be affected by loss of self-esteem, hope, and fear about the future.33  
COPD patients with anxiety and depressive symptoms are at an increased risk of acute 
exacerbations.31 Consequences of an acute exacerbation include deterioration in: lung 
function; peripheral muscle function; exercise capacity activity level; and quality of life.19,30 
The frequency of exacerbations accelerates the disease process.26 A patient with COPD 
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suffers from about two to three exacerbations a year and the recovery time from an 
exacerbation can take up to three months.26  
 
The burden of COPD on society includes lost taxes, increased state benefits and lost 
productivity. A global survey in 2011 of people aged 45-67 years was carried out to reveal 
the impact of COPD on the individual, health service use and economies.34 The survey 
revealed that the COPD costs the economy nearly €1.7 billion (UK £1.5billion, US $2.4 
billion). The annual lost productivity costs, due to early retirement, amounts to €500million.34 
 
COPD is the most costly respiratory disease in Europe, estimated at €38.7 billion annually.35 
In the UK, COPD is responsible for over 30,000 deaths, 1.4 million GP consultations, a 
million hospital bed days and costs the NHS over £800 million each year36 more than half of 
which is related to hospital care.22 About one in eight emergency hospital admissions maybe 
due to COPD;19 It is the second most common cause of emergency admission;22 and the fifth 
most common cause for hospital readmissions.37 In England and Wales, COPD direct costs 
per patient was £819.42 and indirect costs was £819.66 in 2000/01;38 the cost of an 
exacerbation per patient by severity was £7.94 for mild, £23.43 for mild/moderate, £139.74 
for moderate and £1446.48 for severe disease.38 According to a BLF report, in 2007, an 
estimated annual cost of treating a patient with mild disease was reported to be £149 and 
£1307 for a person with severe COPD.22 
 
1.1.1.4 Non-pharmacological management of COPD 
COPD cannot be cured but can be treated or managed.30 Effective COPD management 
includes focusing on four key areas:  
1) assess and monitor disease;  
2) reduce risk factors;  
3) manage stable COPD; and  
4) manage exacerbations 
http://www.who.int/respiratory/copd/management/en/ (accessed 30-11-2012).39  
 
The goals of effective COPD management include: 
 Prevent disease progression 
 Relieve symptoms 
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 Improve exercise tolerance 
 Improve health status 
 Prevent and treat complications 
 Prevent and treat exacerbations 
 Reduce mortality 
 
1.1.1.4.1. Guidelines and recommendations given by experts on COPD non-
pharmacological management 
The effective management of COPD includes both pharmacological and non-
pharmacological interventions.34 The non-pharmacological management complements 
pharmacological treatment and enhances patient outcomes.40 This study will place emphasis 
on two non-pharmacological interventions namely, self-management (SM) interventions and 
pulmonary rehabilitation (PR). 
Table 1.1 presents a summary of the various non-pharmacological interventions 
recommended by global health guidelines including the UK (i.e. based on best available 
research evidence). 
 
Table 1.1 Summary of national and international guidelines recommended for COPD 
non-pharmacological management 
Name of organisation  Guidance  
WHO 
http://www.who.int/respiratory/copd/management/en/ 
(accessed 30-11-2012) 
Health education, Exercise training programmes, and 
Oxygen therapy (for stable COPD) 
 
Non-invasive positive pressure ventilation (for 
exacerbation management) 
GOLD 2011 
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Smoking cessation, PR, Physical activity, and 
Vaccinations (for all respiratory disease patients) 
GOLD 2013 
17
 Smoking cessation (essential), Physical activity 
(recommended), Flu or pneumococcal vaccinations 
ATS/ERS 2006 
41
 PR to consider provision of SM education instead of 
didactic education 
BTS 2013 
42
 Educational talk within PR to include SM 
NICE 2010 
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Smoking cessation, Oxygen therapy, Non-invasive 
ventilation, PR with education and multidisciplinary 
management comprising of education and SM (for 
stable COPD) 
 
Non-invasive ventilation; oxygen therapy; and 
Physiotherapy (for exacerbation management) 
NICE 2012 
44 Home care by outreach nursing for COPD patients, 
Complex patient education programmes (comprising of 
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 SM action plans with limited education and/or a disease 
management programme) 
 
PR to be delivered to patients who have recently 
experienced an exacerbation 
Consultation strategy document for COPD services 
2010 
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‘Self-care’; Chronic disease management approach, 
moderate exercise, and standardisation of tools to 
support implementation of SM plans, and provision of 
SM support 
Outcome strategy for COPD and asthma in England 
2011 45 
Holistic focus with a call to action from the health and 
social care system. Recommendations included 
effective proactive disease management, partnership 
between HCPs and patients to be partners in their care; 
patients should be able to self-manage their condition 
and have a voice in their treatment and where it is 
delivered. The management plan for patients with 
chronic disease was also suggested for COPD 
management and SM i.e. risk profiling, integrated care 
and self-care.  Provision of SM support was also 
suggested right across the COPD patient pathway.  
Key: 
WHO – World Health Organisation; GOLD – Global Initiative for Chronic Obstructive Lung Disease; ATS – 
American Thoracic Society; ERS – European Respiratory Society; BTS – British Thoracic Society; NICE – 
National Institute of Health and Clinical Excellence; PR - Pulmonary rehabilitation; SM – Self-management; 
HCPs – health care professionals 
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Besides health policy guidelines, several workshops have also been convened by experts to 
discuss the place of SM and PR in COPD management. A common theme among these 
workshops was: delivery of PR that includes SM education,41,46(Professor Mike Morgan, 
personal communication 5Dec2012) for patients with more severe problems,46 or those who 
had suffered an acute exacerbation,30 patients that have capacity to understand(Professor 
Mike Morgan, personal communication 5Dec2012), or taking account of their level of health 
literacy41 to help improve exercise adherence which could lead to positive health behaviour 
change following completion of PR.41 In addition, provision of SM programmes for patients 
with less severe problems and disease management by HCPs was suggested for patients with 
more severe problems.46 The delivery of SM education within PR was reported as an element 
of the integrated model which was considered synonymous or interchangeable to the disease 
management or chronic care model.47   
 
Improving SM or ensuring patients with long term conditions including COPD are better able 
to self-manage their condition is the scope of the abovementioned policy guidelines, experts’ 
recommendations and a major focus of the NHS strategy.48,49 However, within some policy 
guidelines the term ‘education’ has been used synonymously with ‘SM education’; and, ‘SM’ 
has been incorporated within an ‘educational package’41,43,44. The terms ‘SM’ and ‘self-care 
support’ have been used interchangeably49. More recently in the research literature the term 
‘SM programme’ was used synonymously to ‘disease management’50 which we debated in a 
recent article51 and called for a universally common definition of SM improve 
communication between researchers, clinicians and policy makers alike. The lack of clarity 
between these terminologies and how they might function at the expert/policy level could 
create further confusion or lack of understanding at the practice level among health care 
professionals. This might prevent referral or delivery of these types of non-pharmacological 
management to patients thus affecting patient SM and health outcomes. Thus, the next 
section defines each of these terminologies, clarifies their function and shows the relationship 
between these terms.  
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1.1.1.4.2 Self-management (SM) 
This section defines and describes SM and its derivatives and how they might be interrelated. 
Next, the role of SM in COPD is explained; from published research existing evidence of SM 
benefit in COPD is reported, existing patient participation and completion rates in SM and 
PR programmes, and existing reasons given for participation and completion in these 
programmes is presented. The section concludes with the current service provision of SM in 
COPD. 
 
1.1.1.4.2.1 Definition, function and relationship between SM and its derivatives 
a) Definition of SM 
There is neither one nor a universally accepted definition for the term ‘self-management’.  
For the purpose of the study the definition given by Barlow52 has been adopted where SM 
refers to an “individual’s ability to manage symptoms, treatment, physical and psychosocial 
consequences and lifestyle changes inherent in living with a chronic condition.”  
Efficacious SM encompasses ability to monitor one’s condition and to effect the cognitive, 
behavioural and emotional responses necessary to maintain a satisfactory quality of life. This 
definition has also been adopted by the DH. 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Pub
lications/PublicationsPolicyAndGuidance/Browsable/DH_4890904 (accessed 28-12-12).  
 
The US Institute of Medicine http://www.iom.edu/ (accessed 28-12-12) has defined SM as 
“the tasks that individuals must undertake to live with one or more chronic conditions.  These 
tasks include having the confidence to deal with medical management, role management and 
emotional management of their conditions.”   
 
The Australian National chronic disease strategy defined SM as “active participation by 
people in their own health”.53  
 
One study54 explored the meaning of SM from patients living with a chronic illness and 
patients revealed that “SM is a dynamic, active process of learning, trialing and exploring the 
boundaries created by illness.” Patients perceived SM of a chronic illness as more than just 
‘doing’ but was enmeshed with a sense of ‘being’ and ‘becoming’; Patients had to constantly 
plan, pace, and manage daily life based on recognising the physical and psychological 
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responses to their illness. Another study55 also reported that an individual’s ability to manage 
their health and condition was a result of internal factors; additionally, external factors such 
as, political, economic and social factors that create social determinants of health can also 
affect SM.  
 
b) Aim of SM 
The aim of SM, reported by the NICE guidance in 201043 was very similar to its 
recommendations for COPD management, to prevent exacerbations by lifestyle adaptation 
through acquisition of skills to treat exacerbations from SM education and/or SM plans. 
 
c) Description of SM 
Effective SM of chronic illness is complex and requires significant participation by both 
patients and their families; the SM components include:56,57 
 engaging in activities that promote physical and psychological health; 
 interacting with health care providers and adherence to treatment recommendations; 
 monitoring health status and making associated care decisions and 
 managing the impact of the illness on physical, psychological and social functioning. 
Achieving effective SM would involve the adoption of core SM skills such as58: 
 problem-solving; 
 action planning; 
 decision-making; 
 act of finding and utilising resources and 
 forming partnerships with health care providers 
The effects of SM are achieved through operationalisation of the self-efficacy theory,59 
“beliefs in one’s capabilities to organize and execute the courses of actions required to 
produce given attainments”, a major component of the Social Cognitive Theory (SCT).58 The 
latter feature is unique to SM interventions that set it apart from health promotion and patient 
education interventions. The self-efficacy enhancing components, incorporated within the 
structured teaching processes of a SM programme, include performance mastery, modelling, 
interpretation of symptoms, and social persuasion58. Specifically: 
 performance mastery or skills mastery is action planning e.g. action plan to begin 
exercise; 
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 modelling can take place in several ways such as, provision of materials (written, 
video) suited to the population they are developed for, peers with a similar chronic 
condition and people, can act as models for each other e.g. observation of breathing 
technique; 
 interpretation of physiologic symptoms is aimed at people to help them form 
alternative explanations for their symptoms as these might occur due to several 
reasons and this could result in managing symptoms in different ways e.g. how to 
respond when anxious due to breathlessness; and 
 social persuasion is an important element suggesting that if people around you are 
performing a behaviour or not, then people are more likely to follow e.g. peer support. 
 
d) The various derivatives of SM and the relationship between them  
The various derivatives of SM include self-care, self-care support, SM support, education, 
SM education, and disease management. The relationship between these terms is illustrated in 
Figure 1.1. 
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Figure 1.1 Illustration of relationship between SM support and disease management 
interventions  
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Difference between the terms ‘self-management’ and ‘self-care’ and the relationship 
between them 
The DH60 has defined self-care as “the actions people take for themselves, their children and 
their families to stay fit and maintain good physical and mental health; meet social and 
psychological needs; prevent illness or accidents; care for minor ailments and long-term 
conditions; and maintain health and wellbeing after an acute illness or discharge from 
hospital.” Another definition has been given by Barlow,52 “care taken by individuals towards 
their own health and wellbeing: it comprises the actions they take to lead a healthy lifestyle; 
to meet their social, emotional and psychological needs; to care for their long-term condition 
and to prevent further illness or accidents”. Parsons61 in the context of understanding 
experiences of SM and expectations from older people in their report defined SM as “those 
actions individuals and others take to mitigate the effects of a long term condition and to 
maintain the best possible quality of life.”; and referred to self-care as a “wider set of 
behaviours which both the healthy and the not so healthy take to prevent the onset of illness 
or disability, and, again to maintain quality of life.” 
Based on the above definitions of SM and self-care, SM is one activity among various other 
activities within self-care that an individual living with a chronic condition can utilise to 
better manage their condition. However, self-care can be performed by individuals who are 
healthy, at risk or ill and include activities/behaviours such as, self-diagnosis, SM, self-
medication and self-monitoring.62  
 
Self-care support 
Self-care support has been defined as “increasing the capacity, confidence and efficacy of the 
individual for self-care by providing a range of options”.63 Roger’s64 in their study 
encompassed the Expert Patient Programme (EPP), through which an individual with chronic 
disease can undertake to manage their illness such as, negotiating the way through the health 
service, utilise skills, information, technology and resources, and mobilise and draw on social 
networks, within self-care support. However, based on the above definition of self-care the 
EPP fits more within the remit of SM and SM support as the EPP is only aimed at individuals 
with chronic disease.   
 
The definitions also clarify that perhaps the terms ‘self-care support/self-management’ 
grouped together and illustrated at the bottom of the risk pyramid model in the DH 
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Supporting people with long term conditions report 49 and aimed particularly at 70-80% of 
people living with chronic disease might not be appropriate.  
 
SM support 
SM support has been defined as “the systematic provision of education and supportive 
interventions by health care staff to increase patients’ skills and confidence in managing 
their health problems, including regular assessment of progress and problems, goal setting, 
and problem-solving support.”65 
According to the COPD consultation document,23 provision of SM support is about helping 
people manage work and leisure activities and developing strategies to deal with the 
psychological consequences of illness. 
Provision of SM support forms one component of the chronic care model – a disease 
management model;66 The model is a guide for health systems to improve the health of 
people with chronic conditions by making changes to the health system organisations, to 
improve delivery of patient care alongside empowering patients to manage their health 
through the provision of SM support.23,66  
Effective SM support is more than telling patients what to do; patients’ central role in 
managing their health needs to be emphasised and acknowledged by health care providers.  
The goal of SM support has been reported as changing patient behaviour by increasing their 
self-efficacy and knowledge to achieve health and functional outcomes.67 Patients and 
professionals need to work in collaboration and form partnerships to identify and define 
problems, set priorities, establish goals, create treatment plans and solve problems 
simultaneously; and resources in the community need to be in place to provide ongoing 
support to patients. http://improvingchroniccare.org/index.php?p=Self-
Management_Support&s=22 (accessed 4-1-13)60,62  
For professionals, to encourage effective partnerships with a patient (or to deliver SM 
support), it would require other components of disease management to work together for 
example, provision of training for professionals to provide the right clinical and behavioural 
support (decision support); delegation of tasks to other team members (delivery system 
design) e.g. nurses allocated more time to deliver SM support;43 assessment of patient needs; 
delivery of information from evidence based guidelines (clinical information systems) to 
patients using computers or telephone; and changes at the organisational level (health care 
organisation) where appropriate e.g. at personnel level.68 
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Delivery of SM support within a clinical consultation setting could include delivery of SM 
plans and outside of a patient-professional clinical consultation context could include 
delivery of effective programmes that provide education, emotional support and strategies for 
living with a chronic illness among patients though, provision of SM support cannot begin 
and end with attendance in one class or programme. The two key programmes that support 
and enable patients with COPD to better self-manage their condition include SM and PR 
programmes.  
 
(1) SM programmes 
SM programmes have been promoted as one of the most important, non-pharmacological 
way of helping people with intractable chronic conditions;69 The programmes are group-
based programmes either tailored to a specific disease (e.g. COPD, asthma, diabetes) or 
multiple chronic conditions via a generic programme (the Expert Patients Programme (EPP)).  
In the UK, the EPP, is the anglicised version of the Chronic Disease Self-management 
Programme developed by Lorig and colleagues in Stanford, USA.70 The EPP comprises six 
weekly sessions, each lasting two and a half hours and is led by trained and accredited lay 
tutors who themselves have chronic illnesses.70 
Pilot generic SM programmes were delivered by several primary care trusts (dissolved now 
into clinical commissioning groups (CCGs)) across England in 2002-2004 to persons living 
with a long term condition (LTC).71 In 2005, the national evaluation71 of the EPP revealed 
recruitment difficulties for the group-based programmes including lack of engagement in 
these programmes from the participating trusts1. The generic SM programmes faced criticism 
for not recruiting people of lower socio-economic or with low health literacy which was 
perhaps due to the programme commissioners foreseeing this group as difficult to recruit.73 
However, the critics reported that people who had participated in the programmes may 
already have been good self-managers in comparison to people who did not participate in the 
programmes thus affecting outcomes. 
The evaluations of the generic SM programmes reported that effect on health status was 
weak.74 A Cochrane review75 of 17 studies of lay-led SM interventions reported that many of 
                                                          
1 Note: The responsibility of the primary care trusts shifted to a GP consortia in 2012/2013. The consortia took 
the role of commissioning in 2012/2013 and makes funding allocations for 2013/2014. The GP consortia has 
taken full financial responsibility from April 201372. Department of Health. Equity and Excellence. Liberating 
the NHS. London: 2010 2010. Report No. 
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the studies used volunteer patients, overall the patients were predominantly female (70%) and 
were quite well at baseline. 
Nonetheless, the national evaluation identified some patients’ desire for disease-specific 
EPP.71 Another study76 suggested that impact of lay-led programmes may be enhanced by 
including specific disease management advice delivered by a health professional and 
complementing lay tutoring. This led to wide interest in the development and delivery of 
disease-specific SM programmes e.g. in asthma, COPD and diabetes. 
 
A SM programme has been defined (by experts in the field around SM for chronic pain 
http://www.ihse.qmul.ac.uk/chs/pctu/current_projects/copers/index.html (accessed 4-1-13) 
as: 
Structured programmes with the broad goal of improving participants' health status or 
quality of life. They are: 
1. always aimed at, and delivered to, patients, and at patients where there is scope for 
improvement in managing their own health. (Carers may be involved but the programmes are 
principally directed at patients). 
2. always structured. (Individual elements are organised and delivered in a particular way). 
3. always include a taught or self-taught component that aims to increase participants' skills 
and knowledge and to enable participants to deploy these enhanced skills in aspects of their 
lives beyond the intervention.  
In addition: 
A. Self-management programmes are often multi-faceted. 
B. They may be directed at some or all of the following, 
Managing the Illness: 
- Taking medications 
- Changing diet and exercise 
- Managing symptoms of pain, fatigue, insomnia, shortness of breath, etc. 
- Interacting with the medical/social care system 
- Managing daily activities and roles  
- Maintaining roles as spouse, parent, worker, etc. 
- Managing the emotions  
- Managing anger, fear, depression, isolation, etc. 
C. They may include some or all of the following components: 
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- Psychological training, aimed at increasing awareness, changing attitudes and beliefs. 
- Physical training, including exercise, biofeedback, diet etc. 
Programmes that only involve exercise training do not constitute as SM programmes. 
 
While, Burtin77 proposed a narrow aim of SM programmes focusing mainly on exacerbation 
management, more holistic aims have been provided such as, to provide people with the 
knowledge and skills that are needed to manage their risk factors, monitor their disease, make 
effective use of services and manage the impact of disease on their lives53 thereby, reducing 
the burden of chronic illness on individuals and the community.78; to teach skills needed to 
perform a specific medical regimen, guide health behaviour change, and provide emotional 
support for patients to control their disease and function better.79 The latter author has 
illustrated (Figure 1.2)80 the behaviour change process caused by enhancement of self-
efficacy, knowledge gained, and learnt skills within a SM programme. 
 
 
Figure 1.2 Causal model of behaviour change 
 
 
 
 
 
Some studies have reported that knowledge and skills might not be enough to cause 
behaviour change as SM is dependent upon other variables such as, health beliefs, decision-
making ability, quality of communication with clinician32,67 and sense of power and control.81 
Development of knowledge and skills can be influenced by psychological factors such as 
intrinsic motivation, depression, panic, anxiety, fear, frustration, regret and a feeling of 
helplessness; lack of social support,32 and health literacy.82 These factors may prevent 
patients wanting to engage in complex SM strategies32 e.g. exercise. 
 
Difference between the terms ‘education’ and ‘SM education programmes’  
One study has defined the term ‘education’ as “provision of information to patients about 
their condition and what to do, so that knowledge may lead to changes in health behaviour 
that will in turn improve health and other outcomes”.83 
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Several research studies84,85 have evaluated SM education programmes (or also be referred to 
as SM programmes) among COPD patients. Blackstock’s86 review of disease-specific health 
education for COPD differentiated the 13 included studies into studies of SM education and 
didactical education. The former was defined as “education focusing on changing health 
behaviours through knowledge, goal setting and development of action plans” and the latter 
was defined as “education given in a passive lecture format, with opportunity to interact, but 
no focus on health behaviour change.” A similar distinction between education and SM 
programmes has been reported in other studies.46,81,87 Effing in a recent study46 recognised 
that different meanings of SM programmes have been assigned by several health guidelines 
(acknowledged in the beginning of this section) and reported that as ‘SM’ is aimed mainly at 
behavioural change and ‘education’ is normally interpreted as transmission of knowledge 
which mostly will not lead to behavioural change, it would be advisable to either use the term 
‘SM’ or ‘SM training’ instead of ‘SM education’ in the future. 
 
(2) PR programmes 
Provision of SM education and/or support within PR has been recommended by policy 
guidelines41 experts (Professor Mike Morgan, personal communication 5Dec2012) and as the 
role of PR is to assist patient SM,42 PR has been referred to as a SM support 
intervention/programme throughout the study. 
In the UK, The IMPRESS (Improving and Integrating Respiratory Services in the NHS)88 
group have defined features of a successful rehabilitation programme. 
“Such a programme: 
- is an individually tailored, multi-disciplinary intervention for symptomatic patients that is 
integrated into their overall care. 
- aims to reduce symptoms, improve functional performance, increase participation and 
reduce health care costs. 
- contains effective, individually prescribed, physical exercise training together with lifestyle 
and self-management advice 
- addresses the social and psychological impacts of the disease on the patients and those 
close to them 
- monitors progress with appropriate individual outcome measures and programme quality 
control” 
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The IMPRESS statement further distinguishes between “encouragement to the individual to 
remain active” (SM programmes) “and the deliberate supervised therapeutic process of 
restoring function through the process of formal rehabilitation” (PR programme). IMPRESS 
states that “PR must include individually prescribed lower limb physical training with twice 
weekly supervised sessions at least and that supervised sessions should be augmented by 
further daily home based sessions. The typical duration of a PR session is 6 to 12 weeks.” 
 
(3) SM plans 
A SM plan has been defined as “a plan (either written or verbal) designed with the primary 
purpose of patient self-management of COPD exacerbations”.43 
Delivery of SM plans have been coupled with limited education and/or part of disease 
management and in PR in the above mentioned recommended by the policy guidelines. 
 
 Disease management programmes 
Disease management has been defined as a “system of coordinated health care interventions 
and communications for populations with conditions in which patient self-care is 
significant”.89 Another study90 has defined these programmes as, “a group of coherent 
interventions designed to prevent or manage one or more chronic conditions using a 
systematic, multidisciplinary approach and potentially employing multiple treatment 
modalities. The goal of disease management is to identify persons at risk for one or more 
chronic conditions, to promote self management by patients and to address the illnesses or 
conditions with maximum clinical outcome, effectiveness and efficiency regardless of 
treatment setting(s) or typical reimbursement patterns.” 
 
1.1.1.4.3 Role of SM in COPD 
Chronic conditions cannot be treated or cured but need prolonged SM by patients.81 Patients 
have to be responsible for the daily management of their condition which affects both their 
physical and psychological health; and participation in managing one’s own condition is 
often a reality and a necessity rather than a choice.81 
Central to COPD management includes adherence to medication, early recognition of 
symptoms and prompt access to early treatment in the event of an exacerbation,91 reducing 
frequency of exacerbations, preventing hospitalisations and improving quality of life.32 
Furthermore, management includes adopting breathing techniques, exercising, attending 
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nutritional programmes and stress management.91 This necessitates the patient understanding 
their disease and management. However, several studies24,82 have reported that patients with 
COPD do not understand their disease and/or management. A recent qualitative study82 
showed patients with severe COPD had limited knowledge of COPD, and performed limited 
SM skills. Another study92 explored the needs of patients with advanced COPD belonging to 
three GP practices where smoking rates were higher than the national average and found that 
patients had poor understanding about their condition, and some patients did not know the 
condition was known as COPD. 
Specifically, with regard to management, patients with COPD would like: to avoid getting 
breathless,67 more information on how to control or manage breathlessness, 
exacerbations,24,93 to learn about medications,93 treatment options94 and new methods and 
interventions to improve outcomes.67 Additionally, patients would like to know what to 
expect from the condition now and in the future,93 and more information on nutrition, diet 
and healthy weight.95 Besides management of the clinical aspect of the disease, patients with 
COPD would like: information about the services available which they can understand easily; 
to be empowered to makes decisions about their care and be supported in decision-making; to 
be treated as a whole person and be enabled so they can take part in activities of daily 
living.23 Patients with COPD consider activities relating to personal care and housework 
important96 and have a strong desire to engage in social activities and be independent.97 
One way to achieve the above could be through patient self-managing which could include 
making decisions about their health and engaging in behaviours that affect their health in a 
positive manner;98 this would require support from HCPs (right support at the right time).23,46 
for example, provision of information on SM strategies.95 These strategies may provide 
patients with valuable skills to help manage their condition and which may have the potential 
to have a lasting effect beyond completion of delivery of the intervention.99 However, SM 
strategies are complex behaviour change strategies and require significant effort and 
commitment from patients.32 In COPD, these strategies among several, include smoking 
cessation, learning and implementing breathing and coughing techniques, adhering to 
exercise programmes, using inhaled medication regularly and self-initiating use of 
corticosteroids or antibiotics at the onset of an exacerbation through following set action 
plans, deploying effective coping and behavioural skills learnt from SM education32,67 and 
health outcomes would be dependent upon the degree of effective SM 
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http://improvingchroniccare.org/index.php?p=Self-Management_Support&s=22 (accessed 4-
1-13). 
One barrier to adoption of SM skills could be due to poor communication between patient 
and professional.67 Communication style may influence patients’ motivations and 
commitments towards making health-related goals and plans resulting in behaviour change.67 
Another barrier could be lack of referral to programmes that implement SM strategies such 
as, PR programmes.82 
 
1.1.1.4.4 Evidence of SM benefit in COPD 
The evidence presented below is from studies of COPD SM programmes, disease 
management programmes including SM support, SM action plans and PR programmes. 
The most popular way to enable SM among patients with chronic conditions including COPD 
has been mainly through delivery of group-based PR and SM programmes.53,100 
The disease-specific SM programmes have tended to produce more positive outcomes than 
the generic programmes;74 this is certainly true for asthma (i.e. improvement in health 
outcomes including improvement in health care use, days lost from work and quality of life,86 
and diabetes (i.e. improvement of glycaemic control).101 Patients with chronic disease with 
effective SM skills make better use of HCPs time, make daily decisions about medications, 
self-monitoring and exercise and hence play a central role in determining the course of their 
disease. However, this does not seem to apply to patients with COPD.87 This may be because 
of the evidence of benefit for SM in COPD is patchy. 
Blackstock’s review86 reported that studies of SM education had the potential to improve 
quality of life of patients with COPD and improve health care utilisation in comparison to 
studies of only didactical COPD education and concluded that future research should 
concentrate on SM educational programmes with underlying Social Cognitive Theory (SCT) 
health behaviour theory.59 Effing’s review84 of COPD self-management education suggested 
that SM education may reduce hospital admissions but because of heterogeneity (in 
populations, outcome measures, follow up times and interventions) among the included 
studies definite conclusions on effectiveness could not be made. One recommendation by the 
review was also that future SM programmes should be designed using theoretical model of 
behaviour change such as the SCT. The heterogeneity in Effing’s review was mentioned in an 
editorial by Bourbeau87 who suggested that heterogeneity may affect implementation of SM 
in clinical practice and further explained, that the studies in the review instead of focusing on 
43 
 
the complex sequence of effects that result in behaviour change, placed focus on measuring 
patients unscheduled visits to the hospital, with expectations to see a reduction in health care 
utilisation within a short period of time and this was unrealistic. Furthermore, the same study 
suggested that studies need to assess behaviour change as behavioural change will increase 
the likelihood of obtaining better patient outcomes and a reduction in health care utilisation. 
Our recent pilot study85 evaluated a COPD-specific SM programme underlying with the self-
efficacy theory, a major component of the SCT. Patient measures included behaviour change 
measures such as, self-efficacy scales around managing disease, SM behaviour scales for 
exercise and communicating with clinicians. The study results suggested that patients who 
received the intervention were more likely to exercise and have improved quality of life. 
Despite the positive results, one limitation of the study was poor patient recruitment (23%) 
from primary care and 35% of patients amongst those registered to attend the programme did 
not attend any sessions of the programme (0 out of 7 sessions). Subsequently, the low 
participation rate prevented a further evaluation of the programme in a larger RCT as patient 
numbers would have to increase drastically to see the programme effect. 
 
Meanwhile, the evidence of benefit from studies of PR programmes is well established and 
has been widely reported.40 PR improves exercise capacity, improves breathlessness, quality 
of life and reduces health care use.40 Recent health policy guidelines, experts and a review77 
on effectiveness of rehabilitation strategies to counteract consequences of patients suffering 
acute exacerbations in the field of COPD management, have suggested that the incorporation 
of SM within PR would be advantageous for patients as, SM skills could help with 
exacerbation management while, PR could help to prevent new exacerbations from occurring. 
However, considerable published reports exist around the problem of poor patient 
participation and high attrition in studies of PR programmes (discussed further in the next 
section). 
 
Regarding effectiveness of disease management in COPD, a review by Adams102 with 32 
studies saw significant reduction in healthcare use (admissions and unscheduled visits) by 
COPD patients specifically, in trials that implemented interventions with two or more 
components of the chronic care model. On the whole, the review, because of lack of 
published evidence on chronic care interventions in COPD management, concluded that more 
rigorous conducted trials with multi-component chronic care interventions were needed. 
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The evidence from individual studies of disease management in COPD has been positive103 
and recently more negative.104,105 A study of disease management by Rice103 showed that 
education, an action plan and monthly phone calls by a case manager to patients who had 
recently suffered an acute exacerbation, was effective in reducing the number of COPD-
related hospitalisations and unscheduled care. 
Two recent studies104,105 of disease management directed at patients with severe COPD 
presented negative findings; the aim of both studies was to demonstrate a reduction in time to 
hospital admission for acute exacerbations. In Fan’s study105 patients’ received SM 
educational sessions, in a prescriptive and instructional format, based on the Precede-Proceed 
model89 of health programme planning and evaluation with a focus on exacerbation 
management and an action plan from a case manager. This study had to be terminated early 
because of an excess of patient deaths in the intervention group, however, the cause of 
mortality could not be determined. Bucknall’s104 intervention comprised of SM (empowering 
patient mainly through didactic teaching sessions) and case management, with a focus on 
exacerbation management by activation of an action plan through self-regulation - a model of 
disease management; this meant being observant and making judgements based on 
observation and reacting appropriately to achieve a goal.106 The intervention was not 
effective and only 42% of patients who received the intervention were able to respond 
appropriately to signs and symptoms of an exacerbation.  
 
A review107 of SM action plans with limited education (1.5 hours or less) for COPD 
concluded that action plans and limited education were helpful for patients to recognise and 
respond to exacerbations by taking appropriate medication. However, to see improvement in 
quality of life and reduction in health care use, the delivery of action plans and education on 
its own were not enough and should be delivered to patients as part of ongoing SM or a 
disease management programme. 
 
1.1.1.4.5 Patient participation in studies of SM support programmes 
Examination of the evidence on proportions currently reported for patient participation and 
completion in COPD SM programmes showed that the proportions varied in studies and were 
unclear whether the proportion referred to the study or the intervention. 
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Regarding participation and attrition in COPD SM programmes, besides our study85 that 
showed poor patient participation and poor programme non-attendance (35%), in Effing’s 
review,84 an overall participation rate was not reported, data was provided on the total 
number of patients who completed the studies (86%) and only one study in the review 
reported a dropout rate of 30.4%. In addition, patients’ in the included studies were identified 
from a variety of different sources, some studies did not report how patients were identified 
or invited, or the number of patients approached the proportion who were eligible. A study86 
has reported that it is unreasonable to expect more than 85% of COPD patients to complete a 
SM intervention. 
Regarding participation and attrition in PR, studies have reported that about 34% of 
participants attend after being referred to PR;108 uptake figures of 33%-39% have been 
reported from outpatient clinics109 though, it was not clear whether the figures were based on 
patient referrals or patient assessments; between 20% and 40% of eligible patients do not 
complete PR programmes;110 one study111 reported a programme dropout rate of 39% and 
23% in the intervention and control group respectively; one review112 examined what 
prevents people with COPD to attend PR and reported proportions for PR non-attendance 
(8.3% to 49.6% amongst referrals) and non-completion (9.7% to 31.8%) from a mix of both 
qualitative and quantitative studies; and a recent study113 examined attendance and 
completion rates of an integrated PR service in clinical practice and also found low uptake 
(54% from PR assessment) of programme and completion (40% from those referred). 
Due to the varied reports of uptake and retention in studies of PR and limited reports of 
uptake and retention in the case of COPD SM, the study will examine the current evidence in 
a systematic review (Chapter III) to see if a problem of poor patient participation and 
retention in the studies of these programmes does exist before determining ways to address 
the problem. 
Some explanations from both qualitative and quantitative studies have been given for patient 
non-participation and non-completion in PR and COPD SM programmes. 
From the literature, factors that influence non-attendance and non-completion in PR 
programmes included: socio-demographic factors such as, current smokers;25,114,115 stigma;115 
practical or physical barriers such as, transport difficulties including longer travel time to get 
to the programme; organisational factors for instance, length of programme; and clinical 
factors such as, previous hospital admissions or higher MRC dyspnoea scale score. 
Specifically, the reason given for PR non-attendance was health system organisational factors 
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such as, inadequate local service provision, difficult referral process,116 health care 
professionals’ not knowing the benefits of PR.30  
Reasons given for PR non-completion included, socio-demographic factors such as, higher 
age;25 clinical factors such as, being less ill,117 lower quadriceps strength, high smoking pack 
years, depression, high MRC score,118 and lack of physical performance;119 and also 
participants’ personal reasons for instance, personal beliefs such as, lack of perceived benefit, 
lack of motivation and expectations not being met,111 termination of group programme, loss 
of supervision and not being able to achieve goals.120 
Studies have also reported on factors that influence PR adherence and they were: an 
individual’s perceived benefit from programme adherence in relation to their illness 
beliefs;110,120 presence of supervision; development of an exercise routine;120 and group and 
family support.120,121 
 
Only our study of a COPD SM programme explored reasons for patient attendance and 
non-attendance by patients with moderate to severe COPD from the perspectives of patient 
and lay tutors who delivered the programme and the reasons comprised a mix of 
socio-demographic, personal and health factors.122 
Due to the limited evidence on patient reasons for non-participation and non-completion in 
studies of PR and COPD SM programmes, the latter will be explored further from 
perspectives of COPD patient stakeholders (Chapter V) and experts comprising lay and HCPs 
(Chapter VI). 
 
A study has suggested that non-adherence with PR may indicate non-adherence with other 
SM strategies.123 In addition, two recent reviews112,121 concluded that patient demographics 
and/or clinical factors may not be enough to understand the problem of patient participation 
and retention in interventions that promote SM. As a result, Chapter IV of this study will 
synthesise qualitative evidence and apply behavioural/psychological theories (identified in 
Chapter II) to findings of existing primary studies to further understand participation 
behaviour of COPD patients in studies of SM support programmes. 
 
1.1.1.4.6 Current service provision of SM support in COPD 
Even though delivery of PR and SM education/advice for COPD management has been 
reported as a priority,24 studies have reported that patients with COPD have limited access to 
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PR programmes in practice124 which could be due to local PR centres closing down owing to 
poor programme uptake by patients (Dr Anne Kennedy, personal communication 
26May2012) or perhaps because of limited availability of PR. 
Despite the NICE guidance,43 about referral/offer of PR to patients with MRC score ≥ 32 
there are several reports of poor PR referral. A recent study125 attempted to identify 
characteristics of patients who had a first hospital admission (in a North London district 
teaching hospital) with a COPD exacerbation and found that only 17% of patients were 
considered for PR even though, 59% of patients were eligible for referral. A survey93 in 
primary care (Lambeth and Southwark GP practices) on palliative needs of patients with 
advanced COPD detected that more than 50% of patients had not been referred to PR. 
Another survey16 examined differences by ethnicity in COPD prevalence, severity and 
management of COPD in East London and found that only 18.5% of patients (Whites 19.3%, 
south Asians 16.7% and Blacks 12.6%) with COPD were offered PR. 
In the UK, the variability in PR availability has been acknowledged whereby, in some cases 
patients have to be referred to a respiratory specialist unit to attend PR and others might be 
able to access PR from primary care  
http://www.cks.nhs.uk/chronic_obstructive_pulmonary_disease/management/scenario_stable
_copd/assessment/assessment_of_severity/medical_research_council_dyspnoea_scale#-
474714 (accessed 13-1-11). 
The poor service provision of PR also exists in other developed countries. A study124 that 
surveyed PR providers (Canada, Australia and UK) reported that only 1-2% of eligible 
patients were able to access or receive PR programmes and the reasons were attributed to 
patient factors, inadequate referrals from primary care and lack of infrastructure for provision 
of PR. The lack of patient referral and lack of supply of PR programmes82 to eligible patients 
with COPD would be more likely to have worse outcomes30 which is matter of huge clinical 
concern.112  
 
                                                          
2 Medical Research Council (MRC) Dyspnoea Scale: Grade 1- Not troubled by breathlessness except during 
strenuous exercise; Grade 2- Short of breath when hurrying or walking up a slight hill; Grade 3- Walks slower 
than contemporaries on the level because of breathlessness, or has to stop for breath when walking at own pace; 
Grade 4- Stops for breath after walking about 100 m or after a few minutes on the level; and Grade 5- Too 
breathless to leave the house, or breathless when dressing or undressing 
http://www.cks.nhs.uk/chronic_obstructive_pulmonary_disease/management/scenario_stable_copd/assessment/
assessment_of_severity/medical_research_council_dyspnoea_scale (accessed 13-1-13) 
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Regarding provision of SM education/advice for COPD management recommended by policy 
guidelines, the generic SM programme or the EPP was suggested as one mainstay way to 
reduce the burden of LTCs (comprising of 70-80% of population) including COPD for 
patients at low risk63 thus reducing the burden of cost on the health services. Following pilot 
delivery of the EPP and its evaluation, the UK government pledged to treble the investment 
in the EPP and established the Expert Patients Programme Community Interest Company 
(EPP CIC) www.expertpatients.co.uk (accessed 24-1-13) in 2007 to increase delivery of SM 
programmes from 10,000 to 100,000 in England. The EPP CIC delivered several generic or 
disease-specific (asthma, arthritis, diabetes, epilepsy, heart disease, COPD and multiple 
sclerosis) programmes to patients in the community following its commissioning by several 
NHS PCTs/CCGs and/or organisations (e.g. research organisations). The EPP CIC also offers 
online programmes to patients who cannot access programmes in the community as a result 
of their condition (e.g. mobility issues) which can include patients with COPD. Though, there 
is much anecdotal evidence that there is poor patient participation and high dropout in COPD 
SM programmes (COPD SM programme tutor, personal communication 8Jun2011) including 
in ongoing research studies (Co-Creating health respiratory nurse, personal communication 
9Sep2011). 
 
Furthermore, delivery of SM plans (either in written or verbal format) in clinical practice 
within overall management of COPD have been introduced for patients with COPD 
http://www.cks.nhs.uk/chronic_obstructive_pulmonary_disease/management/scenario_stable
_copd/self_management_plan#-472499 (accessed 13-1-11); the plan needs to be personalised 
to help patients recognise early signs of an exacerbation and respond appropriately and 
contact their doctor if no improvement takes place. However, it was difficult to estimate the 
proportion of GP practices that offer SM plans to COPD patients because the NHS QOF do 
not require practices to report the delivery of SM plans to patients. 
The QOF, does, however, (as part of ongoing management) include a COPD indicator that 
records “The percentage of patients with COPD with a record of FEV1 in the previous 15 
months (COPD 10)”, to help GPs identify potential patients who could benefit from PR. 
There are no COPD indicators that require direct recording of percentage of PR referrals from 
practices;126 though, this might change in 2013/2014 as the QOF Advisory Committee 
meeting127 for COPD indicators made recommendations on piloting two new indictors for 
COPD recording, 
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(1) “The percentage of patients with COPD and Medical Research Council (MRC) Dyspnoea 
Scale ≥3 at any time in the preceding 15 months;” 
(2) “With a subsequent record of an offer of referral to a pulmonary rehabilitation 
programme.” 
So, the implementation of SM support in practice for COPD management, despite the 
guidelines recommendations, is poor/ patchy and needs improvement to enable patients with 
COPD to self-manage their condition and gain health benefits. How patients can be better 
supported with SM will be covered in Chapter V and VI. In addition, a novel way to provide 
SM support to COPD patients in a non-group setting which will be described and discussed 
in Chapter VII. 
 
1.1.2 In summary the rationale for this study  
Chronic conditions are health problems that require ongoing management over a period of 
years or decades.128 The increasing prevalence of chronic or LTCs) worldwide is placing 
considerable pressure on governments, health systems and the broader community.53 In the 
United Kingdom (UK), around 80% of general practitioner (GP) consultations take place 
with patients with chronic diseases, and these patients also account for 60% of hospital bed 
days.129 One of the policy goals for managing LTCs in the UK is to reduce GP consultations 
and episodes in hospitals, whilst promoting the health and wellbeing of patients.129 The new 
National Health Service (NHS) mandate,48 calls for supporting and empowering people with 
LTCs to help patients manage their condition to reduce hospital admissions.  
A huge proportion of healthcare costs in the UK are attributed to COPD.24 COPD, is 
preventable130 and the widely acknowledged risk factor for COPD, mostly in high income 
countries, is exposure to tobacco smoke20,130 while, in middle to low income countries, it is 
exposure to air pollution and occupational dust and chemicals.17 Once established, it is a 
progressive and irreversible manageable condition characterised by breathlessness, cough and 
sputum production.15 The progression of COPD, if smoking related, can be slowed down or 
arrested if exposure to cigarette smoke ceases.131 A UK survey in 2006 including 11,000 
COPD patients found that more than 36% were current smokers, compared to 22% of the 
general population http://www.emphysema-copd.co.uk (accessed Dec 2009). COPD leads to 
30,000 deaths, 1.4 million GP consultations, a million hospital bed days, and costs the NHS 
over £800 million, each year.36 
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Patients with COPD suffer from both physical and psychological limitations; and commonly 
have several comorbidities which add complexity to their management. Thus, services and 
treatments need to be integrated and tailored to the needs of each patient.30 
Non-pharmacological treatments complement pharmacological treatments in COPD and 
enhance outcomes.40 The non-pharmacological treatments recommended in the government 
consultation document24 for COPD care included, smoking cessation, oxygen, pulmonary 
rehabilitation (PR), cognitive behavioural therapy, and self-management (SM) advice, SM 
education programmes to support self-care and personalised action plans. 
The focus of this doctoral study is on two non-pharmacological interventions, COPD SM 
programmes and PR deemed necessary for COPD management. As PR includes a SM 
component and enables patient SM,47 these programmes will be referred together as SM 
support interventions/programmes throughout this study. The goal of SM support 
programmes is to bring about behaviour change in patients by increasing their self-efficacy 
skills and knowledge to achieve health and functional outcomes.67 
In the literature,19,112 the problem of poor participation and retention in COPD SM support 
programmes is well documented, more for well evidence-based PR programmes in 
comparison to COPD SM programmes (with some evidence of benefit); however, the 
problem of poor uptake and dropout in both these types of programmes, is widely and well 
acknowledged in practice (personal communication, Camden Primary Care Trust). 
A Cochrane review84 (comprising of 14 studies) of COPD SM education suggested that the 
intervention may reduce hospital admissions but concrete conclusions could not be made 
owing to the heterogeneity among the included studies in study populations, interventions, 
follow up times, and outcome measures. Only one study in the review reported a dropout 
rate: 30.4%, however it was unclear whether the proportion reported was for the study or 
intervention. Moreover, patients were identified from a variety of different sources, some 
studies did not report how patients were identified or invited, or the number of patients 
approached the proportion who were eligible. 
In 2009 we conducted a pilot mixed-methods study85 that evaluated delivery of a COPD-
specific SM programme for patients with moderate to severe COPD. We showed that, on 
what was effectively an intention to treat analysis, the intervention had the potential to 
improve the quality of life of patients in the intervention group and the potential to be a cost-
effective intervention. However, despite the positive findings patient recruitment in the study 
was only 23% of those eligible and invited to take part. About 35% of intervention arm 
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patients who had registered to attend the intervention did not attend any of the seven sessions 
of the programme. Thus, a decision by the pilot study team was made not to conduct a larger 
randomised controlled trial (RCT) until the challenge of patient recruitment was addressed 
and improved (this PhD arose in response to these findings).  
Some studies have explored patients reasons for non-attendance and/or non-completion in 
studies of PR programmes112 but only our pilot study122  explored reasons for high and poor 
attendance in the COPD SM programme from the perspective of both the recipients and the 
lay tutors who had delivered the programme. 
The delivery of PR and SM programmes to eligible COPD patients who are in need, and 
would benefit from SM support, remains a priority for the government, HCPs, charities and 
patients.19,24 Therefore, to ensure good uptake so that the majority of COPD patients receive 
these interventions and not just a particular few, there was need for further research aimed at 
understanding non-participation in SM support programmes for COPD and how participation 
could be improved. 
 
1.1.3 Aims and objectives 
Research aims  
1) To identify existing rates of participation and completion of interventions that support SM 
amongst people with COPD. 
2) To gain a better understanding of the factors relating to the uptake and completion of 
interventions that support SM, amongst patients with chronic disease, particularly COPD. 
3) To refine an existing COPD SM programme and/or adopt a new delivery method or 
deliver a new SM support intervention that will help to increase both intervention uptake 
and programme completion by patients with moderate to severe COPD. 
 
Research objectives comprise of three stages  
Stage 1: To conduct a conceptual review to explore the meaning of patient participation in 
health care and health care interventions and identify behavioural theory that has explained 
patient participation in health care interventions including self-management interventions 
among patients with chronic disease; to conduct a mixed-methods review, the quantitative 
element will quantify existing participation and completion rates in SM support interventions 
and the qualitative element will identify and explain, using behavioural theory, factors that 
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influence participation and completion of SM support interventions among patients with 
COPD. 
Stage 2: To conduct focus groups and interviews with patients with COPD of varied severity 
and with experts who develop and/or deliver SM interventions for COPD patients and who 
are involved in the management of COPD patients to explore: 
a. reasons for poor uptake and completion of  SM support interventions by 
patients with COPD, 
b. what might be done to make COPD SM support interventions more appealing 
and applicable for patients with varying levels of COPD severity, including 
changes to programme content and different modes of delivery,  
c. whether different modes of SM delivery should be considered for patients with 
different degrees of airflow obstruction, and 
d. what might be the most suitable delivery method for patients with moderate to 
severe COPD to increase programme uptake and completion.  
Stage 3: To describe a non-UK developed SM support intervention adapted for the UK.  
53 
 
1.1.4 Structure of the thesis 
The structure of the thesis follows steps suggested by the new MRC guidance for developing 
and evaluating complex interventions.132 The guidance has defined a complex intervention as 
an intervention with several interacting components (complexity could be the result of 
interacting components within the intervention, range and variable outcomes to be measured, 
delivery of intervention by range of people at various levels to different types of population, 
and/or flexibility available to tailor the intervention).  Behaviour change interventions (e.g. to 
exercise, adhere to medications, attend a screening programme) are complex interventions 
which include several components.133 One such behaviour change intervention is a self-
management intervention (which for example, promotes exercise, healthy eating, medication 
adherence, conducting breathing techniques and smoking cessation).  
This thesis includes three stages, described, discussed and presented in eight chapters 
including this chapter.  The findings of each stage informed the development of the next stage 
which made the steps within each stage logical and feasible to carry out.  
 
This Chapter I begins with the rationale for conducting the study and outlines the study’s 
aims and objectives; the background sections describes COPD, its non-pharmacological 
management particularly SM support interventions; and introduces the problem of poor 
participation and retention reported for COPD SM support programmes in the literature. 
 
Following the MRC guidance on developing a complex intervention: 
Stage 1 of the study comprises of Chapter II, III and IV which examines the existing 
evidence base on patient participation and completion in SM support programmes and utilises 
appropriate theory to explain patient participation and completion in SM support 
programmes for COPD. 
Specifically, Chapter II presents a conceptual review. The review, from relevant literature 
helped uncover the origins, concepts and definitions of patient participation and 
non-participation in health care and health care interventions; Theoretical concepts and 
models, particularly behavioural models, were explored to explain an individual’s reasoning 
behind health service use and participation and non-participation in health care interventions 
particularly SM interventions. 
Next, a mixed methods review is covered in Chapter III and Chapter IV. The quantitative 
element of the systematic review in Chapter III identifies existing participation and dropout 
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rates in studies of COPD SM support programmes and Chapter IV presents the qualitative 
synthesis that explored patient given reasons for participation and dropout in studies of 
COPD SM support programmes. 
 
Stage 2 of the study comprises a primary qualitative study presented in Chapter V and VI 
where a theoretical understanding was further developed on the problem of poor patient 
participation and retention in COPD SM support programmes and how change (improvement 
in patient participation and retention) can be further achieved. 
Particularly, patient reasons for non-participation and completion in SM support programmes, 
how participation may be improved and how patients with COPD, who cannot or do not want 
to participate or attend SM support programmes, can be better supported with their SM was 
explored from patient stakeholders in Chapter V and from lay and health care professionals in 
Chapter VI. 
 
Stage 3 includes Chapter VII that describes a non-UK developed SM support intervention, 
new to the UK, to be delivered in a clinical setting. 
 
Then, Chapter VIII presents the summary findings of chapter II, III, IV, V, and VI, 
discusses findings of the study and its implications for future research and clinical practice 
and presents overall conclusions. 
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Next, Chapter II describes the origin of patient participation in health care and in health 
policy guidelines; reviews the various meanings given to the term ‘patient participation’ in 
health care and explains the relationship between patient participation and self-care/self-
management; and identifies literature that has used theory to explain patient participation in 
health care, health care interventions including SM interventions among patients with chronic 
disease including COPD.  
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Chapter II. Meanings of patient participation in health care 
and factors that influence participation in health care 
including self-management interventions - a conceptual 
review 
Chapter II describes a conceptual review. The results of the review explore: 
 the various meanings ascribed to patient participation in health care  
 the relationship between participation and self-care/self-management 
 a description of health behaviour models that have been utilised to explain health care 
seeking behaviour and participation in health care interventions particularly, 
self-management interventions among patients with chronic disease 
 Theoretical factors that explained health care seeking behaviour and participation in 
health care interventions with particular reference to SM interventions among patients 
with chronic disease 
Following this the chapter presents a discussion and conclusion. 
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2.1 Background 
Before examining and attempting to understand the problem of poor participation from 
published studies of group-based SM and PR programmes for COPD patients (Chapters III 
and IV) it is important to understand the meaning of patient participation in health care, 
whether participating in health care is similar to participating in a SM intervention for a 
patient with chronic disease and what factors influence patient participation in health care and 
health care interventions.  
 
Patient participation is receiving increasing attention in health care134,135 and in healthcare 
activities136 such as decision-making, self-medication, self-monitoring, patient education, 
goal setting or taking part in physical care,137,138 which suggest that the concept of ‘patient 
participation’ could have different functions and meanings to simply ‘taking part’. 
In addition, patient participation is being considered at every level of the NHS, in varying 
health care contexts, from making choices about the care patients receive, to making a 
contribution towards policy-making, to making decisions in clinical consultations, to making 
decisions about their health outside the clinical setting.139 This could lead to varied 
definitions or interpretations of the concept of ‘patient participation’, amongst both patients 
and professionals.138 Very few studies have previously reviewed the concept of ‘patient 
participation’ in health care - and those that have addressed the concept have been mainly 
limited to nursing practice.135,138  
 
It is important to understand the reasoning behind an individual’s decision to seek health care 
and participate in health care interventions. Theories help to provide conceptual 
understandings of things that are complex and cannot be pinned down e.g. why people 
interact in certain ways.140 There is a vast amount of literature141-144 that has examined, using 
social, psychosocial or health behaviour theories, health care seeking behaviour of healthy 
individuals or their participation behaviour in health promotion programmes e.g. screening. 
However, in comparison to healthy individuals, the factors that might influence patients with 
chronic disease to seek health care and/or participate in health care interventions, such as 
self-management (SM) interventions, have received little attention. Thus, the focus of this 
review was to examine studies that have utilised theory to understand health care seeking 
behaviour and participation behaviour in SM interventions amongst patients with chronic 
disease.  
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The aim of this review was to uncover the origins, concepts and definitions of patient 
participation and non-participation in health care. Theoretical concepts and models, 
particularly social, psychological or behavioural models, were explored to explain the 
reasoning behind health service use and participation or non-participation in health care 
interventions particularly SM interventions amongst patients with chronic disease.  
The review questions were: 
1) What do we mean by ‘patient participation’ and ‘patient non-participation’ in health care?  
2) Can theory help to explain the factors that influence an individual with chronic disease to 
seek health care and participate in SM interventions?   
 
In addition, the assessors at the nine month PhD review also asked me to critically analyse 
the relevant policy literature in this chapter specifically, to explore who and why it was 
decided that it is important for patients with chronic disease/COPD to participate in SM and 
SM support programmes in policy. As a result, policy literature/guidelines that explained 
patient participation in health care with a focus on chronic disease self-management was 
explored including key references denoted by the policy guidelines which in turn led to going 
back further to examine the origins of patient participation in health care. Before moving to 
the methods, this section describes the origin of patient participation in health care and origin 
of patient participation in health policy guidelines.  
 
2.1.1 Origins of patient participation in health care  
Since the 15th century, the medical model of disease and management focused on causes and 
symptoms and often treatment of the disease.81 In the UK, in the early 19th century, while the 
wealthy utilised the health services, many other people were responsible for their own health 
because of necessity and relied on the limited resources of their community and is reflected in 
the saying “None practice physic nor professeth midwifery but charitably one neighbour 
helpth another”.145 This practice, was referred to as part of a ‘dual system’ of health care 
which was followed from ancient Greece, where care was provided both by professionals and 
by ordinary citizens using home remedies and folk medicine.146 In the latter part of the 19th 
century the medical profession grew in power, the health services were more comprehensive 
and some freely available.81 Around the same time and continuing in the early 20th century 
the ‘public health movement’ resulted in the reduction of communicable disease because of 
improvements in housing, nutrition, education and social changes.145 This occurred through 
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the participation of people with wealth or status or in a position of academic standing. The 
wider public were not heavily involved in this movement but they were the beneficiaries of 
reduced hours of work, clean water supply, efficient waste disposal and many other 
reforms.145 Because of these environmental reforms and improvements the pattern of disease 
changed81 whereby, recovery from acute illnesses was replaced by the emergence of chronic 
conditions e.g. heart disease.81,145 As a result, sociologists stated that the medical profession 
was transforming health problems into technical issues, non-life threatening conditions were 
being treated, and thus, people’s autonomy to manage their own health problems was being 
undermined, or they were being prevented from leading independent lives.81 This change in 
the nature of health and illness, the shift from acute to chronic illness was one of the first 
contributing factors towards the rise of patient participation in health care.145  
The limitations of modern medicine were another contributing factor in the rise of patient 
participation in health care. Self-help groups were originated by people who had lost trust in 
the medical profession145 e.g. following the catastrophe of thalidomide where thousands of 
babies were born with malformed limbs because of side-effects from a new drug prescribed 
to pregnant mothers.147 During the 20th century people became more knowledgeable about 
health, the wider influences on health were acknowledged, people were aware of available 
services, various forms of self-help were available, people became aware of disparities in 
clinical practice and their rights. This was a result of information being available outside of 
the formal health services (e.g. voluntary groups, books, leaflets, help-lines, internet)81 and 
negative health stories in the media.148  
Various mass movements in the United States during the 20th century led to change in 
society,81 which encouraged people to participate in health care.145 ‘The human rights 
movement’ placed emphasis on the participation of lay individuals in health policy, 
self-determination and a reduction in the influence of professionals and technology.149 There 
was a general trend towards encouraging people to accept more responsibility for their own 
health81 and well-being, instead of relying on health services and also, for lay people to have 
a voice in policy making.145 However, because there were consumers who still asked for 
prescriptions for minor complaints and the doctors who were willing to provide the 
prescriptions, it was argued that patients should at least be fully involved in the decision-
making process.145 The ‘consumer movement’ of the 1960s established the consumers’ right 
to safety, the right to be informed, the right to choose and the right to be heard.137 
Consumerism included mass movements around national issues such as the ‘civil rights 
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movement’, ‘the women’s movement’, and the ‘welfare rights movement’. These movements 
challenged basic assumptions about the way the country was governed and demanded 
changes in national policies. As a result of certain events that took place nationally and 
internationally people felt they needed to act for themselves rather than asking the state to act 
on their behalf. In a health care context, consumerism had its impact both at the group and to 
a lesser extent, at the individual level.145 At a group level, for instance in occupational health 
and safety field, the community increased their skills and informed themselves of the health 
hazards that could affect their work or home or the general community. Communities no 
longer just had to accept whatever was handed down to them or done for them. The public 
had, ‘the right to know, right to a safe workplace and the right to withdraw labour’.147 
However, consumerism was seen less at an individual level145 which suggests this was 
because individuals feared confrontation or dismissal of their views, or that they might not 
get treated by their health professionals in an emergency. This perhaps arose from the 
historically accepted assumption that illness could be only diagnosed and treated by health 
professionals. Patients were regarded as passive recipients of care135 i.e. “to seek competent 
help and cooperate with the physician in order to get well”.81 A modern view of the patient 
role defined the patient as an active consumer.135 It was believed that the relationship 
between patient and health care professional (HCP) should involve mutual participation, a 
model where both patient and professional have equal power, need each other and engage in 
activity that would be satisfactory to both parties.81 
Consumerism into the NHS135 led consumers to become more actively involved in the 
provision of health care.145 Although the aims of the NHS policy were  
(1) to accommodate the demands for national policies designed to share out scarce resources 
in a fair and rational way,  
(2) participation in decision-making by those (professionals) actually working in the 
organisation and  
(3) being responsive to the views of the users about services offered at point of delivery. 
McEwen145 argued that these policies were conflicted because implementation of national 
policies required centralised control and effective participation by either staff, or consumers, 
required flexibility, local democracy and diffusion of control. So, within the system there was 
both the facility of the centralised power to create policy and the facility of the staff and 
recipients to reject it.  
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Within healthcare, the role of community participation was considered important in health 
matters where different interested parties had different opinions.147 This form of participation 
was a way for people who had less or no scientific knowledge on a health matter to be 
involved in decision-making. The role for community participation in health was 
strengthened by the Alma Ata declaration ‘Health for All’ (considered important by all 
governments).147 The declaration was made to protect and promote the health of all people 
around the world because of the gross inequality in health amongst people seen both between, 
and within, countries. Among the 10 declarations made, one declaration was that, “The 
people have the right and duty to participate individually and collectively in the planning and 
implementation of their health care”.150 Another was, “Primary health care is essential 
health care based on practical, scientifically sound and socially acceptable methods and 
technology made universally accessible to individuals and families in the community through 
their full participation and at a cost that the community and country can afford to maintain at 
every stage of their development in the spirit of self-reliance and self-determination. It forms 
an integral part both of the country's health system, of which it is the central function and 
main focus, and of the overall social and economic development of the community. It is the 
first level of contact of individuals, the family and community with the national health system 
bringing health care as close as possible to where people live and work, and constitutes the 
first element of a continuing health care” 150 
During the 1980s, primary health care was considered broader than simply medical care. 
Provision of services were to be based on need, were to be culturally acceptable and included 
health promotion, housing and education and involving the community in the primary care 
process (nhshistory.net accessed 28-3-13). Changes in life style were needed, particularly in 
smoking, diet, exercise, alcohol consumption, sexual activity and behaviour on the roads. The 
adoption of the Alma Ata declarations was not immediately recognised in Europe, including 
in the UK (nhshistory.net accessed 28-3-13); people with the greatest need were not always 
prioritised and patient participation was rare. One explanation given was because the 
declarations posed a threat to the values and beliefs of professionals and professionals 
disregarded active participation as too irrelevant, too political or difficult135 (nhshistory.net, 
accessed 28-3-13). Section 2.3.1 and 2.3.2 presents some perspectives of patients and 
professionals regarding patient participation in health care.  
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Due to the abovementioned reasons, patient and public participation in health care involved, 
the public taking control of their lives and becoming less reliant on health/professional 
services and technology. The public became aware of their rights and wanted to be involved 
in decision-making with clinicians. The role of being a passive recipient of care was shifted 
to an active consumer in their care.  
This shift of taking responsibility for one’s own care or participation in care was particularly 
emphasised or was considered important for people living with a chronic illness.135 While, 
patient passivity during an acute illness was considered normal135 participation in care by a 
patient with a chronic condition was recognised as a reality or was considered necessary and 
not seen as a choice;81 It was acknowledged that treatment of patients with chronic disease 
may need a long-standing regime of SM and participation in self-help such as rehabilitation 
procedures were considered appropriate for this group of patients to lead a suitable 
lifestyle.145 In addition to proposing SM as a way of giving patients control over their 
condition, a different concern, increasing health care costs was the reason for encouraging 
self-care including self-management among chronic disease patients.151,152 These two drivers 
led to the emergence of the self-care/SM initiatives in government policy documents for 
patients living with a long term condition (LTC) (see section 2.1.2).  
 
The focus on SM for patients with chronic disease originated within the context of another 
mass movement of the 1960s and 1970s called the ‘self-care movement’.152,153 Two 
studies146,154 have explained the shift of ‘self-care’ from sitting within the field of social work 
and outside of policy and medicine in the 1970s, to becoming a key component of chronic 
disease management in policy and in the medicine field whereby the concept of patient 
‘self-care’ and ‘activated patient’ became intertwined.146  
Historically, the trend of self-care, along with other mass movements, was also a result of 
social, economic and technological changes, changed illness patterns and also because of the 
increased workload faced by primary care which was being inappropriately utilised (e.g. most 
visits to doctor were for minor complaints).146 The self-care movement sat outside, and was 
not given importance to the field of medicine and policy and promoted individual 
self-reliance and not worrying about what professionals cannot do.146 In DeFriese’s study,154 
‘self-care’ was referred to as “actions taken by laypersons in their own health interest 
without formal medical supervision.” or “the practices of individuals and families through 
which the forms or symptoms of illness are detected and treated, other diseases are prevented 
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and positive health behaviour is generally promoted.” The latter terminology is similar to the 
self-care definition presented in Chapter I (section 1.1.1.4.2.1). In the 1970s, the HCPs who 
were not involved in, or privy to, the role of ‘self-care’ saw self-care as making laypersons as 
independent as possible of conventional medical care. They believed several training 
programmes were designed to train laypersons in the performance of tasks normally 
considered to be those of the medical or allied health care professions and they felt the 
message of these programmes appeared counter-medical. However, the rising health care 
costs and recognition of limitations of modern medicine led professionals to change their 
view and they started to believe that people’s health status would improve from making 
lifestyle changes involving changing or adopting health behaviours. Thus, educational efforts 
to bring about lifestyle changes became important.154 There was also an emphasis on 
partnerships and communications between patients and professionals but at the same time 
there was emphasis on increasing the relative degree of control amongst consumers and 
patients in matters related to health – but mainly in the case of minor ailments; they saw 
‘self-care’ as care ‘until the doctor comes’.154 While, some professionals were fearful of the 
concept of ‘self-care’ it was some professionals themselves who soon developed self-care 
educational programmes.154 During the 1980s self-care became absorbed into the US health 
care system and self-care programmes delivered were classified as health service delivery 
organisations. The self-care concept was denoted as medical self-help/self-care in clinical 
medicine, nursing and allied health literature, with a focus mainly on disease management 
and maintenance of functional status.154 
Defriese154 in their study, when talking about self-care programmes, was referring to one 
self-care programme namely, ‘The Course of Activated Patients’.146 The programme 
originated in Herndon, Virginia in 1970 and was delivered to people with the skills to enable 
them to take a more ‘active’ role in their own health and that of their families.146 According 
to Senhert,146 the course differed from traditional health education lectures as it 
complemented health promotion activities, taught self-care/self-help methods and emphasised 
greater energy, independence, and increased fitness. The course was complementary to 
professional care but also advocated that professional care might not be necessary. 
‘The course facilitators helped people to look at health not as an absence of disease but as a 
way to achieve the energy needed to set and then meet life goals. The end result of the course 
was termed ‘health activation’. This involved the use of positive health habits and 
self-regulation to achieve greater harmony between the body and its external and internal 
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environments.’ The course was adopted by HCPs for their communities in several American 
states because of its benefits e.g. improved patient-provider relationship. Senhert146 believed 
the course would be utilised in the future by health maintenance organisations, fee-for-service 
groups and by private industries where methods were being examined to reduce increasing 
health care costs. 
During the 1990s, in the UK, attempts to reduce the burden of health care costs on health 
services associated with the increasing prevalence of chronic disease led to policy initiatives 
such as the promotion of self-care, and the adoption and delivery of SM programmes, a 
component of self-care, aimed at patients with LTCs so patients would become responsible, 
participate or take an active role towards their health. This is discussed in the next section.  
 
2.1.2 Origins of patient participation in UK health policy  
This section describes the origin of patient participation in health care, the type of patient and 
public involvement in health care within UK health care policies, including involvement by 
patients with chronic disease in the form of self-care and/or SM. Box 2.1 briefly describes 
development of policy. 
 
Box 2.1 Brief description of policy development 
 
 
 
 
 
 
 
 
 
 
 
 
 
In line with McEwen’s145 views, the aims of the NHS policy during the 1970s and 1980s 
included being responsive to the opinions of service users about services at point of delivery. 
According to Liddiard and Ritvo2 policy development is dependent upon organisational interests, 
financial constraints, professional domains, client needs, government structures and national ideologies.  
The different perspectives for policy development include: 
1) Development in response to commonly recognised problems e.g. community mental health services  
2) Development with population needs in mind resulting in the development and delivery of 
programmes to meet those needs e.g. mobile food programmes 
3) Via geographic analysis – what are the needs of a specific state, local authority etc e.g. water 
conservation efforts 
 
Other views include:  
1) Policies develop as a result of collective sense of the most efficient and effective path to goal 
achievement. In this model it is assumed that decision-makers know most relevant facts, understand and 
subscribe to social values, and select the most appropriate policies to implement these aspirations  
2) Policy is an outcome of an elite group action. Decisions reflect those who are in, or possess, power 
3) Extending (number 2 view) another model appears – which is developing policy by compromise. 
Here policy includes a strategy to balance diverse views. Compromise is a form of decision-making that 
allows policies to develop almost without attention to related events. The authors suggested that the 
third view might lead governments to consider health promotion and disease prevention efforts here and 
reported that self-care fell within the second and the third view.  
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Government policy documents show that prior to the 1990s the role or extent of patient and 
public involvement was limited to encouraging individuals to give their views on services to 
improve the care and delivery of health services within the NHS.  
For instance: In 1974, the UK government, following re-organisation of the NHS (established 
in 1948), had set up Community Health Councils to protect the rights of patients and public 
and gave importance to their views to improve health care in the NHS 
http://www.achcew.org/index.html (accessed 28-3-13). The Councils tried to support 
individual patients and complainants; monitored local hospital and community (but not 
primary care) services; and provided a citizen’s perspective on service changes.139  
 
In 1989, patient choice in service delivery was central in the Working for Patients 
document.155 This document was a result of reforms in the NHS (to manage the growth in 
health care costs from the mid-1970s and to make the NHS more efficient) where in addition 
to being responsive to the needs of users, another change suggested was creation of a market 
whereby health authorities would identify patients’ needs and contract for services; services 
would be provided by hospital and community units and these services would compete to 
obtain contracts to provide the services (nhshitory.net accessed 28-3-13). However, Geoffrey 
Rivett (nhs.history.net accessed 28-3-13) commented that this model was more suited to 
elective surgery but less appropriate for elderly people and for psychiatric services as the 
needs of the elderly or those needing psychiatric support were different and these needs could 
not be fulfilled by hospitals or community units. During this period, self-care was not 
included in policy when the health of individuals was on the policy agenda. Liddiard and 
Ritvo’s2 argument to introduce ‘self-care’ within health policy was centred on the elderly for 
whom the medical model was no longer appropriate. They believed self-care included 
environmental, cultural, biological, social and economic factors and introducing and 
supporting the elderly to self-care would prevent their exclusion from society.  
 
The tragedy at the Bristol Royal Infirmary, where about one-third more than expected infants 
had died after open-heart surgery between1984-1995 in a paediatric cardiac unit led to the 
Bristol enquiry report in 1998 which laid out several recommendations for improvements in 
the care of patients. http://www.bristol-inquiry.org.uk/final_report/report/sec1_chap_4_8.htm 
(accessed 21-8-12). One recommendation was that a new NHS culture should emerge which 
should include patient involvement, wherever possible, in decisions about their treatment and 
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care; another was that public involvement in the NHS must be embedded in the structures 
such that their views must be heard and taken into account wherever decisions regarding the 
provision of healthcare were made. 
During the late 1990s, in addition to being responsive to the needs of the consumers, the 
focus of the UK government was on building partnerships between the Government, local 
organisations and individuals. The strategy was to increase involvement of: patients in 
decisions about their own care; users in the NHS and development of health services; the 
public in the NHS and their health generally;156 and to reduce inequalities in health (by 
reducing 300,000 deaths from accidents and in four conditions namely, heart disease, stroke, 
cancer and mental health) 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Pub
lications/PublicationsPolicyAndGuidance/DH_4007059 (accessed 21-8-12) and.156 
One action to reduce inequalities in health suggested in The White Paper: ‘Saving Lives: Our 
Healthier Nation’ published with ‘Reducing Health Inequalities: an Action Report’156 was 
the ‘Health Citizens’ programme. This programme initiated a shift in responsibility where 
people were encouraged to develop key skills e.g. first aid skills, links to NHS Direct (a 
health advice and information service) were made perhaps for people to perform self-care. 
An element within this programme was the ‘Expert Patients Programme’ (EPP) aimed at 
patients living with LTCs. The EPP or the SM programme was about promoting patients to 
take responsibility for their health and to help them take control over the management of their 
condition.156 The EPP initiative was conceived as part of a government commitment to place 
patients ‘at the heart of healthcare’. The initiative had the potential to meet three elements of 
chronic disease management:  
1) involvement of patients in their own care 
2) minimising unnecessary visits and admissions to health care providers/facilities 
3) providing care in the least intensive care setting 
This EPP policy initiative was further justified in “The Expert Patient: A new approach to 
chronic disease management in the 21st century”.153 The report first stressed that the 
patient-centred NHS must recognise the increasing burden of chronic disease (such as cancer, 
heart disease, stroke, arthritis, mental illness, diabetes mellitus and asthma), seen from second 
half of the 20th century and beginning of the 21st century, because people are living longer 
into their seventies, eighties and beyond and so, “When acute disease was the primary cause 
of illness, patients were generally inexperienced and passive recipients of medical care. Now 
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that chronic disease has become the principal medical problem, the patient must become a 
co-partner in the process.” Secondly, health and social services had failed to recognise that 
patients already played a role in self-managing their condition. Patients were ineffectively 
managed; some common experiences of patients included: lack of involvement in decisions; 
no-one to talk to about anxieties and concerns; tests and/or treatments not clearly explained; 
insufficient information for family/friends; and insufficient information about recovery. 
Thirdly, the report quoted views of HCPs about their chronic disease patients, “…my patient 
understands her disease better than I do. They are, in fact, “experts” in their own right for 
they have acquired the life skills to cope with a chronic condition and have the potential to be 
confident partners with professionals in their care.” Hence, the EPP was seen as a systematic 
approach whereby patients could be supported to manage their LTC. Furthermore, the policy 
stated that the concept of SM was used in the 1960s and 1970s in the context of the ‘self care 
movement’, described above, when the concept ‘self-care’ was outside of the medical 
profession and health policy but now both concepts are ingrained in heath policy and should 
be integrated in health services.  
 
Rogers,157 from a sociological perspective, has explained that the SM/EPP mentioned in UK 
health policy is actually different to the ‘self-care’ within the self-care movement and which 
they referred to as the ‘social movement’. Rogers mentioned that during the social movement 
in the 1980s and 90s, the health voluntary bodies in England had some influence over health 
policy and these bodies had started to align themselves with the views of the social 
movements. Particularly, some support groups for chronic conditions, such as Arthritis Care, 
were running SM programmes – and a new role was found for lay people in the changing 
policy climate. However, Rogers pointed out that the policy vision for chronic disease 
management had gone farther than the need for chronic disease patients to adopt desirable 
behaviours to manage their condition or take responsibility for their health, to a type of 
patient that needs to be fashioned – the ‘empowered’ or ‘expert’ self-caring individual. They 
claimed that the policies that focused on what patients should do to maintain their health for 
LTC management, instead became what sort of person the patient should become - there was 
an expectation that an ideal self-managing individual would include being ‘activated’, 
‘empowered’ ‘ co-producer’, ‘expert’ or ‘autonomous’ and this was different than the older 
self-care/self-help traditions. Rogers further continued that another reason for the adoption of 
SM in policy was because the ‘Wanless report’158 had presented three scenarios, ‘Solid 
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Progress’, ‘Slow Uptake’, ‘Fully Engaged’, regarding future resource requirements to 
preserve high quality services in the NHS and the ‘Fully Engaged’ scenario was the least 
expensive option modelled and it appeared to present better health outcomes.  
The chronic disease self-management programme (CDSMP), on which the EPP was based, 
was a result of Kate Lorig’s work in Stanford, California in the field of arthritis (Arthritis 
Self-Management Programme, ASMP) for 20 years.153 The CDSMP was utilised by several 
voluntary patient bodies to design a version of the SM programme applicable for various 
conditions. In England e.g. the ‘Challenging Arthritis’ course was developed. The ‘Expert 
Patient’ report52,153 based on Barlow’s review (the report referred to an unpublished review – 
I was unable to locate) on effectiveness of SM programmes amongst chronic conditions, 
concluded that the programmes were beneficial, patients experienced reduced severity of 
symptoms, pain, improved life control and activity and improved resourcefulness and 
satisfaction. However, Barlow’s published review52 (not referred to in the report) recognised 
the heterogeneity amongst the included studies in the review and reported that SM 
approaches were effective in increasing patient knowledge, symptom management, use of 
SM behaviours, self-efficacy and improvement in mood, particularly depression, in 
comparison to standard care i.e. no SM intervention. But these improvements were not seen 
in all conditions, e.g. all studies did not assess psychological well-being and all programmes 
did not show improvement in all outcomes. Despite these results Barlow’s Arthritis SM 
programme (1998) was utilised to develop the generic EPP. The EPP was developed by the 
Expert Patient Task Force which comprised both professional and lay members. The report 
recommended the pilot delivery and evaluation of the EPP between 2001 and 2004 and the 
wider delivery and its integration within health services between 2004 and 2007.  
 
Perhaps the limited evidence of effectiveness in most chronic conditions, despite being rolled 
out by the Government, led to the criticism of the expert patient policy and the EPP by 
several authors.73,159 64 One critique was that the EPP had taken a narrow view by focusing on 
changing the behaviour of individuals with chronic disease using one psychological theory, 
the self-efficacy theory59 i.e. through increasing confidence of patients, and has ignored or 
failed to recognise that self-efficacy is also dependent upon the social and historical context 
of the individual.73,159 Wilson159 stressed that an individual’s past life experiences and 
positive perceptions of these experiences play a major part in self-efficacy, while Lindsay and 
Vrijhoef73 reported that an individual’s perceptions of their world and the function of illness 
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in that world can shed light on health-related behaviours. In addition, Wilson159 reported that 
the terms ‘expert’ or ‘active’ and ‘patient’ are a contradiction; the expert patient cannot be 
seen in the same light as professionals because the knowledge and understanding that an 
expert patient has is from their experience of the illness and not education.  
 
The Government in 2004 gathered evidence on benefits from patient and public involvement 
in health decision-making in the ‘Health in Partnership’ report160 and reported that patient 
and public involvement is necessary to improve patient experience of the health service. The 
report was the result of patients’ and professionals’ perspectives on 12 funded projects with a 
condition that patients and public had to be involved in the design and execution of projects. 
Out of the 12 projects: 
o six projects focussed on patient and carer involvement in decisions about their 
own treatment and care e.g. a qualitative study exploring patient participation 
in decision-making 
o four addressed public involvement in service planning and delivery e.g. a 
survey examining decisions about service development from young people 
with chronic illness or physical disability 
o two were principally concerned with education and training issues e.g. shared 
decision-making and risk communication in general practice by delivering 
training programme and evaluating clinical consultations  
 
Shared decision-making in the report was defined as, “The process of involving patients in 
clinical decisions. The ethos is one where professionals (should) work to define problems 
with sufficient clarity and openness so that patients can comprehend the uncertainties that 
surround most decisions in medicine and therefore appreciate that choices have to be made 
between competing options.” 
 
The findings from the projects were divided into perspectives of patient involvement and 
public involvement.  
 
a) The value of patient involvement from patients’ perspectives of decisions about their care 
was: being treated as equal partners, being listened to, and being informed, however, for the 
latter to take place in a clinical consultation there was need for privacy and time. The report 
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mentioned that not many patients had experienced shared decision-making but patients had 
different expectations of what level of responsibility they wanted to accept. Patients looked 
for information and guidance from HCPs, the sharing of information or communication and 
how it was received could affect how much patients would share during a consultation.  
The report highlighted that one source of information outside of the consultation setting for a 
patient was the EPP, but also reported about the programme in a negative tone, particularly, 
‘the EPP exploited and acknowledged that patients might know more about their condition 
more so than their HCPs’. The report argued that patients do not have knowledge about their 
health and health care options and this limits their judgement on decisions made about their 
health.  
Furthermore, the results of the report suggested that shared decision-making was further 
hampered because of lack of training and skills among both professionals and patients. A 
patient’s level of participation in shared decision-making would vary according to their 
situation and context e.g. women may be more likely to involve themselves in decision-
making about family planning than about ear nose and throat cancers; and patients may find it 
difficult to get involved in decision-making if they have not done it before. Thus, a solution 
offered in the report was that shared decision-making should be promoted through 
professional training and patient empowerment.  
 
b) The value of patient involvement from the professionals’ perspective was: 
The attitude towards patient involvement was generally positive amongst HCPs but in some 
cases patient involvement was constrained due to wider professional values and expectations, 
for instance patient involvement in decision-making was sometimes not allowed when nurses 
wanted to protect patients from negative experiences; GPs (not in all cases) would rather not 
allow shared decision-making if there was only one good option, or if it was something to do 
with technical details or practical issues, or if patients were not willing to compromise.  
HCPs were aware of the importance of good communication but they did not think it would 
work in practice such as with patients with communication difficulties, or when there was 
lack of time. HCPs’ shared decision-making was dependent upon the context, e.g. they would 
consider shared decision-making more with patients with chronic disease and less with life 
and death situations. As a result, one conclusion in the report was that patient involvement 
cannot be constant or smooth.  
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The outcomes of patient involvement were different for patients, reduction of anxiety and 
fear, greater control, new knowledge, reinforcement of knowledge, in comparison with 
professionals, improved patient compliance, change in health related behaviour leading to 
better health outcomes. As a result the report concluded that shared decision-making does not 
necessarily lead to more shared decisions.  
 
c) The value of public involvement from the perspectives of the public was: 
Although public awareness of what public involvement means was low, people had some 
view of how and whether members of the public should be involved in NHS 
decision-making. The motivation for public participation was driven by altruism, personal 
and family experiences and the desire to improve services. The findings suggested that people 
who pay tax should have a say in how the NHS works. People were concerned that a counter 
balance should exist in public participation, keeping people’s interests balanced against those 
of political parties. This was important because people could be asked to give their views for 
service development and delivery but might not be included in making decisions about 
services. Several people preferred to be kept informed about the NHS national and local plans 
because the NHS should be accountable to its citizens. Whereas some people felt the public 
should not be involved in the NHS because diverse views or opinions would complicate 
matters, make it bureaucratic and costly.  
 
d) The value of public involvement from institutional perspectives:  
The members of voluntary organisations saw their involvement as being to: represent 
people’s views; represent their organisation; fulfil their organisational aims; get resources for 
these aims; and develop relationships and services within the NHS. On the other hand, some 
primary care trust members did not see the value of public involvement and believed that 
those who volunteer might not be true representatives and might be getting involved to 
address their own self-interested agenda. This view was also expressed by some clinicians.  
 
The outcomes of public involvement were that it increases confidence, understanding and 
skills of the people who participate; influences policies, plans and services of primary care 
organisations; and partnerships will enable learning, resources and expertise to be shared 
across health economies. 
72 
 
The background section presented a historical account of the origin of patient participation in 
health care and in health policy guidelines mostly in relation to chronic disease management. 
Next, the conceptual review helps to answer the review questions. 
 
2.2 Methods 
2.2.1 Conceptual review 
A conceptual review was conducted to address the review/research questions. Conceptual 
review (CR) is a methodology or a review of a methodological nature to understand concepts 
which may be contested because they have multiple meanings.161 This type of review is also 
carried out to help in the interpretation of results of the systematic review of both quantitative 
and qualitative studies.162 This CR was conducted in parallel to the systematic review 
(Chapter III and IV). 
Three published articles were used as a guide to inform the process of CR, recognising its 
limitations and how they might be addressed.161-163 Unlike a conventional systematic review 
which needs to be conducted in a very systematic and consistent approach i.e. explicit and 
transparent searching strategies, specific inclusion and exclusion criteria and quality 
assessment, a less structured approach was taken to conduct this review.162 The process 
included identifying key papers, using different databases and sources that were relevant to 
the study. The relevance of the literature was decided mainly by discussion with the study 
supervisors. Due to the diverse nature of the work, the necessity of an exhaustive search of 
the literature to identify all definitions and concepts on the topic under study has been 
questioned.161 The cyclical process of searching, analysis and writing was continued (with 
input from the study supervisors) until an understanding about the research topic was 
developed which then helped to answer the review questions. 
 
2.2.2 Literature search 
The literature was identified from three sources: relevant texts after discussion with study 
supervisors and a colleague health psychologist (LS), biomedical databases and relevant 
citations from identified journal articles. The database PubMed was used to identify studies 
that explained the meaning of ‘patient participation’ in health care and further studies that 
defined and described patient participation in health care were obtained from the citation list 
of the included studies. 
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Four databases were searched Medline/PubMed, EMBASE, Web of Science and PsycINFO 
to identify studies that had used theoretical models to explain participation in health care or 
health care utilisation among patients with chronic disease.  
The search terms were: 
1. "behavior and behavior mechanisms"/ or "psychological phenomena and processes"/ or 
"behavioral disciplines and activities"/ or behavior control/ or behavioral sciences/ or 
behavioral medicine/ or behavioral research/ or sociology/ or sociology, medical/ or "health 
care (non mesh)"/ 
2. conceptual adj (framework or review or guide or model).ab. 
3. Models, Psychological/ or Models, Theoretical/ 
4. ((behav* or social or psych*) adj (theory or model)).ab. 
5. Psychological Theory/ or Health Knowledge, Attitudes, Practice/ or Health Behavior/ or 
Behavior/ 
6. Sociology, Medical/ or Sociology/ or Social Environment/ or Social Sciences/ 
7. Attitude to Health/ or "Patient Acceptance of Health Care"/ 
8. help-seek* adj model.ab. 
9. (health adj (care or seek*) adj model).ab. 
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9  
11. Health Services/ut [Utilization] 
12. "Delivery of Health Care"/ut [Utilization] 
13. Health Services Research/ or Health Services/ 
14. ((health or medical) adj (care or service) adj utili*tion).ab. 
15. (health adj (service or care) adj uptake).ab. 
16. 11 or 12 or 13 or 14 or 15 
17. Health Education/ut [Utilization] 
18. Patient Education as Topic/ut [Utilization] 
19. ((health or medical) adj educat*).ab. 
20. 17 or 18 or 19 
21. 16 or 20 
22. Chronic Disease/nu, pc, px, rh, th [Nursing, Prevention & Control, Psychology, 
Rehabilitation, Therapy] 
23. (chronic adj (disease or illness)).ab. 
24. 22 or 23 
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25. Patient Participation/ut [Utilization] 
26. Consumer Participation/ut [Utilization] 
27. ((patient or client or consumer) adj participat*).ab. 
28. 25 or 26 or 27 (the four search terms were omitted from the search strategy as the search 
at this level yielded 0 results in all except in EMBASE) 
29. 21 and 10 
30. 29 and 24 
31. limit 30 to (english language and humans) 
The titles and abstracts of all identified papers were assessed to check their relevance. The 
review included all studies that explained health care utilisation and participation in health 
care interventions particularly, SM interventions amongst patients with chronic disease via 
theoretical models.  
 
2.2.3 Data extraction and synthesis 
Following the methods adopted by a previous, published CR,161 a data extraction form was 
not used but the studies identified were succinctly summarised and structured. This was 
continued until data saturation was achieved.161 (Priebe S. Professor of Social and 
Community Psychiatry. Personal communication. 2011.). As a result, the studies identified 
were succinctly summarised and structured into: meanings, definitions, concepts of patient 
participation and non-participation in health care; and theoretical factors that explained health 
care seeking behaviour and participation in SM interventions amongst patients with chronic 
disease. The literature was presented as a narrative using a non-quantitative approach.164 
 
2.3 Results 
Literature on the meanings of ‘patient participation’ in health care was identified from journal 
articles, online dictionaries and texts. Regarding the databases searches for studies using 
theory to explain patient participation in health care including SM interventions among 
chronic disease patients, when the search term ‘participation’ was added to the existing 
search strategy, the searches yielded either none or less than 10 results (only in the EMBASE 
database). As a result, this term was excluded from the search strategy following which 634 
references were identified. Next, based on title and abstract screening 27 articles were 
identified that seemed potentially relevant. Subsequently, on reading the full text, five 
studies5,165-168 met the review’s inclusion criteria. In addition, a further 20 studies142,169-187 
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were identified from citations of the included studies and from discussion with LS (Figure 
2.1). 
 
The results are presented under two headings: definitions of ‘patient participation’ in health 
care (section 2.3.1) and theoretical factors that influence HCU and participation in health care 
interventions particularly, SM interventions amongst patients with chronic disease (section 
2.3.2).  
76 
 
Figure 2.1 Selection of articles for review to explain theoretical factors that might influence 
participation in health care interventions including SM interventions  
 
Articles identified and screened based 
on title and abstract, n=634 
Potentially appropriate papers, full text 
scrutinised, n= 27  
Papers excluded, n= 607 
Reasons for exclusion – not focused on 
explaining patient participation, did not 
use theory to explain patient 
participation; population not chronic 
disease 
 
 
Papers included in conceptual review, 
n= 5 
 
Papers excluded, n= 22 
Reasons for exclusion – not focused on 
explaining patient participation, did not 
use theory to explain patient 
participation; population not chronic 
disease 
 
Plus studies identified and included 
from citations of included articles and 
discussion with health psychologist 
and included in review, n=20 
 
Total number of articles included in the review, 
n= 25 (discussed in section 2.3.2) 
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2.3.1 Results: Definitions and concepts of patient participation in health 
care 
This results section focuses on the varying definitions of participation, definitions and 
descriptions of patient participation and non-participation in health care; and, differentiates, 
where possible, between patient participation and patient involvement, patient-centred care, 
the activated patient, patient engagement in policy documents, research studies and in 
practice.  
The studies that explored the meaning of patient participation were a mix of quantitative and 
qualitative studies but in most a qualitative perspective was obtained from HCPs and patients 
including those with chronic disease.  
 
2.3.1.1 Dictionary definitions and descriptions of participation and 
non-participation 
The noun ‘participation’ is from Latin participatio(n-), from participat 
http://oxforddictionaries.com/definition/english/participation?q=participation  
(accessed 1-10-2012).  
‘Participate’ is a verb which means, be involved; take part. The origin of ‘participate’ was in 
late 15th century: from Latin participat ‘shared in’, from the verb participare, based on pars, 
part-‘part’+ capere ‘take’. 
http://oxforddictionaries.com/definition/english/participate?q=participate (accessed 1-10-12). 
‘Participation’ is the act of participating; the state of being related to a large whole. The first 
known use of the term ‘participation’ was in the 14th century 
http://www.merriamwebster.com/dictionary/participation (accessed 1-10-12) for peasant 
women in court http://www.marginalia.co.uk/journal/05margins/smith.php (accessed 18-5-
14) 
In addition, ‘participation’ has specific meanings in several different areas such as:  
Participation (in decision making), a notion in theory of management, economics and 
politics; 
Participation (in ownership), sharing something in common with others;  
Participation (in finance), getting some benefit from the performance of a certain underlying 
asset. http://www.reference.com/browse/participation?s=t (accessed 1-10-12) 
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On the other hand, ‘Non-participation’ has been defined as the “absence of participation” 
(http://dictionary.reference.com/browse/non-participation?s=t (accessed 1-10-12)  
The meaning ‘take part’ and ‘absence of participation’ given above matched the definition of 
‘participation’ and ‘non-participation’ adopted by this study (see glossary page). 
 
2.3.1.2 Definitions and descriptions of patient participation and 
non-participation given by medical dictionaries 
‘Patient participation’ is a Medical Subject Heading (MeSH) term within the world’s largest 
biomedical library, the US National Library of Medicine, The MesH term defines ‘patient 
participation’ as “patient involvement in the decision-making process in matters pertaining to 
health”   
http://www.nlm.nih.gov/cgi/mesh/2013/MB_cgi (accessed 19-2-13) 
The webpage has differentiated between this term and ‘patient compliance’ which was noted 
as the “voluntary cooperation of the patient in following a prescribed regimen”  
http://www.nlm.nih.gov/cgi/mesh/2013/MB_cgi?mode=&term=PATIENT+COMPLIANCE 
(accessed 19-2-13) 
The term ‘non-participation’ is not a MeSH word; however, ‘Refusal to participate’ was 
noted as “Refusal to take part in activities or procedures that are requested or expected of an 
individual.” This may include refusal by health personnel to participate in specific medical 
procedures or refusal by patients or members of the public to take part in clinical trials or 
health promotion programs.” 
http://www.nlm.nih.gov/cgi/mesh/2013/MB_cgi?mode=&term=Refusal+to+Participate 
(accessed 19-2-13).  
 
2.3.1.3 Research studies definitions and descriptions of patient participation 
and non-participation in health care 
Brownlea147 referred to the process of involvement of people in health care decision-making 
from ‘tokenism’ to actual participation which involved people getting their voices heard, 
which was from the rise in consumerism and legislation (section 2.1.1 and 2.1.2). Brownlea 
defined participation as, “getting involved or being allowed to become involved in a 
decision-making process or in the delivery of a service or the evaluation of a service or being 
consulted on an issue or matter.”  
79 
 
a) Nursing practice/Outpatient context 
Because of the importance given to ‘patient involvement’ in government policy, and the 
move from the medical model of health to patient-centred care135 in particular, patients 
position in nursing care was given importance whereby one of the roles of nurses has been to 
encourage patients to participate in their care.138 Thus, Cahill and Sahlsten’s135,138 review 
analysed the concept of ‘patient participation’ in care particularly in nursing practice. 
 
Cahill’s review135 explored the concept of ‘patient participation’ in nursing within a hospital 
context and reported several definitions of participation of a collective/collaborative nature. 
Brownlea’s abovementioned definition was one amongst the four mentioned under this 
approach. Other definitions included: 
Participation “relates to the act of participating, which implies that one becomes actively 
involved in or shares in the nature of something with others.” 
Participation “is the involvement of many people in decisions, giving them some feeling of 
control or responsibility.” 
Within a human relations perspective, participation “is the involvement of subordinates in a 
task”.  
According to Cahill, the abovementioned definitions did not capture the complexity of 
‘patient participation’ within the hospital context and hence presented definitions that 
suggested the role of an individual in the delivery of medical or nursing care. The following 
definitions were given:  
“patient participation in health care relates to: the activities performed by an individual on 
behalf of others in the maintenance and promotion of health, the prevention of diseases, 
detection, treatment and care of illness and the restoration of health, or, if recovery is not 
possible adaption to continuity of disability.” 
This definition corresponds closely with the definition of ‘self-care’ given by Barlow52 which 
suggests that ‘patient participation’ and ‘self-care’ are interlinked or that one aspect of patient 
participation in health care includes self-care. 
Cahill presented that patient participation “implies patient engagement in problem 
identification and prioritisation, establishment of change objectives and the process of 
making decisions about how change will be accomplished.”  
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“Patient participation is an active process which involves a patient performing clinical or 
daily living skills or partaking in the decision making process from the time of admission to 
discharge”. 
Cahill further noted that the role of an individual or patient participation included other 
aspects of care such as patient compliance, self-medication, self-monitoring, patient 
education, goal setting, sharing information and taking part in physical care and hence 
concluded that ‘patient participation’ was indeed an ill-described concept in nursing and 
further research was required for clarification of the term.  
Cahill’s review also explored patients’ and professionals’ perspectives on the value of patient 
participation; the rationale behind it was the assumption that patients’ want and benefit from 
having, a more active role in their health care. Based on the literature examined 
(self-completed questionnaires, interviews and recall, with small sample sizes and limited to 
within the nursing care context but without observation of patient participation in practice), 
Cahill concluded that the results could not be generalisable. Briefly, the results revealed that 
certain patient characteristics such as, younger patients, better educated, increased knowledge 
of their condition, and higher social class were predictors of desire for participation and these 
characteristics may have a role within participation in medical care as decision-makers. 
Older patients, the seriously ill or patients with a chronic or terminal illness preferred a less 
active role in their care, they were happy for nurses to make the decisions and accepted the 
passive role. This view was considered unusual by the author who believed that patients with 
chronic disease do need to participate in their care as it is necessary for the management of 
their illness. The author further explained that adoption of the passive role by patients with 
chronic illness was perhaps because they lacked knowledge and hence were happy for others 
to make decisions about their care and thus a solution offered was more provision of 
information.  
Patients’ views on the outcomes from participation in care were reported as control of the 
interaction, patient satisfaction, and compliance and goal attainment.  
On the other hand, views of professionals on patient participation in care were mainly that 
they continued to see patients as passive recipients of care, or were not ready to give up 
control or power over patients during consultations. An explanation given for this reluctance 
of HCPs was attributed to the Government trying to reduce professional services or reduce 
costs of services. Other reasons given were that professionals had reservations about people’s 
abilities to look after themselves, or they would be bombarded with unreasonable requests. 
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Despite the negative findings, Cahill felt that professionals prepared to facilitate participation 
would find it beneficial in some scenarios such as clarifying aims of the practice, providing 
feedback for evaluation of services to patients, improving communication and relationships, 
increasing job satisfaction and reducing or defusing complaints. 
 
Sahlsten et al138 in their review attempted to unpick the concept of ‘patient participation’ and 
acknowledged that the term may have varying interpretations and the concept may mean 
different things to patients and nurses within the nursing care context. Commenting on 
previous reports Sahlsten stated that the term ‘participation’ had been discussed as ‘collective 
or indirect participation’, which is practiced as lay participation in research, formulation of 
policy, and commissioning of services, or as a third-party parent, close relative or carer; and 
‘individual or direct participation’ which may be practiced for example, in health care and 
promotion, mental and social care and in different situations such as discharge planning, 
decision-making in treatment or care, and bed-side reporting.  Sahlsten presented definitions 
of ‘patient participation’ in relation to nursing practice from a ‘philosophical approach’ and a 
‘practical approach’. From the former approach, definition of ‘patient participation’ given 
was: “individual or holistic care, realistic plans based on negotiation, a positive outcome for 
patients and encouraging patients to be active rather than passive during their hospital 
stay.” From the latter approach, ‘patient participation’ involves: “using the nursing process, 
seeing what the patient wants regarding discharge, self-care i.e., physically take part in care, 
and informing patients during their hospital stay.”  
Two other definitions were cited: “Patient participation means being involved in the 
decision-making process concerning the delivery and evaluation of the patient’s own care.” 
For this to happen, patients need to be treated as individuals, their opinions need to matter 
and more control in their own care needs to be handed to them. This definition seemed to be 
similar to Brownlea’s147 abovementioned definition. “Patient participation is a dynamic 
process that changes over time and is integral to the work of nurses and carers.” The 
dynamic nature involves understanding, facilitation and partnership between patient and 
nurse. ‘Partnership’ is essential for participation to take place as here one’s values and beliefs 
are identified on which negotiation is based (This is the premise of the ‘CENTREd’ Model, in 
Chapter VII). 
Moving on, Sahlsten described some of Eldh’s188 work (which I have described below). Eldh 
has explored the meaning of ‘patient participation’ from the perspective of patients and 
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professionals in nurse-patient clinical scenarios not captured in Cahill’s study135 Based on the 
analysis of the definitions and descriptions of the ‘patient participation’ concept, Sahlsten138 
produced a list of four attributes of the concept of ‘patient participation’ in nursing practice: 
1. “An established relationship” 
2. “A surrendering of some power or control by the nurse” 
3. “Shared information and knowledge” 
4. “Active mutual engagement in intellectual and/or physical activities”  
These attributes are further described by referring to Eldh’s work next. 
 
Eldh has published several studies that have specifically explored the meaning of 
‘patient participation’188-190 and is the only author to have explored the concept of 
‘patient non-participation’ in health care.188,190,191 Some of Eldh’s studies188,189 recognised 
that patient participation was more than just decision-making which was in contrast to the 
above mentioned studies.135,138 In one of their first studies,188 Eldh listed various descriptions 
of participation which included, ‘the action of partaking’, ‘taking part’, ‘associating’, or 
‘sharing’ with others in some action or matter, more specifically described as “the active 
involvement of members of a community or organisation in decisions which affect their lives 
and work.” Eldh further described ‘patient participation’ as common desires between patient 
and health professional. The process of participation is twofold, whereby the professional and 
patient must have a common understanding as well as respect for each other’s contribution. 
Another perspective of participation given by Eldh was the perception of self-determination; 
patients want their right to self-determination. However, Eldh,188 similarly to Cahill’s 
study,135 also acknowledged that some patients may not want to be involved in decisions and 
they are confident in the care and treatment they receive. 
Other descriptions of ‘patient participation’ given by Eldh included: taking part in planning; 
performing tasks of self-care, and to participate in making decisions on treatment. These 
descriptions have been reported in the abovementioned studies. Eldh’s qualitative study 
findings188 showed that according to patients with chronic heart failure in a nurse-led clinic 
‘patient participation’ in health care meant: 
 “to be confident” in one’s own ability, in the caregiver and in one’s goals; 
 “to comprehend” information, body’s reactions and symptoms, disease and benefits 
and barriers of treatment; 
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 “to seek and maintain a sense of control” which involved demanding proper care, 
making appointments before being asked to make appointments, but also recognising 
the need to stand up for oneself. 
‘Non-participation’ to patients’ meant: 
 “to not understand”, the health care structure, expectations from others, the treatment 
given and why, not recognising the signs and signals from one’s own body, the 
disease process and progression. 
 “to not be in control”, over the disease and treatment which included not setting any 
goals or plans for treatment. It also meant that these patients wanted more access to 
the care which they felt they needed. 
 “lack of relationship” is the lack of continuity in care provided by the health 
professional or lack of support by the professional. 
 “to not be accountable” included four other subthemes: (1) not being respected, 
(2) lacking value as an individual, (3) being exposed both (physically and 
emotionally) and (4) the individual was looked at not as a person but as a body with 
disease. 
Eldh et al188 compared the above with the definition for ‘patient participation’ in the national 
Swedish report, “the possibility to choose treatment and to seek a second opinion.” and the 
WHO, The International Classification of Functioning, Disability and Health (ICF), 
“as involvement in a life situation.” and concluded that there was a difference.  
Eldh188 went on to state that the phenomenon of patient participation and non-participation 
changed for patients with time and during different phases of the disease and treatment, e.g. 
regarding creating relationships, patients had no expectations to participate in care in the 
emergency department, but they expected to participate in their care at the heart failure 
specialist clinic. This demonstrated that participation was a dynamic process and this process 
was recognised in a definition presented above by Sahlsten138 and, unlike the findings in 
Cahill’s study135 mentioned above, patients in Eldh’s study wanted to participate in their care 
as outpatients. 
 
A second study by Eldh189 explored the phenomena of ‘participation’ and ‘non-participation’ 
by means of narrative interviews with chronic heart failure patients and nurses and 
observations of the nurse-patient interaction/consultation in an outpatient clinic. The study on 
the one hand reported that patients experienced ‘participation’ as taking responsibility, 
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obtaining knowledge they lacked and being treated like an individual. The study 
differentiated between the term ‘taking responsibility’ and ‘accepting responsibility’. 
Taking responsibility is a personal trait which is dependent solely on an individual, whereas 
accepting responsibility is an interaction that is dependent on the both patient and HCP. 
While, patients experienced ‘non-participation’ as not knowing what was planned for them, 
not having the same information as a HCP or perhaps information being withheld from the 
patient, and not being seen as an individual. On the other hand, nurses viewed ‘patient 
participation’ as patients having received information based on their individual needs for their 
disease and its treatment, and ‘non-participation’ as lack of bonding and perceived that 
patients did not acknowledge the provision of  information (not accepting). Meanwhile, the 
observed nurse-patient interaction demonstrated that nurses dominated the consultation, 
patient followed the nurse’s initiative and the information given was standardised.  
 
A third study by Eldh190 explored the conditions for ‘participation’ and ‘non-participation’ 
from both inpatients and outpatients by means of a structured questionnaire. The results 
suggested that conditions for non-participation included lack of knowledge and lack of 
respect, and, conversely, having knowledge and being respected were reported as conditions 
for participation. 
 
Finally, Eldh191 moved from presenting a simple definition of ‘non-participation’ as 
“not taking part”  to assessing the meaning of ‘patient non-participation’ in health care from 
a diverse group of patients with somatic disorders who had recently experienced being 
patients in an acute care hospital via a study questionnaire. The findings suggested that 
‘non-participation’ was not about not being involved in decision-making and treatment 
planning related to their care, or did not refer to the legislative focus on participation and, 
‘patient involvement’ as seen above, but it was about not being listened too and not receiving 
proper information from HCPs. The latter finding had been reported by Eldh previously.189 
 
b) The primary health care context 
In a primary health care consultation context of promoting patient participation, Protheroe192 
defined participation in health care as: 
“an interaction, or series of interactions between a patient and the healthcare system or 
health care professional in which the patient is active in providing information to aid 
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diagnosis and problem-solving, sharing his/her preferences and priorities for treatment or 
management, asking questions and/or contributing to the identification of management 
approaches that best meet his/her needs, preferences of priorities” 
Here the patient was acknowledged as a ‘co-producer’ of their health and was considered an 
integrated member in the care process. This definition was also presented in another study by 
Protheroe193 within the context of shared decision-making which mentioned that the gap 
between ‘having choices’ and ‘making choices’ was best filled by the notion of 
patient participation. Choices were explained as decisions ranging between predetermined 
options such as different health care providers to different options for treatment which were 
in fact outcomes. And the role of decision-making and participation were concerned with 
collaboration between HCP and patient which was required to develop that list of options. 
So participation is more than offering choice versus no choice and was conceptualised as a 
process. Protheroe193 stressed that this process was necessary to avoid the problem of 
disempowerment and ‘personal identity threat’ which could lead to patient’s dissatisfaction 
with health care. However, the study reported that achieving participation is difficult and 
characteristics of patients who participate include being younger, female, educated, belonging 
to higher socioeconomic status with similar backgrounds and values as their health 
professional. Some of these patient characteristics were also reported in Cahill’s review.135 
 
The term ‘active’ has been used in relation to ‘participation’ in each of the abovementioned 
studies, e.g. participation has been referred to as: ‘becoming actively involved’, ‘an active 
process’,135 ‘active involvement’,138,188 and the ‘patient is active’.192 
Hence, definitions of ‘active participation’ are presented: “recognising an individual’s right 
to participate in the activities and relationships of everyday life as independently as possible; 
the individual is an active partner in their own care or support rather than a passive 
recipient.” These definitions highlight two key principles underpinning care, ‘the rights of 
the individual’ and ‘the independence or autonomy of the individual’.  
http://freedomtoteach.blogspot.co.uk/2012/01/health-and-social-care-benefits-of.html 
(accessed 5-4-13). One study reported that ‘active’ patients ask questions, seek explanations, 
state preferences, offer opinions and expect to be heard;81 these behaviours have been 
considered active forms of participation by another study194 as they bring the patient’s 
perspective into the patient-professional interaction which can influence the professional’s 
behaviour and decision-making. 
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Hibbard195 has defined the term ‘patient activation’ as “an individual’s knowledge, skill, and 
confidence for managing their health and health care” and suggested that these three 
components were important for active engagement and participation. These three components 
have also been described to cause behaviour change necessary for patient SM (Chapter I). 
This demonstrates that the terms ‘patient activation’, ‘self-management’ and ‘participation’ 
are interlinked.  
Hibbard has further explained the four levels of patient activation: 
Level 1: Individuals tend to be passive and feel overwhelmed by managing their own 
health. They may not understand their role in the care process. 
Level 2: Individuals may lack the knowledge and confidence to manage their health. 
Level 3: Individuals appear to be taking action but may still lack the confidence and 
skill to support their behaviours. 
Level 4: Individuals have adopted many of the behaviours needed to support their 
health but may not be able to maintain them in the face of life stressors. 
 
A study136 explored the meanings of ‘active participation’ from patients’ (including those 
with chronic disease) perspectives by examining their illness-management stories to help 
health professionals understand how patients conceptualise participation in order to promote 
more productive illness-management strategies amongst patients. The first two emergent 
themes were: (1) the central position taken by the illness in the individual’s life story and (2) 
the individual’s perception on how changeable the illness was in terms of getting better. The 
next two themes were: (3) the extent the patient engages in their illness-related activity and 
(4) the role of partnership with the patient’s HCP in health decision-making and illness 
management. Haidet136 developed a conceptual model (Figure 2.2) of patient participation 
based on the relationships between the four themes across participants’ illness-management 
narratives. Five illness management strategies were described with a decreasing level of 
participation which was dependent upon patients’ perspectives of their illness and the actions 
taken as a result of the illness including the role of partnership with HCPs:  
 “Negotiated empowerment” was the most productive strategy in terms of generating 
patient behaviours such as disease monitoring, preventive actions, and engagement 
with HCP.  
 “Self-motivated change” was where the patient gathered most of their 
illness-management behaviours without great influence from HCPs.  
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 Within “Adherence” the patient’s main strategy was to strictly follow the orders of 
the HCP without questioning, explanation or a need to engage with the HCP other 
than to receive orders.  
 “Unguided searching” was when the active patient searched for illness-related 
information on their own and continued, unsuccessfully to try to find a HCP they 
could trust and work with.   
 “Passivity/fatalism” was the least productive strategy and served to block efforts 
toward illness management by either patient or HCP.  
These strategies were not necessarily static but sometimes changed as the four themes 
(1-4 above) and their associations changed. The dynamic nature of patient participation was 
exemplified: for one diabetic patient their condition took central role which meant their 
whole life revolved around their condition (centrality, 1). The patient did not think their 
condition would get better as they were unable to control their diet (change for the better, 2). 
But the patient, unlike their other family members, wanted to manage their condition so they 
could keep their limbs intact till the end. This led the patient to actively seek a doctor 
(self-initiated unguided searching) who might be able to help keep their limbs and to find a 
doctor with whom they developed a good (partnership, 4) who suggested activities more 
suited to the patient’s personality (illness-related activity, 3). As a result, the patient gained 
control over their illness, felt empowered and was able to engage in SM activities 
(negotiated empowerment). 
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Figure 2.2 A conceptual model of patient participation in communication and illness care.  
 
 
Source: Haidet (2006) (*) The dashed arrow from ‘Change for the Better’ to ‘Centrality’ indicates that 
this association, while theoretically possible, was not observed in any of the participants’ narratives. 
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2.3.1.4 Synonymous terms of ‘Patient participation’  
The term ‘patient participation’ being used interchangeably with ‘patient involvement’, 
‘patient collaboration’, ‘patient partnership’, ‘patient empowerment’ or ‘patient-centred care’  
has led several studies135,137,138 to report that it causes confusion and has made it difficult to 
reach a consensus on the definition of ‘patient participation’ in health care. One study 
suggested that the above terms might be used in policy documents for different agendas and 
hence could have different meanings.138 
This section attempts to highlight any differences, where possible, between 
‘patient participation’ and these other terms. 
 
1) Patient participation and patient involvement 
According to the previously mentioned MeSH definition, patient participation was referred to 
as ‘patient involvement’. Eldh’s study191 indicated that a legislative focus of patient 
participation is denoted by ‘patient involvement’ - which has been demonstrated in the 
abovementioned health policy documents (section 2.1.2).  
The policy documents have normally referred to ‘public involvement’ alongside ‘patient 
involvement’ except in the ‘Health in Partnership’ report160 (section 2.1.2) and the lack of 
clear distinction between the two terms has been acknowledged.196 Florin and Dixon196 
explained the difference whereby ‘patient involvement’ was referred to as the “involvement 
of individual patients, together with their health professionals, in making decisions about 
their own health care” and ‘public involvement’ was referred to the “involvement of 
members of the public in strategic decisions about health services and policy at the local and 
national level.” The public comprise of volunteers who represent the views of patients, 
public and hard to reach groups http://healthandcare.dh.gov.uk/patient-and-public-
engagement-and-involvment/ (accessed 21-8-12). The EPP Task Force can be used as an 
example here because the Task Force comprised members of the public who were patients or 
service users and they contributed to the development and piloting of the EPP (public 
involvement) aimed at patients with LTCs.153 Participation of patients in the EPP was to 
result in the empowerment of patients, and one role of these ‘expert patients’ was to become 
key decision-makers so they could participate in decision-making about their care with HCPs 
(patient involvement). 
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Sahlsten et al138 has further attempted to differentiate between patient, client, consumer and 
user involvement and reported that a ‘patient’ or a ‘client’ is a person receiving health/mental 
or social care; ‘consumer’ relates to the right to make a choice; and ‘user’ is an individual 
who is a current, or potential, recipient of health care. 
 
A study by Thompson148 demonstrated a distinction, and a relationship between 
‘patient participation’ and ‘patient involvement’ within a clinical consultation context to help 
professionals, managers and policy makers understand the difference between these two 
concepts and produced a taxonomy (Table 2.1). Thompson utilised Arnstein’s197 ladder of 
citizen participation and explained that ‘patient involvement’ occurs at one of three levels of 
increasing power (consultation, partnership and lay control) and these levels of power are 
seen in the four most discussed models of treatment decision-making:  
 “paternalism”, where the professional knows best and patient involvement is limited 
to being given information or giving consent 
 “shared decision-making”, where both the process and outcome of decisions about 
treatment options are shared between patient and professional (similarly reported in 
Protheroe’s study193 as discussing shared discussion-making) 
 “professional as agent”, where professionals possess the technical expertise, but 
patient preferences are incorporated into their decision-making 
 “informed decision-making”, where the technical expertise is transferred to the 
patient, who makes the final decision 
Thus, along the continuum of high level of patient power to low level of patient power, 
professional-determined patient involvement would start at: informed decision-making, 
shared decision-making, professional as-agent, paternalism and exclusion. Thompson148 
explored these levels of involvement from patients’ and citizens’ perspectives and the results 
suggested that ‘involvement’ for participants meant, one or more of information, explanation, 
openness, building partnerships and access for all. On the other hand, ‘patient participation’ 
in consultation was understood as involving patients in discussions about their condition, 
providing them with the relevant information, asking for their opinion on possible treatment 
and involving them in the decision-making process. But it was noted that not everyone 
wanted to be involved at all times and in all situations. These findings are consistent with 
studies reported above.135,138,188 
Thus, patient-determined involvement ranged from:  
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 “Non-involvement” is the patient putting their trust in the professional, that they 
would do their best for them 
 “Information-seeking/information receptive” where it is normal for patient to expect 
information and being receptive to such information is the initial stage of involvement 
 “Information-giving/dialogue” patient is confident that they have the knowledge, the 
patient wants to be heard and believes professionals should listen 
 “Shared decision-making” where the patient wants to makes an informed choice, 
patients should be guided and allowed to express opinions in partnership with 
professional  
 “Autonomous decision-making” where patients can make decisions independently 
without support, patients believed they had more knowledge about their condition 
than professionals, particularly amongst patients with chronic illness  
The views ranged from patients not wanting to be involved at all in consultations to an active 
role resulting in full autonomy dependent on the context. Based on these findings, Thompson 
developed a taxonomy (see below) and explained that patients’ desire to be involved in 
dialogue or the sharing of decisions, can only be possible if professionals are willing for 
patients to engage in dialogue and allowed to express opinions and make decisions. 
Thompson labelled this is as ‘co-determined involvement’, or, ‘participation’. Patients’ desire 
for involvement was determined by three main characteristics including:  
(1) The nature of health care need, the type of illness, whether it was acute or chronic. There 
was an increased chance of involvement by patients with chronic disease because of their 
longer experience and the seriousness of the condition which was related to a degree of 
expert knowledge. This view is different to Cahill’s study135 where patients with chronic 
disease were reluctant to be involved in care, especially giving opinions related to medical 
expertise. (2) Personal characteristics of individuals such as socio-demographic factors linked 
to knowledge and experience and personality factors. (3) A patient-professional relationship 
characterised by trust. Trust featured when patients had little experience or knowledge. 
Break in trust could result in greater involvement until trust was restored but it was possible 
that greater demand for involvement would be less strong. However, trust which emerged 
through greater involvement may have created the conditions for a sustained desire for 
involvement, as self-confidence and competence grow and mature.  
The main distinguishing feature between ‘patient involvement’ and ‘patient participation’ 
concerned the degree to which patients take part in the decision-making process, suggesting a 
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degree of transfer of power from the professional to the patient in the form of increased 
knowledge, control and responsibility. The same patient may wish to be involved at different 
levels in relation to different circumstances, and it may change over time for the same person 
in the same context. Patient involvement is, therefore, a complex, multi-faceted and dynamic 
concept and based on the study findings ‘patient participation’ is an aspect of ‘patient 
involvement’.  
  
Table 2.1 Levels of involvement 
Patient-desired 
level 
Patient-Determined 
involvement 
Co-Determined 
 
(PARTICIPATION) 
Professional-Determined 
involvement 
 
4 Autonomous decision-
making 
 Informed decision-making 
3  Shared decision-making Professional as-agent 
2 Information-giving Dialogue Consultation 
1 Information 
seeking/receptive 
 Information giving 
0 Non-involved  Exclusion 
Source: Thompson 2007 
 
2) Patient participation and patient partnership or collaboration 
The term ‘collaboration’ or ‘partnership’ is the working together of patient and professional 
in a primary care or clinical consultation context which is necessary or essential for 
‘participation’ and decision-making to take place.138,148,193 
 
3) Patient participation and patient-centred care 
Patient-centred care is encouraging involvement of patients in decision-making about their 
care and has been defined as “as a philosophy of care that encourages: (a) shared control of 
the consultation, decisions about interventions or management of health problems with the 
patient and/or (b) a focus in the consultation on the patient as a whole person who has 
individual preferences situated within social contexts”.55,160 
 
4) Patient participation and patient engagement 
‘Engagement’ has been defined as “actions individuals must take to obtain the greater 
benefit from the health care services available to them”.198 ‘Patient engagement’ is “active 
participation in health care”. It includes patients preparing for appointments, exchanging 
relevant information with clinicians, shared decision-making, and adherence to agreed plans 
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of care.199 Based on the latter definition one can assume that ‘patient participation’ is 
synonymous with ‘patient engagement’.135 
 
5) Patient participation and patient empowerment 
Within a clinical context, the partnership between patient and professional can result in 
‘patient empowerment’.136,200 While, outside of a clinical setting, participation and 
completion of a group-based SM support programme or the EPP can result in ‘patient 
empowerment’ via peer sharing, learning and working in groups.201 
 
In summary, the dictionary definition of ‘participation’ and ‘non-participation’ were in line 
with the definitions given in the glossary of this thesis. In addition, various definitions have 
been presented for the term ‘patient participation’ in health care with regard to patients with 
chronic disease by studies through use of different approaches, philosophies and perspectives 
within a nursing, hospital or clinical consultation context. The definitions presented could be 
assembled into a broad individual context whereby, patient participation was about patients 
taking responsibility for their own health. Within a clinical consultation setting through 
patient engagement, patient-centred care the aim was to help patients to take responsibility 
for their health. Besides decision-making, studies that explored the meaning of patient 
participation from the perspectives of patients and health professionals showed that patient 
participation and non-participation was about the type of relationship/extent of bonding 
between patients and professionals. In addition, patient participation was not static but 
dynamic in nature and this process was dependent upon multiple patient, professional and 
contextual factors. From existing evidence, figure 2.3 illustrates the various meanings given 
to the concept of ‘patient participation’ in health care and its synonymous terms. 
 
This section has briefly highlighted some factors or patient characteristics that might 
influence an individual to participate in their care and have been mainly within a clinical 
consultation context. The next section, further demonstrates other factors, specifically, 
theoretical factors, that might influence both health care seeking and participation in health 
care including SM interventions amongst patients with chronic disease.  
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Figure 2.3 Illustration of definitions, concepts and meanings given for patient participation in health care and differences between its 
interchangeable terms in health care  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DYNAMIC NATURE 
co-determined 
between patient and 
professional 
Role of patient: being active, asking questions, 
sharing information, stating preferences.  
Label of patient ‘co-producer’ 
 
Accepting responsibility with the help of professional 
 
Role of professional: involves negotiation, identifying 
what patients want, seeing patient as a whole 
 
Patient is being involved in decision-making 
 
Setting requires: an established relationship, power 
shift to transfer control, active mutual engagement 
Professional-determined involvement 
4. Informed decision-making 
3.  
2. Consultation 
1. Information giving 
0. Exclusion 
 
 
Influenced by: 
type of illness, actions taken in 
relation to illness; 
patient characteristics; and 
relationship with professional 
(trust) or role of partnership 
Meanings in a patient-professional consultation context 
Decreasing level of patient 
participation: 
Negotiated empowerment includes  
PATIENT ENGAGEMENT 
 
Self-motivated change 
 
Adherence 
 
Unguided searching 
 
Passive 
In legislative or policy focus it is PATIENT INVOLVEMENT e.g. patient choice; chronic disease 
patients taking responsibility for their own health 
Patient-professional consultation context in health care  
PATIENT 
PARTNERSHIP 
PATIENT 
COLLABORATION 
PATIENT-
CENTRED CARE 
encouraging patient 
participation  or to be active 
working together of patient 
and professional 
SHARED DECISION-
MAKING/ 
DIALOGUE 
Meanings in an individual context 
Taking responsibility (trait of a person) 
Decision-making 
Performing activities /SM activities/ self-care tasks 
 
Active patients: asks questions, seek explanations, 
offer opinions and expects to be heard 
 
Means to be confident in oneself and professional; 
To comprehend information about condition and 
treatment 
Seeking and maintaining a sense of control 
 
Patient-determined involvement 
4. Autonomous decision-making 
3.  
2. Information giving 
1. Information seeking 
0. Not involved 
 
DYNAMIC NATURE 
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2.3.2 Results: Theoretical models that explain patient participation in 
health care and health care interventions 
The previous section revealed that patient participation in health care, particularly within a 
clinical consultation context, could be influenced by the type and nature of illness, patient 
characteristics and the relationship between patient and professional;135,136,148,193 and patient 
participation may result in a patient becoming actively involved or engaged in making 
decisions about their health and health care. 
Patients making decisions about health care can include accessing and seeking appropriate 
care from professionals, and making decisions about health could include participation in 
health care interventions such as, health promotion interventions to prevent disease or 
participation in SM interventions for chronic disease.198 
 
This results section presents findings of the included 25 studies that utilised theoretical 
models to explain health care utilisation or participation in SM interventions among patients 
with chronic disease. The findings of these studies are presented under the following three 
headings. 
2.3.2.1. Theoretical factors that may influence health care utilisation within a clinical setting 
2.3.2.2. Theoretical factors that may influence the utilisation of ongoing SM/health services, 
outside of a clinical setting, for the maintenance of SM behaviours 
2.3.2.3. Theoretical factors that may predict or influence attendance in SM interventions or in 
studies of SM interventions  
The number of studies described under each heading was six, four and fifteen respectively. 
Table 2.2 presents a summary of the study characteristics. 
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Table 2.2 Summary characteristics of the 25 studies 
Author 
(Date)/Country 
Title of study Aim of study Study design Theoretical 
model 
Chronic 
disease 
de Boer (1997)/ 
The Netherlands 
Predictors of health care 
utilization in the chronically 
ill: a review of the literature 
To identify predictors of health care utilization 
in the chronically ill. 
Literature review Andersen’s socio- 
behavioural model 
Chronic 
disease 
Uphold 
(2005)/USA 
Use of health care services 
among persons living with 
HIV infection: state of the 
science and future directions 
To describe the current status of health care 
utilisation research and to provide 
recommendations to guide researchers, 
clinicians, and policy makers to improve 
utilisation patterns among person living with 
HIV infection. 
Literature review Andersen’s socio-
behavioural model 
HIV 
Ciechanowski 
(2003)/ USA 
The relationship of 
attachment style to 
depression, catastrophizing 
and health care utilization in 
patients with chronic pain 
The hypothesis was in a sample of persons 
with chronic pain, fearful and preoccupied 
attachment style would be associated with 
higher levels of reported pain intensity, 
depression, catastrophizing and physical 
dysfunction.  
To explore whether catastrophizing might 
influence the relationship between attachment 
styles and health care utilization following 
multidisciplinary pain management. 
Quantitative – 
secondary analysis 
Attachment theory Chronic pain 
Ciechanowski 
(2006)/ USA 
The interpersonal experience 
of health care through the 
eyes of patients with diabetes 
Hypothesized that compared to patients with 
secure attachment style, those with dismissing 
and fearful attachment style would be:  
(1) less satisfied with 
interactions with health care providers;  
(2) less trusting of health care providers and 
(3) less able to collaborate in health care 
settings. 
Qualitative Attachment theory Diabetes 
Ciechanowski  
(2006)/USA 
Where is the patient? The 
association of psychosocial 
factors and missed primary 
care appointments in patients 
with diabetes 
To predict that compared to secure attachment 
style, fearful and dismissing attachment styles 
would be associated with greater number of 
missed primary care visits in patients with 
diabetes. 
Quantitative – 
predictor study 
Attachment theory Diabetes 
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Gately 
(2007)/UK 
 
Re-thinking the relationship 
between long-term condition 
self-management education 
and the utilization of health 
services 
To explore participants’ perceptions of illness, 
ascertain the nature of self-care and 
engagement with health care services over 
time, with participants being interviewed pre- 
and post-training course. 
Qualitative – 
longitudinal design 
Social theory – 
Illness work 
Chronic 
disease 
Gucciardi 
(2009)/Canada  
Education and psychological 
aspects individual and 
contextual factors associated 
with follow-up use of diabetes 
self-management education 
programmes: a multisite 
prospective analysis 
To identify factors influencing follow-up use 
of diabetes self-management education 
services. 
Quantitative – 
prospective analysis 
Andersen’s socio-
behavioural model 
Diabetes 
Sniehotta 
(2010)/UK 
Adoption of community-
based cardiac rehabilitation 
programs and physical 
activity following phase III 
cardiac rehabilitation in 
Scotland: A prospective and 
predictive study 
To test, compare and combine the predictive 
utility of the Common-Sense Self-Regulation 
Model (CS-SRM) and the extended Theory of 
Planned Behaviour (TPB) with action 
planning for two rehabilitation  
behaviours: physical activity and phase IV CR 
attendance. 
Quantitative – 
prospective cohort 
design 
CS-SRM; TPB 
with advanced 
action planning 
Varied chronic 
heart disease 
patients 
Dohnke 
(2010)/Germany 
Motivation and Participation 
in a Phase III Cardiac 
Rehabilitation Programme: 
An Application of the Health 
Action Process Approach 
It examines the correlates 
of motivation and participation 6 months after 
inpatient phase II CR (T1) and the predictors 
of dropout 6 months later (T2) 
using the health action process approach 
(HAPA). 
Quantitative – 
longitudinal study 
HAPA Varied chronic 
heart disease 
patients 
Pentecost 
(2011)/UK 
Understanding exercise 
uptake and adherence for 
people with chronic 
conditions: a new model 
demonstrating the importance 
of exercise identity, benefits 
of attending and support 
To identify the influences on uptake and 
adherence behaviour for people with chronic 
conditions, using a diverse sample by age, 
gender, ethnicity and attendance level and 
presenting a new model of exercise uptake and 
adherence, with implications for a diverse 
range of people. 
Qualitative A conceptual 
model of exercise 
uptake and 
adherence 
Chronic 
disease 
Petrie 
(1996)/New 
Zealand 
Role of patients' view of their 
illness in predicting return to 
work and functioning after 
To examine whether patients' initial 
perceptions of their myocardial infarction 
predict subsequent attendance at a cardiac 
Quantitative – 
predictor study 
SRM CHD 
98 
 
myocardial infarction: 
longitudnal study 
rehabilitation course, return to work, 
disability, and sexual dysfunction. 
Cooper 
(1999)/UK  
Why patients do not attend 
cardiac rehabilitation: role of 
intentions and illness beliefs? 
To determine whether the illness beliefs held 
during hospitalisation by patients who had 
suffered acute myocardial infarction or who 
had undergone coronary artery bypass graft 
surgery could predict cardiac rehabilitation 
attendance. 
Quantitative 
prospective study 
SRM CHD 
Whitmarsh 
(2003)/UK 
Illness perceptions, mood and 
coping in predicting 
attendance in cardiac 
rehabilitation 
To identify psychological variables in 
poor/non-attendance at cardiac rehabilitation. 
Quantitative cross-
sectional study 
SRM CHD 
French 
(2005)/UK 
Do illness perceptions predict 
attendance at cardiac 
rehabilitation and quality of 
life following myocrdial 
infarction? 
To examine the extent to which illness 
perceptions predict attendance at cardiac 
rehabilitation and quality of life following 
myocardial infarction (MI) 
Quantitative 
prospective 
predictor study 
SRM CHD 
French 
(2006)/UK 
Illness perceptions predict 
attendance at cardiac 
rehabilitation following acute 
myocardial infarction: A 
systematic review with meta-
analysis 
To examine whether illness perceptions really 
predict attendance at cardiac rehabilitation and 
to examine factors that moderate this 
relationship. 
Systematic review 
and meta-analysis 
SRM CHD 
Blair (2013)/UK The influence of non-
modifiable illness perceptions 
on attendance at cardiac 
rehabilitation 
To examine the influence of socio-
demographic factors, illness perceptions and 
social isolation on patient attendance at 
cardiac rehabilitation. 
Quantitative SRM CHD 
Cooper 
(2005)/UK  
A qualitative study 
investigating patients' beliefs 
about cardiac rehabilitation 
To elicit patients' beliefs about the role of the 
cardiac rehabilitation course following 
myocardial infarction. 
Qualitative NCF CHD 
Cooper 
(2007)/UK 
Assessing patients' beliefs 
about cardiac rehabilitation as 
a basis for predicting 
attendance after acute 
myocardial infarction 
To develop a valid and reliable measure of 
patients' beliefs regarding cardiac 
rehabilitation and to ascertain the relationship 
between such beliefs and attendance. 
Quantitative SRM; SRM-NCF CHD 
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Keib 
(2010)/USA 
Poor use of cardiac 
rehabilitation among older 
adults: A self-regulatory 
model for tailored 
interventions 
The self-regulation model was used to guide 
the development of interventions targeting 
other health behaviours, and may provide a 
useful guide for the development of 
interventions tailored to improve older adult 
participation in cardiac rehabilitation. 
Quantitative – 
descriptive study 
SRM; SRM-NCF CHD 
Wyer (2001)/UK  Predicting attendance at 
cardiac rehabilitation: a 
review and recommendations 
To investigate how attendance at CR could be 
increased 
Literature review SRM; TPB CHD 
Wyer (2001)/UK Deciding whether to attend a 
cardiac rehabilitation 
programme: an interpretive 
phenomenological analysis 
To explore beliefs held on recovery and CR by 
attenders and non-attenders; and to examine 
the usefulness of the Self-Regulatory Model 
and the Theory of Planned Behaviour when 
interpreting the results. 
Qualitative study SRM; TPB CHD 
Lemaigre 
(2005)/Belgium  
Understanding participation 
in an asthma self-
management program 
To investigate social cognitive determinants of 
the intention to participate in an asthma self-
management program. 
Quantitative ASE Asthma 
Helitzer 
(2007)/USA  
Relationship of Stages of 
Change to Attendance in a 
Diabetes Prevention Program 
To determine whether pre-intervention stage-
of-change measures are indicative of 
subsequent attendance at diabetes prevention 
intervention sessions. 
Quantitative cross-
sectional study 
SoC Diabetes 
O’Brien 
(2009)/UK 
Predicting adherence to phase 
III cardiac rehabilitation: 
should we be more 
optimistic? 
Aim not specified Quantitative SoC CHD 
Toth-Capelli 
(2012)/USA 
Stage of Change and Other 
Predictors of Participant 
Retention in a Behavioural 
Weight Management Program 
in Primary Care 
To investigate stage of change and other 
predictors of retention in a behavioural 
intervention program that enrolled adult obese 
patients at three primary care sites. 
Quantitative SoC Obesity 
Key: HIV- Human immunodeficiency virus; CHD – coronary heart disease; SoC – Stage of Change; ASE - Attitude-Social Influence-Self efficacy; NCF- 
Necessity-Concerns Framework; SRM - Self-Regulation model; TPB – Theory of Planned Behaviour; CS-SRM - Common-Sense Self-Regulation Model; HAPA 
- Health Action Process Approach 
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2.3.2.1 Theoretical factors that may influence health care utilisation within a 
clinical setting 
Health care utilisation or health care seeking was viewed as a health behaviour in this study. 
‘Behaviour’ denotes something that people “do or refrain from doing”, although not always 
consciously or voluntarily. It is not something “done to them”.202 
Gochman202 defined ‘Health behaviour’ as “those personal attributes such as beliefs, 
expectations, motives, values, perceptions, and other cognitive elements; personality 
characteristics, including affective and emotional states and traits; and overt behaviour 
patterns, actions, and habits that relate to health maintenance, to health restoration, and to 
health improvement.”  
A definition has been given for ‘Health care utilisation (HCU) behaviour’ which “is the use 
of health services, whether it be clinical public health services or the services of medical 
professionals”. HCU behaviour can range from “using preventive services, such as getting 
immunisations or early detection and screening tests to elective surgery or involuntary 
hospitalisation after an injury” http://www.healthline.com/galecontent/behavior-health-
related#2 (accessed 14-2-13). 
 
Among the 25 included studies, six studies (see Table 2.2), described below, explained HCU 
among patients with chronic disease via the following three theories: the ‘Andersen’s 
Socio-Behavioural model’, the ‘Attachment theory’ or the Social theory – ‘Illness work’. The 
studies explained HCU patterns of patients within the context that lack of optimal use of 
health services was associated with worse health outcomes and higher costs to health 
services. 
Box 2.2 briefly describes the three theories. Table 2.3 presents a summary of the theoretical 
factors that influenced increase in HCU in the six studies. 
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Box 2.2 Brief description of the ‘Socio-behavioural model’, the ‘attachment theory’ and the 
social theory - ‘illness work’ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Andersen’s Socio-Behavioural model 
This model explains that4 people use health services due to their predisposition to use health services 
and the predisposing characteristics include demographics, social structure – occupation, ethnicity, 
education and health beliefs; enabling factors enable or prevent use of health services such as 
personal/family income, insurance, community resources- physician and hospital bed ratios, place of 
residence; and need for care or services through perceived needs of an individual and/or evaluated 
need considered important by professionals. Andersen and Newman found that predisposing 
characteristics had low mutability; health beliefs had medium mutability and some enabling factors 
had high mutability e.g. health insurance benefit and personal need could be changed through health 
education programmes or changing financial incentives and evaluated needs could change as a result 
of emergent clinical guidelines which in turn could be changed to promote equitable access. The 
health care system (policy, resources, and organisation) and the external environment constructs 
(physical, political and economic components) were also recognised as primary determinants of health 
care utilisation along with population characteristics to further explain health care use (such as type, 
site, purpose and when these services were used in case of an illness) and changes of use over time 
which were dependent on health outcomes such as consumer satisfaction, perceived health status and 
evaluated status.  The model recognised that personal health practices such as diet, exercise, self-care 
would interact with the use of health care and thus affect health outcomes. Figure 2.4 illustrates a 
dynamic model with a recursive nature. The feedback loop showed that the health status outcomes in 
turn affect subsequent predisposing, enabling factors and needs which influence health behaviour 
(health service utilisation and personal health practices).   
 Figure 2.4 Behavioural model 
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Box 2.2 continued 
Attachment theory 
Ciechanowski5 describes Bowlby’s10 attachment theory as a theory about how interpersonal 
development process may affect care seeking behaviour in response to illness. Early experiences with 
health care providers lead to formation of cognitive schema or representations of relationships that 
influence whether an individual perceives themselves to be worthy of care (view of self) or whether 
they trust others to provide care (view of other). These representations influence how an individual 
interacts with others, and the interpretations of these interactions, all through life. There are four main 
attachment styles that are a result of interpersonal experience (Figure 2.5): (1) Secure – persons may 
have consistently experienced responsive early caregiving. These persons are comfortable and readily 
comforted by others. They have a positive view of themselves and are worthy of care and others are 
trustworthy to provide care when needed. (2) Dismissing – persons are believed to have experienced 
early caregiving as consistently unresponsive and as a result these individuals become compulsively 
‘self-reliant’. They are uncomfortable trusting others but nevertheless have a positive view of 
themselves and hence are ‘self-reliant’. (3) Preoccupied – here persons have received inconsistently 
responsive caregiving and as a result these individuals become vigilant and emotionally dependent on 
others. They become ‘clingy’ in terms of seeking support especially when distressed. Persons here are 
associated to have low self-esteem, negative affect and have increased subjective stress. (4) Fearful – 
persons here share characteristics of the ‘preoccupied’ style where they desire social contact when 
they are distressed but the desire to seek support is inhibited by fear of rejection. Individuals may have 
received harsh caregiving in early life and as a result adults express patterns of fleeing when they 
receive certain amount of closeness. These persons may not see themselves as worthy of care or others 
as trustworthy to seek needed care. They too have low self-esteem, negative affect and have increased 
subjective stress. 
 
      
Model of self 
    +   _  
 
Secure 
- trusting of others; feels worthy of 
others attention 
Preoccupied 
- emotionally dependent on others; low 
self-esteem; focus on negative affect 
Dismissing 
- low trust of others; compulsively 
self-reliant 
Fearful 
- low trust of others; fearful of intimacy; 
low self-esteem; focus on negative affect 
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Figure 2.5 Attachment style categories and model of self and other  
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Box 2.2 continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Social theory – ‘Illness Work’  
Corbin and Strauss1 have viewed illness as a sociological concept and used the term ‘illness 
trajectory’. The trajectory refers to the (1) course of illness, (2) to all the related work’ including (3) 
the impact on the person and their relationships that (4) affect the management of the course of illness 
and the fate of the person who has the illness. Specifically, the related work includes ‘illness-related 
work’ and ‘everyday life work’.  
Corbin and Strauss explain that: Illness-related work/Illness work consists of regimen work, crisis 
prevention and symptom management.  
Everyday life work is act of living or the essential daily tasks/actions taken for living e.g. employment, 
marital work, housekeeping, eating. Between the illness work and everyday life work there is 
interactions with family, friends, HCPs and others who might be providing information, show or 
express concern and care for patients. In addition, several clusters of tasks/jobs take place within and 
between the illness and everyday life work need to fit into an individual’s daily routine. As illness 
trajectory and everyday life can differ from day to day, the tasks to be done can differ in amount, 
degree of difficulty, time it takes and consistency with which it must be done. In addition, at each 
change within the illness trajectory e.g. patient returning home from an acute exacerbation or everyday 
life work there will be changes in the type and nature of work. The structure e.g. in home in which 
management needs to take place might need to change with every change in the illness trajectory 
change to meet the needs of trajectory management. A person’s trajectory management takes place in 
everyday life context which might change to temporary or permanent depending on change in the 
performance ability. Trajectory management would vary depending on the severity of illness and type 
of trajectory. As a result, depending on the severity or type different tasks might need to be performed 
or required for trajectory management and various different resources might be necessary to perform 
the tasks. A change in illness can bring change in management of the illness trajectory and also affect 
the management of everyday life. And a slight change in everyday life can affect trajectory 
management. 
The ill person’s biography or biographical work gives direction to the management process and has a 
reciprocal impact. 
To live (illness work, everyday life work, biographical work) requires balance and development of 
action plans that will satisfy these works. The equilibrium achieved would be relative – achieving 
equilibrium regardless of struggle put forward is not easy – there is tendency for instability of the 
balance because of consequences via: competition of resources, unbalanced workloads, distribution of 
workflow and conditional motivation. Equilibrium is needed to prevent the downward spiral and so to 
prevent the irreversibility of downward spiral the equilibrium needs to be checked in the early stages 
of the illness. So to keep the consequences in check and maintain a sense of relative equilibrium there 
needs to be “management in process” with emphasis on adaptation to change. Four basic strategies 
include: (1) Resources calculation; (2) Maintaining fluid boundaries in division of labour; (3) Ongoing 
articulation work (requires planning and coordination for work to proceed smoothly and completion); 
and (4) Mutual sustaining.    
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Table 2.3 Summary of factors that influenced health care utilisation 
Study (year); theoretical model used, 
n=6 
Factors  
(a) de Boer (1997); Andersen’s socio-behavioural 
model 
Perceived need  
(b) Uphold (2005); Andersen’s socio-behavioural 
model 
Perceived need;  
To some extent – Pre-disposing, Enabling factors 
and Contextual factors 
(c) Ciechanowski (2003); Attachment theory ‘Preoccupied attachment style’ and clinical factor -  
catastrophizing 
(d) Ciechanowski (2006); Attachment theory Clinical factor - depression  
To some extent - ‘Preoccupied attachment style’ 
(e) Ciechanowski (2006); Attachment theory To some extent - ‘Fearful attachment style’ 
(f) Gately (2007); Social theory  Factor was ‘Illness work’ 
 
(a)  
Andersen’s behavioural model of health services utilisation (HSU)4 (Box 2.2) has often been 
referred to as ‘the health services utilisation model’.202 
de Boer’s review142 comprising 53 studies utilised Andersen’s and Newman’s 1970s model to 
evaluate the effects of ‘predisposing’, ‘enabling’ and ‘need’ factors on hospital admissions 
(admissions and length of stay) and physician visits (number of visits at outpatients) amongst 
patients with chronic disease.  
The main findings suggested that the predisposing and the enabling factors had less 
predictive value and the need factors were strong predictors of HCU amongst the chronically 
ill (heart disease, arthritis, stroke and diabetes).  
 
The need factors were strongest predictors of utilisation particularly perceived health status 
(both physical and psychological). Worse perceived health, specifically depression and 
psychological stress, led to more HCU. While professional assessed need which included 
disease duration or comorbidities did not affect HCU. 
 
(b)  
Uphold’s literature review168 examined, using Andersen’s socio-behavioural model 
population characteristics and contextual factors, the HIV-related HCU of people living with 
HIV who were older, non-white, heterosexual men or women and injection drug users (IDUs) 
to ensure that these patients received services according to their needs.  
The study findings showed that HIV-related HCU was influenced by predisposing and 
enabling factors but perceived needs were the most important predictors of HCU.  
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Patients’ perceived needs were dependent upon patient perceptions of health and symptoms 
and influenced HCU. Increased symptom intensity plus adverse effects from medication led 
to increased use of inpatient, outpatient and emergency visits. Two or more clinical HIV-
related symptoms were the most important predictors of HCU. Poor functional status and 
health-related quality of life resulted in increased HCU; depression and mental illness also 
led to higher HCU and could also lead patients to miss scheduled appointments and not seek 
care. Comorbidities also affected HCU.  
Professionals’ evaluated need, whether a person with HIV needed appropriate services was 
dependent upon clinical guidelines.  
 
Contextual factors such as the type of care received (e.g. VA centres – had longer lengths of 
stay), geographical area (e.g. the northeast area had a longer lengths of stay) and place of 
residence at individual level (those living in rural areas were less likely to receive HAART 
compared to urban areas), including provider characteristics, such as experience (experienced 
providers provided more antiretroviral therapies and patients received primary care visits), 
gender, and training of HCPs (patients cared for by nurses reported fewer problems with their 
care and had better outcomes in terms of accessing care), influenced HCU amongst this 
patient group. Experience and perceptions of the health care system also influenced HCU, 
e.g. if patients with HIV had problems accessing primary care due to long waiting times, or 
experienced difficulties making appointments, then that influenced primary care visits. 
 
(c)  
Ciechanowski utilised the attachment theory10 (Box 2.2) to study three different aspects of 
HCU amongst patients with chronic pain5 and diabetes.165,169 
In the first study, Ciechanowski5 conducted a secondary analysis on a subsample of chronic 
pain patients who had previously participated and completed a pain treatment programme 
which resulted in a significant decrease in measures of depression, catastrophising, pain 
perception, pain-related HCU and physical dysfunction from a pain programme to 12 month 
follow-up. The results suggested that the preoccupied attachment style predicted high post-
treatment pain-related utilisation after controlling for baseline utilisation, catastrophising and 
depression, and there was no significant correlation between depression, catastrophising and 
the pre-occupied attachment style. In addition, the study found that the ‘fearful attachment 
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style’ predicted moderate time levels (greater than monthly visits, more than three visits in 
three months) of post-treatment pain-related HCU. However, this finding became 
insignificant when catastrophizing was controlled. The author explained that the fearful 
attachment style may lead to higher pain-related HCU (greater than weekly visits, more than 
12 visits in three months) only in the presence of catastrophizing. This is because chronic 
pain patients with the fearful attachment style may overcome their anxiety to seek care when 
they are faced with a catastrophic threat.  
 
(d)  
Ciechanowski in another study165 examined whether the attachment styles and depression 
was associated with the number of routine missed primary care visits amongst diabetics. 
The rationale behind it was that non-attendance in primary care clinics was associated with 
worse health outcomes e.g. poorer glycaemic control, non-adherence to medications. The 
findings suggested that depression was associated with missed primary care visits via an 
individual’s attachment style. Patients with the pre-occupied attachment style were associated 
with more scheduled and same day appointments; while, those with the fearful attachment 
style had significantly more same day appointments but were not scheduled visits. This is 
consistent with the fearful attachment style where patients may approach HCPs with needs 
and problems but are fearful and unable to trust others; they make same day appointments (a 
solution to them) in desperation because they have delayed making scheduled appointments 
for acute somatic symptoms or psychological distress. Patients with the fearful attachment 
style had 25% fewer scheduled preventive care visits in the study sample. 
Missed appointments were more likely in patients with the dismissing or fearful attachment 
style amongst patients without major depression (88% of sample). But in patients with major 
depression, the depressive symptoms may override the tendency amongst these individuals to 
take care of things themselves and so in this case they may not miss the scheduled 
appointments. Furthermore, the study compared patients with one or more missed scheduled 
visits with those who did not miss any scheduled visits, and the presence of depression 
presented a greater risk of missed appointments compared to presence of either the fearful or 
dismissing attachment style.  
(e)  
A third study by Ciechanowski169 explored the experience of interaction between patients 
with diabetes and professionals in tertiary care, and how that might influence the engagement 
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of the patient in the interaction. The study rationale was because of a system-wide 
fragmentation (where patients with chronic disease may not be receiving chronic disease 
management support) may especially be challenging for patients with the fearful or 
dismissing attachment style which might affect their interaction or engagement with the 
health care system.  
The study found that regardless of the attachment style most patients perceived the health 
care system as rushed, impersonal and fragmented. In addition, patients with the dismissing 
or the fearful attachment style also perceived (e.g. via professionals’ attitude or body 
language) a power divide or difference between themselves and the HCP which affected their 
interaction. In line with the cognitive schema of the attachment theory, patients with the 
fearful attachment style were aware of indications of rejection and those with the dismissing 
attachment style were sensitive to being controlled. But despite this, if they noticed that HCPs 
were trying to get to know them and they were accepted in a non-judgemental manner, then 
these patients would be more likely to engage in the interaction. In addition, patients with the 
fearful attachment style, when they were dissatisfied with the interaction with HCPs instead 
of changing HCPs, they played the role of ‘the good patient’, as a way of tolerating the 
interaction and because changing HCPs was perceived as difficult.  
 
(f)  
Gately166 looked at chronic illness and health care seeking from a sociological perspective. 
They reported that a sociological approach questions the assumption that people are 
consistent in their preferences, knowledge level and ability to make rational decisions. Gately 
proposed that instead of an individual following a static framework where the individual 
might make choices from a list of options provided, a social process approach works in a 
different way and that the process of help-seeking is an ongoing contact lasting months or 
years which is modified by individuals based on adaptations and their responses to living 
with a chronic illness. Gately continued that most illness management usually takes place 
outside of formal health services and referred to Corbin and Strauss’s1 work where the 
process of symptom management is included within ‘illness work’ (Box 2.2) and is different 
to ‘everyday life work’ (daily housework tasks) and ‘biographical work’ (relating to the ill 
person’s biography). However, Gately pointed out that normally patients with chronic disease 
have some level of interaction with health services for their symptom management making 
illness work a shared activity between patients and professionals. So, Gately et al. in a 
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longitudinal qualitative study explored patients’ perceptions of their illness, the nature of 
self-care and utilisation of health services over time before and after attending the EPP. 
In addition, they described two case studies to highlight the point of the social context, illness 
trajectory and HCU through everyday life work and biographical work.  
The study found that a reduction in HCU patterns (one of the impacts as expected from the 
delivery of SM education) was not seen among patients with chronic disease despite 
improvement in self-efficacy because patients might have not made the connection that they 
could reduce the need for medical care by changing their behaviour. The study highlighted 
health service use, amongst patients with chronic disease, was routine and habitual for 
management of their condition; the study participants knew their way around the health 
services and used strategies to access services that had been adapted over time; and the 
content of the programme had focused upon improving communication between patient and 
one professional (as in GP-patient), and had not acknowledged the importance of the 
biographical context and patterns of pre-existing health services utilisation of patients. The 
authors further stated that people who find the EPP useful might be those whose needs have 
been unmet by traditional services whilst those with chronic conditions who use health 
services on a regular basis may find it difficult to change their behaviour - especially if the 
professionals also have a different agenda to self-care.  
 
2.3.2.2 Theoretical factors that may influence the utilisation of ongoing SM 
services, outside of a clinical setting, for the maintenance of SM behaviours 
Among the 25 includes studies, four studies (Table 2.2), described below, explained 
utilisation of ongoing health/SM services outside of a clinical consultation setting but within 
the wider health services via the following three theories: the Common-Sense Self-
Regulation Model (CS-SRM), the Theory of Planned Behaviour (TPB) or the Health Action 
Process Approach (HAPA). The SM services mentioned in the four studies were referred to 
as ongoing or follow up services that were offered to patients with chronic disease for 
maintenance or long term adherence of behaviours that were deemed necessary for the 
prevention and management of chronic condition to have better health outcomes. These 
studies are described below. 
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Box 2.3 briefly describes the three theories. Table 2.4 presents a summary of the theoretical 
factors that influenced patient participation or the utilisation of ongoing SM services in the 
four studies. 
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Box 2.3 Brief description of the Common-Sense Self-Regulation Model, The Theory of Planned 
Behaviour and the Health Action Process Approach 
The Common Sense Self-Regulation model (CS-SRM) 
Leventhal8 explained that a health threat can generate an emotional response (fear or distress) and a 
corresponding need for procedures to manage the emotional response; and simultaneously a cognitive 
representation of the threat is formed (via information about the threat and physical stimuli) along with a 
corresponding need for procedures to manage the threat by using action plans. Leventhal went on to state, that 
symptoms experienced as a result of an illness and the name of the illness form one small part of an illness 
representation – termed ‘identity’ – a label given to illness and the symptoms people associate with illness. 
Four other domains of illness representations identified from several studies of different conditions included: 
‘timeline’ - expected duration of illness or expected age of onset of illness; ‘consequences’ - severity and 
impact on life functions; ‘cause’-internal (e.g. genes) or external (e.g. infection); and whether the illness was 
perceived as ‘preventable’, ‘curable’ or ‘controllable’. As a result, these illness representations (Figure 2.6) 
can lead one to generate goals, develop action plans and evaluate response self-efficacy (evaluation of whether 
the threat has been eliminated or controlled). In 2002, new constructs were added to the model13 comprising 
coherence (extent to which patients understand their illness/symptoms); cyclical timeline; personal and 
treatment controllability and emotional representations (emotional impact of the illness). 
 
 
 
Situational stimuli 
Representation 
of danger 
Coping procedures 
Action plans 
Appraisal 
 
IDENTITY 
(label) 
TIMELINE 
(duration) 
CONSEQUENCES 
(expected outcomes) 
CAUSE CONTROL 
(yes/no) 
Symptoms Perceived time e.g, Physical 
disability 
e.g. Lack of sleep 
contact with sick 
individual 
Treatment 
effective? 
The action plans or coping procedures can also be classified in the five domains and hence an individual can 
form representations of a coping procedure via expectations from a procedure, information about a procedure 
or experience of a procedure. As a result, Leventhal pointed out that both illness and treatment representations 
can prove useful in understanding an individual’s adherence to their medication and behavioural regimens. 
Furthermore, Leventhal stated that self-regulation by an individual is dependent upon age, health self-
assessment and perception of strength of immunity. Self-regulation is not done in isolation but is dependent on 
the input and expertise of others (e.g. families, clinicians) and cultural factors. 
Figure 2.6 The five domains of illness representations 
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Box 2.3 continued 
The Theory of Planned Behaviour (TPB)  
The Theory of Planned Behaviour (TPB) was developed by Ajzen3 and is an extension of Fishbein’s and 
Ajzen’s12 Theory of Reasoned Action (TRA). The TPB was used to predict and explain human behaviour 
under incomplete volitional control (if a person can decide at will to perform or not perform a behaviour) in a 
specific context (whereas the TRA is about behaviour undertaken under volition control). Ajzen explained that 
intention or motivational factors are needed to carry out an action or behaviour; in addition, non-motivational 
factors such as opportunities and resources (e.g. time, money, skills, co-operation of others) are needed which 
represent an individual’s actual control over the behaviour. An important construct of the model is perception 
of behavioural control that impacts on an individual’s intentions and actions in the TPB. 
Perceived behaviour control (PBC) refers to an individual’s perception of ease or difficulty of performing the 
behaviour of interest. According to the TPB, PBC and intention can be used to predict behaviour change. 
However, at times a person has to undertake a behaviour that is new, or if they have little information about it, 
or if available resources have changed, or if something new has occurred or changed in the situation, then 
under these conditions PBC has little to offer in terms of accuracy of behavioural prediction. 
The TPB suggests three conceptually independent determinants of intention: (1) Attitude towards the 
behaviour which may be favourable or not after its appraisal; (2) Social factor or subjective norm which is the 
perceived social pressure to perform the behaviour or not; and (2) PBC. These factors in the prediction of 
intention may vary across behaviours and situations. Ajzen, based on empirical studies, stated that for 
behaviours that have been considered an individual’s personal attitudes tended to overshadow the influence of 
perceived social pressure.  
Next, Ajzen explained that the TPB have tried to not only predict human behaviour but also explain human 
behaviour through the role of beliefs via the expectancy-value model which suggested that salient beliefs 
could be the main determinants of an individual’s intentions and behaviours. The beliefs are: behavioural 
beliefs which influence attitude towards behaviour; normative beliefs underlie subjective norm and control 
beliefs provide basis for PBC. However a direct relation between the beliefs and the corresponding intention 
determinants has not been demonstrated. Despite this, Ajzen believed that it is at the level of beliefs that 
perhaps more understanding can be obtained about how one person can engage in positive health behaviour 
and another person might follow a different course of action. In addition, other predictors outside of the model 
that might help to predict intentions and behaviour reported were personal pressures/moral obligation or 
responsibility to perform, weighing the costs and benefits of an action (evaluative judgement) versus feelings 
after performing an activity (affective judgement) and the role of past behaviour.  
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Box 2.3 continued 
The Health Action Process Approach (HAPA)  
The HAPA has been developed by Schwarzer and Fuchs7 which is an extension of other behavioural models such as 
the health belief model (HBM) (not described in this chapter), the TPB and has been particularly influenced by the 
socio-cognitive theory (SCT).  
The authors explained that the adoption, initiation, and maintenance of health behaviour must be conceived as a 
process that consists of 2 stages: 1) motivational phase and 2) volitional phase which is further divided into i) 
planning phase, ii) action phase and iii) maintenance phase. Self-efficacy plays a crucial role at all stages (to adopt, 
initiate and maintain behaviour because if one does not believe in one’s capability to perform a desired behaviour 
they will fail), whilst other cognitions are of limited scope such as risk perception (perceived susceptibility and 
vulnerability of the HBM) which start the contemplation process early in the motivation phase but do not progress 
beyond it; outcome expectancies (attitude) are important in motivation phase when an individual thinks about the 
pros and cons of certain consequences of behaviours but they lose predictive power after a personal decision has 
been made.  
In detail, within the motivational phase (what people choose to do), outcome expectancies can be seen as the 
precursors of self-efficacy as people normally make assumptions about the possible effects of behaviours before 
inquiring whether they can take the action themselves. If self-efficacy is specified as a mediator between outcome 
expectancies and intention, then the direct influence of outcome expectancies on intention may dissipate. However, 
both factors are important for motivating change. In conditions where an individual does not know the behaviour to 
perform or, has no experience with the behaviour they are contemplating it is assumed that outcome expectancies 
may have a stronger direct influence. And when sufficient experience is gained then self-efficacy can effect the 
intention variable. Social outcome expectancies (a subset of outcome expectancies) should be considered as a 
determinant within the motivation phase. Our intentions and actions depend on our desire to maintain or enhance 
self-esteem or self-consistency within normative reference groups and from a social support perspective which 
suggests that people draw on their social networks and resources when making decisions. A certain amount of 
threat/risk perception helps to stimulate outcome expectancies which further stimulate self-efficacy.  
Although intentions are influenced by the socio-cognitive constructs, behavioural intentions are far from being 
sufficient to initiate a difficult action. The volitional phase consists of the postintentional and preactional stage. The 
authors explain this phase via the transtheoretical model (TTM) wherein, the preparation stage reflects a 
postintentional preactional state. In HAPA an individual at this stage prepares to carry out the intended behaviour 
by imagining scenarios of how and under what circumstances, they could perform the action -‘action plans’. Here 
self-efficacy plays an important role as individuals rely more or less on optimistic self-efficacy beliefs when facing 
self-imposed challenges. So when the individual carries out the action then that represents a successful outcome of 
cognitive activities in the planning and preparation stage.  
Once action is initiated, it needs to be controlled by cognitions in order to be maintained. Action has to be protected 
from being interrupted and abandoned prematurely due to incompatible competing intentions which may become 
dominant when carrying out behaviour. Self-efficacy will determine the amount of effort invested in perseverance 
(e.g. self doubt – chance of failure, optimistic self-efficacy – chance to succeed). Self-efficacy helps to re-establish 
(through action plans and goals) the perseverant efforts needed for the accomplishment of self-imposed goals. All 
this depends on the evaluation of the success or failure and attributes the perceived outcome to possible causes. 
Depending on this cognitive event, emotions and expectancies are varied and volitions strength may be increased or 
decreased for subsequent similar actions. Situational barriers play a part here too – influenced by perceived and 
actual environment.  
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Table 2.4 Summary of factors that influenced participation, mainly attendance in ongoing SM 
services 
Study (year); theoretical model, 
n=4 
Factors 
(g) Gucciardi (2009); Andersen’s socio-behavioural 
model 
Contextual factors; 
Enabling factors; 
Predisposing factors 
(h) Sniehotta (2010); Self-Regulation model and 
Theory of Planned Behaviour and action planning 
Intention; 
Action planning  
(i) Dohnke (2010); Health Action Process Approach Motivation;  
Intention 
(j) Pentecost (2011); Conceptual model of exercise 
uptake 
Exercise identity;  
Availability of support;  and  
Perceived benefits of attending 
 
(g)  
Gucciardi et al167 utilised Andersen’s socio-behavioural model (Box 2.2) to identify factors 
that influenced the ongoing utilisation of diabetes self-management education services 
(DSME) (comprised diabetes counselling or educational classes) over a one year period. The 
study rationale was that these services undergo high attrition rates and evidence suggested 
that those who dropout prematurely adhere less to SM activities and have worse glycaemic 
control.  
The following factors influenced the ongoing utilisation of DSME services:  
Contextual factors or health system characteristics such as the referral source to the diabetes 
management centre (DMC), which was an important predictor of DSME utilisation. 
Self-referrals were higher than primary care referrals perhaps because these patients were 
highly motivated and more proactive in seeking DSME support; different delivery methods 
adopted by the participating DMC might have influenced greater utilisation from Centre 2 in 
comparison to Centre 1. (DMC 2 delivered SM education more frequently, classes were less 
intensive and included options on delivery of interest-specific modules to patients which may 
have led to further patient participation in centre 2.)  
 
Enabling factors such as employment status enabled DSME utilisation and patients were less 
likely to attend the DMC which had highly structured or inflexible interventions.  
 
Within predisposing characteristics, men were less likely to utilise DSME than women. 
Patients who smoked were less likely to follow up DSME services. Perception of health 
status also influenced utilisation of DSME services - high BMI scores led to decrease in mean 
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number of contacts, possibly due to embarrassment. Utilisation was not associated with 
HbA1c values. Furthermore, recently diagnosed patients had lower usage of DSME services 
than those living longer with diabetes - one explanation was perhaps these patients 
experienced fewer symptoms and complications and did not realise the preventive benefit of 
DSME.  
 
(h)  
Sniehotta et al170 tested, compared, and combined the SRM and the TPB with action 
planning (Box 2.3) to predict physical activity during phase III cardiac rehabilitation (CR) 
and attendance in phase IV CR amongst coronary heart disease (CHD) patients. Phase III CR, 
in the UK, is a hospital-based structured exercise programme and includes provision of 
education and psychosocial support; Phase IV CR is a recommended community-based 
programme to promote long term adherence to physical activity and a beneficial lifestyle. 
This phase IV CR public health service sat outside of the NHS.  
The results of this study are presented only with respect to factors influencing attendance and 
not levels of physical activity. After measuring participants’ illness perceptions with regard 
to their ‘heart condition’, predictors of behaviour (intention and PBC) regarding ‘attending 
phase IV CR’, and action planning items, the results suggested that intention and action 
planning (i.e. when and where to attend the programme whilst in the last week of phase III 
CR) were strong predictors of phase IV CR uptake and illness perceptions were not.  
 
(i)  
A German study by Dohnke171 utilised the HAPA to identify factors that influenced 
participation in phase III CR six months after participation in phase II CR (an inpatient 
programme).  
The study participants in the ‘motivational phase’ were labelled ‘non-intenders’; and those in 
the ‘volitional phase’, in the ‘preactional’ stage, – were labelled ‘intenders’ and those at the 
‘actional’ stage – were labelled as ‘actors’.  
In phase III CR 31% participated (‘actors’). Amongst non-participants, 13% were ‘intenders’ 
and 56% were ‘non-intenders’. Patients who ‘intended’ to participate expected more positive 
consequences and reported higher self-efficacy in comparison to ‘non-intenders’. However, 
risk perception and negative outcome expectancies did not differ significantly between 
‘intenders’ and ‘non-intenders’. An explanation given was that negative behavioural 
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consequences seemed to be a characteristic of the mindset of ‘non-intenders’ and ‘intenders’ 
and a decrease in negative outcome expectancy characterises the mindset of ‘actors’. 
Thus, expecting negative consequences as a result of participation in phase III CR prevented 
‘intenders’ translation of their intentions into action. Regarding risk perception, the authors 
suggested that risk perceptions should still be considered as a factor that influences 
motivation because all patients were well informed about any personal risks after phase II 
CR.  
Amongst ‘actors’ and ‘intenders’, ‘actors’ reported higher self-efficacy and expected more 
positive outcomes in comparison to ‘intenders’. The cognitive constructs amongst ‘non-
intenders’, ‘intenders’ and ‘actors’ differed significantly and above age, gender and eligibility 
of phase II CR which confirmed the independent influence of these factors.   
Regarding dropping out of the phase III CR programme at 12 months follow up, 21% of 
participants were programme dropouts in comparison to maintainers (79%). Dropouts had 
lower intention and ‘maintenance self-efficacy’ which were reported as the strongest 
predictors of dropout. They also appeared to have lower ‘recovery self-efficacy’. Dropouts 
from phase III increased with decrease in ‘actors’ intention and maintenance self-efficacy. 
One reason given was that a new behaviour cannot be maintained with strong intention alone. 
Here self-regulatory skills and strategies to cope with barriers might occur after adopting the 
new behaviour which is reflected by maintenance self-efficacy. Recovery self-efficacy was 
not predictive. Both constructs of self-efficacy were considered important by the study 
because these constructs support the stage-specific differentiation (mindsets) whereby 
recovery self-efficacy may reflect the confidence an individual has in strategies for 
readopting phase III CR after a break and not in maintaining exercise. In addition, volitional 
factors such as intention and maintenance self-efficacy differed between ‘actors’ and those 
‘actors’ who did and did not drop out of the programme.  
 
(j)  
In a qualitative study, Pentecost172 developed a new conceptual model of exercise uptake 
and adherence from exploring factors that influenced participation in community-based 
exercise programmes amongst patients with chronic disease. These exercise programmes 
were funded by the UK primary care trusts (PCTs) to increase physical activity for the 
prevention and treatment of chronic disease and included exercise-on-referral services, a 
pulmonary rehabilitation service, community venues with local authority facilities and PCT 
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subsidized exercise classes. The study explored patients’ views based on different attendance 
levels: non-attendance; low attendance (those who did not attend the programme following 
assessment or dropped out of the exercise programme); and high attendance (those who 
completed the programme as per the criteria of the programme and who were continuing with 
exercise post programme). 
The core categories of the model comprised of ‘exercise identity’, ‘benefits of attending’ and 
‘support’ (Figure 2.7).  
 
Figure 2.7 A new model of exercise uptake and adherence for people with chronic conditions 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Pentecost 2011 
 
Exercise identity was the way an individual described themselves in relation to exercise or 
physical activity and how this description influenced exercise behaviour. The major 
influences on exercise identity were social and cultural norms which were dependent upon: 
age – expectations of physical ability, when comparing themselves to younger people, 
influenced exercise behaviour; gender – men who wanted to see themselves as sporty and 
women who wanted to see improvement in health attended to exercise; and cultural identities 
– such as nurturing activities (e.g. finding time to exercise when experiencing family time-
related pressures), and body shape e.g. big body shape was considered normal in some ethnic 
groups. These latter social and cultural norms impacted upon expectations of appropriateness 
and influenced importance of exercising and confidence to exercise. However confidence and 
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importance independently impacted on willingness to overcome pre-existing social or cultural 
identities in order to exercise.  
Perceived benefits of attending specifically, positive social or psychological benefits were 
more important than physiological benefits for high attenders. The social benefits comprised 
comparison with others (how others were coping with the condition) and put their problems 
in perspective, and group or peer support (perceiving everyone was similar, was like a club). 
These social benefits had psychological benefits including increased confidence to exercise 
and increased optimism about the future. In addition, attendance was important to people who 
believed their discomfort could be reduced, feeling low or loneliness could be abated 
(referred to psychological and sociological motivators)  
Support was associated with both uptake and adherence and was a key factor in overcoming 
negative exercise identities, increasing confidence and importance to exercise and impacted 
upon perceived benefits of attending and benefits of uptake.  
So, non-attendance occurred when importance or confidence to exercise was low in 
association with lack of support.  
The factors associated with attendance were presence of psychological and social motivators 
for attending, availability of support and overcoming negative exercise identities through 
support.  
Low attendance was a result of low levels of support and lack of perceived benefits.  
Adherence or high attendance or completion was most strongly associated with the perceived 
benefits of attending and support. 
 
2.3.2.3 Theoretical factors that may predict or influence attendance in 
self-management interventions or in studies of self-management 
interventions   
Among the 25 included studies, 15 studies (Table 2.2), described below, predicted, described 
or explained attendance and/or non-attendance, including dropout behaviour, in SM 
interventions via the following five health behaviour theories: the Self-Regulation Model 
(SRM), the Necessity-Concerns Framework (NCF), the Theory of Planned Behaviour (TPB), 
the Attitude-Social Influence-Self efficacy (ASE) model or the Stage of Change (SoC) 
model. The aim of these studies was to understand these behaviours and target the cognitions 
of patients with chronic disease to help improve the uptake of the intervention  
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Box 2.4 except the TPB (described in Box 2.3) briefly describes the four remaining theories. 
Table 2.5 presents a summary of the theoretical constructs that explained patient attendance 
and/or non-attendance behaviour. 
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Box 2.4 Brief description of the Necessity-Concerns Framework, the Attitude-Social Influence-
Self-efficacy model and the Stage of Change theory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Necessity-Concerns Framework (NCF)  
Horne9 suggested that to understand adherence, more importance should be given to an individual’s treatment 
perceptions. Horne explained treatment adherence via the Necessity-Concerns framework (NCF) which are 
essentially summative evaluations (about potential benefits and costs about a treatment where, one aspect is 
perceptions of necessity or personal need for the treatment and concerns about the negative effects. These two 
categories were commonly reported from exploration of beliefs about medicines. Studies had demonstrated 
that medication beliefs were stronger predictors of adherence in comparison to clinical and demographic 
variables. Adherence was positively correlated with necessity beliefs and negatively correlated with concerns. 
Horne confirmed that an individual’s judgement about their personal need for the treatment relative to their 
concerns would have a greater influence on uptake of treatment and adherence than considering these beliefs 
in isolation. Hence treatment adherence was related to the NCF and it was suggested that these conclusions 
could extend towards other treatments e.g. rehabilitation.  
Horne believed there was a symbiotic relationship between the NCF and the CS-SRM whereby the CS-SRM 
helps to understand how treatment perceptions influence adherence; furthermore, perceptions of treatment 
necessity and concerns in relation to illness beliefs and treatment perceptions can be used to extend the 
explanatory power of the CS-SRM in relation to treatment adherence. 
 
The Attitude-Social influence-Self-efficacy (ASE) model  
According to de Vries14 an individual’s health behaviour was explained mostly from attitude and 
social influence socio-cognitive variables. de Vries wanted to show that a third cognitive factor, personal 
efficacy expectations or self-efficacy was also a relevant variable in explaining  behaviour. de Vries first 
described ‘attitude’ and ‘social influences’ from the Fishbein-Ajzen model12, Attitude is determined by: 
(i) the expectation of various consequences and beliefs about the behaviour, and (ii) the corresponding 
evaluations of these consequences; Subjective norms consist of: (i) the expectation of other important persons 
opinions, normative beliefs, and (ii) the degree to which an individual is inclined to agree with these opinions, 
their motivations to comply.  
Following on, de Vries adopted self-efficacy from Bandura’s (1977) social learning theory, behaviour and 
behavioural change depend on both outcome expectations and personal efficacy expectations. 
Outcome expectations consist of beliefs about whether a particular behaviour will lead to particular 
consequences. de Vries explained that outcome expectations match closely with Fishbein-and Ajzen’s 
conception of beliefs regarding the ‘attitude’ variable. Self-efficacy refers to a person’s expectation regarding 
his capability to realise a (desired) behaviour. It does not reflect a person’s skills but rather one’s judgements 
of what one can do with whatever skills one possesses. Hence self-efficacy is related to beliefs about 
capabilities of performing specific behaviours in specific situations. 
Based on the above, de Vries proposed the ASE model to explain behavioural intentions and behaviour. He 
suggested that when someone intends to perform a particular behaviour, it is determined by personal 
conceptions concerning the behaviour (attitude), the social pressures experienced from other important 
persons (subjective norms) and personal expectations about the skills needed to realise the behaviour 
(self-efficacy). These three variables are proximal social cognitive factors and together they result in the 
intention to perform the behaviour (Figure 2.8). 
 
 Attitude  
Intention  
Self-efficacy  
Subjective norm  
Skills  
Behaviour  
 
 
Figure 2.8 The Attitude-Social influence-Self-efficacy model 
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Box 2.4 continued 
 
 
 
 
 
 
 
 
 
 
 
The Stages of Change (SoC) theory   
The Trans-theoretical model (TTM) was developed by Prochaska, DiClemente and Norcross in 1992.6 11 In 
this model, behaviour change is conceptualised as a process that takes place over time and involves 
progression through five stages which explain when a particular shift in attitudes, intentions and behaviours 
occur. The steps are supposed to be sequential but are cyclical and recycled before an individual obtains the 
desired behaviour change. The five stages of change are: Precontemplation – there is no intention to change 
behaviour in the foreseeable future; Contemplation – patients are aware that a problem exists and are thinking 
about overcoming it but have not made a commitment to act; Preparation – individuals are intending to take 
action in the next month and have started to make some small changes; Action – individuals modify their 
behaviour, experiences and/or environment to overcome their problems (time period for an individual to be 
considered in the action stage is from one day to six months); and Maintenance – individuals work to prevent 
relapse and consolidate the gains achieved in the action stage (extends from 6 months to an indeterminate 
period past the initial action).  
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Table 2.5 Summary of factors that might influence/influenced attendance and/or 
non-attendance behaviour 
Study (year); use of theoretical model, 
n=15 
Factors  
During hospital admission 
(k) Petrie (1996); SRM Controllability/Curability 
(l) Cooper (1999); SRM and TPB Controllability;  
Cause associated with lifestyle; 
Intention 
(m) Wyer (2001); SRM and TPB Controllability; 
Cause; 
Attitude;  
Subjective norm  
(n) French (2005); SRM No influence of theory 
(o) French (2006); SRM Controllability/Curability 
(p) Cooper (2007); NCF Perceived necessity; 
Perceived concerns 
Following hospital discharge prior to programme attendance 
(q) Whitmarsh (2003); SRM Identity;  
Consequences;  
Cause; 
Emotional representations 
(r) Cooper (2005); NCF Cause;  
Perceived necessity 
Following attendance and/or non-attendance in programme 
(s) Blair (2013); SRM Cause   
(t) Wyer (2001); SRM and TPB Cause; 
Consequences;  
Controllability/Curability 
Descriptive study 
(u) Keib (2010); SRM and SRM-NCF  Identity; 
Timeline;  
Consequence; 
Cause;  
Controllability;  
Intervention representation;  
Perceived necessity;  
Perceived concerns 
 
(v) Helitzer (2007); Stage of Change (SoC) Action stage  
(w) Toth-Capelli (2012); SoC No influence of theory. 
(x) O’Brien (2009); SoC and optimism Action;  
Maintenance stage 
 
(y) Lemaigre (2005); ASE Attitude; 
Social influence;  
Self-efficacy (external barriers)  
 
Out of the 15 studies, 11 studies had either utilised the SRM or in combination with the NCF 
or in combination with another theory, the TPB to explain attendance and/or non-attendance 
in CR amongst patients with CHD at different points in the illness journey either 
prospectively or retrospectively. Among these 11 studies, the attendance or non-attendance 
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behaviour was explained in six studies among hospitalised patients; in two studies among 
patients following hospital discharge but prior to their programme attendance; in two studies 
among patients following their attendance or non-attendance in the programme; and one 
study described the process of attendance and non-attendance. The patient perceptions were 
assessed by the studies through use of the Illness Perception Questionnaire (IPQ)203 or the 
Revised Illness Perception Questionnaire (IPQ-R)13 and the CR questionnaire.180 
Three out of the 15 studies utilised the SoC theory to predict attendance and dropout 
behaviour in CR, in diabetes SM or a weight management intervention 
One study out the 15 utilised the ASE model to study intention to participate in an asthma 
SM programme.  
 
Patients’ perceptions assessed during hospital admission: 
(k)  
In one of the earlier studies Petrie173 utilised the IPQ to assess patients’ illness beliefs. The 
results indicated that patients, admitted with a first myocardial infarction (MI), with stronger 
beliefs about ‘controllability/curability’ were more likely to attend an outpatient CR 
programme. 
 
(l)  
Cooper et al174 utilised the IPQ amongst hospitalised patients who had suffered an acute MI 
or those who had undergone coronary artery bypass graft (CABG) surgery to predict CR 
attendance and an additional question on ‘intention’ to attend (a feature of the TPB) CR was 
also posed. Of recruited patients, only 40% “had actually attended CR”. The study suggested 
that patients’ illness beliefs were not influenced by them undergoing CABG surgery or 
having a MI, but their beliefs were already established by having CHD over a number of 
years, and by gaining knowledge of the condition from the prevalence of CHD in society. It 
was suggested that patients may have also drawn beliefs from media coverage and the 
experiences of friends and colleagues and these beliefs may have remained fairly stable over 
the varying course of their own illness. However, the study did show that certain illness 
perceptions measured during hospital admissions were associated with future CR attendance; 
patients with stronger beliefs that their condition was controllable and those who attributed 
the condition to their lifestyle ‘cause’ showed higher attendance in CR, suggesting that this 
causal belief was associated with a commitment to change behaviour. Patients’ knowledge of 
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the risk factor cholesterol was associated with attendance while their knowledge of blood 
pressure was not, perhaps because people perceived they had more control over their 
cholesterol owing to dietary changes than over their blood pressure. As patients in the study 
were first time acute MI patients under 65 years of age, they perceived their condition was 
controllable or curable and hence they were more likely to attend CR.  
Although 40% of patients actually attended CR, 72% had expressed an intention to attend CR 
and the intention to attend rate in those actually attending CR was over 90% in comparison to 
58% amongst those not who did not attend. This suggested that intention to attend was a 
useful indicator but insufficient to predict future health behaviour.   
 
(m)  
Wyer et al182 had conducted a literature review to identify factors that influenced CR 
attendance, via the SRM and the TPB, with the aim to suggest how participation in CR might 
be increased. The review included the abovementioned studies by Petrie173 and Cooper174 and 
showed that CR attendance was limited to control/cure and cause variables. 
Wyer explained that those who attended CR believed strongly their friend/family and HCP 
wanted them to attend the programme (subjective norm), they perceived fewer barriers to 
attending (PBC) and perceived CR was beneficial to their health (attitude). Attenders were 
also confident that the programme would help them to initiate a healthy lifestyle and adhere 
to medications and they perceived that the programme might help to prevent another heart 
attack (attitude).  
 
(n)  
A study by French176 prospectively assessed illness perceptions of patients with MI in 
hospital and assessed outpatient CR attendance and health-related quality of life at six months 
follow up. Although one session of the programme was attended by 45% of the patients, 
unlike the previous studies, attendance was not related to any of the illness perceptions.   
 
(o)  
Due to the inconsistent results reported in the above studies, French177 conducted a systematic 
review and meta-analysis which investigated whether illness perceptions predict CR 
attendance, and which specific perceptions were most strongly related to CR attendance 
amongst patients admitted with acute myocardial infarction (AMI). The review (comprising 
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11 studies including the three studies mentioned above) concluded that AMI patients with 
positive ‘identity’, ‘cure/control’, ‘consequences’ and ‘coherence’ beliefs were more likely to 
attend CR. Specifically, the cure/control beliefs were the strongest predictors where the 
patients believed their condition was curable and controllable they were more likely to attend 
CR.  
Regarding disease identity, the perceived symptoms associated with the condition, rather than 
severity of the condition determined CR attendance.  
Regarding coherence beliefs, where the condition did not make sense to the patient then they 
were less likely to attend CR. The lack of understanding about the nature of AMI, or the 
underlying disease process which caused the AMI, resulted in patients not seeing the 
importance or relevance of behavioural interventions such as CR.  
In addition, if patients’ perceived their condition was a result of a one-off stressful event 
(cause) rather than a result of an atherosclerotic plaque, then they might not have understood 
why they were being asked to exercise and/or change their diet.  
 
(p)  
Cooper et al180 assessed the perceptions of AMI patients admitted in hospital via a 
questionnaire about CR based on the NCF alongside assessment of their illness perceptions 
to predict attendance. The results demonstrated that attenders were more likely to believe that 
CR was ‘necessary’ and understood its role; patients who felt CR was more ‘suitable’ for 
younger, active patients were less likely to attend CR, and there was some suggestion that 
patients who were ‘concerned’ about exercise, or who reported ‘practical barriers’ to 
attending CR, were less likely to attend.  
 
Patients’ perceptions assessed following hospital discharge but prior to their 
programme attendance: 
(q)  
Whitmarsh et al,175 in a cross-sectional study assessed illness perceptions of CHD patients 
who were discharged from hospital before attendance in an outpatient CR programme to 
predict and differentiate between attenders and non-attenders. The results suggested that 
attenders perceived a greater number of symptoms (identity) and consequences as a result of 
their illness, experienced greater distress (emotional representation), and attenders had less 
strong beliefs that their illness was a result of a germ or virus (cause) and as a result, used 
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problem-focused coping strategies (e.g. actively planning) more frequently. While, non-
attenders perceived less severity of symptoms and controllability/curability of illness, and 
used more maladaptive coping strategies (e.g. denial).  
 
(r)  
Cooper’s179 study explored patients’ beliefs about the role of CR amongst patients discharged 
from hospital following a MI but before attendance to CR to understand barriers to CR 
attendance and explain their findings via the NCF. As part of usual care, patients were 
informed about their disease such as cause of the MI, the content and role of CR was 
explained following which patients were then invited to attend the programme. The findings 
suggested that the patients’ were unaware of the course content, assumed that CR comprised 
of only exercise, and did not understand how exercise would help with their recovery 
(intervention representation). Some patients perceived that exercise would be more suitable 
for people who were fitter and was not for people who have just had a heart attack. 
In addition, patients had misconceptions about the cause of MI and lack of cardiac knowledge 
led some patients to doubt the necessity or appropriateness of the course. Patients did not 
realise that their heart attack was a result of underlying CHD and could happen at rest; 
patients perceived their illness was a one-off, discrete event, unconnected to underlying 
disease and that it could only happen with a trigger e.g. an unstable emotional state. As a 
result, Cooper suggested that these patients would be less likely to make lifestyle behaviour 
changes and would not attend CR. Furthermore, patients who were unsure how CR was going 
to help were more likely to cite transport barriers.  
 
Patients’ perceptions assessed following their attendance or non-attendance: 
(s)  
A recent study178 assessed CHD patients illness perceptions, via a postal survey, who had 
been offered CR over two years ago and also explored whether non-modifiable factors, such 
as socio-demographic and social isolation, influenced attendance at hospital-based/outpatient 
CR. The results showed that only illness perceptions significantly influenced non-attendance. 
Non-attenders had higher illness perceptions scores particularly with respect to perceived 
cause of the illness. These patients did not believe the cause of disease, or risk factors, could 
be modifiable (smoking behaviour, poor diet, inactivity). Hence these patients might be less 
likely to attend CR and adopt health-related or lifestyle behaviours. 
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(t)  
In a qualitative study by Wyer183 patients’ perceptions or beliefs were explored amongst CR 
attenders and non-attenders and the findings were interpreted via the SRM and the TPB. The 
results suggested that one difference between attenders and non-attenders was that the 
majority of attenders held a psychological model of health whereas non-attenders held a 
medical model of health. This was because attenders and non-attenders differed in their 
beliefs particularly regarding responsibility for illness (control) and treatment of illness 
(cure). Attenders saw themselves as being more responsible for their health and wanting to 
achieve more good health, whereas non-attenders felt that their recovery was the 
responsibility of professionals and gave medications a lot of importance. Unlike non-
attenders, attenders were more likely to attribute their MI to their own lifestyle (cause), 
viewed their illness as having serious consequences but believed that they could have control 
over it.  Regarding coping strategies, attenders used strategies such as information-seeking 
which was often seeking help from others, as a coping behaviour, whilst non-attenders 
seemed more likely to use avoidance strategies, such as denial or minimisation. 
Utilisation of the TPB showed that an individual’s ‘attitude’ towards CR and the ‘subjective 
norm’ in the form of medical recommendation was important in the decision-making process. 
In terms of ‘attitude’, beliefs about outcome were important with those believing that the CR 
programme was going to improve their health and reduce the chances of recurrence and were 
more likely to attend. Interesting findings were that few had a proper understanding of the 
course content, with non-attenders seeming to have poorer understanding. But this could be 
explained in a way that non-attenders may be rationalising their decision not to attend. In 
‘subjective norm’, referral by a professional had been found to be the single most important 
motivating factor for both men and women attending CR programme; recommendations from 
nurses also appeared to have an impact. 
On comparison of the findings, the study concluded that attendance could have been a result 
of an individual giving their illness meaning, who then explored ways of coping (SRM) as a 
precursor to thinking about CR and whether the programme was recommended (TPB). 
 
127 
 
A descriptive study explaining patient attendance and non-attendance behaviour 
(u)  
Keib181 in their descriptive study explained how illness representations of older adults with 
CHD in relation to perceptions of the purpose and benefits of intervention representations 
(CR) via the SRM and the SRM-NCF may influence CR participation behaviour. 
Understanding participation behaviour in CR in this study was to help guide the development 
of tailored interventions for the CHD population at risk and to help improve participation 
rates of CR. According to Keib, patients were less likely to attend CR if an individual 
interpreted CHD symptoms negatively (disease identity); perceived a CHD event to be an 
acute event that could be fixed in short term (timeline); perceived CHD did not affect quality 
of life (consequence); was unaware, or had no knowledge, about the cause of disease (cause); 
believed that own efforts would not help to control disease or that a recommended treatment 
might not bring benefits (controllability); with negative perceptions about the exercise 
component of the programme (intervention representation); perceived CR was not necessary 
to improve health (necessity); was perhaps more appropriate for younger patients (suitable) 
and was concerned about the exercise component of the programme including practical 
concerns to attendance (concerns). Figure 2.9 illustrates CR utilisation using the SRM. Keib’s 
framework below was utilised for the qualitative synthesis in Chapter IV. 
 
Figure 2.9 The SRM of CR utilisation 
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(v)  
Helitzer185 assessed low attendance in a diabetes prevention programme and the study 
concluded that the SoC model may be a good predictor of attendance (there was a 
relationship between high attendance and being in ‘action’ stages of change for individual 
diabetes preventive behaviours e.g. eating healthily), but further research was needed.  
 
(w)  
Toth-Capelli186 assessed dropout behaviour of obese patients in a weight management 
programme but found the SoC model could not predict dropout behaviour.  
 
(x)  
O’Brien187 utilised the SoC model and dispositional ‘optimism’ to explain attendance in 
phase III CR programme (supervised exercise delivery in a hospital setting) amongst patients 
with CHD who had attended the programme. The findings suggested that patients who were 
in the action and ‘maintenance’ stages were more likely to adhere to the programme. Non-
adherers were pessimists who believed that, regardless of what they did, the outcome would 
be the same and hence they reduced their efforts and quit.  
 
(y)  
Lemaigre184 had utilised the ASE model to predict intention to participate in an asthma SM 
programme by means of a structured interview amongst patients with asthma but with no 
prior experience of participation in an asthma SM programme. The structured interview was 
based on the proximal socio-cognitive factors of the original ASE model and was piloted to 
identify patients’ beliefs about the asthma SM programme via open-ended questions. 
The questions addressed the possible advantages of, and barriers to, participating. Following 
the pilot, the answers were used to draft a final structured interview which was administered 
to study participants.  The questions assessed the patient’s ‘attitude’ toward the programme in 
terms of personal benefits, assessed beliefs about barriers to participate – set up as a 
‘self-efficacy’ measure and assessed ‘social influence’. The questionnaire also included 
patient characteristics and health outcome measures (referred to as distal factors that can also 
explain behavioural intention). 
The significant predictors of intention behaviour were educational level (high), perceiving 
personal benefits (having a more positive attitude), self-efficacy (having fewer barriers to 
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participate – having higher self-efficacy expectations)3 and social influence (higher influence 
for better self-care). Figure 2.10 illustrates the factors that explained intention to participate 
in an asthma SM programme. Lemaigre’s framework below was also utilised for the 
qualitative synthesis in Chapter IV.  
Figure 2.10 The ASE framework 
 
 
 
 
 
 
 
 
 
 
 
                                                          
3 A factor analysis of the structured interview questions resulted in the self-efficacy scale including external 
barriers. The barriers to participate were identified as: no time, living too far away, financial barriers or program 
characteristic such as group-based. This limitation where the cognitive variable was not explored as intended in 
the study was acknowledged by the study author. 
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Based on the preceding work, Figure 2.11 summarises the social/psychological/behavioural 
factors that may influence health care utilisation and participation in SM interventions 
amongst patients with chronic disease. 
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Figure 2.11 Illustration of socio-behavioural, interpersonal and psychological factors that may influence participation in health care and health care/ 
self-management interventions among patients with chronic disease 
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2.4 Discussion  
The aim of this review was to present the meanings, concepts and definitions of patient 
participation in health care and identify factors, using theory, that influence health care 
seeking behaviour and participation in SM interventions amongst patients with chronic 
conditions. The scope of this review, unlike a conventional systematic review, was to identify 
key papers from various sources to understand the various meanings given to the concept 
‘patient participation’ in health care; to differentiate, where possible, between ‘patient 
participation’ and the many interchangeable terms often used in the literature e.g. ‘patient 
involvement’; and, to review various theoretical or conceptual frameworks that have 
explained patient participation in health care and SM interventions. This section compares the 
findings of the review between the included studies and with other literature. 
 
2.4.1 Conceptual confusion 
2.4.1.1 What is the meaning of ‘patient participation’ in health care? 
Comparison among the included studies of the review 
The emphasis placed by governments on patient involvement in their health and health care 
led several studies to explore and examine the various meanings and definitions given to the 
term ‘patient participation’ in health care.  
The dictionary definition of ‘participation’ and ‘non-participation’ were in line with the 
definitions given in the glossary of the thesis. In addition, this conceptual review took 
account of all the varied definitions that were presented in the included literature and 
regardless of the type of approach, or philosophy or perspective underlying the definition of 
patient participation, the various definitions could be assembled into a broad 
patient/individual context and a patient-professional context. In addition, the distinction and 
relationship between ‘patient participation’ and its synonymous terms was also deduced in 
this review (Figure 2.3). 
The findings of this review (the numerous patient participation definitions), supports the 
contention in previous reviews135,138 examining the meaning of patient participation in health 
care, that there are indeed, many functions that are associated with the term ‘patient 
participation’. However, instead of seeing the functions as distinct entities which as the 
previous studies135,138 had done, this review has helped in understanding that patient 
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participation/active patient participation for patients, particularly those with chronic disease, 
is about taking responsibility for their health themselves, individually and within a clinical 
setting, through patient engagement, patient-centred care, patient partnership, and shared 
decision-making. The aim is to help patients participate in and take responsibility for, their 
health and their use of health care. 
Specifically, within an individual context, the meaning of the term ‘patient participation’ was 
about an individual ‘actively’ making decisions about their health and health care; performing 
self-care tasks; and taking responsibility. Patients who participate in care were labelled as 
‘engaged’ or ‘active’ which meant they asked questions, sought explanations, stated 
preferences, and expected to be heard. 
Within the patient-professional context, the definitions of ‘patient participation’ included a 
role for both patients and professionals. The role of patient was similar to that mentioned in 
the individual context above while, the role of the professional was to involve negotiation, 
identify from patients what they want and need. Within this context, the patient had to be 
involved in decision making, and the outcome of the interaction was that the patient would 
accept responsibility with the help of the professional - thus the label given here to a patient 
was ‘co-producer’. The setting included transfer of control from professional to patient, an 
established relationship and active mutual engagement between patient and professional.  
Furthermore, the various synonymous terms for ‘patient participation’ can be included into 
‘patient participation’: ‘patient partnership’ or ‘patient collaboration’ denotes the working 
together of patient and professional; ‘patient-centred care’ denotes encouraging patients to 
participate as a partner in their care, or to be active; ‘shared decision-making’ denotes the 
dialogue decisions that are co-determined/co-produced by patient and professional; and 
‘patient engagement’ denotes negotiated empowerment. And within policy documents patient 
participation is ‘patient involvement’ in health and health care.  
 
Comparison with other literature 
Within studies that have examined or included the meaning of patient participation in health 
care, the role of actively participating in health and health care was largely attributed to 
patients with chronic disease81 as they have more responsibility compared to those who suffer 
with acute conditions204 and participation was seen necessary for management of the chronic 
illness.135 The sick role – that includes ‘the person exempt from normal role’, ‘the person is 
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not responsible for his/her condition’ was not considered appropriate for patients with chronic 
disease.204 Instead, a new role was felt more appropriate, the ‘impaired role’ where ‘the 
individual with chronic illness does not give up normal role responsibilities but is expected to 
maintain normal role behaviour within the limits of the illness, the individual does not have to 
‘want to get well’ but is encouraged to make the most of the remaining capabilities”.  
One health policy initiative153 to encourage patients to participate in their care was through 
delivery of the EPP – to give people the skills and learning to promote self-care/self-
management, a concept taken from the self-care movement of the 1960s and 1970s. However, 
sociologists believe that delivery of the EPP is no longer about what patients should do to 
manage their health but, that patients should become, ‘empowered’, ‘activated’ and 
‘expert’157 and that if patients with chronic disease do not adopt this role then they are 
considered deviant or inconsistent with their medical condition204 or shifting away from 
responsibility.55 
 
However, the review highlighted the fact that not all patients with chronic illness want to 
participate in their care, including participating in health care/self-management interventions 
and this has been acknowledged elsewhere.159,204 In addition, participation may change with 
time and across different phases of the disease and treatment e.g. patients with chronic 
disease in one study188 did not want to participate in care while receiving care in an 
emergency department but expected to participate in their care at outpatients. In another 
study135 chronic disease patients did not want to get involved in decisions and were confident 
in the care and treatment they received from professionals. 
 
Within a patient-professional setting, two studies136,148 found that patient participation was 
not static, but a dynamic process due to the influence of multiple patient, professional and 
contextual factors. Haidet136 described a hierarchy of decreasing levels of patient 
participation comprising: negotiated empowerment which denoted ‘patient engagement’, self-
motivated change, adherence, unguided searching and passivity. The level of participation 
depended on a patient’s perspective of their illness, and the actions taken as a result of the 
illness including partnership with the professional.  
Thompson148 developed a taxonomy placing patient-determined involvement and 
professional-determined involvement in parallel (in increasing order 0 to 4) to each other. In 
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patient-determined involvement, level 3 denoted ‘dialogue’ while in professional-determined 
involvement, level 3 denoted ‘shared decision-making’. As a result, Thompson called this 
level ‘patient participation’ and explained that this level meant that if a patient desired to be 
involved in decision-making, it would only be possible if a health professional allowed the 
patient to engage in dialogue, express opinions and make decisions. In addition, the different 
levels of patient involvement (such as, autonomous decision-making, shared decision-
making/participation, information-giving, information-seeking, non-involvement) was 
dependent upon the nature of health care need, e.g. there was an increased chance of 
involvement among chronic disease patients because of their longer experience and greater 
knowledge of the condition, patient characteristics linked with personality factors and a 
patient-professional relationship characterised by trust. In addition, Protheroe193 reported that 
shared decision-making was difficult and this partnership working was mostly seen among 
young, female, educated patients with higher socio-economic status and similar values as 
health professionals and this has been reported previously.194 
Furthermore, Protheroe205 in another recent study, on exploration of understanding of 
participation from chronic disease patients of low and high socio-economic status, found that 
patients from lower socio-economic groups felt they were less able to ask questions to the 
doctor and if they did it was mainly about medicines, while some thought it was not their role 
to question the doctor as it could be taken that they do not trust the doctor. The wider 
proactive questioning about diagnoses and management plans was reported among patients 
with higher socio-economic groups and understanding in detail about chronic illness and its 
management positively reinforced engagement with active self-management and shared 
decision-making.  
 
To understand ones illness and its treatment was the meaning given to ‘patient participation’ 
by patients with chronic disease in one of Eldh’s studies188 that went beyond 
decision-making. In addition, from Eldh’s several studies,188-191 ‘patient participation’ to a 
patient living with chronic disease in an outpatient clinical setting meant being confident, 
being in control, gaining knowledge and being respected. Conversely, non-participation 
meant not being in control, lack of support from professionals, not having the same 
information as or not receiving information from professionals, not being respected or 
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listened to. These meanings could perhaps be viewed as factors that may influence a patient 
with chronic disease to participate in the consultation with the professional.  
Eldh, in one study,190 also observed the interaction between patients and nurses and reported 
that the interaction was dominated by nurses and patients just following their initiative. The 
lack of engagement of professionals as an influence on patient participation has been reported 
previously.194,206 One study194 found that patients were active participants in clinical 
consultations when professionals frequently engaged in partnership-building (e.g. through use 
of open-ended questions) and supportive talk (such as encouragement) and so professionals’ 
lack of engagement could affect patient participation in medical consultations.194 Some 
patients with chronic disease, e.g. those with lung cancer interacted more with professionals 
in comparison to patients with systemic lupus erythematosus. Street194 explained that this 
could be because patients with lung cancer were fearful and uncertain about their new 
diagnosis and more time might have been allotted to them than to patients with lupus. The 
same study reported other contextual factors such as type of practice and medical speciality 
that could influence active patient participation; in addition, they found white patients 
initiated more active participation than non-white patients which was explained not owing to 
demographics but the communicative style of professionals particularly, lack of any 
encouragement given to non-white patients. This lack of engagement among professionals 
could either be due to their understanding of patient participation being different to what is 
expected from their new role; they could feel threatened by their role change i.e. moving 
from instructing and making decisions to advising, supporting and navigating.207 Perhaps 
professionals need further information, education or training in seeking patient preferences 
for decision-making to encourage patient-centred consultations or patient participation in 
care.194,206 
 
An avenue to help patients participate in their care or to become active, was through the 
delivery of the EPP/SM programmes for chronic disease; the role of the EPP was to help 
make more patients with chronic disease become informed about their condition to enable 
them to become involved in decisions about their care, to help them better communicate their 
needs to professionals by working with them and take better control of their lives.153 
However, the problem of poor participation reported in studies of the EPP including a 
COPD-specific programme85,208 led this review to explore the next question (see below). 
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2.4.1.2 Can theory help to explain the factors that influence an individual 
with chronic disease to seek health care and participate in SM interventions?  
The findings showed that a patient with chronic disease to better manage their condition is 
required to participate or attend SM support interventions to learn skills to better manage 
their condition, enable better communication with clinicians and use health services 
optimally; utilise or attend ongoing SM services for maintenance and adherence of SM 
behaviours which may help optimal use of health services; and utilise health services 
optimally. These forms of participation in health care and health care interventions were 
shown to be influenced or explained, from limited literature, by socio-behavioural, inter-
personal and psychological/behavioural factors (Figure 2.11).  
 
Only psychological or health behavioural theories were used to predict or explain attendance, 
non-attendance in SM interventions possibly because performing self-management has been 
seen as the responsibility of the individual with chronic disease. Attendance at SM 
interventions was mostly influenced by patient perceptions of their illness (via the SRM), the 
intervention (via the SRM-NCF) and beliefs about intervention attendance (via the TPB, 
ASE). Specifically, patients who chose to attend or attended SM interventions was owing to 
changes in their illness (‘health threat’) whereby they perceived greater number of symptoms 
associated with the illness, perceived greater consequences as a result of the illness, perceived 
cause of illness was modifiable,175,182 perceived controllability of their condition173,174,177,182 
and perceived the intervention was necessary180 for health improvements. In addition, 
patients who attended SM interventions also believed that attending the intervention would 
produce health benefits, believed that family, friends or health professionals wanted them to 
attend the intervention and perception of fewer barriers to attending.182,183 In contrast, patients 
were less likely to attend SM interventions if they perceived the intervention to be 
‘unnecessary’ which could be because patient might not know what the intervention involved 
or how it could benefit them or patient might lack understanding about their illness.179  
These findings suggested that a patient taking part in this aspect of health care is as complex 
as a patient adopting or maintaining health-related/SM behaviours. A study,209 in the context 
of health care use, used the ‘illness behaviour’ sociological perspective and reported that 
perception of illness is the first step to behaviour which could influence help seeking 
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behaviour e.g. asking for help, going to the doctor and that the interaction between perception 
and behaviour is a continuous process. Based on the behavioural findings above, one can also 
say that perceptions of illness and, indeed treatment can influence patient participation or 
patient attendance behaviour in SM interventions and an individual’s evaluation of 
attendance at the intervention feeds back into the perceptions which can further influence 
continuation or discontinuation of the behaviour.  
Other behavioural and several non-behavioural or external factors have also been reported by 
several studies to influence patient attendance or participation in SM interventions. They 
were: communication and sharing concerns with others with the same condition, lack of 
information or receiving contradictory information;210 cost, transport to venues, and low self-
confidence in attending group meetings in an unfamiliar environment;54 time availability to 
attend;211 patients with multimorbidities having higher physical function, primary care 
providers being less supportive of patient activation212 or patients’ needs, not being met by 
traditional services.166 
 
In comparison, illness or intervention perceptions did not explain patient attendance in 
ongoing SM services.170 This could be because the illness was no longer perceived as a 
threat, the condition was stable or that perceptions may change over time.170 The adoption or 
maintenance of lifestyle-related health behaviours, including symptom management, in 
chronic disease involves complex behaviours and long term behaviour change is required in 
comparison to a person attending for comparatively simple one-off activities such as 
screening or immunisation.213 Thus, the maintenance of lifestyle-related health behaviours 
requires an individual to be more motivated204 and perhaps this explains the use of socio-
behavioural and psychological theories by studies to understand participation in ongoing SM 
services. One study172 also explained patient attendance in ongoing exercise maintenance 
programmes via a conceptual model.  
Attendance in SM services was explained by a patient’s intention to attend the service (via 
the TPB) and action planning. Previously, a person’s ‘intention’ has been reported as a useful 
indictor, but not a useful predictor, of future health behaviour.144,174 Action planning 
(facilitating the when and where),  a bridge to close the ‘intention-behaviour gap’, 
independently predicted attendance and was reported to be a simple and promising strategy to 
increase uptake of the service.170 Action planning is one of the core SM skills that enables 
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confidence-building in patients which in turn helps with adoption and maintenance of health 
behaviours.58 However, patients need to be supported to develop action plans which require 
the support of professionals including professionals valuing the service enough to 
recommend it to patients.170  
Attendance was further explained by the forward and backward working of an individual’s 
mindset where an individual passes through different psychological stages from motivational 
(non-intentional) to the volitional (intentional to action) phase (via the HAPA). Attenders 
(‘actors’) had positive outcomes expectancies, higher self-efficacy and higher risk perception 
in comparison with ‘non-intenders’ and ‘intenders’. ‘Intenders’ expected more positive 
consequences and reported higher self-efficacy in relation to regular attendance in 
comparison to ‘non-intenders’. Dropout behaviour from the SM service was also explained in 
this review. Dropouts had lower ‘maintenance self-efficacy’ whereby, individuals dropped 
out of the service who could not maintain the new behaviour in face of barriers.171 
Other patient perceptions were identified to influence the uptake of a SM service particularly 
uptake of an ongoing exercise maintenance programme among patients of ethnic minorities 
and they were: perceived social and psychological benefits, availability of support, positive 
exercise identity and perceived importance and confidence to exercise.172 
 
Finally, in study by Gucciardi,167 via the Andersen model, population factors e.g. men who 
did not smoke, flexible service and contextual factors e.g. self-referrals influenced 
participation in a SM service and not patient perceptions/behavioural factors. The act of self-
referral indicates the active approach to self-management that health professionals and policy 
makers would like to see. However, self-referred patients may already be good self-managers 
and may not have much to gain from attending the service diminishing the apparent effects at 
evaluation. In the same study, non-participation was influenced by the lack of perceived 
severity of symptoms among patients who were newly diagnosed and they might have not 
seen the value of the service. Hence, Gucciardi suggested that these patients might need more 
support and attention to improve their adherence to recommendations of self-care behaviours. 
From a sociological perspective,204 the service might not be appropriate for patients if their 
illness is not limiting; newly diagnosed patients might need more time and support to accept 
the condition; they might be resistant due to stigma. Another explanation could be that 
patients may already be self-managing but their method might be different to the 
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professionals’ concept of SM.55 Patient demographics (e.g. more than 80 years of age, low 
socio-economic status, less education and recent immigration) and clinical factors (e.g. 
having mental health conditions or comorbidities) have been reported elsewhere to affect 
patient participation in ongoing SM services.214 
 
In contrast to the above findings, on using the Andersen model, patient perceptions 
particularly perceived need or increased perceived severity of symptoms was shown to 
influence health care utilisation among patients with chronic disease particularly unscheduled 
primary care and secondary care services.142,168 Outside of this, some population factors168 
also explained health care use e.g. being elderly, non-white, lack of social support.  
While, Gately166 via ‘illness work’ showed that  an individual with chronic disease seeking 
health care cannot be seen as part of a static framework, the behaviour is a result of ongoing 
contact of months and years in response to changes within an illness and adaptations that 
follow to manage the illness and hence health care use might not reduce for patients with 
chronic disease particularly for those whose needs are being met by the health services.    
This patient interaction with professionals over the years via the attachment theory explained 
that patients with the ‘pre-occupied attachment style (persons reliant on others) used health 
services more5 irrespective of previous use of SM programmes/services in comparison to 
patients with the ‘fearful attachement style’ (persons like to seek care but distrust others) or 
the ‘dismissive attachment style’ (self-reliant).5,215 
 
Besides explaining patient participation, a few of the included studies that used health 
behaviour theories,171,180 highlighted the need for assessment of patient perceptions to help 
improve uptake of SM interventions and SM services. However, if we want to improve 
patient participation in SM interventions or services and increase optimal use of health 
service, changes in behaviour cannot occur by focusing solely on an patient perceptions and 
beliefs. If behaviour change is required from a large number of people living with chronic 
disease interventions, focus should be placed both on an individual and at the societal level 
(e.g. social networks, environment, policy).213 
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2.4.2 Limitations 
Methodological considerations 
The conceptual review in comparison to a conventional systematic review does have several 
limitations such as: the problem of specifying a search strategy in advance, which can result 
in far too many or a paucity references;163 difficulties exist in extracting relevant material in a 
consistent and unbiased manner and in synthesising the literature;161,163 at the analysis stage, 
there is no form of formal quality assessment for the included studies - except in the form of 
the researchers’ views of their merits or relevance.163 This may influence the transparency 
and reproducibility of the results. Extensive reliance on the expertise and interests of the 
research group may bias the review’s focus, and important reports can be missed if the study 
group are not aware of them or if not referenced in bibliographic databases.163 
These limitations can be addressed by setting up a study team to identify relevant texts161 and 
discussion with the team about the summarised literature which could include going back to 
the identified literature if necessary to ensure the review aim is achieved.161 There should be 
an overlap in various stages of the review process for example searching, analysis and writing 
so the precise nature and scope of the review can be clarified.161,163 
On reflection of these limitations and how they may be addressed, the search strategy was not 
meant to be exhaustive and involved the identification of publications from several sources 
that were most relevant to the study; the relevance of the literature was decided mainly by 
discussion with the study supervisors e.g. explore all health behaviour models that might 
have examined health care seeking behaviour prior to understanding participation behaviour 
in SM interventions. A detailed search strategy was not developed to identify the various 
meanings of ‘patient participation’ in health care. Instead, some key publications were 
identified from one bibliographic database (PubMed) and further studies were identified from 
citations of the identified studies. The cyclical process of searching, analysis and writing was 
continued (with some input from the study supervisors) until an understanding about the 
research topic was developed which then helped to answer the review questions. The review 
could have benefitted from regular and detailed discussions with experts in the 
methodology/topic area; important publications may have been missed which could limit 
replicability of the review. 
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Other considerations 
Health care utilisation is commonly utilised as a health outcome measure in the field of health 
including research studies and several factors can influence HCU e.g. economic models;144 
however, the remit of the review was to gain better understanding of HCU from a behavioural 
perspective with respect to individuals with chronic disease. 
The review comprised of a mix of qualitative and quantitative (mostly predictor) studies 
including reviews that applied older and newer versions of theories to examine/explore HCU 
in different health care settings i.e. primary care; secondary care; utilisation of SM services; 
and attendance at SM interventions, among different disease groups (chronic pain, diabetes, 
heart disease). As a result, the review has shed light on the numerous factors that could 
influence an individual to participate in health and health care including SM interventions. A 
few included studies compared two or three theories to assess participation behaviour; use of 
multiple theories and comparison of theories has been recommended for the advancement of 
health behaviour research.216 
 
As the study sample of the included studies comprised a variety of different chronic 
conditions, but it is possible that the factors that might have been shown to influence 
participation in SM services among one condition, say diabetes could be different for patients 
with another condition, say heart disease. Overall the findings may not be generalisable to a 
specific chronic condition but, even if this is the case, they could be used as a conceptual 
guide to further understand and assess participation behaviour in a patient group of interest 
for example COPD in this study (see Chapter IV). 
 
2.5 Conclusions 
The definition of the term ‘patient participation’ used in this thesis, ‘taking part’ in a study of 
SM intervention or in a SM intervention can be supported by the meanings uncovered in this 
review.  ‘Patient participation’ is a dynamic process where it involves making a decision to 
take part in one’s own health, health care or health care interventions such as SM 
interventions through the influence of several non-theoretical and theoretical factors. With 
regard to the latter, health care seeking can be influenced by perceived need particularly for 
symptom management and the established interpersonal relationship with health 
professionals over time. Utilisation of SM services was influenced by some population and 
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contextual factors, behavioural intention and action planning, motivation, perceived social 
and psychological benefits, positive exercise identity, availability of support, and perceived 
importance and confidence to exercise. Attendance in SM interventions was influenced by 
patient perceptions of their illness and treatment and their beliefs regarding attending the 
programme.  
   
2.6 Implications 
The review findings have suggested that health care seeking could be mostly attributed to 
increased perceived need particularly, perceived severity of symptoms. Though, living with a 
chronic illness means ongoing management of the illness including symptom management 
which professional and policy makers believe can be achieved by patients learning about self-
management outside of a clinical setting through their participation in SM interventions and 
ongoing SM services for maintenance of SM behaviours.  
The problem of poor participation in SM services and in SM interventions among patients 
with chronic disease including COPD is well reported both in the literature and anecdotally. 
So, application of health behaviour theory to existing evidence of patient reasons for 
participation in COPD SM support programmes (shown in Chapter IV) and using theory as a 
conceptual guide to understand the problem of participation from patients with COPD is 
crucial before suggesting any improvements (shown in Chapter V).  
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The next chapter is a systematic review which identifies existing participation and dropout 
rates reported in studies of SM support for COPD patients. 
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Chapter III. Identifying and reporting ‘actual’ patient 
participation and retention rates in research studies of COPD 
self-management support interventions – A systematic 
review 
Chapter III informs the quantitative aspect of a systematic review while Chapter IV presents 
the qualitative aspect of the review – qualitative synthesis. 
This chapter: 
 Quantifies the existing participation and dropout rates in research studies of COPD 
SM support programmes including in the programmes 
 Conducts a meta-regression to examine if any of the study characteristics might have 
influenced the actual study participation rates.  
 
Note: The initial aim of the review was to identify and compare participation and dropout 
rates in SM support programmes among patients with COPD, asthma and heart failure. The 
search results yielded 431 articles comprising the above mentioned conditions including 
mixed conditions. Keeping the limited time and resources in mind to conduct the review 
within the bigger doctoral study and following discussion with the PhD supervisors a 
decision was taken to focus on only the COPD population for the review. Consequently, 
studies comprising of population other than COPD were placed in the excluded studies pile 
under ‘reasons for exclusion: population’. For the same reasons, observational studies were 
also excluded and placed under the pile ‘reasons exclusion on: study design’. 
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3.1 Introduction  
This review is not a conventional systematic review of effectiveness as the evidence of 
benefit for SM support programmes particularly, PR programmes is well known (shown in 
Chapter I). A recent review by Bensten (comprising of four studies)217 on effectiveness of 
COPD SM interventions (including education, exercise, action plan) on patient quality of life 
reported that patients who participated in these interventions were less likely to experience 
the disease burden, have improved physical condition, increased physical and social activity 
and better quality of life. However, Bensten’s review, similar to a previous Cochrane 
review84 of SM education was unable to present concrete conclusions on effectiveness of 
COPD SM interventions. This lack of tangible evidence could be one reason for the lack of 
implementation of SM support programmes in practice84,87 which may affect patient access to 
these programmes. Another form of provision of SM support for patients with COPD is 
through PR. Despite considerable evidence of benefit for PR in COPD one study reported 
that only one to two per cent of patients might be able to access PR programmes and the 
reasons could be due to a mix of patient factors, lack of referral from health professionals and 
lack of infrastructure for provision of PR.124 Besides this, another explanation for the lack of 
implementation of SM and PR programmes could be because of poor patient participation 
and retention reported in studies of these interventions19,110 and this problem is reported more 
commonly among studies of PR programmes as it has been a longer-running intervention for 
patients with COPD in comparison to SM programmes. Reduced patient participation or high 
attrition in studies of PR or SM programmes for COPD patients may, affect the 
generalisability of the study findings to the target population.  
 
In Chapter I varied reports of poor participation and high dropout rates reported in studies of 
SM and PR programmes have been presented. In addition, a recent study reported that only 
57% of patients with COPD were referred to PR from tertiary care with only 18% attending 
PR.218 Another study that examined attendance and completion rates of an integrated PR 
service in clinical practice also found low uptake (54% from PR assessment) of programme 
and completion (40% from those referred).113 
 
So, before we can begin to address the apparent problem of poor patient participation and 
retention reported in studies of COPD SM support programmes, it is first important to 
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identify the actual proportions reported by these studies. Thus, a systematic review was 
conducted to identify the actual participation and retention rates reported in randomised and 
non-randomised studies evaluating SM support programmes including within the 
programmes among patients with COPD. 
 
3.1.1 Review aim 
To quantify existing participation and completion rates reported in studies of SM support 
programmes for COPD patients  
 
3.1.2 Review research question 
From published quantitative studies what are the participation and completion rates for self-
management support programmes for patients with COPD? 
 
3.1.3 Review objectives 
1) Identify study participation and completion rates including dropout rates 
2) Identify the intervention attendance and completion rates 
3) Identify the process of recruitment including the setting, method of patient identification 
and method of participant recruitment  
4) Identify factors that may be associated with participation or attendance or completion in 
SM programmes  
5) Identify reasons for patient participation/non-participation and completion/non-completion 
reported in studies  
3.2 Methods  
The methods followed the guidance laid out in the Centre for Reviews and Dissemination219 
for undertaking reviews in health care.  
 
3.2.1 Literature search 
A scoping search was initially conducted typing key words from a previous COPD 
self-management education review,84 it included search words such as ‘patient participation’ 
or patient participation in health’ to identify key articles for the review. Next, a 
comprehensive search strategy was developed from other self-management systematic 
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reviews (COPD self-management education, uptake of cardiac rehabilitation, 
self-management in musculoskeletal pain),69,84,86,220 MeSH headings and free text words were 
used. The search strategy and search terms are presented below. A single search strategy was 
applied to identify both quantitative and qualitative studies for the broader mixed-methods 
review. This was suggested as a useful approach to reduce the risk of omissions of studies if 
the quantitative and qualitative studies were identified separately (Booth A. Reader in 
Evidence Based Information Practice. Personal communication. 9 Sep 2010). 
The following sources were used to identify the relevant studies:  
 Electronic databases 
i) Cochrane Collaboration central register (CENTRAL/CCTR) (available through Cochrane 
library) 
ii) Effective practice and organisation of care (EPOC) (Cochrane library) 
iii) Database of Abstracts of Reviews for Effectiveness (DARE) (Cochrane library) 
iv) Biomedical science databases 
a) PubMed/MEDLINE (available through OVID) 
b) Embase (available through NHS Evidence Health Information Resources/ NHS 
library) 
c) CINAHL (Cumulative Index to Nursing and Allied Health Literature) (NHS 
library) 
d) PEDro (physiotherapy evidence database) 
e) PsycINFO (psychological, social, behavioural and health sciences) (available 
through OVID) 
f) AMED (Allied and Complementary Medicine) (NHS Library) 
g) British Nursing Index (BNI) (NHS Library) 
h) Research registers UK, USA 
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j) Applied Social Sciences Index and Abstracts (ASSIA) (available through ProQuest 
(part of Cambridge Information Group) - CSA Illumina web-based information 
system)  
k) Education Resources Information Centre (ERIC) seminal 
l) Social Science Citation Index (available through Web of Science) – forward citation 
tracking from identified “seminal” papers 
 Unpublished material and grey literature were to be included such as internal reports 
produced by organisations that develop and deliver SM programmes in the UK (e.g. 
Social Action for Health (SafH) and Expert Patient Programme Community Interest 
Company (EPPCIC)). A letter (Appendix 3.1) was sent to these organisations 
requesting them to send published or unpublished reports that might include reporting 
of participation, attendance and completion rates of self-management programmes for 
adults living with long term conditions.  
 Further studies were identified from reference lists of identified systematic reviews 
and other studies.  
The search terms were (Pulmonary Disease, Chronic Obstructive) OR (Lung Diseases, 
Obstructive) OR (chronic obstructive adj (pulmonary or lung or airway*) adj (disease* or 
obstruction or limitation*) OR (Emphysema) OR (Pulmonary Emphysema) OR (Bronchitis, 
Chronic) OR (Chronic Bronchitis) AND (Pulmonary rehabilitation) AND (Health Education/ 
or Patient Education as Topic/) OR (Health or patient) adj educat*) OR (Self Care) OR (self 
adj manage*) OR (psych* or behav*) adj (educat* or manage*) OR (expert adj patient) OR 
(self help) AND (Patient Participation) OR (patient* or particip*) adj (participat* or attend* 
or attitude* or motiv* or satisf* or involve* or accept* or refuse* or uptake or recruit* or 
rate*) OR (Consumer Participation) OR (Patient Acceptance of Health Care) OR (Patient 
Satisfaction/ or Attitude to Health/ or Aged/) OR Patient Dropouts) OR (drop out* or non 
attend* or barrier* or non participat*) OR (Program Evaluation) OR (programme evaluation) 
OR (Self Concept/ or Self Efficacy) OR (self-efficacy) OR (Cognition Disorders/ or 
Socioeconomic Factors/ or Depression) OR (Predict* adj attend*) OR (Health Services 
Accessibility) OR (complet* adj rate*). 
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3.2.2 Study selection  
Studies that met the following criteria were included:  
 Studies type  
Controlled clinical trials (randomised and non-randomised) including before-after studies 
published since 1984.  
Rationale:  
The first study on Chronic Disease Self Management Programme, underpinned by the 
self-efficacy construct of the social cognitive theoretical model and developed by Kate Lorig 
for patients with arthritis, was published in 1984.221 
 
 Population 
Adults with a diagnosis of COPD  
COPD definitions for determining COPD severity were adopted using the GOLD 
classification. These definitions now include ‘severe’ and ‘very severe’ COPD.15 
 
 Interventions 
The interventions included structured self-management, self-care, pulmonary rehabilitation, 
and health education/COPD education programmes. Interventions could be either 
group-based or targeted at individuals and conducted in any setting e.g. outpatients, 
inpatients, participant’s home, GP surgery, community, or remote (web-based or telephone) 
or a combination of these settings. Intervention delivery could be by a health professional, or 
a trained lay person or both. 
The definition of the named interventions here adopted for the review have been presented in 
Chapter I (section 1.1.1.4.2.1)  
Only English language papers were included in the review due to lack of funding provision 
for translation of non-English language papers. 
 
Studies were excluded based on the following criteria:  
Non-English language studies, conference abstracts, surveys and interventions that only 
included exercise, SM plans/COPD action plans. 
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The full copies of the papers were obtained, following being identified as eligible based on 
titles and abstracts. The full copies of the potentially eligible papers were obtained to assess 
whether the studies met the pre-specified inclusion criteria. If additional information was 
needed, the corresponding authors of the study were contacted via a letter or email (Appendix 
3.2).  
 
3.2.3 Definitions of patient participation 
For the purpose of the review, the following definitions were adopted (Figure 3.1):  
 ‘Study participation’- eligible patients taking part in a study of PR or SM or HE 
intervention and ‘study participants’ - patients that take part in the study  
 ‘Study non-participation’- not taking part in a study of PR or SM or HE intervention 
and ‘study non- participants’  - patients who do not take part in the study 
 The ‘study participant’ in the intervention arm can be subdivided into an ‘attender’  - 
one who is exposed to at least part of the intervention (e.g. attends at least one 
session) and ‘non-attender’ – one is not exposed to any part of the intervention (e.g. 
does not attend any sessions of the intervention) 
 The ‘attender’ can be further divided into ‘intervention dropout’ – one who drops out 
from the intervention and ‘intervention completer’ – one who completes the 
intervention 
 ‘Study completer’ – A ‘non-attender’, ‘intervention dropout’ or ‘intervention 
completer’ who completes the study  
 ‘Study dropout’ - A ‘non-attender’, ‘intervention dropout’ or ‘intervention completer’ 
who withdraws or is lost to follow-up from the study 
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Figure 3.1 Illustration of patient participation definitions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.4 Validity assessment 
The data extraction and quality appraisal of the studies were conducted simultaneously. 
Quality assessment in systematic effectiveness reviews is normally conducted to remove 
studies of low methodologically quality. Low methodological quality studies include biases 
(of different kinds) that can result in overestimation or underestimation of the true 
intervention effect. This review (which is not an effectiveness review) included studies of any 
quality to examine whether high participation rates were reported in studies of high quality. 
The methodological quality of both randomised and non-randomised primary studies 
including before-after studies was appraised using the criteria generated by Downs and 
Black222 (Appendix 3.3). The Downs and Black checklist for quality assessment was selected 
as it has been developed to use with both randomised and non-randomised studies and is 
recommended as being suitable for use in systematic reviews.233,238 Validity and reliability on 
the original version of the checklist was conducted by experienced epidemiologists and 
‘Non-attenders’ or 
‘Programme 
dropouts’ or 
‘Programme 
completers’ may also 
drop out from the 
study to become 
Study dropouts 
Eligible patients invited to a study of 
PR, SM or HE intervention  
Patients willing to take part and 
recruited - Study participants 
Programme completers complete the 
study – Study completers 
Patients not willing to take part and 
not recruited – Study 
non-participants  
Study participants attend intervention 
(e.g. comprising of 7 sessions) - 
Attenders 
Attenders complete the programme e.g. 
all 7 sessions – Programme 
completers  
Participants not willing to attend 
intervention at all - Non-attenders  
Participants dropped out e.g. after 3 
sessions – Programme dropouts  
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statisticians and a revised version produced.222,223 Further assessment of the revised checklist 
showed that the Quality Index had high internal consistency, good test-retest (r = 0.88) and 
inter-rater (r = 0.75) reliability and good face and criterion validity (0.90).222 The checklist 
allows an overall score for study quality to be reported as well as scores for each of the 
subscales. The question on power was simplified to a simple check whether the study had 
conducted a statistical power calculation. The maximum score achievable for each of the 
subscales was: 11 for reporting, 3 for external validity (an area which has been ignored in all 
checklists of RCTs), 7 for internal validity - bias in the measurement of the intervention and 
outcomes, and 6 for internal validity - confounding (selection bias), totalling to maximum 
score of 27. 
 
3.2.5 Data abstraction  
A data extraction form was developed and piloted for particular questions to be addressed by 
the review and final versions were used to compile summary tables of the data and quality 
classification (Appendix 3.4A in Word and 3.4B in Excel). Data extracted included: study 
characteristics (study design, study setting, study eligibility criteria, recruitment process), 
population characteristics, intervention characteristics, definition of intervention completion 
and study outcomes that included participation data. The items selected for data extraction 
were based on the previous review of COPD SM education84 and research25,110,114,118,123 that 
have given some explanation on factors affecting patient participation and retention in SM 
support programmes, e.g. among population characteristics factors such as, living alone, 
widowed or divorced and lack of disease specific social support have been reported as 
predictors of PR non-adherence;123 Patients smoking currently or with high pack years of 
smoking drop out of PR;114,115,118; It is important to consider the impact of age, gender, stage 
of illness, and comorbidities on motivation to engage in research trialling SM strategies.224  
Regarding intervention characteristics, location of PR and journey to PR venue have been 
reported as barriers to attend or withdraw from PR.115,117 
The patient participation data (before and after recruitment) was extracted from studies by 
referring to the Consolidated Standards of Reporting Trials (CONSORT) participant flow 
diagram.225 and the checklist suggested by extension of the CONSORT statement for 
reporting of pragmatic trials.226 The following data was extracted: ‘numbers of potential 
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participants identified’ ‘numbers assessed for eligibility’, ‘numbers eligible’4, ‘numbers 
included (and randomised or not randomised)’ to all intervention groups, ‘numbers received 
allocated intervention’, ‘numbers did not receive allocated intervention’, ‘numbers lost to 
follow-up’, ‘numbers discontinued intervention’, and ‘numbers analysed for the primary 
outcomes’. 
A second reviewer checked extraction and calculation of participation rate data from 10% of 
the studies sampled at random using a web-based random integer generator (random.org). 
 
3.2.6 Data syntheses 
Due to heterogeneity among the included studies a narrative synthesis approach was 
followed.  
Calculation of patient ‘participation rates’ from the extracted participation data was based on 
the adopted definitions (Figure 3.2). The study participation rate (SPR) was calculated based 
on ‘numbers included in study’ by ‘numbers eligible’. This method of calculation for SPR is 
consistent with wording used in extension of the CONSORT statement for reporting of 
pragmatic trials “...numbers were eligible for study of whom (%) agreed to participate”.226 
Glasgow227 also recommended expanding the criteria in the original CONSORT statement to 
include eight items on external validity, one of which was “report the participation rate 
among those eligible”.  
For studies that reported both the number of eligible people and the number who were finally 
included, participation rate was determined with a 95% confidence interval calculated using a 
score method with a continuity correction.228 A random effects logistic regression, with 
participation of each individual as a binary outcome and a random effect of study, to estimate 
the effects of different study characteristics on participation rates was utilised. This amounts 
to a meta-regression of study results, and allows studies to be included even if their estimated 
participation rate is100%.  
Because of the relatively small number of studies with complete data, following discussion 
with the study team, four study characteristics: year of publication (linear effect per year), 
                                                          
4 In five studies ‘Numbers eligible’ was not clearly stated. So to calculate study participation rate in the five 
studies ‘numbers eligible’ were extracted the following way: reasons reported for not taking part in the study, 
between numbers assessed for eligibility and numbers included in study, were reported as numbers that declined 
to participate and numbers that were ineligible for the study. The numbers who declined to take part were added 
to numbers included in the study and were extracted as ‘numbers eligible’. 
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quality score (linear effect per scale point), exercise versus non-exercise intervention, and 
group versus individual treatment (divided into three categories: individual, combined group 
and individual group) were examined. There was heterogeneity between studies in COPD 
severity, but this variable was inconsistently reported and difficult to categorise, so was not 
selected for inclusion. Results are reported as adjusted odds ratio from a multivariable 
regression model including all four study characteristics. 
Comparisons of what was reported by studies before and after publication of the CONSORT 
guidelines were made using chi-squared tests (or Fisher’s exact test where any expected 
frequency was <5). 
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Figure 3.2 Calculation of participation rates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.7.2 Narrative synthesis  
Narrative synthesis was used to group the included quantitative studies in a meaningful way 
to make the studies as similar as possible and answer review question 1. Grouping was done 
by intervention of interest (PR, SM, and HE) to identify similarities, and differences in study  
Eligible patients invited to a study  
Patients included and randomised  
Participants assigned to 
intervention arm  
Participants complete 
intervention 
Participants dropout or 
discontinue 
intervention  
Patients are ineligible and do not 
take part for various reasons  
Participants assigned to 
control arm  
Participants complete study or 
numbers analysed 
Participants dropout (withdraw or 
loss of follow up) from study 
Participants dropout (withdraw or loss 
of follow up from study  
Calculation of participation rates: 
 
Study participation rate (SPR) = numbers included (randomised and non-randomised) in study   X 100 
numbers eligible for study  
 
Study completion rate (SCR) = numbers completed (all groups) study   X 100 
numbers included in study 
 
Study dropout rate (SDR) = numbers dropped out (all groups) from study   X 100 
numbers included in study 
 
Proportion assigned to intervention arm (AIA) = numbers assigned to intervention group    X 100 
numbers included in study 
 
Intervention completion rate (ICR) = numbers complete intervention    X 100 
numbers assigned to intervention group 
 
Intervention dropout rate (IDR) = numbers dropout of intervention    X 100 
numbers assigned to intervention group 
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3.3 Results  
3.3.1 Search results 
Table 3.1 presents a breakdown of the number of studies identified from each of the 
electronic databases.   
Table 3.1 Database search results 
AMED  109 
BNI 40 
CINAHL 326 
Clinical trials 1 
Cochrane library 314 
Embase 724 
ERIC 9 
Medline 1510 
PsycINFO 218 
SSCI 226 
PEDRO 351 
 
In addition, 13 studies were further identified from other sources: reference lists of included 
studies (n=9), PubMed saved alerts (n=2) and grey reports (n=2) which were published soon 
after in 2012 (n=2). 
 
3.3.2 Study selection and exclusion  
3.3.2.1 Number of studies identified and number of and type of studies 
included and excluded 
The combined database searches yielded 3828 studies with 13 studies from additional 
sources. After screening, 56 studies met our inclusion criteria (PRISMA flowchart,229 Figure 
3.3), 51 were RCTs, three quasi-experimental studies and two before-after studies. Thirty-one 
studies evaluated PR programmes, twenty evaluated SM programmes, one evaluated SC 
programme and was combined with studies of SM programmes and four studies evaluated 
HE programmes. Appendix 3.5 presents the list of excluded studies (the reasons for exclusion 
were: systematic reviews, study design, population, not primary study, interim results, same 
sample published in various studies). The focus of this chapter is quantitative studies.  
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Figure 3.3 PRISMA flowchart showing the number of included studies in the review  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source:  Moher D et al. 
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Additional records identified through 
other sources 
(n = 13) 
Records after duplicates removed 
(n = 3003+13) 
Records screened 
(n = 96+13) 
Records excluded (n = 2907)  
Excluded on: 
 Topic or Intervention 
(n=1379) 
 Population (n=1069) 
 Study design (n=164) 
Excluded for other reasons: 
 No abstract available 
(n=82) 
 Duplicate (n=188) 
 Non-English language 
(n=10) 
 Study setting (n=11) 
 Full papers could not be 
obtained (n=4) 
 
Full-text articles assessed for 
eligibility 
(n = 49+13) 
Full-text articles excluded, with 
reasons 
(n = 47) 
 Systematic reviews 
(n=14) 
 Topic or Intervention (n= 
15) 
 Study design (n= 3) 
 Population (n= 1) 
 Not primary study (n= 3) 
 Interim results (n= 3) 
 Same sample (n=8) 
 
Studies included in 
qualitative synthesis 
(n = 6) 
Studies included in mixed-methods review 
Quantitative n=56 
Duplicates removed  
(n = 825) 
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3.3.3 Quality assessment of studies 
The study quality was variable (Table 3.5). The overall quality of study reporting was good 
(9.9), external validity was low (1.3), internal validity was better amongst studies but, more 
bias was present in selection of study subjects (3.6) in comparison to bias in the measurement 
of the intervention and outcome (4.8). Less than half of the studies had conducted a power 
calculation. There was no clear pattern observed from the quality assessment that high quality 
studies had higher participation rates. The second reviewer checked a randomly selected 10% 
of data extractions and there was 100% agreement between the two reviewers. 
 
3.3.4 Narrative synthesis 
The findings are presented under the following headings: 
 Study characteristics 
 Population characteristics 
 Process of recruitment  
 Intervention characteristics 
 Study outcomes – participation and dropout rates 
 Reasons reported by the included studies for patient participation/non-participation 
and/or completion/non-completion 
 
3.3.4.1 Study characteristics 
Fifty six studies were conducted across different parts of the globe, majority of the articles 
were from Europe (32%), followed by America (29%), the UK (27%), the Far East (5%) and 
equal number of articles originated from Australia (2%), New Zealand (2%), Egypt (2%) and 
Iran (2%).  
The study setting amongst the included studies were diverse and comprised mainly 
outpatients (41%), then home of participant (20%), a combined setting (13%), community 
(11%), primary health care (9%), medical centres (4%), university clinic (2%) and inpatients 
(2%). 
The total sample size of all included studies was 5735 with the highest proportion of sample 
from studies of SM programmes (44%), a third from studies of PR programmes (34%) and 
23% of sample from studies of health education. Sixty six per cent of the studies had a 
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sample size that was below 100 with two RCT studies230,231 comprising of only 20 
participants, 27% of studies had a sample that ranged between 101 to 200, and 4% of studies 
had a sample that ranged between 201 to 300 and 300 plus. Table 3.2 presents details on the 
country of origin, study design, setting and sample size of the included studies. 
 
Table 3.2 Study characteristics 
Author Country Study design Study setting Sample size, n 
Studies of PR programmes, n = 31 
Barakat232 France RCT Outpatients 80 
de Godoy 233 Brazil RCT Outpatients 30 
Finnerty234 UK RCT Outpatients 65 
Karapolat235 Turkey RCT Outpatients 49 
Carr236 Canada RCT Inpatient or 
outpatients – 
usually inpatients 
34 
Liddell237 UK RCT equivalency – 
pilot 
Outpatients 30 
Reardon230 US RCT Outpatients 20 
Ries238 US RCT Outpatients 119 
Ringbaek239 Denmark RCT Outpatients 45 
Sewell240 UK RCT Outpatients 100 
Theander241 Sweden RCT two group pre-
post test 
Outpatients 26 
White242 UK RCT Outpatients 103 
Seymour243 UK RCT Outpatients 60 
Green244 UK RCT Outpatients 44 
Guell245 Spain RCT Outpatients 40 
Guell246  Spain RCT Outpatients 60 
Prince247 UK RCT Outpatients 31 
Lindsay248 Hong Kong RCT Primary care 
teaching clinic 
affiliated with 
university (primary 
care) 
50 
Boxall249 Australia RCT-cross over Home 46 
Na250 Korea CCT/ quasi-
experimental 
Home 43 
Oh251  South Korea RCT control group 
pre-post test 
Home 23 
Resqueti252 Spain RCT Home 38 
Sridhar253 UK RCT equivalency Home 122 
Wijkstra254 The Netherlands RCT Home 43 
Goldstein255 Canada RCT Inpatients, 
outpatients and 
periodic home visits 
89 
Ghanem256 Egypt RCT Home and 
outpatient 
supervision 
39 
Strijbos257 The Netherlands RCT Outpatient and 
home care 
50 
Wedzicha258 UK RCT Home and hospital 110 
Man259 UK RCT Community health 42 
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centres 
van  Wetering260 The Netherlands RCT Community-based 199 
Zakrisson26 Sweden Quasi-experimental Primary health care 
centres 
103 
    Total n = 1933 
Studies of SM programmes, n = 21 
Bourbeau261 Canada RCT-parallel group Home 191 
Effing262 The Netherlands RCT 2X2 factorial 
design 
Community-based 142 
Monninkhof263 The Netherlands RCT Outpatients 248 
Ninot264  France RCT-parallel group Outpatients 45 
Nguyen265  US RCT –pilot Clinical academic 
medical centres 
50 
Zimmerman266 US Before-after study Community 
hospital 
10 
Taylor85 UK RCT-pilot  Community centre 
(community-based) 
116 
Casas267 Spain and Belgium RCT Hospital and home 155 
Rea268 New Zealand RCT-cluster Primary care and 
home visit 
135 
Emery269 US RCT PR facility 
(outpatients) 
79 
Kara270 Turkey RCT Outpatients 60 
Khdour271 UK RCT Outpatients 173 
Kheirabadi272 Iran RCT-pilot Pulmonary clinics 
(outpatients) 
42 
Hill273 Canada RCT Primary care 93 
Koff274 US RCT –pilot At clinic once and 
remote monitoring 
40 
Moore231 UK RCT –pilot Home 20 
Cockcroft275 UK RCT Home 75 
Sassi-Dambron276 US RCT University clinic 89 
Howland277 US Quasi-experimental Community-level 538 
Efraimsson278 Sweden RCT Primary health care 
COPD clinic 
52 
Coultas279 US RCT Home 151 
    Total n = 2504 
Studies of HE programmes, n = 4 
Littlejohn280 UK RCT Outpatients 152 
Lemmens281 The Netherlands Before-after Primary care 189 
Petty282 US RCT-parallel group Home 214 
Rice283 US RCT Medical centres 743 
    Total n = 1298 
SUMMARY OF THE STUDY CHARACTERISTICS 
France – 2 
Brazil – 1 
UK – 15 
Turkey – 2 
Canada – 4 
US – 11 
Denmark -1 
Sweden – 3 
Spain 3 
Hong Kong – 1 
Australia – 1 
Korea – 1 
RCT – 51  
Quasi-experimental 
– 3 
Before-after - 2 
Primary health care  
- 5 
Combined – 7 
Outpatients – 23 
Home – 11 
Medical centres – 2 
University clinic – 
1 
Community level– 
6 
Outpatient or 
inpatients (mainly 
1 to 100 - 37 
101 to 200 – 15 
201 to 300 - 2 
300 plus - 2 
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South Korea – 1 
The Netherlands – 6 
Eygpt – 1 
Spain and Belgium – 1 
New Zealand – 1 
Iran – 1 
inpatients) – 1 
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3.3.4.2 Population characteristics 
The number of studies that have reported on each of the population characteristics is 
presented in Table 3.3. With the exception of age group reported by all 56 studies, none of 
the other population characteristics were reported by each individual study. In addition, the 
studies differed in the way they collected and recorded data on the population characteristics 
e.g. age group was either recorded in the form of mean age of all participants or mean age of 
participants in each group or median age-range.  
Fifty four (94%) studies reported on sex of the study participants and two studies246,250 of PR 
programme comprised only male participants; 36 (64%) studies reported on the smoking 
behaviour of the participants; less than half of the included studies (43%) provided data on 
severity of COPD using various guidelines such as, the GOLD classification (19.6%) or other 
such as, MRC dyspnoea group, American Thoracic Society, British Thoracic guidelines, 
hospital registrar; only 15 studies (27%) reported on educational level; 14 reported (25%) on 
marital status; 13 (23%) on employment status; 10 (18%) on previous experience of 
participation in health care interventions which normally was PR; two studies (4%) reported 
on illness beliefs of study participants; and only one study (2%) reported on carer status.  
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Table 3.3 Number of included studies that reported on each of the population characteristics 
Population characteristics 
Intervention Age Sex COPD 
severity- 
GOLD 
criteria or 
other 
Educational 
level 
Employment 
status 
Marital 
status 
Carer 
status 
Smoking 
behaviour 
Co-
morbidities 
Illness 
beliefs 
Previous 
experience of 
participation 
in health care 
intervention 
PR (n= 31) 31 29 9 1 2 2 1 18 4 0 4 
SM (n= 21) 21 21 11 13 8 10 0 14 8 0 5 
HE (n= 4) 4 4 3 1 0 1 0 4 1 0 1 
Total (n=56) 56 54 23 15 10 13 1 36 13 0 10 
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3.3.4.3 Process of recruitment (Recruitment characteristics) 
Table 3.4 provides the number of studies that reported on where and how patients were 
recruited into the study. It was unclear from five studies (8.9%) where patients were 
identified and from more than a third of studies (35.71%) on how patients were 
approached/invited to participate in the study. A third of the studies (33.3%) from 51 studies 
identified patients from outpatients and these studies were mostly evaluating PR programmes 
as PR is commonly delivered at outpatients; Nine studies (17.6%) identified patients from a 
combination of avenues e.g. outpatients and GPs, physician and advertisements, HCPs in 
primary and secondary care settings, hospital admission and GP records, advertisement, web-
based and non-web-based sources; Six studies (11.7%) utilised physician referrals; While, 
five studies (9.8%) identified patients from hospital admissions,  five other studies identified 
patient using patient database; three studies (6.4%) used PR waiting list; two (3.9%) used 
flyer; and one study (1.9%) each identified previous PR attendees, patient from ongoing PR 
programme and Veteran Affairs medical centre. 
Of the 36/56 studies who invited patients to participate in the study the most common mode 
of invite was verbal (44.4%); followed by a written letter (30.5%); four studies (11.1%) 
invited patients by a combination of letter and phone call, letters, advertisements and 
announcements and word of mouth, advertisement and telephone; three studies (8.3%) 
invited patients verbally and by a written letter; on verbal agreement patients were invited by 
a written letter by one study (2.7%); and one study used a written letter and phone to invite 
patients. 
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Table 3.4 Number of studies that reported on various forms of patient identification and patient invite for study recruitment 
Place of patient identification 
Intervention Outpatients Physician 
referral 
Combination Hospital 
admission 
Previous 
PR 
attendee 
Database Ongoing 
PR 
programme 
PR 
waiting 
list 
Another 
sub 
study 
Flyer Veteran 
Affairs 
Centre 
Unclear 
PR (n=31) 12 1 4 3 1 2 1 2    5 
SM (n=21) 4 4 4 2  3  1 1 2   
HE (n=4) 1 1 1        1  
Total  
(n =56) 
17 6 9 5 1 5 1 3 1 2 1 5 
Mode of patient invite 
Intervention Verbal verbal & written written verbal, agreed, 
written 
written & phone Combination Unclear 
PR (n=31) 10 3 3 1   14 
SM (n=21) 6  6  1 3 5 
HE (n=4)   2   1 1 
Total (n =56) 16 3 11 1 1 4 20 
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3.3.4.4 Intervention characteristics 
The intervention characteristics data (presented in Appendix in 3.6) comprises information on 
components of the intervention, description of the intervention such as, setting - group-based 
or individual, location, duration, delivery, underlying with theory, if the study defined 
participation and type of control group. 
There was heterogeneity in the intervention content among studies of PR, SM and HE 
programmes and between studies of each programme. A summary of the intervention 
characteristics is divided and presented under studies of exercise (n=36) (including studies of 
PR and SM programmes) and non-exercise (n=20) (SM and HE education programmes). 
Regarding studies of exercise programmes including education/SM education, 23 studies 
delivered the intervention in groups, seven individually and it was unclear from three studies. 
Studies reported location of the intervention as outpatients (n=8), home (n=7), combination 
(n=5), community (n=2), primary care (n=2), PR facility (n=1) and outpatient and inpatient 
(n=1). The duration of the intervention ranged between 2 weeks to 24 weeks among the 36 
studies, ten studies delivered the intervention for 8 weeks, six studies delivered the 
intervention for 6 weeks and another six for 12 weeks. In addition, among 22 studies that had 
reported on the number of intervention sessions delivered, most studies delivered once or 
twice a week and in a couple of studies it was more than twice a week. Furthermore, two 
studies also had an exercise maintenance programme of 6 months246,252 and one study of 20 
months.260 Except one study that was unclear, the intervention was delivered either by health 
care professional/s (HCPs) or a multidisciplinary team. None of the programmes were based 
on theory. Among 35/36 studies, the control group comprised of usual care and 21 studies 
had specified type of usual care. Regarding definition of patient participation, seven studies 
had reported a pre-definition such as, patients who had attended 75% of the supervised 
sessions (6 out of 8 sessions) were labelled a ‘study completer’;237; To succeed, patients had 
to participate in four out of eight weeks;239 Patients were required to attend at least 10 of the 
12 sessions;242 Non-attendance within three weeks of the designated follow-up was deemed 
‘failure to attend’;243 Analysis was confined to those who completed 8 out of 16 sessions;258 
‘Adherence’ was defined as completion of 7 out of 8 sessions;264; and a patient who attended 
16 education, 37 exercise and 10 stress management sessions over 10 weeks was labelled an 
‘intervention completer’.269 
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Regarding studies of non-exercise programmes (SM education/education), five studies 
delivered the intervention in groups, 12 individually, 1 combined and it was unclear from one 
study. The intervention was delivered mostly in a combination format e.g. at outpatients and 
telephone, telephone and tele-monitoring, or at hospital and home (n=8), equally at home and 
in the community (n=3), in primary care (n=2), at outpatients (n=2), in a university clinic 
(n=1) and a nurse-led clinic (n=1). The duration of the intervention was reported clearly 
among 15 studies and varied between studies for example, the duration of the intervention 
ranged 7 weeks, 6 weeks or 8 weeks; 3, 6 or 12 months; two one to one education sessions, 
two visits with a 3-5month interval or two hours before discharge and weekly phone calls 
during first month following discharge. Among 19/20 studies, HCPs delivered the 
intervention in 18 studies and in one study85  both lay SM tutors and a clinician delivered the 
intervention. Five studies evaluated interventions that were underlying with theory namely, 
socio-cognitive self-efficacy theory,85,270 self-efficacy theory and the health belief model,266 
the nursing model,275 the transtheoretical model278 and socio-cognitive and stage of 
motivational readiness.265. Only one study had reported a definition of patient participation – 
patients who attended five out of seven sessions were labelled ‘intervention completer’. 
Finally, among the 18 RCTs, 11 studies specified usual care for the control group. 
 
 
3.3.4.5 Study participation, intervention attendance, intervention 
completion, study and intervention dropout rates (study outcomes) 
Table 3.5 presents the following study outcomes by intervention of interest: time of study 
assessment and follow-ups, participant flow data (‘number of potential participants 
identified’, ‘numbers assessed for eligibility’, ‘numbers eligible’ for study, ‘numbers 
included (randomised or non-randomised)’ to all intervention groups, ‘numbers lost to follow 
up’ and ‘numbers discontinued intervention’ and patient ‘participation rates’ – study 
participation rate (SPR), study dropout rate (SDR) and intervention dropout rate (IDR), the 
quality assessment scores and whether the intervention was effective on the study primary 
outcome.   
The time points that patients with COPD were followed up ranged between one to eight times 
with 32/56 (57.14%) studies followed up patients only once. The follow up period ranged 
from 2 weeks to 72 months and most studies followed up patients at three, six and 12 months.   
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Excluding three quasi-experimental, two before-after studies and six pilot RCTs, 27/45 (60%) 
RCT studies had not reported a primary outcome. The interventions were effective in 12 
studies (7 PR, 4 SM, 1 HE) and the primary outcomes included either quality of life or health 
care use (hospital readmission rate, hospital admissions, number of hospital bed days). 
Authors of 49 studies were contacted for further information regarding the participant flow 
data. 25 authors (51%) responded with further information, 10 authors responded but could 
not help due to studies being old and they no longer had access to the study data and 14 
authors did not respond.  
Participant flow data was poorly reported in all studies. Only nine (16%) studies reported 
‘numbers of potential participants identified’ (4/31 PR, 4/21 SM and 1/4 HE) and twenty-two 
(39%) studies reported ‘numbers assessed for eligibility’ (12 PR and 10 SM). ‘Numbers 
eligible’ by studies was better reported, 43 (77%) studies, (21 PR, 19 SM and 3 HE). Fifty-six 
studies reported ‘numbers included (both randomised and non-randomised)’ in study, out of 
five non-randomised studies, two were before-after studies without a control group. Only 
seven (13%) studies recorded participant flow numbers right up to participant recruitment. 
Forty-one (73%) studies were published after the CONSORT statement in 2001. Better 
reporting of participant flow was seen in studies published in and after 2001 in comparison to 
studies published before 2001, ‘numbers of potential participants identified’ 9/41 (22%) vs. 
0/15 (0%) (Fisher’s exact test P = 0.094); ‘numbers assessed for eligibility’ 18/41 (44%) vs. 
4/15 (27%) (chi-squared = 1.37, df = 1, P = 0.24) and ‘numbers eligible’ 33/41 (80%) vs. 
10/15 (67%) (chi-squared = 1.18, df = 1, P = 0.28). 
Based on the data available, we were able to calculate SPRs for 43 studies. Half of the 
highest value in the range of proportions for SPR, SDR and IDR was taken as a cut-off value 
to show studies with participation rates above or below the chosen cut-off value. The SPR 
among studies of PR programmes ranged from 35 to 100% (that is, a cut-off value of 50%), 
only three (14%) studies having less than 50% SPR. In studies of SM programmes, SPR 
ranged from 23 to 100%, with four (21%) studies having less than 50% SPR. And amongst 
the three studies of HE programmes, SPR was 43%, 73% and 92%. Altogether for 43 studies 
(21 PR, 19 SM, and 3 HE) the SPR was less than 50% for only 8 (19%) studies with 12 
(34%) studies reporting SPR of 100% (9 PR and 3 SM) (Table 3.5). 
The SDR was calculated for all 56 studies and the IDR for all studies except for the two 
before-after studies (here the result of IDR and SDR was the same). Among PR studies, study 
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dropout rates ranged from 0 to 59% (that is, cut-off value of 30%) with 27 (87%) studies 
having SDR of less than or equal to 30%. For studies of SM and HE programmes, the SDR 
ranged from 0 to 30% and from 11 to 21%. Overall, 52 (93%) studies had an SDR of less 
than or equal to 30% (Table 3.5). 
The IDR among studies of PR programmes ranged from 0 to 54%, 30 (97%) studies having 
IDR of less than or equal to 30%. Among studies of SM programmes, IDR ranged from 0 to 
60% (that is, a cut-off value of 30%), 18/20 (90%) studies having less than 30% IDR. And in 
studies of HE programmes IDR ranged from 7 to 29%. Overall, IDR for 51/54 (94%) studies 
was less than or equal to 30% (Table 3.5). 
Despite being able to calculate the SDR and IDR, it was difficult to identify and differentiate 
between the number of participants who were lost to follow-up and participants who 
discontinued the intervention. We assumed that participants who dropped out of the study 
also dropped out of the intervention unless papers explicitly stated otherwise. 
As SPR was calculated for 43 studies, 31/43 (72%) studies with SPR of >50%, had SDR of 
≤30%. However, no obvious pattern could be deduced as 26/31 (84%) studies had not 
reported on participant flow data (‘potential participants identified’ and/or ‘numbers assessed 
for eligibility) before recruitment (Table 3.5). 
In the analysis of study characteristics, there was no evidence for effects of year of 
publication, study quality, exercise vs. non-exercise, and group vs. individual treatment on 
participation rate (Table 3.6). Figure 3.4 illustrates how year of publication had no effect on 
participation rate. Confidence intervals for effects were wide, and did not rule out the 
possibility of a five-fold increase in the odds of participation in exercise vs. non-exercise 
interventions, or a five-fold decrease in group vs. individual interventions. 
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Table 3.5 Study outcomes 
Pulmonary rehabilitation programmes, n=31 
Author 
(year) 
and 
Study 
design 
Time of 
study 
assessments 
and follow-
ups 
Participant flow data Quality 
assessment 
Participation rates What is the primary outcome? Is 
the intervention effective for the 
primary outcome? 
  Potential 
numbers 
identified, 
n = 4 
Numbers 
assessed, 
n = 12 
 
Numbers 
eligible,  
n = 21 
 
Numbers 
included and 
randomised, 
n (I, C) 
a, b, ci, cii, 
d 
SPR, n 
(%) 
SDR, 
n (%) 
IDR, n 
(%) 
 
Barakat 
(2008) 
RCT 
0, 14 weeks not 
reported 
80 80 80 (40, 40) 9, 2, 6, 4, 
no 
80 
(100) 
9 (11) 5 (13) not reported  
Boxall 
(2005) 
RCT 
0, 12 weeks not 
reported 
not 
reported 
not 
reported 
60 (30, 30) 10, 1, 5, 3, n/c 14 
(23) 
5 (18) not reported 
Carr 
(2009) 
RCT 
T0- before 
AECOPD,  
T1 - 2 weeks, 
T2 - 3 weeks 
T3 - 12 
weeks  
not 
reported 
364 94 60 included, 
34 (17, 17) 
10, 2, 5, 4, 
yes 
34 (36) 5 (15) 1 (6) Health-related quality of life 
(HRQoL) -  limited benefit 
 
de Godoy 
(2003) 
RCT 
0, 12 weeks not 
reported 
not 
reported 
39 30 (14, 16) 11, 1, 5, 5, 
no 
30 (77) 0 0 not reported 
Finnerty 
(2001) 
RCT 
0, 12, 24 
weeks 
not 
reported 
108 100  100 (50, 50) 10, 1, 6, 2, 
no 
65 (65) 16 
(25) 
4 (11) Change in quality of life (QoL) – 
YES 
Goldstein 
(1994) 
RCT 
0, 12, 18, 24 
weeks 
not 
reported 
244 126 89 (45, 44) 11, 1, 4, 3, 
no 
89 (71) 11 
(12) 
7 (16) not reported 
Ghanem 
(2010) 
0, 2 months not 
reported 
not 
reported 
50 45 (30, 15) 10, 1, 5, 5, 
yes 
39 (78) 0 0 not reported 
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RCT 
Karapolat 
(2007) 
RCT 
0, 8, 12 
weeks 
not 
reported 
not 
reported 
not 
reported 
49 (27, 22) 9, 1, 5, 2, 
no 
n/c 4 (8) 1 (4) not reported  
Liddell 
(2010) 
pilot 
RCT 
0, 2 weeks of 
end of 
programme 
36 on 
waiting 
list 
36 30 30 (15, 15) 9, 1, 5, 4, 
no 
30 
(100) 
10 
(33) 
4 (27) measures reflected potential 
changes in exercise tolerance and 
HRQoL, n/a 
Lindsay 
(2005) 
RCT 
0, 6 weeks 
before 
programme, 
12 weeks, 3 
months 
not 
reported 
not 
reported 
50 50 (25, 25) 10, 1, 5, 4, 
yes 
50 
(100) 
9 (18) 4 (16) not reported 
Man 
(2004) 
RCT 
0, 3 months not 
reported 
69 52  42 (21, 21) 11, 1, 5, 5, 
yes 
42 (81) 8 (19) 2 (10) exercise capacity and disease 
specific and generic health status - 
YES 
Na 
(2005) 
Quasi 
0, 12 weeks, 
1 year  
not 
reported 
not 
reported 
43 43 (25, 18) 
(not 
randomised) 
10, 1, 6, 1, 
yes 
43 
(100) 
20 
(47) 
5 (20) not reported, n/a 
Oh 
(2003) 
RCT 
0, 8 weeks not 
reported 
not 
reported 
34 34 (19, 15) 10, 1, 5, 2, 
no 
34 
(100) 
11 
(32) 
4 (21) not reported 
Reardon 
(1994) 
RCT 
before start 
of PR, after 6 
weeks 
not 
reported 
not 
reported 
not 
reported 
20 (10, 10) 11, 1, 6, 3, 
no 
n/c 0 0 not reported 
Resqueti 
(2007) 
RCT 
0, 6 months not 
reported 
not 
reported 
42 38 (19, 19) 10, 1, 5, 4, 
no 
38 (90) 9 (24) 5 (26) not reported 
Ries 
(1995) 
RCT 
0, 2 months, 
for 
physiologic 
measures 12, 
24, 48, 72 
months. For 
not 
reported 
352 128 119 (57, 62) 9, 2, 6, 6, 
no 
119 
(93) 
70 
(59) 
31 (54) not reported 
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psychological 
measures 6, 
12, 18, 24, 
36, 48, 60 
and 72 
months 
Ringbaek 
(2000) 
RCT 
0, 8 weeks not 
reported 
not 
reported 
130  45 (24, 21) 10, 1, 5, 5, 
no 
45 (35) 7 (16) 7 (29) not reported 
Sewell 
(2006) 
RCT 
0, 4th week 
and 7th week 
for 
intervention 
group, 7 
weeks for 
control, 6 
months  
not 
reported 
not 
reported 
not 
reported 
100 (50, 50) 10, 1, 6, 4, 
yes 
n/c 29 
(29) 
9 (18) exercise capacity - NO 
Sridhar 
(2008) 
RCT 
0, 2 years 1247 574  297 122 (61, 61) 9, 2, 4, 5, 
yes 
122 
(42) 
18 
(15) 
6 (10) hospital readmission rate - YES 
Theander 
(2009) 
RCT 
0, 12 weeks 64 55 30 30 (15, 15) 10, 2, 4, 5, 
yes 
30 
(100) 
4 (13) 3 (20) not reported 
White 
(2002) 
RCT 
0, 3 months 160 116 107 103 (54, 49) 11, 2, 6, 4, 
yes 
103 
(96.2)  
15 
(15) 
9 (17) mastery and emotional subscales 
of Chronic respiratory 
questionnaire - NO 
Wedzicha 
(1998) 
RCT 
0, 8 weeks not 
reported 
not 
reported 
not 
reported 
126: 
moderate -66 
(33, 33) 
severe-60 
(30, 30) 
 
10, 2, 5, 4, 
no 
n/c 17 
(13) 
16 (25) Exercise capacity for moderate 
severity group of patients – YES 
but not for severe patients.  
Wijkstra 
(1994) 
0, 12 weeks not 
reported 
not 
reported 
not 
reported 
45 (30, 15) 10, 1, 5, 2, 
no 
n/c 2 (4) 2 (7) not reported 
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RCT 
Seymour 
(2010) 
RCT 
72 hours of 
discharge and 
3 months 
not 
reported 
not 
reported 
not 
reported 
60 (30, 30) 10, 1, 5, 4, 
yes 
n/c 7 (12) 7 (23) Hospital admission - YES 
van 
Wetering 
(2009) 
RCT 
0, 4, 12, 24 
months 
not 
reported 
355 199 199 (102, 97) 10, 2, 4, 4, 
yes 
199 
(100) 
41 
(21) 
18 (19) Disease-specific QOL -  YES; 
frequency of exacerbations NO  
Green 
(2001) 
RCT 
0, 4 weeks or 
7 weeks 
Unclear 
not 
reported 
not 
reported 
not 
reported 
44 (23, 21) 8, 1, 3, 1, 
no 
n/c 0 0 QoL - NO 
Guell 
(2006) 
RCT 
0, end of 4 
months 
not 
reported 
not 
reported 
not 
reported 
40 (20, 20) 9, 1, 5, 3, 
no 
n/c 5 (13) 2 (10) not reported 
Guell 
(2000) 
RCT 
0, 3, 6, 9, 12, 
18, 24 
months 
not 
reported 
not 
reported 
65 60 (30, 30) 10, 1, 5, 3, 
no 
60 (92) 13 
(22) 
6 (20) HRQoL - YES 
Strijbos 
(1996) 
RCT 
0, 3, 6, 12, 18 
months 
not 
reported 
not 
reported 
50 50 (18, 17, 
15) 
10, 1, 4, 2, 
no 
50 
(100) 
9 (18) 5 (14) not reported 
Prince 
(1989) 
RCT 
before and 
after 6 weeks  
not 
reported 
not 
reported 
not 
reported 
31 (13, 18) 7, 1, 5, 3, 
no 
n/c 6 (19) 2 (15) not reported 
Zakrisson 
(2011) 
Quasi 
0, 2, 5 
months and 1 
year 
not 
reported 
1828 176 176 (83, 93) 
(not 
randomised 
but allocated 
10, 1, 3, 1, 
yes 
176 
(100) 
12 (7) 0 Exacerbation – YES, NO for 
walking and QoL, n/a 
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Self-management programmes, n=21 
Author 
(year) 
Study 
design 
Time of 
study 
assessment
s and 
follow-ups 
Participant flow data Quality 
assessmen
t 
Participation rates What is the primary outcome? 
Is the intervention effective for 
the primary outcome? 
  Potential 
numbers 
identified, 
n = 4 
Numb
ers 
assesse
d, 
n = 10 
Numbers 
eligible,  
n = 19 
Number
s 
included 
and 
randomi
sed, n (I, 
C) 
a, b, ci, 
cii, d 
SPR, n 
(%) 
SDR, n 
(%) 
IDR, n (%)  
Howland 
(1986) 
Quasi 
0, 1 year not 
reported 
1834 923  659 
(254, 
405)  
10, 0, 5, 2, 
no 
659 
(71) 
121 (18) 41 (16) not reported, n/a 
Cockcroft 
(1987) 
RCT 
November 
1984, 
August 
1985 
not 
reported 
not 
reporte
d 
92 75 (42, 
33) 
10, 3, 4, 3, 
no 
73 (79)  11 (15) 3 (8) 
 
not reported 
Sassi-
Dambron 
(1995) 
RCT 
0, 6 weeks, 
6 months 
not 
reported 
497 98 98 (47, 
51) 
10, 1, 5, 3, 
yes 
89 (91) 13 (15) 5 (11) not reported 
Zimmerm
an (1996) 
Before-
after 
pretest-
postest 6 
weeks 
not 
reported 
not 
reporte
d 
not 
reported 
10 not 
randomi
sed 
8, 1, 3, 1, 
no 
n/c 0 Same as SDR Self-efficacy - partly 
Emery 
(1998) 
RCT 
baseline T1, 
T2 –after 10 
weeks 
not 
reported 
not 
reporte
d 
92 79 (29, 
25, 25) 
10, 1, 7, 5, 
no 
79 (86) 6 (8) 4 (14) not reported, n/a 
Bourbeau 
(2003) 
RCT 
0, 4, 12 
months. In 
addition 
not 
reported 
not 
reporte
d 
469  191 (96, 
95) 
10, 1, 6, 5, 
yes 
191 
(41) 
26 (14) 10 (10) Hospital admission - YES 
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standardised 
telephone 
interview 
every 4 
weeks 
Monninkh
of (2003) 
RCT 
0, 1 year 615 not 
reporte
d 
509 248 
(127, 
121) 
11, 1, 5, 5, 
yes 
248 
(41) 
12 (5) 5 (4)  not reported 
Kara  
(2004) 
RCT 
preprogram
me and post 
and 1 month 
after 
programme. 
For control 
group after 
1 and 2 
months of 
initial 
interview 
not 
reported 
not 
reporte
d 
60 60 (30, 
30) 
11, 1, 4, 4, 
no 
60 
(100) 
0 0 not reported 
Rea 
(2004) 
RCT 
0, 12 
months 
not 
reported 
700 158 135 (83, 
52) 
10, 1, 4, 5, 
yes 
135 
(85) 
18 (13) 12 (14) Change in hospital bed days - 
YES 
Coultas 
(2005) 
RCT 
0, 6 months 2120 535 217 217 (72, 
72, 73) 
10, 2, 5, 5, 
yes 
217 
(100) 
66 (30) 44 (31) not reported 
Casas 
(2006) 
RCT 
0, 6, 
12months 
not 
reported 
850 160 155 (65, 
90) 
10, 3, 7, 4, 
yes 
155 
(97) 
35 (23) 17 (26) Hospital readmission - YES 
Nyugen 
(2008) 
pilot RCT 
0, 3, 6 
months 
not 
reported 
173 84  50 (26, 
24) 
10, 2, 5, 5, 
no 
50 (60) 11 (22) 7 (27) QoL – YES, n/a 
Kheirabad
i (2008) 
pilot RCT 
0 – before 8 
weeks, after 
8 weeks, 3 
not 
reported 
not 
reporte
d 
59 42 (21, 
21) 
10, 1, 4, 4, 
no 
42 (71) 0 0 Health status – partly, n/a 
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months 
Efraimms
on (2008) 
RCT 
2 visits with 
a 3 – 5 
month 
interval 
between 
first and last 
visit 
110 110 62 62 (26, 
26) 
10, 1, 4, 4, 
no 
52 (84) 0 0 not reported 
Effing 
(2009) 
RCT 
0, 7, 12 
months 
not 
reported 
not 
reporte
d 
421 153 (77, 
76) 
10, 1, 5, 5, 
yes 
153 
(36) 
11 (7) 11 (16) not reported 
Taylor 
(2012) 
pilot RCT 
0, 2, 6 
months 
not 
reported 
not 
reporte
d 
507 116 (78, 
38) 
9, 2, 5, 6, 
no 
116 
(23) 
25 (22) 47 (60) No primary outcome, n/a 
Khdour 
(2009) 
RCT 
0, 6, 12 
months 
not 
reported 
not 
reporte
d 
295 173(86, 
87) 
10, 1, 4, 4, 
yes 
173 
(59) 
30 (17) 15 (17) Hospital admission and HRQoL - 
NO 
Koff 
(2009) 
pilot RCT 
0, 3 months not 
reported 
not 
reporte
d 
not 
reported 
40 (20, 
20) 
11, 0, 4, 4, 
yes 
n/c 2 (5) 1 (5) QoL – YES, n/a 
Moore 
(2009) 
pilot RCT 
0, 8 weeks 
for I, 7 
weeks for C 
not 
reported 
40 33  27 (14, 
13) 
10, 1, 5, 3, 
no 
27 (82)  7 (26) 4 (29) No primary outcome, n/a 
Hill 
(2010) 
RCT 
0, for 
intervention 
group 1 
month after 
2nd session 
and 3 
months after 
baseline 
assessment 
in control 
group to 
131 110 100 100 (55, 
45) 
10, 3, 5, 4, 
yes 
100 
(100) 
7 (7) 5 (9) not reported 
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make 
timeline 
similar 
Ninot 
(2011) 
RCT 
0, 1 year not 
reported 
101 61 45 (23, 
22) 
11, 1, 4, 4, 
yes 
45 (74) 7 (16) 1 (4) Walking - YES 
Health education programmes, n=4 
Author 
(year) 
study 
design 
Time of 
study 
assessment
s and 
follow-ups 
Participant flow data Quality 
assessmen
t 
Participation rates What is primary outcome? Is 
intervention effective for the 
primary outcome? 
  Potent
ial 
numbe
rs 
identif
ied, 
n = 1 
Numb
ers 
assesse
d, 
n = 0 
Numbe
rs 
eligible,  
n = 3 
Numbers 
included and 
randomised, 
n (I, C) 
a, b, ci, 
cii, d 
SPR, 
n 
(%) 
SDR, n 
(%) 
IDR, n (%)  
Littlejohn 
(1991) 
RCT 
0, 1 year not 
reporte
d 
not 
reporte
d 
166 152 (73, 79) 11, 1, 6, 4, 
yes 
152 
(92) 
19 (13) 5 (7) not reported 
Petty 
(2006) 
RCT 
0, 4, 8 
weeks face 
to face, 4, 9 
months by 
post 
more 
than 
500 
not 
reporte
d 
not 
reported 
214 (72, 69, 
73) 
10, 3, 3, 5, 
no 
n/c 40 (19) 21 (29) not reported 
Rice 
(2010) 
RCT 
0, 12 
months 
not 
reporte
d 
not 
reporte
d 
1739 743 (372, 371) 10, 1, 5, 4, 
yes 
743 
(43) 
84 (11) 36 (10) Combined hospital admissions and 
emergency visits - YES 
Lemmens 
(2010) 
Before-
after 
0, 12 
months 
(postal) 
not 
reporte
d 
not 
reporte
d 
259 259 included  10, 2, 3, 1 
no 
189 
(73) 
39 (21) n/a not reported, n/a 
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Table 3.6 Odds ratio for participation according to study characteristics 
Variable Odds ratio (95% confidence 
interval) 
P 
Year 0.99 (0.92, 1.08) 0.891 
Quality score 0.85 (0.65, 1.10) 0.215 
Exercise intervention 1.55 (0.47, 5.07) 0.470 
Group intervention 
Individual 
 
Combination 
 
Group 
 
1.00 
 
0.17 
 
0.60 
 
- 
 
(0.03, 0.81) 
 
(0.17, 2.11) 
0.506        trend 
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Figure 3.4 Participation rates in different studies ordered by year of publication. Error bars 
show 95% confidence interval 
0% 20% 40% 60% 80% 100%
Howland 1986
Cockcroft 1987
Littlejohn 1991
Goldstein 1994
Ries 1995
Sassi-Dambron 1995
Strijbos 1996
Emery 1998
Guell 2000
Ringbaek 2000
Finnerty 2001
White 2002
Bourbeau 2003
de Godoy 2003
Monninkhof 2003
Oh 2003
Kara 2004
Man 2004
Rea 2004
Coultas 2005
Lindsay 2005
Na 2005
Casas 2006
Resqueti 2007
Barakat 2008
Efraimsson 2008
Kheirabadi 2008
Nyugen 2008
Sridhar 2008
Carr 2009
Effing 2009
Khdour 2009
Moore 2009
Taylor 2009
Theander 2009
van Wetering  2009
Ghanem 2010
Hill 2010
Lemmens 2010
Liddell 2010
Rice 2010
Ninot 2011
Zakrisson 2011
Participation rate  
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3.3.4.6 Reasons reported by the included studies for participation/non-
participation, completion/non-completion 
Non-participation among eligible patients was seen among 27 studies, 11 studies did not 
report any reasons for non-participation and 16 studies reported reasons for study non-
participation that amounted to external, programme-related, study-related, personal and 
clinical/health-related factors and other reasons. It was difficult to differentiate between the 
participants who dropped out of the study and those who dropped out of the programme 
however, 48 studies reported reasons for study and/or programme dropout and the reasons 
given again fell into the same headings given for study non-participation. And two studies 
stated reasons for programme nonattendance which were mainly health-related. Table 3.7 
presents reasons reported by studies for study non-participation, study and/or programme 
dropout and programme non-attendance 
 
Table 3.7 Reasons reported by studies for study non-participation, study and/or programme 
dropout and programme non-attendance 
Reasons for study non-
participation  
Reasons for programme non-
attendance  
Reasons for study and/or 
programme dropout 
- Refused participation or did not 
wish to participate in study/ 
programme but no reasons for 
refusal were recorded/reported  
 
- Lived too far away  
- Lack of time  
- Transport problems 
- Participation in other research 
projects 
- Clash with other social 
activities/prior commitments 
 
- PR programme too extensive 
 
- Not contactable/no response 
- Failed to attend study 
appointment 
- Did not cooperate adequately  
 
- Could not commit 
- Changed mind before start of 
study 
- Lack of perceived benefit 
- Lack of interest 
- Refused without financial 
compensation 
- Too ill 
- Ineligible 
- Fractured hip, exacerbation of 
low back pain 
- Cardiac 
problems/comorbidities/illness 
- Surgery/exacerbation 
- Died 
- Diagnosed with lung 
cancer/neoplasm 
- Hospital admission because of 
abdominal pain 
- Admission to respite 
care/nursing home 
- Palliative care 
 
- Burden of 
evaluation/unwillingness to 
complete questionnaire  
- Lost to follow up 
- Withdrew extent 
- Did not return/did not keep 
appointment 
- Non-compliant/failed to 
cooperate 
- Insufficient diary data (not 
motivated, not capable) 
- Unable to use technology 
- Ineligible 
 
- Hypothesis that intervention 
encouraged uncomfortable levels 
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- Problems with change in 
medication 
- Hospital admission due to 
exacerbation 
- Died 
 
- Other reasons 
of activity 
- Extent of exercise programme 
 
- Inconvenience of hospital 
attendance (assumed by study)  
- Transportation problems 
(inconvenience) 
 
- Change of address 
- Too busy 
- Angry not receiving oxygen 
- Lack of interest 
- Lacked motivation to continue 
- Language barrier 
- Phone line problem 
- Prior commitments 
- Following alternative therapy 
- Accident 
- Do not want to participate in 
group 
 
3.4 Discussion 
3.4.1 Summary findings 
3.4.1.1 Incomplete reporting of participant flow data 
This review provides information on how randomised and non-randomised studies, including 
before-after studies, of interventions that help to improve SM in patients with COPD, report 
participant flow and the actual ‘participation rates’ amongst these studies. The reporting of 
participant flow amongst studies of the two main interventions (PR and SM) was generally 
incomplete but better reporting was seen in studies published in and after 2001 (the 
publication year of the CONSORT statement). Only 16% of studies reported ‘potential 
participants identified’, and slightly more than a third (39%) reported ‘numbers assessed for 
eligibility’. ‘Numbers eligible’ was better reported amongst studies (77%) but only seven 
(13%) studies reported on all levels of the participant flow before patient recruitment. 
The SPR was not calculated for 13 (23%) studies due to lack of information on ‘numbers 
eligible’ for study. The SPR for the remaining 43 studies was higher than expected. Only 
eight (19%) studies had an SPR of less than 50%. Another unexpected finding was that 93% 
and 94% of the studies had an SDR and an IDR, respectively, of less than or equal to 30%. 
However, it was difficult to differentiate between ‘numbers lost to follow-up’ and ‘numbers 
discontinued intervention’. In addition, 31 (72%) of 43 studies with SPR of >50%, had SDR 
of ≤30% but no obvious pattern could be deduced because of the lack of reporting on 
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participant flow data from 26 (84%) of the 31 studies. The incompleteness of data among the 
majority of the studies, limited the choice of study characteristics (including recruitment 
characteristics) to assess the effect on study participation rates and the four chosen 
characteristics did not influence the study participation rates. The reasons reported for study 
non-participation and for study/intervention dropout were similar and they comprised 
external, programme-related, study-related, personal and clinical/health-related factors. 
 
3.4.2 Comparison with other literature 
Some studies of both pharmacological and non-pharmacological interventions and surgical 
interventions, have examined reporting of participant flow diagrams (CONSORT statement 
recommended) including the type of information within the diagrams, in published studies 
identified from a single electronic database,284 in six high-quality285 and four high-impact 
journals,286 with most journals endorsing the CONSORT reporting of participant flow.284 
These studies concluded that participant flow was poorly reported. In Toerien’s study285 40% 
of studies failed to report ‘numbers assessed for eligibility’. Meanwhile, only 39% of studies 
in this review reported ‘numbers assessed for eligibility’ but the study selection was not 
based on the quality of the journal. There was low reporting at this level of participant flow in 
studies perhaps because studies did not think it important to record numbers for external 
validity, they might not have considered that patients are part of the trial at that level or 
before randomisation and hence failed to record and report numbers at this level.285,287 It has 
been acknowledged that studies of PR programmes do not include details or discuss 
adequately ‘numbers assessed for eligibility’ nor the refusal rate.121,123  
Regarding reporting ‘numbers of potential participants identified’ the aforementioned studies 
did not look at this level (this level is not included in the CONSORT flow diagram). A 
drawback of strictly designed RCTs may be limited generalisability as the focus is often to 
have homogenous groups of patients to limit individual variation.288 A recent literature 
review121 of PR programmes looked at reporting of sample selection in studies of PR 
programmes and only 12% of studies had reported the number of people contacted for the 
study. In this review, the proportion of studies that reported at this level was slightly higher 
(16%). Bjoernshave121 explained the lack of recording at this level was because people with 
COPD are not normally recruited from prevalence studies as prevalence of COPD is difficult 
to estimate and recruitment normally takes place from clinics or outpatient settings. 
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Nevertheless, if an attempt is made to record the total number of patients registered at a 
recruitment site ‘denominator’ then this data can be utilised to help generalise the study 
findings to the target group.227 
Gross’s review286 found that only 43% of studies had reported ‘numbers eligible’. In this 
review, more studies had reported this (77%) perhaps because most of the studies were 
published in and after 2001. Numbers at this level and numbers recruited helped to calculate 
the SPR, SDR and IDR and identify the actual patient ‘participation rates’ in studies of PR, 
SM and HE programmes for COPD patients. Only Keating’s review112 has explored patient 
non-attendance and non-completion, but only in PR programmes and the reported proportions 
were from a mix of quantitative and qualitative studies. A cut-off value of 20% for SDR is 
regarded as acceptable according to a quality assessment checklist 
http://www.sign.ac.uk/methodology/tutorials.html (accessed 20-8-14). And less than a third 
(29%) of studies in our review had a SDR of >20%, which suggests that most studies in this 
review would have fulfilled this particular quality criterion. Similarly to other studies284,285 
this review experienced problems in clearly identifying or differentiating between reports of 
‘numbers lost to follow-up’ and ‘numbers discontinued intervention’. A distinction needs to 
be made between these two types of attrition287 to inform on implementation of interventions. 
 
3.4.2.1 Variable definitions of participation among studies 
Based on the study findings, previous reports of poor participation and retention in studies of 
PR and SM programmes85,108,109,112 might not be justified. One explanation could be studies 
having different definitions for patient participation and thus the method of calculation of 
participation rates may have differed108,289 or not having clear definitions making it difficult 
to identify if the proportions refer to the study or intervention.109. Recent reviews112,285 
acknowledged that their studies gave varying definitions for ‘loss to follow-up’ and ‘non-
completion’. Examples here show discrepancies in reports of participation rates: two 
studies238,255 in this review (Table 3.5) had high SPRs of 71% and 93%, respectively but 
Young123 reported, SPR of 34% and 36% for these two studies. On investigation it appears 
that Young calculated SPR from ‘numbers assessed for eligibility’ and not ‘numbers 
eligible’; Another study in this review240 (Table 3.5) had a SDR of 29% and IDR of 18% 
respectively but Sabit115 reported a dropout rate of 30% and it is unclear whether the 
proportion refers to the study or intervention. 
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3.4.3 Strengths and limitations 
An attempt was made to identify numbers reported at each level of the participant flow from 
effectiveness studies. These studies may have decided to give more importance towards 
recording and reporting numbers for internal validity – a key feature of strictly designed or 
high-quality RCTs288 rather than external validity. This finding is also acknowledged by the 
new Medical Research Council guidance on evaluation of complex interventions.290 There is 
need to be cautious of the findings of high participation rates as only a minority of studies 
reported on all levels of participant flow before recruitment and in some cases 100% of 
eligible patients were recruited without providing the whole recruitment picture. 
 
3.5 Conclusions 
This systematic review has identified the ‘actual’ levels of participation and dropout rates in 
research studies evaluating PR, SM and HE programmes for COPD patients. These studies 
should consider recording and reporting participant flow numbers more completely. Only 
19% of studies had SPR of less than 50%. The SDR and IDR was less than or equal to 30% 
in the vast majority of studies. These findings negate previous reports of poor participation 
and retention in studies of PR and SM programmes. Possible explanations include studies 
using their own definitions for what constitutes patient participation in both the study and the 
intervention within the study, or studies, not stating definitions clearly, making it difficult to 
identify whether the proportions reported refer to the study or intervention. Clear and uniform 
definitions will help to identify a valid estimate of patient participation rates in the study and 
the intervention and could promote the correct interpretation of studies and the 
implementation of effective interventions in routine care. 
 
3.6 Implications 
3.6.1 Implications for clinical practice 
Based on the study findings of high study participation rates and low dropout rates in 
research studies of PR, SM and HE programmes, there is still a need to strongly endorse the 
active implementation of PR and SM programmes in routine care, as patients with COPD are 
participating, attending and completing them. Despite notable evidence of benefit from 
studies of PR programmes291 and some benefit from studies of SM programmes,84 in practice, 
these programmes do not seem to be widely implemented or some actively running ones are 
  
 186  
 
closing down (Kennedy A. Senior Research Fellow. Personal Communication. Jun 2012) 
thereby, reducing opportunities for suitable patients to attend and gain benefits from the 
programmes.  
 
3.6.2 Implications for future research 
A recommendation is that future research studies provide clear definitions when reporting 
patient participation, enabling a true estimate of patient ‘participation rates’ and avoiding 
confusion amongst readers. To calculate ‘participation rates’, it is important for studies of PR, 
SM and HE programmes, to provide more information on patient participant flow. 
Incomplete reporting of patient recruitment data will affect external validity.121 It is essential 
for studies to report these data to help HCPs interpret the study results and to decide if the 
results could be applied to their patients.285,286 
 
Much focus on the implementation of non-pharmacological interventions has resulted in a 
shift, from conducting explanatory trials to pragmatic trials.288. One of the features of 
pragmatic trials is that they tend to recruit a heterogeneous patient group all with the 
condition of interest to maximise the trial results to usual care settings.292 To record and 
report a clear picture of the recruitment process, studies can utilise the checklist provided by 
the extension of the CONSORT statement for reporting pragmatic trials.226 Gross286 stressed 
that studies should at least record and report ‘numbers eligible’ for recruitment. The addition 
of several boxes to the CONSORT flow diagram, before and after randomisation, has been 
recommended by Toerin,285 which may help to get a better assessment of generalisability, 
estimate a true non-participation rate, and to establish a true intervention effect. 
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The next chapter will explore from published qualitative studies and using theory, 
factors/reasons that influenced an individual with COPD to participate and/or dropout from 
studies of PR, SM and HE programmes (SM support programmes) including from the 
programmes.  
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Chapter IV. A qualitative synthesis and application of theory 
to understand participation behaviour of patients with COPD 
in research studies of COPD SM support programmes 
 
This chapter through the thematic ‘framework’ synthesis: 
 Identifies the reasons reported by patients with COPD for attending, not attending and 
dropping out of studies of SM support programmes including from the programmes 
 Applies behavioural theories to the identified patient reasons to explain patient 
attendance, non-attendance and dropout behaviour 
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4.1 Introduction 
The previous chapter showed high study participation rates in studies of COPD SM support 
programmes and low dropout rates that were contradictory to previous reports, however, due 
to the poor/unclear recruitment picture seen among the majority of the included studies the 
problem of participation may still remain. In addition, the problem of poor participation and 
retention in COPD SM support programmes has been acknowledged in clinical practice113 
and there is plenty of anecdotal evidence too. Understanding the problem of poor patient 
participation and retention is therefore critical293 to help improve patient participation and 
retention. 
In Chapter I (section 1.1.1.4.5) various reasons reported for patient non-attendance and 
non-completion have been presented. In addition, a mixed-methods review112 of participation 
in PR programmes attributed patient non-attendance and dropout to personal, clinical, social 
and physical barriers. Only one study122 of a COPD SM programme has explored reasons for 
high or low attendance and the findings comprised a mix of socio-demographic, personal and 
clinical factors. It has been suggested that socio-demographic and clinical factors may be 
insufficient to understand the problem of poor participation and completion in COPD SM 
support programmes; a new approach was therefore needed.19,113,294  
An approach which views participation as a health behaviour, and utilises health behaviour 
theory and constructs related to behaviour change, could further understanding of 
participation behaviour.295 Such an approach could help identify appropriate targets for an 
intervention294 with the ultimate aim of improving patient participation in COPD SM support 
programmes and thus enhancing patient outcomes. Health behaviour theory has been utilised 
in several studies as shown in the previous chapter to explain or predict participation, 
particularly attendance in patients with a variety of conditions, however, only one study110 
has used such an approach in COPD. 
The aim of this qualitative synthesis was, therefore, to explore the factors that might explain 
participation in COPD SM support programmes. 
 
4.1.1 Review aim 
To explore factors that might explain patient participation, non-participation, completion and 
non-completion in both studies of interventions that provide self-management support and in 
the actual interventions by patients with COPD.  
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4.1.2 Review questions 
(1) What are the possible reasons affecting patient participation and/or completion in studies 
of COPD SM support programmes including in the programmes? 
(2) Can behavioural theory help to explain patient participation behaviour in studies of COPD 
SM support programmes including in the programmes?  
 
4.2 Methods 
This qualitative synthesis was part of the broader systemic review in Chapter III and so, one 
search strategy (section 3.2.1) was implemented to identify the relevant qualitative and 
quantitative studies. As a result, the population of interest and the interventions were also the 
same.  
 
4.2.1 Study selection 
All qualitative research exploring reasons for participation and/or completion in studies of 
SM support programmes and including in the programmes by patients with COPD were 
considered for inclusion. 
 
4.2.2 Quality assessment 
The modified checklist from the critical appraisal skills programme (CASP) was used to 
assess the quality of the qualitative studies as operationalised by Campbell296 (and personal 
communication September 2010). Campbell’s modifications included identification of a 
theoretical perspective from the primary studies, overall grading of the quality of the paper, 
and a summary of questions about specific aspects of the method. Description in qualitative 
studies, have been differentiated by the ‘thickness’ or ‘thinness’ of data.297 Noyes in their 
review appraised, using the CASP checklist to assess methodological quality and Popay’s 
checklist298 to assess theoretical dimensions among the included studies. Studies of high 
quality or of ‘thicker’ description, offer greater preference to subjective experiences and 
meanings e.g. verbatim quotes and use theory to offer explanation for a behaviour, which 
increases the potential for explanations and transferability of findings to other settings.297 
Whilst, studies of low quality or of ‘thinner’ description offer little if any preference to 
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respondents’ views, and do not use theory. In this review, studies of both high and low 
quality were included to show the comprehensiveness of the literature.299 Low 
methodological quality studies can still produce new insights, grounded in the data, while 
high quality studies may not be clear in their interpretation, hence none of the included 
studies were excluded after quality assessment.300 The study findings were differentiated 
between participant verbatim quotations and authors interpretations of the views. Greater 
weight was placed on directly reported views301 or studies of ‘thicker’ description. 
 
4.2.3 Data abstraction 
Unlike Campbell296 who used the CASP checklist to also identify key concepts emerging 
from the studies, all of the text given under the ‘Results’ section of each study was extracted 
because some studies undertake simple analysis which only includes describing and 
summarising of data making it difficult to identify key concepts.301 Data synthesis in this 
review included either verbatim quotations, verbatim quotations with authors’ interpretations 
and/or authors’ interpretations of the study data but not exemplified by verbatim quotations 
e.g. “Some of the participants described how they wanted to help themselves and be active 
partners in the management of their condition. The following quote reflects this view:  
“...giving me the opportunity to help myself and do something positive instead of just 
taking this, taking that”” (author’s interpretation supported by verbatim study data)   
Or 
“One patient had asked for pulmonary rehabilitation himself. He had been in 
rehabilitation before and was very positive about it. Moreover, fear resulting from 
worsening dyspnoea led him to search for alternative treatments. Being eventually 
referred was a great relief and the anticipation of being in pulmonary rehabilitation 
reduced his feelings of anxiety” (author’s interpretation of data not supported by 
verbatim study data) 
 
The study characteristics extracted from the included studies were: 
 Whether or not they were part of a mixed-methods study 
 Sample selection 
 Data collection 
 Data analysis 
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 Themes exploring factors influencing an individual’s participation (and attendance, 
non-attendance, or dropout) behaviour in a SM support intervention 
 Themes exploring an individual’s beliefs, knowledge or behaviour of disease and/or 
of self-management which might influence participation (and attendance non-
attendance, or dropout) behaviour in a health care intervention 
 
Appendix 4.1 includes the data abstraction form with the embedded quality assessment 
checklist  
 
4.2.4 Data synthesis – Thematic ‘framework’ synthesis  
The thematic ‘framework’ synthesis301,302 was conducted to answer the review question.  
Thematic synthesis301 has been adopted from the term thematic analysis, translated for the 
analysis of primary research in reviews. Thematic analysis is ‘not another qualitative method 
but a process that can be used with most, if not all, qualitative methods’. The analysis has 
been used previously to identify recurring themes, conduct analyses of these themes and draw 
conclusions in systematic reviews.303 All the text under the ‘Results’ section of the included 
primary studies was uploaded into the Nvivo8 software. The synthesis involved three distinct 
stages:301 
1) Coding text 
 Line by line coding of the text in each of the primary studies was conducted to 
identify concepts or initial free codes keeping the review question in mind. This stage 
is an important stage as it includes the translation of concepts from one study to 
another. Translation is taking the concepts from one study and recognising the same 
concepts in another study, though they may not be expressed in identical words. For 
example: data under a subtheme ‘positive influence of the referring medical 
practitioner’ in Arnold’s study304 was similar to data presented under the subtheme 
‘referral to rehabilitation’ in Fischer’s study.305 
 In addition to identifying initial codes from primary studies, new codes or concepts 
not identified in the original studies were also developed, for example: ‘last resort to 
learn to cope’. In some cases, a statement could be categorised into several codes, for 
example ‘last resort to learn to cope’ or ‘only hope to remain independent’ 
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 Furthermore, codes were generated from texts in primary studies that were interpreted 
under a single code, e.g. we generated the following codes, ‘negative view of 
programme from experience and created by others’, ‘negative experience with health 
care staff in location of programme’, and ‘location of the programme’ from text 
placed under a single code ‘past negative experience(s)’ in Taylor’s114 study. 
 
2) Development of descriptive themes and subthemes 
 The identified codes or concepts were looked for similarities and differences, grouped 
accordingly and placed under new codes to capture the meaning of groups of initial 
codes. This process led to the production of descriptive themes and subthemes, e.g. 
Theme - ‘reasons for attending PR programmes’; Subtheme – ‘referrals by health care 
professionals (HCPs) – with explanation for referral’.  
 
3) Generation of analytical themes 
 These descriptive themes and subthemes were ‘mapped’ onto two a priori theoretical 
models with subsequent ‘generation of analytical themes’ that went beyond the 
findings of the original studies. A priori ‘framework’ characteristic to framework 
synthesis is informed from the literature and team discussion to synthesise findings.306 
In this stage, the recommended ‘best fit’ framework approach302 was applied 
whereby, an existing conceptual model/framework, that most closely matches the 
research topic under study is utilised to carry out the framework synthesis. This 
review utilised the ‘ASE’ model that was previously used to explain intention to 
participate in an asthma SM programme184 and the ‘SRM’ that included the ‘NCF’ 
that was used to explain cardiac rehabilitation utilisation181 and examined whether our 
results were consistent with either or both these models. Both the original models and 
how Lemaigre184 and Keib181 utilised the respective model to explain patient 
participation in their studies has been described in Chapter II (section 2.3.2.3, study 
denoted by (y) and (u)). It should be noted that the definition of one of the ASE model 
constructs vary slightly from those used in the original de Vries model14 (Figure 2.8 in 
Box 2.4), particularly that of ‘self-efficacy’ which focuses primarily on external 
barriers and is labelled by Lemaigre as ‘external or structural barriers’. Figure 2.10 
(Chapter II) illustrates the distal, proximal socio-cognitive and external constructs of 
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the ‘adapted model’ that explained intention to participate in an asthma SM 
programme in Lemaigre’s study.184 Hence, this review refers to the ASE model as the 
‘adapted ASE model’.  
 
4.2.5 Quality assessment and data validity 
A second reviewer (TM, expert in qualitative research) read the included studies to 
familiarise themselves with the data, extracted emerging themes and subthemes and 
conducted the quality assessment from a sample of three of the identified studies at random. 
The coding for the emerging themes and subthemes were discussed between the two 
reviewers. Following this discussion a list of definitive themes and subthemes was produced. 
The second reviewer commented on the draft, any disagreements were discussed. A third 
reviewer (the study supervisor) was consulted to resolve any unresolved disagreements and a 
final version was agreed.   
In addition, another reviewer (LS, health psychologist) independently mapped the themes and 
subthemes onto the two chosen theoretical frameworks and the mapping was discussed. 
Following that, a final version was agreed. 
 
4.3 Results  
Six studies were included in the review (Chapter III, Figure 3.3, PRISMA flowchart). Two 
studies307,308 were excluded because patients reasons for participation and/or completion were 
not explored. Five of the included studies examined PR programmes,114,304,305,309,310 just one 
study examined a COPD SM programme.122 Table 4.1 presents the study characteristics 
including the quality appraisal score. 
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Table 4.1 Characteristics of included qualitative studies 
Study  Arnold (2006) Fischer (2007) Taylor (2007) Denn (2008) Gysels (2009) Sohanpal (2012)* 
Intervention PR PR PR PR PR SM 
Country UK Netherlands UK UK UK UK 
Aim of study Explore experiences of 
patients who had been 
invited to attend PR to 
gain some insights into 
the aspects that may 
influence adherence 
Explore factors (role 
of patients treatment 
beliefs, goals and 
practice barriers ) 
predicting dropout in 
rehabilitation  
 
Explore why 
participants who took 
part in a randomised 
controlled trial of a  
nurse-led intermediate 
care package 
(intervention: 4 week 
group-based PR 
programme) declined to 
take part in the 
intervention. 
Explore patients 
understanding and 
expectations 8 weeks 
before and after taking 
part in a PR 
programme 
Understand how 
people respond to 
breathlessness: role 
of PR 
Explore reasons for 
participation to a 
COPD-specific SM 
programme from 
patients with COPD 
and lay tutors.     
The following was 
explored from the 
included studies for 
the synthesis  
Experience of PR 
adherence 
Factors predicting 
participation and 
dropout in PR 
Reasons for non-
participation in research 
study of a PR 
programme 
Expectations before 
and after taking part in 
a PR programme 
which include factors 
affecting participation 
Challenges of 
participation in PR 
Reasons for high and 
poor attendance in a 
COPD SM 
programme 
Was the study part 
of a mixed-methods 
study? 
No No Yes No No Yes 
Sample 20 12 39 5 5 20 
Type of data 
collection 
Individual interviews Individual interviews Individual interviews 
face to face and by 
telephone 
Focus group Observations, 
interviews and field 
notes 
Individual 
interviews 
Primary study 
underpinned by 
behavioural theory 
No No No No No No 
Emergent themes 
and subthemes from 
primary studies on 
participation and/or 
completion 
1) Experience of 
adherence to PR:  
Positive influence of 
the referring medical 
practitioner 
- Self-help 
 
1) Reasons for referral 
to rehabilitation. 
 
2) Beliefs about PR:  
- Anticipated benefits 
of participation in PR 
programme. 
1) Travel to and location 
of pulmonary 
rehabilitation 
class 
 [n = 19/39] (48.7%) 
 
2) Perception of Benefit  
1) Stoicism 
 
2) Fear 
 
3) Comradeship 
 
4) Empowerment 
1) Pulmonary 
rehabilitation 
 
2) Challenges  
 
 
3) Benefits 
1) Reasons for poor 
attendance 
 
2) Reasons for high 
attendance 
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2) Experience of non-
adherence to PR: 
- Negative influence of 
the referring medical 
practitioner 
- Social support and 
motivation 
 
3) Experience of 
adherence to PR 
 
- Concerns about 
participation in a PR 
programme. 
- Anticipated reasons 
for dropout. 
 
 
 
[n = 19/39] (48.7%) 
 
3) Competing 
commitments or 
demands  
[n =15/39] (38.5%) 
 
4) Poor or negative 
understanding of 
research study 
[n = 12/39] (30.8%) 
 
5) Past negative 
experience(s)  
[n = 11] (28.2%) 
 
6) Perception of health 
status  
[n = 10/39] (25.6%) 
 
5) Concept of severity 
 
 
Modified CASP 
quality checklist 
score (out of 28) 
22 25 24 21 24 27 
Key: 
PR – pulmonary rehabilitation 
SM – self-management 
CASP - critical appraisal skills programme 
*The study was included in the review as a grey report (2009) after it met the reviews’ inclusion criteria. The grey report was published in 2012.  
  197  
 
4.3.1 Quality assessment and data validity 
Reviewer TM conducted the data abstraction and quality assessment on one of the three 
studies to discuss any queries about the form, and to clarify interpretations of the quality 
assessment questions. Following that TM carried out the data abstraction and quality 
assessment on the remaining two studies. The agreement on the modified CASP checklist 
score was 100%. The studies were judged to be of reasonable quality. There was variation in 
study reporting. Particularly, there was lack of clear reporting on sampling strategy;304,305,309 
the data analysis process;310 the research questions;309 the researcher-participant relationship 
was not reported in any study; and in some cases the authors’ interpretation of data was not 
supported with verbatim data.114,305,309 
 
The level of agreement with LS with regard to the mapping of themes and subthemes onto the 
adapted ASE model was better (97%) in comparison to mapping onto the SRM (88%). The 
subthemes did not map quite easily onto the SRM and this might be because the data was not 
explored in studies in line with illness or intervention representations. An agreement was 
reached with the mapping following another discussion. 
 
4.3.2 Synthesis findings: Development of descriptive themes and 
subthemes 
The following were the emergent themes with 30 subthemes from studies of COPD SM 
support programmes: 
4.3.2.1 Themes emerging from studies of COPD SM support programmes  
(A) Reasons for attending programmes 
(A1) Reasons to continue and complete programmes 
(B) Reasons for not attending programmmes 
(C) Reasons for dropping out of programmes 
(C1) Potential reasons for dropping out of programmes 
 
4.3.2.1 Themes with emerging subthemes from studies of COPD SM support 
programmes  
(A) Reasons for attending programmes 
1. To help themselves – to improve health status  
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Participants in three studies122,304,305 wanted to attend the programme to learn about their 
condition and to help themselves. One participant saw taking part as a positive step to help 
oneself:  
 “giving me the opportunity to help myself and do something positive instead of just 
taking this, taking that”304  
 
Another participant305 initially decided not to attend the programme as attending would have 
interfered with their plans for the summer and the exercise would have left them exhausted. 
But then the same individual decided to attend as their health was interfering with their social 
activities:   
 “I always say to my friends: ‘I’ll be back in the summer and then we’ll have a good 
time together’. So I thought I’d be training three days a week and the other days I’d be 
completely worn out. My summer would be lost. So, at first I decided not to participate. But 
last time, I went to the beach. It was such a disappointment. And I thought: something needs 
to happen if I want to be able to do something next year. And that’s when I decided to go” 
 
2. Overcoming prior commitments and demands - to see improvements in health 
Nearly all patients in Fischer’s study305 were happy to give up various prior personal or 
professional commitments and chose to attend the programme to see improvements in their 
health: 
 “Even if you have to give up those things...you have to make choices. Do you want to 
grab a cup of coffee with someone or do you want to work on your health?” 
 
3. Gain control of condition  
Three studies304,305,309 reported that participants felt immense relief on getting an opportunity 
to participate in the programme as it would help them gain control of their condition (not 
exemplified by quote). Some participants felt that living with COPD had left them vulnerable 
to events outside of their control, such as the weather, which left some patients anxious about 
how they were going to manage:  
 “It’s going to be hotter this summer, I’m dreading it.”309 
 
4. Last chance to cope and remain independent 
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For some attending the programme was their only hope or last chance of coping with the 
disease and remaining independent. The thought of being dependent on others was for some 
their “greatest fear” and described as “devastating” (not exemplified by quote).309   
 
5. Referrals by health care professionals – with explanation for referral   
The majority of participants in two studies304,305 attended the programme because they were 
referred by health professionals and were told that attendance may bring health benefits. One 
participant was explained by their doctor that attending the programme might improve their 
health and breathing.   
 “she said it would be half-exercising and then talks about it and it might improve 
your general health which would help your breathing”304 
 
Another participant305 did not understand or think they needed to be referred but went 
because the doctor thought it would be beneficial  
 “No, there was no real reason for referral, because the X-rays were unchanged and 
my lung volume was the same. The oxygen in my blood had gone up so there was no real 
reason. But [the doctor] thought it might be beneficial. I did not ask why.” 
 
Fischer’s study reported that referral to the programme was made for patients who had 
frequently been admitted to hospital and how the hospital couldn’t do anything more for them 
but that participating in the programme could help improve their condition. A participant 
attended PR because they were told how other patients were able to take up activities (e.g. 
walking more than usual) after participation in the programme.  
 “The lung specialist said: ‘There’s nothing I can do for you’. But he said that he had 
seen patients who were able to take on some activities after participating in a rehabilitation 
programme. ‘Cos now I can walk up and down the street and that’s it. Perhaps I’ll be able to 
walk one block then. And that was the doctor’s aim. They also told me: ‘We can’t cure you. 
But the intention is to get you some more [lung] volume.” 
 
In some cases participants attended because they themselves had no knowledge of the 
programme and had no reason to doubt the opinion and advice given by their consultant 
about the programme.  
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 “because X (consultant) advised it and I go on advice from somebody I think should 
know what they are talking about”304 
 “because if people in those positions make suggestions then I listen to them because I 
have no medical knowledge”304 
These participants completed the programme. 
 
Also, four of the seven participants in Fischer’s study305 did not remember why they were 
referred and stated that they were not provided any explanation but went anyway (not 
exemplified by a quote).  
  
A participant (now an enthusiast of the programme) in one study310 was initially surprised of 
being invited to enrol in the programme which involved exercise. Perhaps the participant 
decided to attend because the HCP mentioned they were an ideal candidate to join the 
programme. 
 “...She did research into exercise for us respiratory patients, […] she said to me: 
‘I’ve looked at your papers and you’d be an ideal candidate, would you like to join?’ and 
hardly being able to breathe I said to her: ‘Well, what’s it all about?’ So she said: ‘Well, it’s 
a little bit of exercise.’ That’s when I blew, I said: ‘You’ve gotta be joking love’, I said: ‘I 
can’t walk, I can’t talk, how the bloody hell do you think I can do exercise?” 
 
6. Previous positive experience of the programme – social and emotional support from staff 
and other participants  
The study by Fischer,305 unlike the other four studies, explored and reported reasons for 
attending amongst both participants who were new referrals and those who had attended the 
programme previously. Reasons for re-attendance from previous attendees included:  
One participant took comfort in supervision being provided during the programme and felt 
their care was part of an integrated system.  
 “See, the good thing is you’re being supervised when you’re busy. And then they 
suddenly say: ‘You’d better see the speech therapist’. And that’s nice. It’s one integrated 
system. All these people are watching you” 
 
Participants felt understood by healthcare staff and felt they could talk openly with them:  
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 “I noticed it during the intake consultation and when talking to the nurse: they 
quickly understand what you mean. Of course, they deal with that everyday. Every story, 
every excuse, they must have heard for at least 80 times. So there’s no need for decorum, 
withholding things. They’ll know. There’s no point in trying to deceive them” 
 
One participant feared their worsening dyspnoea and wanted to attend the programme again 
because of their previous positive experience. A timely referral was a welcome relief which 
reduced feelings of anxiety (not exemplified by a quote).  
 
Participants, both male and female re-attended PR because they enjoyed the social 
experience. The males enjoyed “learning from others” how to do exercises, while the 
females wanted to learn from others how to cope. Participants gave each other 
encouragement and emotional support. Some previous attendees felt strongly that they were 
understood within the programme arena whilst outside they experienced stigma and 
misunderstanding about their condition, especially those who used a wheelchair.  
 
7. To socialise 
Patients’ motivation to attend the programme in two studies122,304 was because it would get 
them out of the house and meet people with the same condition. For some, it was the only 
place they could socialize.  
 “If you’re on your own and you go along to these things and enrol with other people, 
at least it gets you out of the house” 
 
 “I don’t have many friends so I did use it as a bit of social time”  
 
8. Altruism 
Helping others was a motive for programme attendance for two participants.122 
 “I tried to help, really. In myself, I’m all right…I said I’d go...because I’m 
interested…if it can help other people, and I think it probably did…” 
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(A1) Reasons to continue and complete programmes 
Arnold’s study (2006) explored experience of adherence (taking up and completing) to 
programmes. The reported explanations have been sub-divided, taking up is described under 
theme A and reasons for continuation and completion of programmes are described here.   
 
9. Personal benefits and peer support 
Some participants304 enjoyed and felt real benefits in attending the programme. The group 
format was liked as participants could socialise and felt supported. Attendance increased their 
confidence, self-esteem and mood, illustrated with quotes:  
“once I’d gone once I wouldn’t have missed it for anything” 
 
 “I enjoyed going there because I liked the exercise” 
 
 “it made me feel so good that I was achieving so much” 
 
 “I think psychologically I got really low without realising it...it [PR] was a real 
turning point...I improved 100% in being able to get around”  
 
Two participants in Arnold’s study missed a couple of sessions of the programme. Both felt 
that on some days they just could not be bothered going to the programme:  
“most of my days are like that, get up and feel I can’t be bothered” 
 
“I just felt I couldn’t go”  
However, perhaps because of achieving personal benefits, both these participants continued 
and completed the programme.  
 
In study by Denn309 some participants might have continued attendance because of the 
support and suggestions they received from peers. One participant shared his experience of 
exhaustion on attending earlier sessions and received understanding and sympathy from 
peers: 
 “Does it tire you out? It does me [on] that day, the next day I’m alright, I can carry 
on.” 
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 “Another said: ‘When we first started for two days [after attendance] I did nothing.” 
 
Another participant who was angry over not being able to quit smoking despite trying several 
methods heard another participant share their experience of how difficult it had been for them 
to quit and what helped them to quit:  
 “I smoked for nearly 50 years… I can’t tell you how many times I tried to give up… a 
doctor talked nicely and made sense and I never looked at it no more.” 
 
 
(B) Reasons for not attending programmes 
10. Perceived exercise would worsen health 
Taylor’s study114 explored non-attendance from study participants. Ten of the 39 interviewees 
feared taking part as they perceived the programme detrimental to their health. They felt that 
the breathlessness would increase from exercising:  
 ‘‘I wasn’t concerned; I just didn’t like the idea of doing meself in. That is hard, but 
when your breathing is bad it’s a disaster!. just, uh, didn’t like the idea.’’  
Moreover participants perceived the programme content to be vigorous, floor based and 
strenuous.114 
 
11. Perception of health status  
Participants’ reported that the unpredictability of their health status (a commonly reported 
feature of COPD) restricted their ability to commit to the programme.114 Some felt their 
condition was too severe and no improvement was possible and there was no guarantee of 
benefit. Participants were frightened that they might suddenly get ill for example from flu or 
pneumonia and this could become a barrier to attend and dropout from the programmes.305 In 
two studies122,310 the challenge of participation was amongst participants confined to their 
wheelchairs, who were reliant on their family/friends to get them out of the house, who felt 
they could hardly breathe or make any basic movements, and did not believe that they were 
capable of doing any exercise (not exemplified by quote). Whilst, a participant in study by 
Arnold304 refused to attend the programme in the summer as he felt much better in the 
summer months:  
 “I thought that’s going to take two days out of my weeks in the summer- I’m not doing 
that” 
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There were some participants who just did not consider their ill health to be poor or serious 
enough to warrant attending the programme.114  
 
12. Lack of perceived benefit to participation in programme or research study 
Almost half of the study participants in Taylor’s study114 did not perceive benefits from 
programme participation. It seemed that some interviewees expected a new treatment, 
perhaps new drugs with reassurance that it may help, shown in the quote below:  
 “I mean the thing is if someone goes to see you on this study thing, yeah? And you sit 
down there for half an hour and you talk and you tell and there must be something you can 
say “Well, here we are. Try that. That may help you.” 
  
13. Lack of understanding of research study of SM support programme 
Twelve of 39 participants in Taylor’s study114 lacked understanding of the research study and 
programme. Participants felt they were not given enough information about the study and 
medical jargon did not help. Participants felt they were being asked to be guinea pigs to test 
out drugs, illustrated below.  
 ‘‘I just thought it was a ... oh, what can I say ... one of these test programmes, do you 
know what I mean? Like a guinea pig programme.’’ 
 
14. Negative view of programme from experience and created by others 
One participant114 was put off from attending because of receiving negative feedback from a 
friend who did not gain any benefits from attendance:   
 ‘‘See, I’ve got a friend that’s got this ... He’s got very bad breathing. And I said to 
him the other day. And he said ‘‘Ah, it’s a waste of time. I was down there,’’ he said. ‘‘Waste 
of time,’’ he said ‘‘Then we’s sitting there for half the day talking rubbish.’’ So that didn’t 
help me. I thought. ‘‘Yeah,’’ he said, ‘‘That’s all they done.’’...‘‘No,’’ he said, ‘‘I ain’t going 
back there no more.’’ 
In some cases patients were reluctant to attend as they had negative experiences of exercise 
and research studies. Patients had a poor self-image or self-confidence related to exercise or 
patients did not enjoy their previous research experience and feared that the study may 
involve clinical tests (not exemplified by quote).   
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15. Prior commitments and competing demands 
A participant in Arnold’s study304 was unable to commit to taking part because of prior 
commitments which were considered more important and enjoyable: 
 “when the dates came through we were going on holiday and that was more 
important”  
 
 “I would do it but not on Fridays ‘cause I go to a community course. It’s (i.e. the 
community course) great, we really enjoy it so I’m not going to miss that” 
Personal and professional obligations were barriers to attend COPD SM support 
programmes.114,122,305 Fifteen participants in Taylor’s study114 gave competing demands as a 
reason for non-attendance. This reason was given amongst participants not wanting to attend 
or dropping out from the programme in Fischer’s study.305 Competing demands included 
caring for other family members, looking after pets, family summer holidays planned, 
disruption to home care routine and home services. Some others seemed too busy with the 
business of having a chronic condition and missed the course because of hospital 
appointments, hospital admissions and illness. Day times were inconvenient for some in full-
time employment.  
 
16. Burdensome journey (physical barrier) 
Fischer305 explored reasons for not attending and dropping out of programmes and did not 
necessarily differentiate between the two behaviours. Transport difficulties were commonly 
reported as a reason not to attend122,305 and drop out of the programmes.305 Many study 
participants114,305,310 found travelling to the programme venue most burdensome. This was 
mostly experienced by people with restricted mobility or being housebound. Restrictions 
included use of oxygen and nebuliser regimes. The burdensome journey included the use of 
public transport, parking and even walking a long distance to get to the class once at the 
venue as stated by one individual:  
 ‘‘Charing Cross don’t lay on transport (route) ... the ambulance picks up the wife and 
myself because my wife carries me portable oxygen with her ... But I, I definitely wouldn’t be 
able to walk the stairs down to the train and I definitely wouldn’t be able to walk from 
Hammersmith bus stop all the way round to where you pick up the bus to go to Charing 
Cross.’’ 
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17. Negative experience with health care staff in location of programme 
In one study114 attending hospital for the programme was unpopular amongst some of the 
participants because of negative experiences with health care staff and so belief in the 
competency of health care staff was reduced (quote given does not justify this statement, 
hence quote not given here) 
 
18. Location of the programme  
Participants in Taylor’s study114 did not want to attend the hospital-based programme because 
the hospital was known to have MRSA colonisation previously and had received bad press.  
Another participant305 did not want to attend because he described himself as a homebody 
and felt uncomfortable being away from home for such a long time (not exemplified by 
quotes).   
 
19. Seasonal weather  
There was also a concern amongst some participants114 that seasonal weather could affect 
health status and exercise capacity (not exemplified by quotes).   
 
20. Referrals by health professionals – without explanation   
Two participants in Arnold’s study304 had refused participation because one did not know the 
medical referrer and in another case, their doctor was not convinced that the programme 
would be helpful:  
 “this may or may not help you” 
 
A patient in another study305 declined participation as the physician mentioned the 
programme would be “intensive”. 
 
(C) Reasons for dropping out of programmes  
21. Suffering an acute exacerbation  
One study310 reported that when an individual suffers from an acute exacerbation it can make 
them weak which negatively affects their mood and motivation which includes dropping out 
from the programme. The statement does not exemplify dropout but the downward spiral 
experienced by a participant on experiencing an acute exacerbation: 
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 “The pulmonary rehab is a miracle […] because before I went there […] my husband 
would say: ‘Shall we go down and see John and Juliana?’ and the thought of walking out 
that gate into the car, I would be absolutely gasping, […] I made excuses not to go out and 
this is what happens, […] the more you’re housebound, the more depressed you get.” 
   
22. Psychological limitations  
One participant did not complete the programme as he seemed to suffer from depression 
owing to his condition and felt agitated and uncomfortable amongst a large group of 
people122:   
 “I didn’t [want] to sit through too much because I tend to get a bit depressed and 
agitated and what have you…I don’t like getting in with a lot of people…” 
 
23. Not ill enough  
Three out of the seven participants in Sohanpal’s study,122 two of whom, were in employment 
did not consider themselves sufficiently affected by the disease to make attendance 
worthwhile. These participants were able to continue with most of their routine activities and 
did not to require any further help with their condition, illustrated by a quote below: 
 “…basically after 10 to 15 minutes I realized no I don’t belong here [at the course], 
’cos the people there [at the course] are worse than me…these people couldn’t even walk up 
and down the street without having a...breather so I’m not like that...” 
 
24. No change in health status after attending one session 
One patient suggested that patients were looking for miracles just after attending one 
session:310    
 “You get people coming in […] just once and they really expect a miracle over night. 
And because nothing has happened they won’t bother coming back anymore” 
 
25. Social isolation can reduce confidence 
A feature commonly encountered amongst patients suffering from COPD is experiencing 
good and bad days. The author in one study reported that living alone led to five participants 
missing a few sessions and two dropped out of the programme entirely.304 Those who missed 
a few sessions of the programme said:  
 “most of my days are like that, get up and feel I can’t be bothered” 
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 “I just felt I couldn’t go”   
 
Whilst participants who dropped out completely felt bad but could not continue to attend the 
programme because of lack of encouragement or lack of confidence:  
“being on my own there is no-one to give me a bit of a push or encouragement” 
 
“for most people if there’s someone around it gives them a little more confidence” 
 
(C1) Potential reasons for dropping out of programmes 
Fischer’s study305 explored from participants possible reasons for dropping out of the 
programme.  
 
26. Intensity of the programme 
One popular reason that could lead to one dropping out of the programme as the intensity of 
the programme. Some participants felt that attending should not result in exhaustion as it 
would interfere with simple daily routines such as not being able to eat after training, 
illustrated by the quote below:   
 “The only reason I can think of is when I’m worn out when I come home. If it 
lasts...and you are exhausted for the whole evening and the next morning. That’s not what it’s 
supposed to be like. Sure, it can happen the first week, you can expect that. But not that you 
are too tired to eat after training.” 
 
27. No improvements seen 
Three participants who had not previously attended the programme were very clear that if 
they did not see any improvements for themselves halfway through the programme, they 
would dropout:  
 “Look, if I didn’t notice any improvement _ I mean, after three weeks you can’t tell- 
but when I’m halfway through the programme and I can’t feel no difference, I would be 
wasting my time.”  
 
28. Training with other participants 
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Eight patients in the study had concerns about training with other patients which could affect 
participation in these programmes:  
 “Well, some are only there for the fun instead of to get better. That’s not what it’s 
meant for, of course. It can be a nuisance when they’re chattering for 5 or 10 minutes, sitting 
on a fitness machine, while in the mean time you could have used it. But you don’t wanna 
send them away, of course.”  
 
29. Lack of transport  
The author305 mentioned other factors that could become possible reasons for programme 
dropouts and suggestions on how to overcome them but they are not exemplified by verbatim 
quotes. Completing the programme would be difficult for patients who lived alone, had no 
car of their own, who were too ill to drive and who did not want to ask for help from others to 
drive them to the programme. Alternatives should be provided for these patients such as car 
loan, shared transport or financial compensation by healthcare insurance (not exemplified by 
quotes).  
 
30. Psychosocial factors 
According to Fischer305 psychosocial factors such as homesickness, lack of support from staff 
and conflicts with other patients in the programme could result in patients dropping out of the 
programme (not exemplified by quotes).  
 
Appendix 4.2 has documented some instances where there was a difference in the verbatim 
data interpretation to that of the primary study author and this was checked by the study 
supervisor.  
 
The emergent themes were summarised into three main/overarching descriptive themes with 
30 subthemes (Table 4.2)) related to reasons for: 
(1) Attending with reasons for continuing and completing COPD SM support programmes; 
(2) Not attending COPD SM support programmes; 
(3) Reasons, or potential reasons, for dropping out of COPD SM support programmes 
 
Thirty subthemes were mapped onto both the theoretical models (Box 4.1); four subthemes 
were not mapped onto either owing to limited primary data and lack of correspondence to 
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model constructs. In some cases subthemes were mapped onto more than one theoretical 
construct within the same model for example, subtheme ‘14.Negative view of programme 
from experience and created by others’ was mapped onto the ‘attitude’ and the ‘social 
influence’ construct of the adapted ASE model; ‘1.To help themselves – to improve health 
status’, was mapped onto three separate constructs, the ‘illness representations – 
controllability’, the ‘consequence’ and the ‘intervention representations’ construct (Box 4.1). 
In addition, overlap between different model constructs was observed, for instance, the same 
subthemes that were mapped onto the ‘attitude’ construct of the adapted ASE model, were 
also mapped onto the ‘intervention representations’ construct of the SRM (Box 4.1).  
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 Table 4.2 Summary list of overarching descriptive themes and subthemes 
Studies of COPD SM support programmes 
(1) Reasons for attending with 
reasons for continuing and 
completing programmes 
(2) Reasons for not attending 
programmes 
(3) Reasons or potential 
reasons, for dropping out of 
programmes 
1. To help themselves – to 
improve health status 
10. Perceived exercise would 
worsen health  
 
21. Suffering an acute 
exacerbation  
 
2. Overcoming prior 
commitments and demands - to 
see improvements in health 
11. Perception of health status 22. Psychological limitations 
3. Gain control of condition 12. Lack of perceived benefit to 
participation in programme or 
research study 
23. Not ill enough 
4. Last chance to cope and 
remain independent 
13. Lack of understanding of 
research study of PR 
programme 
 
24. No change in health status 
after attending one session 
5. Referrals by health care 
professionals - with explanation 
for referral   
14. Negative view of 
programme from experience and 
created by others 
 
25. Social isolation can reduce 
confidence 
6. Previous positive experience 
of programme– social and 
emotional support from staff 
and other participants 
15. Prior commitments and 
competing demands 
26. Intensity of the programme** 
 
7. To socialise 16. Burdensome journey 27. No improvements seen** 
 
8. Altruism 17. Negative experience with 
health care staff in location of 
programme 
28. Training with other 
participants** 
 
9. Personal benefits and peer 
support* 
18. Location of the programme  29. Lack of transport** 
 19. Seasonal weather 30. Psychosocial factors** 
 20. Referrals by health 
professionals – without 
explanation   
 
Key: 
SM – Self-management 
*Reasons for continuing and completing programme 
** Potential reasons that could result in dropping out of programme 
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Box 4.1 Mapping of descriptive themes and subthemes onto the theoretical models 
Adapted ASE model Themes with subthemes 
 Reasons for attending Reasons for not attending Reasons for dropping out 
Distal determinants 
Demographics – educational level 
n/a n/a n/a 
Clinical – subjective symptoms 1. To help themselves to improve health status# 
  
11. Perception of health status 
 
21. Suffering an acute exacerbation 
22. Psychological limitations 
23. Not ill enough 
 
 
 
Proximal socio cognitive 
determinants 
Attitude – personal and general 
benefits from participating 
 
1. To help themselves to improve health status# 
3. Gain control of condition 
 4. Last chance to cope and remain independent 
 6. Positive previous experience of programme 
 7. To socialise 
 9. Personal benefits and peer support* 
 8. Altruism 
 10. Perceived exercise would worsen 
health 
 12. Lack of perceived benefit to 
participation in research study 
 14. Negative view of programme from 
experience and created by others# 
 
24. No change in health status after one session 
26. Intensity of intervention** 
27. No improvements seen** 
28. Training with other participants** 
 
Social influences 
 
5. Referrals by HCPs – with explanation 
 
14. Negative view of programme from 
experience and created by others# 
20. Referrals by HCPs – without 
explanation 
n/a 
External or structural barriers 
 
2. Overcoming commitments and demands 
 
15. Prior commitments and competing 
demands 
16. Burdensome journey 
18. Location of the programme 
19. Seasonal weather 
 
29. Lack of transport** 
 
INTENTION TO PARTICIPATE 
IN INTERVENTION 
Unmapped subthemes 
 13. Lack of understanding of research study 
of programmeb 
 
25. Social isolation can reduce confidenceb 
 17. Negative experience with health care staff 
in location of programmea 
30. Psychosocial factors**a 
Key: ASE- Attitude-Social influence-External barriers; SM – self-management; * Reasons for continuing and completing  programme; ** Potential reasons that could result in dropping 
out of programme; # Subtheme mapped more than once; a Insufficient information given in the primary studies; b Not within the model remit; n/a not applicable 
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Box 4.1 continued 
The SRM Themes with subthemes 
Illness threat  Reasons for attending Reasons for not attending Reasons for dropping out 
Background influences 
Personal illness experience 
Medical and social communication 
5. Referrals by HCPs – with explanation 
6. Positive previous experience of programme#  
 
14. Negative view of programme from 
experience and created by others# 
18. Location of the programme – bad press 
20. Referrals by HCPs – without explanation 
21. Suffering an acute exacerbation 
25. Social isolation can reduce confidence 
 
Illness representations:   
Disease identity 
 
 
 
11. Perception of health status 
 
23. Not ill enough 
Timeline n/a n/a n/a 
Controllability 
Personal  
 
Treatment 
1. To help themselves – to improve health 
status# 
 
3. Gain control of condition# 
4. Last chance to cope and remain independent# 
 
 
 
12. Lack of perceived benefit to participation in 
research study# 
 
Consequences 1. To help themselves – to improve health 
status# 
4. Last chance to cope and remain independent# 
11. Perception of health status 
 
22. Psychological limitations 
23. Not ill enough 
 
Intervention representations: 
Purpose and benefits  
Necessity-Concerns 
 
 
 
 
 
COPING BEHAVIOUR – 
PREDICTING PARTICIPATION 
IN INTERVENTION 
 
 
 
 
APPRAISAL 
 
1. To help themselves – to improve health 
status# 
3. Gain control of condition# 
4. Last chance to cope and remain independent# 
6. Positive previous experience of programme# 
7. To socialise 
9. Personal benefits and peer support* 
2. Overcoming commitments and demands 
 
10. Perceived exercise would worsen health 
12. Lack of perceived benefit to participation in 
research study# 
14. Negative view of programme from 
experience and created by others# 
15. Prior commitments and competing demands 
16. Burdensome journey 
18. Location of the programme 
19. Seasonal weather 
 
 
24. No change in health status after one session 
26. Intensity of the programme** 
27. No improvements seen** 
28. Training with other participants 
29. Lack of transport** 
 
Unmapped subthemes 
8. Altruismb 13. Lack of understanding of research study of  
programmeb 
 
30. Psychosocial factors**a 
 17. Negative experience with health care staff in 
location of programmea 
 
Key: SRM – Self-Regulation model; SM – self-management; * Reasons for continuing and completing  programme; ** Potential reasons that could result in dropping out of programme; # 
Subtheme mapped more than once; a Insufficient information given in the primary studies; b Not within the model remit; n/a – not applicable 
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4.3.3 Synthesis findings: Generation of analytical themes 
The mapping revealed four key behavioural constructs that formed the analytical themes and 
explained participation (attendance, non-attendance, dropout) in COPD SM support 
programmes. These findings went beyond the findings of the included primary studies and 
explained patient participation beyond the previously reported socio-demographic and 
clinical factors. The key constructs were ‘attitude’ and ‘social influence’ from the adapted 
ASE model; ‘intervention’ and ‘illness representations’ from the SRM. The four analytical 
themes are described below. 
 
4.3.3.1 Attitude 
Attitude of attenders was that COPD SM support programmes122,304,305,309 could help to 
improve their health and condition. Participants wanted to help themselves, and wanted to 
learn about their condition.122,304 Some study participants wanted to gain control of their 
condition.304,305,309 A few wanted to cope with the illness and remain independent.309 Besides 
perceived health benefits, social benefits were important too.122,304 Some participants saw 
COPD SM support programmes122,304 as a reason to get out of the house, to socialise and 
meet others with the same illness. Two interviewees reported attending the programme for 
altruistic reasons.122 In Arnold’s study304 a key reason given for continuing and completing 
the programme was social and health benefits. While, in Fischer’s study305 reasons given for 
programme attendance, among the previous attendees, included a positive past experience of 
the programme, particularly, staff supervision and peer support. 
 
In contrast, an attitude among non-attenders was that SM support programmes was not 
beneficial particularly the exercise component would not improve health.114 Some 
participants chose not to attend because they perceived the exercise as vigorous, strenuous 
and detrimental to their health. Several participants in Taylor’s study114 were more interested 
in research testing new drug treatments and not exercise. Furthermore, among interviewees, 
personal negative experience with exercise in the past and negative research experience were 
other reasons suggested for programme non-attendance. 
 
Regarding dropout, a participant in one study310 suggested that patients with COPD dropped 
out because they expected to see health improvements after just one programme session. 
Potential dropout reasons305 were: inability to keep up with the intensity of the programme; 
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failing to notice any improvements in health halfway through the programme; and feeling 
uncomfortable whilst training with other participants. 
 
4.3.3.2 Social Influences 
Programme non-attendance was influenced by a lack of positive feedback from others or a 
lack of explanation given on the benefits of the programme. Several participants in Taylor’s 
study114 decided not to attend because their friends or family either had not found the 
programme useful or they did not think the programme would be useful. Another trusted 
source, health professionals, being unable to explain or advise participants about the benefits 
of the programme was associated with non-attendance.304,305  
 
Conversely, the majority of attenders in Arnold’s study304 attended the programme because 
their doctor either explained how the programme could benefit them or they simply trusted 
the advice or suggestion to attend the programme.  
 
4.3.3.3 Intervention representations 
A positive perception/representation of COPD SM support programmes influenced 
attendance. Some participants perceived the programme would help them to learn about self-
management;122 the programme was perceived as a positive step to help oneself; some study 
participants believed that attending would help them to gain control of their 
condition.304,305,309 Few participants saw the programme as their only hope of coping with the 
disease and remaining independent.309 Perceived benefits from programme attendance in the 
past also influenced attendance.305 In addition, almost all attenders in Fischer’s study305 
perceived the programme as a necessity if they wanted to see improvements in their health 
and were not concerned about their possible conflicting obligations.  
  
In contrast, the perceived negative benefits of exercise and previous negative experience with 
research and exercise in the past influenced non-attendance among several participants in 
Taylor’s study.114 Non-attendance in SM support programmes was also influenced by 
participants’ perceived physical or practical barriers related to attendance such as, transport 
difficulties;114,122,305,310 location (hospital) of the programme because of previous negative 
experiences with the hospital staff and bad press about the hospital;114 seasonal weather 
  216  
 
because it would affect health and exercise capacity;114 and practical issues such as personal/ 
professional commitments.114,122,305,310  
 
Patients’ dropped out of the programmes because they did not perceive any health benefits 
after attending just one session.310 Additionally, not gaining any benefits when one was 
halfway through the programme, the programme being too intensive and being uncomfortable 
while training with others in the group were cited as potential dropout reasons.305 Lack of 
transport was also cited as a perceived concern by some study participants which could result 
in dropping out of the programme.305 
 
4.3.3.4 Illness representations 
The perceived increased severity of condition and its effect on ability to cope/self-manage, 
partake in social activities, be in control and remain independent prompted attendance by 
several participants in COPD SM support programmes.122,304,305,309 
 
Among non-attenders, some participants felt they were too disabled to carry out any sort of 
activity or leave the house without support122,310 or some perceived that improvements in 
their health were no longer possible.114 One participant in Arnold’s study304 chose not to 
attend SM support because they felt better when they were offered the programme. 
 
The perceived severity of symptoms also influenced patient dropout behaviour. Suffering an 
acute exacerbation often led participants to drop out of the programme as they needed time to 
recover.310 A couple of participants dropped out because of depression associated with their 
condition.122 Conversely, a couple of participants dropped out because they did not perceive 
themselves to be physically or psychologically affected by their condition.122 
 
4.4 Discussion 
The thematic ‘framework’ synthesis with use of theory, aimed to understand participation 
behaviour in group-based COPD SM support programmes and the findings have implications 
for improving attendance and completion in these programmes. 
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4.4.1 Summary findings 
The application of theory helped in gaining an insight into the participation (attendance, non-
attendance, dropout) behaviour of patients in COPD SM support programmes beyond the 
previously reported socio-demographics and clinical factors. The mapped subthemes yielded 
higher order constructs whereby, participation was influenced by an individual’s attitude and 
perceived social influences; and intervention and illness representations. 
Attitudes of wanting to help themselves, the perceived influence of HCPs, perceptions of the 
controllability of illness and perceived positive benefits of the COPD SM support 
programmes, including past experiences, influenced attendance behaviour. Non-attendance 
was influenced by an individual’s negative attitude that improvement in their condition was 
no longer possible, perception that the programme would not benefit condition including 
from past experiences, perceived physical or practical concerns related to attendance and the 
perceived negativity of professionals and family/friends towards the programme. Dropout 
behaviour was influenced by an individual’s attitude and intervention representations that the 
programme was not beneficial after attending a few sessions and perceived severity of 
symptoms. 
 
4.4.2 Comparison with other literature 
In agreement with recently published work100,311 patient non-attendance was associated with 
some participants’ perceived negative benefits of exercise. It has been explained previously 
that this could have arisen from the way information was delivered by professionals, or by 
patients’ lacking understanding of information about the programme benefits.311 Lack of clear 
recommendation or explanation about benefits of the programmes by professionals 
influenced non-attendance in this study. Lack of clear information and lack of referral has 
previously been reported to affect programme attendance.100,124,218 Another social influence 
associated with non-attendance in this study was negative views of the programme given by 
family/friends. 
In addition, the negative experiences with exercise and/or research in the past influenced non-
attendance and positive past experience influenced attendance and completion of the 
programme. Within a behavioural context, the benefits gained from previous experience may 
have led to the formation of positive beliefs about the programme and these beliefs 
contributed to the appraisal of ‘attending’ the programme as positive. The positive appraisal 
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was retrieved312 following invitation to attend which might have led to attendance and 
completion of the programme. Conversely, the reverse could have resulted in non-attendance. 
The physical or practical barriers cited previously100,311 116 were described by non-attenders in 
this review. According to one study100 this could be because health and/or the intervention 
may not be a priority for the study participants. Behaviourally, reporting of practical/physical 
barriers could mean that the individual was unsure of how the programme could help.179 
Another explanation might be that attribution of non-attendance to ‘physical/practical 
barriers’ may be more of a socially acceptable proxy than a reflection of personal 
circumstances, this requires further exploration. 
The findings were compared with studies that utilised the ‘SRM’110,177 to predict patient 
attendance in rehabilitation. Similar to these studies’ findings, patients’ belief in self to 
control/cope with their condition and belief that the programme would help to control their 
condition influenced patient attendance in this study. 
Regarding dropout while being unwell has been reported previously as a major reason for 
programme non-attendance and non-completion,311 the perceived severity of symptoms 
influenced dropout behaviour in this study. In addition, participants’ unmet expectations, 
particularly not observing any health benefit after attending one or a few programme 
sessions, was cited as a reason for potential dropout. Patients not knowing what to expect 
from the programme, or expecting to get cured prior to attendance, has been reported by one 
study313 to affect programme non-completion.  
 
4.4.3 Strengths and limitations 
This qualitative synthesis with application of theory has helped to explain aspects of patient 
participation behaviour in COPD SM support programmes in response to the poor patient 
uptake in these programmes and the limited explanation for the poor uptake however, there 
were some study limitations.  
At the time of the review only five studies of PR and one study of a COPD SM programme 
had explored reasons influencing patient participation qualitatively. The included studies 
were not underpinned by theory and none of the studies explored each aspect of patient 
participation (attendance, non-attendance, dropout) however, application of two theories to 
the studies’ findings has made a contribution towards understanding the cognitions that may 
influence different aspects of patient participation behaviour.  
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The quality appraisal demonstrated that some aspects of methods reporting were insufficient 
in some studies e.g. limited verbatim data. This could affect the transferability of the findings 
in practice.314 However, the study participants were the right people to answer the research 
questions298 and in line with the review aim we were able to identify a breadth of reasons 
given for participation and/or completion in COPD SM support programmes. The inadequate 
data also prevented mapping of few of the subthemes (Box 4.1).  
 
Both the ‘best fit’ theoretical models were able to explain patient participation to a 
considerable extent and our review findings were consistent with both these models. 
However, it was challenging to map an individual’s view or beliefs into the distinct 
theoretical cognitive constructs; at times a reason given for participation was mapped onto 
more than one construct of the same framework. This suggests that an individual’s cognitions 
are interlinked and help to inform an individual’s decision making to perform certain 
behaviour.315 In addition, using the ‘best fit’ approach described by Carroll302 was limiting to 
some extent as the theories used in this study had been previously utilised and were not the 
newer/latest model versions. The ‘ASE’ model14 that was developed in the 1980s now 
includes the ‘stage of change’ concept;316 Leventhal’s8 ‘Self-Regulation’ model developed in 
the 1990s now includes new aspects of illness representations, ‘coherence’, ‘cyclical 
timeline’ and ‘emotional representations’.13 However, due to the limited primary data and 
subthemes being outside of the models remit it is unlikely the addition of the new constructs 
would have influenced overall outcomes. 
 
4.5 Conclusions 
This qualitative synthesis with application of theory is to our knowledge the first to explore 
the full range of patient participation behaviour (attendance, non-attendance and dropout) in 
SM support programmes among patients with COPD, and has helped to explain participation 
beyond the previously reported socio-demographic and clinical factors. The synthesis helped 
to identify a list of reasons that explained patient participation and application of theory 
helped to understand that participation behaviour was influenced by a participant’s attitude 
and perceived social influence and their perceptions towards the illness and the intervention. 
As these psychosocial constructs are amenable to change177,181,312 targeting these key 
constructs may help to improve uptake in COPD SM support programmes and improve 
health outcomes. 
  220  
 
 
4.6 Implications 
Being the first review of its kind to explore participation behaviour among patients with 
COPD, we suggest further qualitative exploration, guided by theory, of patients’ attitudes and 
perceptions towards their illness and COPD SM support programmes to help further 
understand the barriers to participation alongside professional and organisational barriers.317 
Assessment of patient perceptions towards their illness and treatment may help to identify 
eligible and suitable patients for the treatment and predict attendance in the treatment. In 
addition, studies318,319 have suggested assessment of beliefs of patients with COPD during 
routine consultations; the beliefs need to be understood and acknowledged by health 
professionals so that the negative beliefs can be targeted and addressed by behaviour change 
interventions177,180,318 and/or considered in the design of COPD SM support programmes.320 
One way to achieve this could be by adaptation of the illness13 and intervention perception 
questionnaire180 for COPD. 
 
In practice, in order to influence attendance behaviour it is important to understand that an 
individual’s attitudes to the intervention, particularly with a view to their beliefs about the 
benefits of the programme and sense of control over their condition, are critical. 
Non-attendance could be addressed particularly in relation to perceived physical/practical 
concerns related to programme attendance and exercise. Dropout behaviour could be 
managed by ensuring patients have appropriate expectations from the intervention prior to 
their attendance at the programme. Finally, the influence of others on participation behaviour 
has particular implications for HCPs understanding how much patients’ value their advice 
and recommendations regarding their management. To help facilitate the latter, and for 
professionals to be positive and enthusiastic about COPD SM support programmes, provision 
of support and training for HCPs should be considered to help improve participation.321 
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The next two chapters lead into stage 2 of the study of developing and evaluating a complex 
intervention. Chapter V and VI explore from patient and professionals stakeholders reasons 
for non-participation in SM support programmes by patients with COPD; how participation 
may be improved in these programmes and how else patients with COPD could be supported 
with SM  
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Note: Stage 2 of the study comprises of a new qualitative primary study. Regarding the MRC 
‘developing a complex intervention’ phase, the qualitative study develops a theoretical 
understanding from stakeholders about how change (improvement of patient participation in 
COPD SM support interventions) can be achieved. The stakeholders in the study include 
patients with COPD and professionals involved in COPD management. The qualitative study 
is divided into two chapters, Chapter V presents findings, with respect to patient interviews 
and Chapter VI presents findings from interviews with experts. 
 
The bigger qualitative study was referred to as the MY BREATH study – Manage Your 
Breathing for Better Health 
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Chapter V. Understanding reasons for poor participation in 
SM and PR programmes and how participation can be 
improved in these programmes – a qualitative study with 
COPD patients. 
This chapter: 
 in the introduction highlights the problem of patient participation and retention in 
studies of group-based PR and SM programmes (together referred to as COPD SM 
support programmes) (discussed in previous chapters) and explains the rationale for 
this qualitative study 
 describes the methods 
 presents the findings under emergent themes followed by the discussion, conclusion 
and implications  
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5.1 Introduction 
The lack of reporting of participant flow data by studies of SM support shown in Chapter III 
could make it difficult to interpret the findings of the studies in practice and as a result, 
suitable patients may not get the opportunity to participate in SM support programmes. In this 
study, patient non-participation was defined as not taking part in a study of a SM intervention 
or the intervention. Chapter III also showed that some patients who were given the 
opportunity to participate in studies of SM support programmes refused participation, and 
about a third of the studies did not record/report reasons for patient non-participation. The 
need to understand the characteristics of ‘refusers’ or non-participants is vital322 because the 
delivery of PR programmes (one of the most effective and cost-effective interventions in 
COPD)323 including SM support for COPD patients, encompassed within the COPD care 
pathway http://www.networks.nhs.uk/nhs-networks/london-respiratory-network/key-
documents/pulmonary-rehabilitation (accessed 3-7-13) has been regarded as essential for 
better health outcomes.  
While five studies of PR and only one study of a COPD SM programme have explored the 
problem of poor patient participation, particularly the attendance, non-attendance and dropout 
aspects (Chapter IV) no studies of COPD SM programmes and only three studies of 
PR,100,109,114 appear to have explored factors affecting participation or ‘non-participation’ 
from the patients’ perspective. Furthermore, only a handful of studies,100,109,324 have explored 
factors which might lower barriers to participation. 
Due to the limited available evidence there is scope for further qualitative research to help 
gain a better understanding of what factors influence participation and retention in SM 
support programmes and how participation may be improved. The need for further research, 
particularly qualitative research, was raised in a recent study of patients’ perceptions of 
participation in PR;130 in addition, the need to develop strategies to encourage participation 
and attendance and engage patients in SM support programmes19,47,100 has also been 
emphasised.  
The aim of this study was to gain a better understanding from a patient stakeholders’ 
perspective about: factors affecting patient participation in SM support programmes; factors 
that might encourage patient participation in these programmes; and how patients with COPD 
might be better supported in their self-management.  
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5.2 Research objectives 
To explore, with people living with COPD using qualitative methods (individual interviews 
and focus groups) the following questions: 
a) What are the reasons for poor uptake and completion of SM support programmes amongst 
patients with COPD? 
b) What might be done to make an existing COPD SM programme more appealing and 
applicable to patients with varying levels of COPD severity (including changes to programme 
content and different modes of delivery)?  
c) Whether different modes of SM delivery should be considered for patients with different 
degrees of airflow obstruction? 
d) Which is the most suitable delivery method for patients with moderate to severe COPD to 
promote uptake and completion?  
 
5.3 Research questions  
The main results of the research will help to explain:  
1)  Why people with COPD participate in, do not participate in, and fail to complete SM 
support programmes? 
2)  What are the characteristics of people that attend and do not attend SM support 
programmes? (This might help to target programmes towards people who will gain benefits 
from programme attendance) 
3)  Do people with varying levels of COPD severity want different things from SM 
support programmes?  
5)  How should support programmes be delivered to people with different levels of 
severity, and by whom? 
6) How might we make an existing COPD SM programme more appealing, applicable 
and accessible for patients with moderate to severe COPD, or could we deliver SM support to 
these patients in an alternative way? 
 
The findings of the study were intended to help either refine an existing COPD SM 
programme - with adoption of a new delivery method for patients with moderate to severe 
COPD, or to identify another way to provide SM support to patients with COPD.  
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5.4 Methods 
5.4.1 Sampling and recruitment 
Purposive sampling was conducted to obtain a diverse sample of men and women with 
COPD of varying age-groups and severity including housebound patients. The Medical 
Research Council (MRC) score was used to gauge severity of patients as it is the most 
practical means to assess disease severity in the COPD population.325 The patients were 
recruited from a) participating Breathe Easy (BE) groups – these groups are voluntary lung 
support networks for people with respiratory conditions including COPD and are supported 
by the British Lung Foundation (BLF); and (b) Housebound patients from participating GP 
practices in two inner east London boroughs.  
Participating BE groups were identified after liaising with the development officer at the BLF 
who explained the purpose of the study to a number of chairpersons of different BE groups 
across London. The chairpersons invited the study researcher to introduce the study to their 
members at one of their regular monthly meetings. Following the meeting, the researcher 
discussed the eligibility criteria with the chairpersons and handed out copies of the study 
material (invitation, information sheet and consent forms (Appendix 5.1, 5.2, 5.3)) to be 
distributed or posted to their members to invite them to the study. The reason for targeting 
BE groups was because people with COPD who attend these groups are typically targeted by 
SM support programmes and it was anticipated that they would be able to use their personal 
experience of  the condition to shed light on why some people with COPD might not want to 
participate in, or would dropout from, these programmes. Housebound patients were invited 
into the study because COPD SM support programmes are usually conducted in the 
community in a group setting and may be inaccessible to house bound patients with severe 
COPD. These are the patients with the most frequent hospital admissions and it is possible 
that these patients have most to benefit from SM support programmes.249 All the primary care 
practices in two inner east London boroughs were invited to take part in the study via an 
invitation letter (approximately n=94 letters were sent). Participating GP practices were given 
the study material to post to eligible housebound patients on behalf of the researcher. The 
plan was to recruit at least 10 housebound patients. 
Interested potential participants contacted the researcher directly either by telephone or a 
postal reply slip attached to the study invitation letter in a pre-paid envelope.  
The study inclusion criteria were:  
 Adults aged over 35 with a diagnosis of COPD  
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 Willing to participate and fluent in English 
The exclusion criteria were: 
 Not fluent in English (as the COPD SM programme currently is delivered in English 
language) 
 Unstable COPD and/or unstable co-morbidity 
 Serious psychological illness 
 Inability to give informed consent. 
The interviews (either one-to-one or focus group) were arranged by the researcher at a time 
and place convenient to the study participants, which could be their home, Breathe Easy 
group venue, GP practice or at the host institution. As a token of appreciation for their time 
and contribution to the study, each participant was given a voucher worth £20.  
The study was explained to participants over the phone and if they were agreeable an 
interview date was arranged and a consent form was sent to the participant. The participants 
could contact the researcher if they had questions or further queries. 
 
5.4.2 Interview schedule 
The semi-structured interview schedule (Appendix 5.4) was developed from discussion with 
the study team and from previous literature.122 The interview questions were framed under 
the theoretical domains framework.326 This theoretical framework has been previously 
utilised among health professionals to understand and explain implementation problems e.g. 
barriers and enablers to the implementation of evidence-based guidelines. However, due to 
the flexible nature of the framework only the domains relevant to this study were utilised. 
These constructs form a comprehensive coverage of possible influences on behaviour. 
Theoretical or health behaviour change constructs relevant to implementation research were 
synthesised into 14 domains: knowledge, skills, professional role and identity, beliefs about 
capabilities, optimism, beliefs about consequences, reinforcement, intention, goals, decision 
processes, environmental context and resources, social influences, emotion and behavioural 
regulation. So, the domains appropriate to conduct interviews with patients were used for 
example, within the ‘Knowledge’ domain the patient interviewees were asked, “How long 
have you been living with COPD?”; “How much understanding do you have about your 
condition?” Furthermore, where appropriate, the constructs of the Self-regulation model 
(SRM) and the Necessity-Concerns Framework   (NCF) (applied in Chapter IV) were utilised 
as a conceptual guide to explain the study findings.  
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5.4.3 Interviews  
A pilot interview was conducted with a patient advisor member of the doctoral study. The 
preamble for all interviews comprised of an introduction to the study and assurances as to 
confidentiality and anonymity and obtaining consent to record the interview. The interview 
would stop if the participant wished to rest, at the end of the interview the participant was 
thanked for their time and contribution and given a £20 voucher. Semi-structured face-to-face 
interviews explored, patients’ views about their current COPD management, experience of 
attending either a PR or SM programme previously, reasons for attending or dropping out of 
the programmes and why other people with COPD might not participate in these 
programmes. If a participant had not attended a SM programme previously, a brief summary 
(comprising of one A4 sheet) of an existing COPD SM programme was presented (Appendix 
5.5) and they were asked whether they would consider attending such a programme, why 
other people with COPD might not participate in/attend such a programme, what might help 
people to decide to participate in/attend such a SM programme, how else can patients be 
supported and what improvements to the programme should be made to improve attendance 
of the COPD SM programme in the future. Data saturation was achieved as no new themes 
emerged from the interviews; the aim was to interview as many male patients as possible and 
preferably those who had attended, invited but not attended or dropped out of the SM 
programme. The duration of interviews ranged from 30 minutes to 1 hour and 22 minutes, 
were audio-recorded, anonymised, transcribed and imported into Nvivo9 software for 
organisation and facilitation of data analysis.  
 
5.4.4 Data analysis 
Data analysis was conducted using a thematic framework approach.327-329 This approach is 
inductive and grounded but also deductive as it used to answer a set of aims and objectives. 
The interviewer firstly read and re-read the transcribed data several times to become familiar 
with and get a sense of the data.  
The second stage involved identifying a thematic framework where memos or notes of 
phrases from the data were made to get a general impression of the data. The framework also 
included a list of a priori issues or study research objectives. Coding was conducted line by 
line and the data were labelled with codes that captured meanings.  
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The third stage was indexing, where several repetitive codes emerged whilst sifting the data. 
Comparison of quotes was done both within and between the transcripts. There was no 
interpretation of the data at this stage. Initial categories or concepts began to develop where 
similar codes were grouped together to form analytical categories. A constant reference was 
made to the study aims when grouping data under the emerging concepts including issues that 
were raised by the participants.  
Following this, data from all the transcripts was charted under emerging concepts or under 
the thematic framework giving a detailed account of views and experiences of the 
participants. The process of category formation requires constant comparison of data within a 
category with each other and, constant comparison of the data across categories. This is to 
ensure the interpretations remain grounded in the data.  
The development of categories makes the data more meaningful, and more analytical. These 
categories were defined, shared and discussed with another experienced qualitative researcher 
who followed the same process on a sample of six transcripts chosen at random. This process 
of inter-rater reliability was done to ensure the researchers’ own biases and preferences were 
discounted and the findings were not based on the subjective judgement of the single 
researcher.  
The final stage of mapping and interpretation led to the development of themes. Here, in 
addition to making sense of individual quotes in this stage within the charts, it included 
looking at the relationship between the quotes and the links between the data as a whole to 
provide explanations for the findings and the overarching themes which were carried out with 
discussions between the interviewer and the qualitative researcher. 
 
5.5 Ethical considerations 
The study was approved by the National Research Ethics Service, Central London Research 
Ethics Committee (REC1) (11H0718/9). All study participants gave their written informed 
consent before the start of the interview. 
 
5.6 Results 
5.6.1 Sample characteristics 
Eighty seven letters were sent out in total by chairpersons in all of the four participating 
London breathe easy groups and one participating GP practice out of approximately 94 
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practices. Forty one potential participants responded to the letter with 28 expressing an 
interest in the study, 22 potential participants were recruited and interviewed including the 
three housebound patients from the participating GP practice, one claimed to have asthma 
and not COPD. Six who had shown an interest to participate in the study were later not 
contactable or busy. Out of 13 potential participants who were not interested to take part in 
the study, five gave no reason, one was busy, two claimed to have asthma, one was caring for 
their partner, and four letters were returned to the researcher.  
Individual face-to-face interviews were conducted with eighteen patients according to the 
preference and convenience of the participants, all interviews, except one, were carried out in 
the participant’s home and for another the interview was conducted in a health centre. The 
remaining four participants were interviewed in pairs as they did not want to be interviewed 
on their own; hence one interview took place in a health centre and another in a community 
centre. Data saturation was achieved from the patient interviews as no new themes emerged 
as the interviews progressed. The sample characteristics are presented in Table 5.1.  
Out of the 22 participants, the majority (n=18) were female; mean age was 74 years; six 
participants were housebound; 10 participants were diagnosed in hospital, nine participants 
by their GP, one participant was diagnosed in a chest clinic, one by nurses and one by both 
GP and hospital. The years to diagnosis ranged from 8 months-30 years; six participants were 
using oxygen; 14 lived alone; 20 were ex-smokers and two had never smoked previously; 20 
participants had a MRC score of 3 and above. Nineteen participants had attended either a PR 
or a generic or a COPD-specific SM programme. Of the 13 participants who had attended 
PR, three had attended PR more than once, almost all had completed PR (two had missed a 
few PR sessions). Four participants had attended both PR and a SM programme with all four 
completing PR and three completing the SM programme, one participant had only attended 
(and completed) a SM programme and one participant who had attended PR three times had 
also attended and completed cardiac rehabilitation and a SM programme.  
  231  
 
Table 5.1 Characteristics of the 22 patient interviewees 
Patient interviewees 
Study ID Age (years) Sex COPD 
diagnosis 
(years 
ago) 
Housebound
? 
Previous 
attendance in SM 
support 
programme (PR, 
SM, Education) 
Completion of SM 
support programme 
On oxygen?  Lives 
alone? 
Smoker or 
Ex-smoker 
MRC 
Dyspnoea 
breathlessness 
scale (NICE 
2007) 
PP1 pilot 
interview 
not given Female 8  No PR Completed No Yes Ex-smoker 3 
PP2  77 Female 6  No PR Completed No Yes Ex-smoker 4 
PP3 83 Female 4  No PR  Completed No No Never 
smoked 
2 
 
PP4 76 Male 5  No PR thrice Completed No Yes Ex-smoker 4 
PP5 82 Female 2.5  No PR and COPD-
EPP  
Completed PR and 
EPP 
No Yes Ex-smoker 3 
PP6 79 Female 9  No Breathing classes Completed  No Yes Ex-smoker 3 
PP7 80 Male 30  No PR possibly twice Completed Yes No Ex-smoker 3 
PP8 62 Female 16 months No PR Completed No Yes Ex-smoker 4 
PP9 65 Female 4-5 No Exercise course 
and COPD EPP 
Completed PR and 
EPP 
No No Never 
smoked but 
where 
worked, 
people 
smoked 
2 
PP10 68 Female 8 No PR  
 
Completed No No Ex-smoker 3 
PP11 62 Female 2  Yes  PR Completed No No Ex-smoker 4 
PP12 73 Male 7 Yes PR thrice, CR and 
generic EPP 
Completed except 
the last PR 
programme 
Yes No Ex-smoker 5 
PP13 79 Male 2.5  No PR Completed except 
missed one session 
No Yes 
 
Ex-smoker 3 
PP14 79 Female 6-7  No PR Completed Yes  No Ex-smoker 3 
PP15 79 Female 6  No PR Completed No Yes Ex-smoker 3 
PP16 73 Female 18 months  No SM programme Completed No Yes Ex-smoker 3 
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PP17 76 Female 4-5  No PR  Unable to complete 
as missed two 
sessions  
No Yes Ex-smoker 3 
PP18 69 Female 5  Yes PR and SM 
programme 
Completed PR,   
SM programme -  
dropped out 
Yes Yes Ex-smoker 4 
PP19 63 Female 9  No PR and EPP  Completed PR and 
EPP 
No No Ex-smoker 3 
PP20  91 Female 20  Yes Does not  
remember 
N/A Yes Yes Ex-smoker 4/5 
PP21 61 Female 4-5  Yes No N/A Yes Yes Ex-smoker 4 
PP22 86 Female 1.5  Yes No N/A No Yes Ex-smoker 3 
Key:  
MRC – Medical Research Council; COPD- chronic obstructive pulmonary disease; GP – general practitioner; PR – pulmonary rehabilitation, EPP – expert patients 
programme; SM – self-management; CR – cardiac rehabilitation N/A – not applicable 
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5.6.2 Emergent themes and subthemes 
The study findings comprised of a detailed account of views and experiences of people living 
and adapting with COPD and who mostly had previous experience of participation in SM 
support programmes. The findings are presented under emergent thematic categories or first 
order themes (Table 5.2) followed by overarching themes or second order themes. The 
thematic categories comprised findings that relate directly to the research objectives of this 
study e.g. why people with COPD do not participate in SM support programmes, and 
findings that informed the research topic but were not directly related to the research 
objectives e.g. participants’ own reasons for attending SM support programmes. The data 
within and between the emergent categories were examined for relationships and patterns that 
provided explanations for the findings, these explanations grounded in the data were grouped 
to form six overarching themes described in the next section.  
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Table 5.2 List of emergent thematic categories 
Findings that were directly related to study 
research objectives. 
Findings that informed the research topic but were 
not directly related to study research objectives.  
Participants’ own reasons for: 
(1) Factors that might affect participation in COPD 
SM support programmes 
- Patient characteristics e.g. lack initiative, do not want 
to discuss illness 
- Patients’ cannot be bothered owing to physical, 
psychological and emotional limitations leading to: 
---depression and lack of motivation 
---reluctance to do or learn anything 
---frightened/anxious to go to programme alone 
---lacking confidence 
- Patients’ negative views about the programme 
--- programme is about smoking cessation 
--- exercise/self-help not useful or beneficial 
- Programme organisational issues 
---insufficient information about the programme 
---nearby venues closing down 
- Physical or practical barriers 
---cost of transport 
- Awareness about the programme 
- Gender differences  
 (4) Understanding about COPD and its management 
- Knowledge and understanding of condition  
- Confidence to manage 
- Control of condition 
 
(2) Suggestions for improving participation in COPD 
SM support programmes 
- Motivation and encouragement e.g. promotion of 
programme benefits via home visit, invite to trial 
session, allow family members to attend 
- Support with accepting condition 
- Building confidence 
- Creating awareness of COPD and SM support 
programmes and its benefits e.g. adverts, involve 
professional staff to discuss benefits,  
- Improvements in health system and programme 
organisational factors (see point (3) below).  
(5) Attending and adhering to SM support 
programmes 
- To try and see health improvements or attempt to 
take control of condition e.g. to learn forgotten 
tips/skills 
- Recommendation to attend 
- Altruism 
(3) Making SM support programme more applicable 
and appealing to improving uptake 
- Improving organisational issues such as, 
--- Invitation: Informing patients about the benefits of 
the programme face-to-face preferably instead of 
sending an impersonal letter  
---Waiting time: between invitation and attendance 
should be no more than two to four weeks; 
---Venue: needs to accessible, comfortable and 
inviting 
- Improving structure of the programme such as, 
---Time/length of session: e.g. consider patients’ 
medication needs, avoid rush hour times and avoid 
clashes  with PR or Breathe Easy sessions; 
---Content: e.g. assess patient expectations, include 
talks by experts, the topic on ‘depression and COPD’ 
is important and talk on ‘living wills’ should be 
omitted, allow patients to exercise at own pace, have a 
relaxation time 
---At the end of the programme refer patients to 
Breathe easy 
---Facilitators should be well trained  
(6) Dropping out of programmes including reasons 
that might have affected dropout behaviour in others 
- Poor facilitation skills or insufficient support from 
programme staff 
- Physical factors e.g. location of programme 
- Lack of perceived benefit/unmet expectations 
- Illness 
(4) Other ways to support people with COPD with SM (7) Wanting to re-attend programmes again (or not) 
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who cannot or do not want to access group-based 
programmes 
- invite to attend programme each year 
- programme completion boosted confidence to re-
attend 
- unable to or did not want to exercise alone 
- to keep up with learnt and forgotten skills 
- desire to be followed up 
- nothing more to learn 
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5.6.2.1 Overarching themes  
Six overarching themes were generated that helped to address the research objectives.  
Patient non-participation were explained by:  
1) Resignation/Denial  
2) Beliefs about health/illness and treatment beliefs 
3) Programme organisational issues 
 
Patient participation could be facilitated by: 
4) Motivation and encouragement 
5) Promotion of programme benefits  
6) Organisational improvements 
 
Figure 5.1 illustrates within the patient participation definitions (from systematic review 
Chapter III) the overarching themes.  
  237  
 
Figure 5.1 Illustration of barriers to patient participation and facilitators to improve participation in COPD SM support programmes   
Participation could be influenced by 
people of COPD: 
 being resigned to living with 
their condition or in denial 
of condition; 
 negative illness and 
treatment beliefs; and  
 programme organisational 
issues 
It follows that participation and 
completion of SM support 
programme could be improved by: 
 provision of motivation and 
encouragement  
 promotion and discussion of 
programme benefits; and  
 programme organisational 
improvements  
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(1) Resignation/Denial 
The study participants described the type of patients with COPD who participate and do not 
participate in COPD SM support programmes. The former type, fought or pushed for things 
they needed to help their condition, they were motivated, proactive and used initiative to seek 
health improvements. These characteristics were reflected in the participants’ own reasons for 
attending SM support programmes, which were: to live, to adapt, to keep themselves as well 
as possible and not be a burden. 
PP18:...You know, exercising, of course you are, you’re going to improve your 
whole wellbeing...That’s the way I look at it, but then again, that’s only my point of view.  
Because I don’t want to die!... 
 
In contrast, the non-participants were mentioned as people who might not be willing to help 
themselves, they perhaps felt they were entitled to be a burden and wanted to seek care only 
from a HCP. These people might have become resigned to their situation either because they 
felt their condition was not recognised by others or because they could not do anything to 
help themselves and so were not interested in seeking help or learning anything new. 
Discussing the illness might also be uncomfortable for this group of people as they might 
have not accepted their illness, accepting the illness might be frightening for them.  
PP21: I think perhaps it could be something to do with the more you know, the 
more frightened you get, you know...some people don’t want to think about it, because it’s 
almost like acceptance there’s something wrong with them.  
PP8: Feel that they are entitled to be a burden; that this thing (COPD) has 
happened, they’re in a terrible state.  There’s nothing to be done about it.  It’s not fair.  
 PP12: Well, as a disease, COPD, hasn’t been ... it’s not very ... well known 
amongst the common people and the medical (profession).  It’s not had the publicity like 
cancer gets or crippling diseases.  I mean, if you saw me just sitting here, you wouldn’t think 
I was disabled, would you?  Believe you me, I am!  So that kind of thing.  I mean, people 
don’t think you’re disabled. 
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(2) Beliefs about health/illness and treatment beliefs 
Participation might be affected by patients’ negative beliefs about their condition such as 
being incurable or the belief that nothing more could be done. The physical, psychological 
and emotional consequences of living with COPD and associating symptoms with COPD 
might lead patients to become reluctant to try anything new, specifically any physical 
activity, patients might lose motivation, and they would be frightened or have low self-
confidence to go somewhere that was new. These latter effects were mostly stated and 
attributed more to people who lived alone because of participants’ own experience of loss of 
motivation, depression or wanting to give up at some point in their illness journey in the past 
however, they were able to get through as they had support and they sought the help they 
needed. In addition, despite previous programme attendance and due to the unpredictable 
nature of their condition some participants still struggled to say that they were hundred per 
cent confident in managing their condition and being in control of the condition was still 
perceived as difficult by many participants.    
PP9: ...I think some of them have got quite bad chests, but I don’t know, perhaps 
they’ve got to the age where they can’t be bothered, you know?  Perhaps that’s what it 
is.....Perhaps they think, well, you’re never going to be cured, because your lungs are not any 
much good with that. 
PP19: I suppose when you’re really, really ill, like in hospital, you’re so fed up 
with it, it’s very easy to say, oh, I can’t be bothered!...Not everybody is very good at seeking 
that kind of help; I think the stigma attached to mental health is still a stigma!...it took me a 
long time to get over it (my depression). And i’m still on medication, but I sought the help I 
needed to get me through it and help me... 
PP11: ...I mean, before I got struck down with this (condition), I was really 
outgoing, ..... and I was a very strong person, yeah?  But to go somewhere that is very 
strange and on your own, a lot of people would not be able to hack that; they’d be 
frightened.....Well, to actually be sitting and to actually go and do something on your own, 
yeah! ...You know, it would be pretty scary,… 
 
Negative beliefs about SM support programmes could also affect participation. Patients may 
have not understood or seen the value in carrying out self-help behaviours such as exercise. 
Patients who were smoking and were not ready to quit may have perceived the programme as 
preaching about smoking cessation which might have provoked reluctance to hear about 
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smoking cessation. Patients might also not consider the programmes important enough in 
their list of priorities and instead might be more concerned about the weather or cost of travel 
that could affect participation. In comparison, the participants’ own reasons for attending and 
adhering to the programmes included perceived programme benefits or perceived 
controllability of their condition.    
 PP20: ...It’s no good doing exercises, because you do them for a little while and 
then you leave it again, or you will forget again. 
 PP13: ...So you should talk to the people who have the long term condition 
already, ... and they will tell you that other people will try to stop them from smoking, 
because it could help.  And they (who are smoking) keep away from him or her, because they 
don’t want to hear your view, because they want to still smoke!....then by talking about 
COPD, you put me off smoking. ....you don’t tell me not to smoke, but you’re telling me how 
it would affect me when I smoke.  So I listen to you and I don’t want to hear!...Don’t want to 
listen to it, I don’t want to be scared.... 
 PP20: No, because it costs money...I’d have to have a minicab there and I’d have 
to have a minicab back, and I just cannot afford it.  No. 
 
An alternative view was that perhaps patients who smoke feel guilty and stigmatised and 
unworthy of help.  
 
Another view was that it was not that patients might not want to participate in the 
programmes but they might not know about the SM support programmes  
PP1: The biggest problem is not so much making people come as making them 
aware.  Because I don’t think people sit there going, “Oh, I’m not going to do that.”  They sit 
there and go, “Oh, I wish there was something, but I don’t know what!”  I’m sure that’s the 
biggest problem, they’re just not knowing (that these programmes exist)! 
 
(3) Programme organisational issues 
Besides patient/personal factors, several programme organisational issues were suggested that 
could affect participation in SM support programmes, they were: prolonged waiting times to 
attend the programme, unmotivated patients might not make an appointment for PR 
assessment, lack of accessible venues or nearby venues closing down.  
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PP11: I think maybe if it (programme) wasn’t made quite so official, you know?  
You get a letter and then they say that there’s a huge ... there’s a waiting list, and I think that 
can make you go, oh, I can’t be bothered then!....I think it was a couple of months! ....I think 
the biggest barrier is the way that you communicate. Yeah.  I think that that is the crucial 
part. 
PP2: …there’s not enough of them (of PR programmes), not enough ...  you 
know?  
 
(4) Motivation and encouragement 
To improve patient participation the participants’ suggested that patients may need to be 
supported with accepting their condition, reassured that they can do things to take control; 
COPD and its consequences need to be recognised and acknowledged by the general public 
including HCPs; patients may need to believe they are worth something by encouraging them 
and building their confidence to achieve things important to them. Patients might be 
encouraged to participate in the programme by informing them about what the programme 
entails – this could be done at their home or GP practice; by showing them improvement seen 
in others; by inviting them to try out some sessions either at home or at the programme 
venue, without any pressure of commitment. Patients might also be encouraged and have the 
confidence to participate if their support network could also be involved i.e. they could bring 
a family member, friend or a carer to the programme. These suggestions may also help to 
address the psychological and emotional consequences of living with COPD. 
 PP10:...I’m sure you know, it’s for people to know that they’re worth something 
as well...people’s sense of worth, you know, build their confidence up. ...I think maybe people 
need to be encouraged in the things that they do do well. 
 PP8: ...I think if you got the recognition, it would be a motivating factor for me to 
go along (to the programme)...Recognition of your own fear, panic, depression, anxiety. 
 PP6: Well, if there’s someone ...someone to do with COPD, and they know that 
someone else has got it at home and they’re on their own, maybe it could give them a little bit 
of support if they were to go round and tell them about this class....And maybe if possible go 
with them.  You know, like you get a carer?....And go with them for the first time, just to let 
them see what it’s like, and then they wouldn’t be so frightened or nervous, so they’d most 
probably enjoy it...Yeah, maybe I think it would be quite a good idea just maybe once a week 
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that they (carer) could help that person to go to even just one class.  And once they’ve seen 
what it’s like, well, if they liked it, they could go on their own... 
 
(5) Promotion of programme benefits  
Patients might consider seeking help including participation if they perceived health 
improvements could be attained from participation in the programmes. This could be possible 
by, if in addition to advertising the programmes though leaflets and posters in centres that 
patients frequented e.g. GP practice, pharmacy, hospital, day centre, church, Breathe Easy, 
the persons working at these centres who knew the patients best, including their families and 
their situation, could be involved in discussing the benefits of the programmes with patients. 
Use of optimistic phrases to help patient believe in the benefits of the SM support 
programmes was also suggested such as, ‘strengthen’, ‘improve’, ‘gentle exercise’, ‘you’ll 
get fit’.  
 PP4: Well, I think they (patients with COPD) should be convinced that it (SM 
programme) is going to be useful...someone has got to help them. The only thing I can think 
of is GP, you know?  Or a friend or a parent, or a partner or whatever it is; you know, 
there’s got to be somebody who is close to them...Who knows them and knows their 
situation...Well, all you’ve got to do is tell them that it’s good for them and they’ll get 
better...Or it will improve their situation, improve their well being ... 
 PP5: Maybe in day centres as well, you know?  Having leaflets in day centres 
and having a big one on the wall and maybe having people who run the day centres could 
maybe have a discussion about different things that’s going, and discuss: Look, we’ve got this 
so and so plan, if you’d like to be involved.  ......Because they (patients with COPD) would 
think, oh, well, he (staff at day centre) arranges all these things for us, and does everything 
for us, and we enjoy them, so he knows what he’s talking about...! 
 PP2:…Yeah, because when you first get it (the condition) and you go to these 
(programmes), it would help you to manage it (the condition) a bit more better… 
 
One participant also pointed out that it was important for HCPs to know about the 
programmes and believe in the programme benefits for their patients.  
 
A different view by several participants was that despite all efforts to encourage and promote 
patient participation it was up to the individual to decide to take part in the programme.   
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 PP15: ... there’s some people just don’t want to know.....Well, let’s put it this 
way, you can always go to them and tell them about it (the programme) and advise them.  But 
again, it boils down to the same thing, it’s up to them.  
 
Best/Alternative way to support patients with COPD with their self-management 
Furthermore, the views of participants were varied or inconsistent when it came to suggesting 
alternative ways to support patients with COPD with their SM. Most participants suggested 
group-based programmes instead of delivery of the SM programme to patients with COPD in 
their home, face-to-face or by phone or through the internet. This was mainly owing to their 
positive experience and perceived benefits of group-based programmes and lack of interest or 
lack of technology use. Specifically, regarding housebound patients some patients felt it was 
important to provide support to them at home while others believed delivery of the 
programme to housebound patients would not be cost-effective to the NHS and hence would 
not be sustainable and so felt a better option would be to identify housebound patients, 
support them individually first till they felt ready and comfortable to attend the programme.  
 PP1: ...I wouldn’t suggest a one to one, because I don’t think that would work. 
...Because it would cost an awful lot of money for one person to go to one person’s home, and 
do and hour or so.  You know, the funding for that would be so high that no-one’s going to 
want to carry on; they’ll do it for a while and then go, we can’t afford that. ...And also part of 
the self-management thing is to do with being with people.  A lot of their problems are, 
they’re indoors, very lonely and if you keep them indoors, they’re just going to get worse. 
they need to come out.  Even if they are housebound, they need to come out.  
 PP10: In the hospital when they’re (people with COPD are) being 
released.....I’m sure the one to one has got to be (there)... or maybe ... at our GP practice,… 
And that is the way to do it though. ....I’m sure the more the personal (the better) ...  
 PP9: ... Unless, like you have a one to one around their house and spoke to 
them.  By speaking to someone like me, perhaps, and then you make them feel more relaxed 
and it would help them if they went to the group; perhaps something like that. 
 
For patients with COPD in general, two non-technological options had been suggested for 
delivery of the SM programme and they included: have a person who specialises in COPD 
based in the GP practice and who patients could access for more information instead of being 
  244  
 
given information in the hospital or deliver the content of the SM programme in monthly 
Breathe Easy meetings.  
  
(6) Programme organisational improvements 
Suggestions given to improve the organisational and structural aspects of the COPD specific 
SM programme could be applied to other SM support programmes relevant for COPD 
patients to help improve participation and retention. Improvements were suggested for the 
mode of patient invitation and provision of information about the programme to help patients 
believe in the benefits or importance of the programme. In addition, suggestions were given 
to change structural aspects of the programme to help improve participation for example, use 
trained staff, introduce talks by several experts, reduce waiting time between invitation and 
attendance to two to four weeks, hold the programme outside of rush hour times, keep in 
mind that concentration mainly lasts an hour or two, include light exercise with music, refer 
patients to PR or Breathe Easy at the end of the programme. 
 PP3:... it all needs to go ahead quickly. Well, two weeks or something like that; 
not months, because I think people do lose interest, like “Oh, I don’t think it’s going to be 
much good,” or something like that, you know. 
 PP8: ... I’m wondering actually ... If the doctor actually invited you to go in and 
have a chat about this, that might work better than the doctor saying, “Here’s the 
programme that you can do if you want to.”  …You need the help of a good psychologist....To 
understand that key, if there is one, to make people work very hard for a relatively small 
reward. 
 PP10: Well, it could be exercises that are good for you with a bit of music and 
make it a bit of fun, half an hour. You know?....And also you don’t need equipment for 
it....Well, this they could do, maybe in the middle of a session, say the odd half hour and then 
a cup of tea and that. 
 
A number of suggestions had been put forward for improvements to the PR programme as 
well and they included: relaxation sessions, assess expectations and more discussion time and 
allow people with severe COPD to carry out exercises at their own pace. 
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5.7 Discussion 
5.7.1 Summary findings 
This study is the first to provide an insight from a COPD sample of sufficient size to result in 
data saturation with a mixed prior experience of attending SM support programmes about: 
(1)  Factors that might lead to patient non-participation in such programmes.  
(2) Suggestions to improve patient participation in these group-based programmes and views 
on alternative ways of supporting SM in these patients.  
 
(1) Factors that might lead to patient non-participation 
The participants’ characterised people who did not participate in COPD SM support 
programmes for example, as those who were not ready to help themselves, they might have 
not accepted their condition or they might have become resigned to their condition. In 
contrast, those who participated were for example, proactive, used own initiative, ready to 
help themselves; these characteristics were noted among the interviewees.  
From participants’ own experience of living and learning to adapt and managing their 
condition and its consequences over time they felt patient non-participation could also be due 
to negative perceptions about their illness for example, condition is incurable, perceived 
physical, psychological and emotional limitations (particularly those who might be living 
alone), this may make patients lose motivation, confidence and reluctant to try anything new. 
And the negative perceptions about SM support programmes for example, the programme is 
only about smoking cessation, exercise is not useful. Furthermore, non-participants might be 
more concerned about the practical/physical barriers related to attendance e.g. competing 
priorities, cost of transport. Despite previous attendance in SM support programmes, many 
participants were not hundred per cent confident or in control of their condition due to its’ 
unpredictable nature. This highlights the difficulty or the constant work that patients with 
COPD have to do to manage their condition daily; however, most participants were able to 
perform SM strategies which they had learnt from attending PR and so, patients who do not 
participate or attend SM support programmes may be more likely to experience difficulty 
with SM. A different view given about non-participation was that  patients might be unaware 
of SM support programmes. Outside of patient factors, some programme organisational 
issues were also proposed that could affect patient participation such as, long waiting time 
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between invitation and attendance in programme, lack of proper communication about the 
programme, nearby programme venues closing down. 
Some reasons given for why patients might have dropped out of SM support programmes 
included: poor facilitation skills of programme staff or insufficient support or attention paid 
to patients, inappropriate programme venue, lacked perceived benefits of the programme, 
unmet expectations, other programme attendees not serious about the programme and illness. 
 
(2) Suggestions to improve patient participation 
Patient participation in COPD SM support programmes might improve if the barriers 
mentioned above could be addressed by the following proposed improvements: provision of 
patient motivation and encouragement by informing about the programme and its benefits 
using a personalised approach, provision of support to accept condition and reassurance that 
they can learn to take control, build sense of worth and confidence that things important to 
them can be achieved and recognition of the condition and its disabling nature by the wider 
public including health professionals. These above suggestions were also proposed by some 
of the participants for encouraging housebound patients to attend the programmes; as they 
believed group-based programmes were still better for these patients in comparison to using a 
technological approach or an individual approach as it would be costly and unsustainable. A 
wider promotion of SM support programmes in the form of leaflets/adverts in several 
locations such as GP surgeries, day surgeries, hospitals, BE support centres, pharmacies and 
even church was suggested plus involving staff at these locations including family to 
communicate the programme benefits to patients to help improve participation. Lastly, 
several organisational improvements had been suggested for COPD SM support programmes 
to help improve participation and retention (see Table 5.2). 
 
Several participants had also pointed out that despite all efforts to improve patient 
participation in SM support programmes some patients might still not want to participate in 
the programme and the ultimate decision would rest on the individual.  
 
5.7.2 Comparison with other literature 
(1) Factors that might lead to patient non-participation 
The study findings with regard to resignation of living with COPD or in denial of COPD to 
affect patient participation in COPD SM support programmes can be explained by the Corbin 
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and Strauss1 sociological perspective of illness trajectory that comprises of three lines of 
work (‘illness work’, ‘everyday life work’, ‘biographical work’) that are necessary for 
managing chronic illness. The ‘illness-related’ work has been used previously to explain 
health care utilisation among patients with chronic disease166 (described in Chapter II, Box 
2.2) Within the illness trajectory, Corbin and Strauss1 have put forward that for an individual 
with chronic disease to live, there needs to be a balance between three types of work, 
management of day to day illness, carrying out routine daily activities and the biography of 
the individual, however, the struggle to achieve this balance is not easy and the state of 
equilibrium is prone to instability because of several consequences. One consequence 
includes ‘conditional motivation’. Motivation for a person with chronic illness depends on 
having a trajectory scheme – knowing what lies ahead to carry out illness trajectory work; a 
biographical scheme – one must wish to live which would mean the individual must come to 
terms with their illness, their limitations and potential outcomes of their illness; hope – that 
the individual can carry out tasks and can attain something. Without hope the previous two 
conditions would be useless; and commitment – to carry out the trajectory and the 
biographical scheme.1. However, Corbin and Strauss stated that for an individual to remain 
motivated there needs to be some pay-off.  
 
Thus, patients with COPD who have resigned to their illness and cannot see that they can do 
something to manage their condition, those who have not come to terms to their illness or its 
limitations or do not have the confidence that they can achieve things or gain benefits then 
these patients might be more likely to lose motivation to move forward which might lead to 
non-participation in self-care, including in SM support interventions. Resignation to live with 
the illness has not been reported previously to affect participation in SM support programmes 
but this attribute has been recognised among patients living with advanced COPD who may 
have accepted COPD as a ‘way of life’ where patients do not actively seek information or 
would ‘rather not know’.330 SM support staff have previously mentioned that patients who 
lack readiness to take responsibility122 or accept illness313 would find it harder to change 
behaviour and hence may make a decision not to participate in SM support however, SM 
support programmes may not be appropriate initially for these patients until they come to 
terms with their illness and feel that it can be managed. In contrast, the study findings 
suggested that people who do participate in these programmes would be those who are ready 
to help themselves, are proactive, use initiative to get what they need, they want to live and 
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learn to adapt and believe that they can achieve health improvements. This description was 
reflected in the participants’ reasons for attending SM support programmes and within the 
sociological context one could say that these patients are motivated and may be more likely 
to achieve a relative equilibrium necessary for trajectory management.1 While, within a 
policy context – these individuals would be referred as ‘activated’ patients who are taking 
responsibility for their health by asking questions, seeking explanations, stating preferences, 
and expecting to be heard (described in Chapter II).  
A patient with COPD may also become resigned to their situation due to the lack of 
recognition of COPD and its disabling nature by the wider public including HCPs which 
could inhibit help seeking including participation in SM support programmes. Halding308 
reported that patients with COPD, having non-supportive consultations with HCPs and their 
needs receiving little attention as a result of smoking, end up concealing their condition and 
lose out on support – ‘they withdraw into an exile in everyday life to maintain dignity’.308  
 
This study further suggested that individuals with negative health/illness beliefs and 
treatment beliefs (via the SRM, SRM-NCF) within the wider illness trajectory might further 
affect participation. In comparison to a previous study109 that suggested perceived 
uncontrollability of the condition, perceived ‘incurability’ of the condition was suggested in 
this study to affect participation. In addition, the experience of physical, psychological and 
emotional limitations as a result of living with COPD or negative illness perceptions 
(increased perceived symptoms to COPD or ‘disease identity’, increased perceived 
‘consequences’ decreased ‘personal controllability’) and negative ‘emotional perceptions’ 
might lead an individual to become reluctant to be involved in anything new or any physical 
activity. Also individuals may, become depressed and lose motivation, and become 
frightened and have reduced self-confidence to leave their home and go to a new place and sit 
with strangers including the fear of getting breathless when they are outside could affect 
participation. These factors were suggested more for people who might be living alone 
because the participants through their own experience, had battled through these situations 
e.g. depression, coming to terms with illness, being unmotivated but they had learnt or were 
still learning to adapt and manage their condition with the help of support and/or seeking 
help.  
These findings are supported by other studies which have reported that patients with COPD 
who have led sedentary lifestyles will find it harder to become more active;313 Inactivity due 
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to loss of motivation could be seen more in patients who live alone as they may more likely 
perceive their health as negative and disabling82 and hence might consider ‘giving in’ to their 
condition and limitations as opposed to ‘keeping up’ with their condition.331 This can affect 
engagement in complex treatments32 which could include participation in SM support 
programmes. While the fear of exercise or the belief that exercise could be harmful have been 
reported to affect participation in PR in previous studies.100,116 This study identified that 
patients’ might undergo fear, panic, anxiety or nervousness when going to a new place 
delivering SM support and meeting strangers. These emotional consequences have been 
commonly reported in studies in relation to patients living with COPD.32  
The lack of perceived benefits from exercise previously reported in studies100,114 was also 
suggested as a possible reason to affect participation including not seeing the value of self-
help in this study. In addition, the stigma of smoking that can influence patient participation 
reported previously100 and the perception that the programme was preaching about smoking 
cessation could also affect participation among patients not yet ready to quit. Patients’ lack of 
perceived benefit from exercise has been explained as possibly arising from insufficient 
information given about PR100 and patients’ lack of interest in quitting could be because of 
insufficient or inappropriate advice given to patients with COPD about lifestyle modifications 
that are necessary for them to adhere to for the long term for their illness management.332 
Participants in this study also suggested that some physical/practical barriers could be 
perceived as ‘concerns’ by patients with COPD in relation to participation and they were: 
ease of access, cost of transport and other prior obligations or priorities and in light of these 
the programme may not be perceived ‘necessary’ or important. Physical/practical barriers 
have been previously reported to affect PR uptake.100,114 
In this study, some organisational issues such as insufficient communication about the 
programme, not enough centres to provide PR or nearby centres closing down were suggested 
as issues that could affect participation. The insufficient provision of information about PR 
has been reported previously to affect patient uptake.100,114  
Another finding reported in this study to affect patient participation was that patients may not 
be aware about SM support programmes. Patient stakeholders in a previous study313 had also 
mentioned that no information was given to them about PR until their condition worsened 
and some felt that the knowledge of GPs about PR was limited. The lack of awareness or lack 
of provision of information about SM support programmes is indeed a missed opportunity for 
suitable and eligible patients with COPD to consider participation.  
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(2) Suggestions to improve patient participation 
To improve patient participation in SM support programmes, first patients may need to be 
supported to accept their condition and educated to take control of their condition. A study313 
suggested that only through accepting the condition can an individual recognise their needs 
and can think about fulfilling those needs; this may also help to prevent patient resignation or 
going into a downward spiral.1 This provision of support would be usefully delivered prior to 
patients attending the programme including when they attend the programme which was 
previously suggested333 as this may increase the likelihood of more patients considering 
participation in the programme. In addition to assessing patient’s personal motivation to 
change and goals324 this study proposed to improve participation, patients may need to be 
motivated and encouraged by building their confidence in things that are important to them 
and goals that they can achieve so they feel a ‘sense of worth’ and that they are still capable 
of doing things to help themselves. This may be appropriate when a patient is in the earlier 
stages of the disease for better management of their condition.1 In one study313 some HCPs 
had mentioned that it would be useful to know whether a patient with COPD was self-
motivated however, this would only work if health professionals allowed patients to 
participate (described in Chapter II), i.e. become involved, or to engage them as partners in 
their care.47,324  
 
Another way proposed to encourage patient participation in this study was by informing 
patients about the programmes either face-to-face by a GP, SM support staff in a GP practice, 
home visit by persons who know about COPD or even via a DVD and showing how it may 
have benefitted others; by holding a few sessions in a patient’s home or inviting them to a 
trial session without any pressure to commit and by allowing patients to bring a family 
member, friend or carer to at least the first session of the programme was mentioned by many 
participants. Involving the patient’s support network might give patient the confidence or 
may help to allay any fear or nervousness they might associate with leaving the house and 
going to a new place and sitting with strangers. Patients who live alone have been linked with 
becoming socially isolated308 and becoming depressed334 and this was recognised by the 
participants in this study and so, the provision of motivation and encouragement in this study 
may help to alleviate depression and/or anxiety in this group of patients. A study334 identified 
that patients with COPD who live alone and who have not participated in exercise previously 
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need additional support in treating depression and would benefit from motivational interview 
tailored to exercise and referral to PR to increase the likelihood of participation. Use of peer 
support and education from people with COPD100 and asking patient to attend a trial 
session335 have been suggested previously to improve PR uptake. The proposed suggestions 
of motivation and encouragement including provision of support to accept their condition 
would fulfil the criteria that patients with chronic disease have mentioned to participate in 
their care  and which could include participation in SM interventions (discussed in Chapter 
II); the criteria included to be informed/to have knowledge, to be confident in one’s own 
ability, to comprehend information about disease and its treatment and to seek and maintain a 
sense of control.188  
 
A wider promotion of programmes and their benefits was also suggested by the study 
participants alongside creating awareness of COPD among the wider public including the 
medical profession so patients can consider seeking help which could include participation in 
SM support programmes. Creating awareness about COPD among family members of COPD 
patients333 and anticipating patient’s concern, acknowledging and normalising them109 has 
been reported previously to help improve uptake.109 A suggestion given to promote 
awareness through adverts/leaflets suggested in this study was also reported previously;336 the 
participants’ proposed that in addition to placing leaflets and posters in locations such as GP 
practices, day centres, Breathe Easy centres, pharmacies, the staff (trusted by patients) 
working at these centres including the patient’s family could be involved to discuss the 
programme and benefits with patients which may increase the likelihood of participation. 
This approach may prove valuable for a patient as they could then discuss their interest in the 
programme with the health professional when they perceived it as necessary instead of 
waiting to be referred. This proactive role by the patient would further fulfil two requirements 
deemed important according to policy initiatives337 for a patient living with a chronic disease, 
active patient involvement and self-management. Furthermore, so far, respiratory consultants 
or physiotherapists have been mostly reported to influence participation in PR311 and hence it 
may be useful if that role could be adopted more by GPs to help improve participation 
however this would be facilitated if GPs were made more aware about SM support 
programmes and believed in the benefits for their patients – this was also deemed important 
by a few participants in this study. Several participants also suggested that it should be 
recognised that despite all efforts to improve patient participation in SM support 
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programmes, some patients may still not want to participate and the decision would rest on 
the individual.  
 
This study appears to be the first to explore whether the SM programme could be delivered to 
patients on a one-to-one basis who cannot or do not want to attend group-based programmes 
e.g. housebound patients. However, most of the study participants felt that group-based 
programmes was still the best way to offer SM support instead of using an individual 
approach or technology (including phone calls). This finding was mostly based the 
participants’ preference and the perceived benefits of group-based programmes, most either 
disliked, did not know how to use or were disinterested in technology.  
An individual approach and provision of support to housebound patients was deemed 
important e.g. through use of community nurses who already visited patients in their home as 
part of their service provision but some participants felt this form of support would be too 
expensive for the NHS and hence not sustainable. These participants felt that a better use of 
resources could be to identify and provide one-to-one support to housebound patients till they 
felt ready or comfortable to attend group-based programmes – this suggests that the 
approaches suggested above to improve participation in SM support programmes: e.g. 
motivation and encouragement and promotion of programme benefits may also be beneficial 
for these housebound patients to consider participation in SM support. However, the needs of 
housebound patients may benefit from further exploration.  
Moore100 has suggested the development of home-based services e.g. via DVD for patients 
with COPD who do not find it feasible to attend PR in a group however, based on the study 
findings the latter might not be the best option. One study338 had explored barriers to adoption 
of telehealth services amongst patients with chronic disease including COPD and the 
findings, patients’ being uncomfortable or did not know how to use technology and would 
have preferred to speak to someone in person support the findings of this study. The literature 
is inconsistent about the place of internet among patients with chronic disease for example 
one study337 reported that some patients with chronic illness might find internet interactions 
most relevant soon after diagnosis and perhaps place less value in them for long term 
management of their chronic condition while, another study333 has reported that patients may 
like to receive written information on paper in the earlier stages of the disease than read 
information on the internet, these issues may benefit from further exploration. Two non-
technological options had been offered by a few participants and they included have a 
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person/specialist based in a GP practice that patients could regularly access for COPD-related 
queries and deliver sections of the COPD SM programme in Breathe Easy meetings.  
 
Besides focusing on the patient, improvements to the organisational aspects of the SM 
programme might also help to improve patient participation.  The improvements suggested in 
this study (section 5.7.1) can be added to the previous evidence suggested for SM122 and PR 
programmes100,114 or applied to programmes that might be being developed or re-designed to 
improve patient participation. 
 
5.7.3 Strengths and limitations of the study 
This study is believed to be the first of its kind to explore factors affecting participation in 
SM support programmes by patients with COPD, how participation might be improved in 
these programmes and how patients with COPD might be best supported with their SM from 
the patient stakeholders’ perspectives. However, there were some study limitations.  
Firstly, most study participants had previously attended a SM support programme and so, 
their views might not be transferable to patients with COPD who have not been exposed to 
these programmes. However, these participants were purposefully selected to give an insight 
into patients’ reluctance to participate in SM support programmes because they had the same 
condition and they were familiar with the research topic of patient non-participation. The 
participants themselves, were mostly elderly and suffering from moderate to severe COPD 
and were a true representation of a patient living with moderate to severe COPD and their 
reasons for non-participation were based on their own difficult experiences of living and 
coping with COPD and how these experiences could impact on participation in SM support 
programmes. These reasons might have been difficult to obtain from non-participants as this 
would have required self-critical insight and they might have been reluctant or uncomfortable 
or embarrassed to discuss these reasons; in addition, these patients may have been difficult to 
recruit in the study due to their non-participation.93,122  
Secondly, the majority of the participants were female even though the prevalence of COPD 
is commoner among males, and so the findings may not be transferable to male patients with 
COPD. The issue of gender and participation was explored in this study and the findings 
presented in the descriptive themes could be used as a starting point for further exploration of 
non-participation among male COPD patients.  
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Thirdly, only three out of a target of 10 housebound patients (one of whom claimed to have 
asthma and not COPD) were recruited from a single participating GP practice out of the 
possible 94 practices that were invited to participate in this qualitative study. The best way to 
recruit housebound patients or patients with advanced COPD in a research study is by having 
their clinician introduce the study,94 within primary care or hospital78 however, this approach 
was unsuccessful for this study. One study33 has suggested that housebound patients may 
have difficulties responding to a letter of invitation which can result in high non-response 
rates however, in this case, patients were not even given an opportunity to respond to a letter 
as 93/94 GP practices did not take part in the study. Unlike this study, a qualitative study by 
White93 was able to recruit their target number of housebound patients from a large number 
of GP practices and this could be because the recruitment was carried out by a local GP and 
suitable patients were identified from the disease register. Despite the poor recruitment three 
more housebound patients were recruited from the participating Breathe Easy groups and 
valuable insight was obtained from these participants on the research topic.  
Fourthly, although, the participants were the appropriate group of people to suggest 
improvements for patient participation in SM support programmes and how patients might be 
best supported with their SM their preferences for group-based programmes and dislike or 
disinterest in technology might have biased the findings. Another way to better support 
patients with their SM needs further exploration from patients not exposed to SM support 
programmes to identify their preferences for SM support. Conducting serial ‘snapshot’ 
interviews would be useful to capture patients’ preferences in a future study.339 
Lastly, the study was also aware of the researcher’s attitude in influencing design, data 
collection and analysis of qualitative themes and used an expert in qualitative research and 
the lay patient advisory group to obtain a balanced interpretation of the collected data.339 
 
5.8 Conclusions 
This study is believed to be the first of its kind to explore from COPD patient stakeholders 
factors that could affect participation in SM support programmes by COPD patients, how 
participation might be improved in these programmes and how might patients be supported 
with their SM in a non-group setting. The findings have contributed to the limited evidence 
base that exists on this research topic deemed necessary to explore.47,130  
Participation in SM support programmes might be affected by patients with COPD (1) being 
resigned to their illness either because they may feel there is nothing they can do to help 
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themselves or the lack of recognition of their illness and its disabling nature, being in denial 
of their illness and so they may be not ready to help themselves and might feel entitled to be a 
burden; (2) negative illness beliefs e.g. the perceived incurability of condition, perceived 
physical, psychological and emotional consequences might lead patients to become reluctant 
to be interested in anything, particularly physical activities, become depressed, fearful, lose 
motivation, and lose the self-confidence to go out to a new programme and be among 
strangers; (3) Negative treatment beliefs e.g. perceived programme to be about smoking 
cessation, might not see the benefit of self-help or exercise or might not perceive exercise as 
important or necessary and may perceive increased physical/practical concerns related to 
participation or lack awareness about the programmes; and (4) programme organisational 
issues.  
The following reasons might predispose patients to drop out of SM support programmes: 
poor facilitation skills of programme staff or insufficient support or attention paid to patients, 
inappropriate programme venue, lacked perceived benefits of programme, unmet 
expectations, other programme attendees not serious about the programme and illness. 
 
The following suggestions might help to improve patient participation in SM support 
programmes: (1) provision of motivation and encouragement to build patient self-confidence 
and self-worth,  provision of support with accepting condition, recognition of COPD among 
the general public including the medical profession and involving patients and their support 
network to see the programme benefits; (2) wider promotion of programmes and discussion 
about the programme and its benefits particularly addressing beliefs about physical activity or 
exercise by health professionals involved in provision of COPD care and including family; 
and (3) improvements to organisational aspects of the programme. Provision of group-based 
programmes was felt appropriate even for housebound patients in comparison to the 
individual approach or use of technology; better use of resources was suggested to provide 
individual support initially to housebound patients till they felt comfortable to attend 
group-based programmes.   
 
5.9 Implications  
The study findings suggested that if professionals support patients to accept their condition, 
provide motivation and encouragement and discuss the programme benefits then that might 
help with addressing some of the patient barriers to participation and improve participation. 
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In addition, creating awareness of COPD among the general public including health 
professionals and programme organisational improvements may further boost participation.  
  
This means that to address the patient factors HCPs might have to facilitate a 
partnership/patient-centred care approach55 and assess within the patient’s illness journey 
their beliefs about the illness and its treatment but also if they have hope and can commit to 
managing their condition.1 If patients’ can comprehend information about their condition and 
its management, are confident in their ability to manage their condition and recognise that 
they need to help themselves188 then they might be more likely to self-manage their condition 
which could include participation in SM support programmes. Providing training to 
professionals in patient engagement340 may help them to support their patients and their 
needs.  Along with education and an emphasis on the complementary nature of SM support 
programmes to medical management among non-pulmonary professionals,30 COPD and its 
disabling nature also needs much recognition among the larger public including the medical 
profession so patients with COPD can seek the help they need and prevent the downward 
spiral of resignation, loss of motivation and thus non-participation. 
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This qualitative study continues into the next chapter which presents and discusses findings 
from interviews with experts’ (both lay and HCPs) involved in COPD management and 
self-management about patient reasons for non-participation in SM support programmes. It 
considers how participation might be improved including how patients with COPD might be 
better supported with their SM.  
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Chapter VI. Understanding reasons for poor participation in 
SM and PR programmes and how participation can be 
improved in these programmes – a qualitative study with 
experts 
 This chapter continues from the previous Chapter V and so the research objectives 
and the research questions are the same; the data analysis and ethics consideration 
section will not be repeated. The focus of this chapter is to present findings from 
interviews with experts.  
 The chapter begins with a brief introduction followed by the methods with sections on 
sampling and recruitment, interview schedule and interviews; next, the study findings 
will be presented followed by the discussion, conclusion and implications.
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6.1 Introduction 
The previous chapter IV and V have already established the limited number of qualitative 
studies that have explored the problem of participation and retention in COPD SM support 
programmes from the patients’ perspective. Efforts to understand this problem from the 
perspectives of lay or health care professionals (HCPs) (referred to as experts in this study) 
are meagre.  
The only one well documented124,218 reason for patient non-participation in PR has been 
explored qualitatively among HCPs particularly, the poor or inadequate patient referral of 
eligible COPD patients to PR. One UK study116 and a recent Australian study218 explored the 
barriers and facilitators to PR referral of COPD patients among primary care professionals. 
No studies have explored factors affecting participation specifically in COPD SM 
programmes among HCPs except, one study122 that explored how participation could be 
improved in a COPD SM programme among lay tutors that delivered the intervention.  
The aim of this study was to gain a better understanding of factors affecting patient 
participation in SM support programmes; factors that might encourage patient participation in 
these programmes; and how might COPD patients be better supported with their SM from 
experts involved and/or interested in management of COPD patients and SM.   
 
6.2 Research objectives 
To explore, from experts (lay and health care professionals) involved and/or interested in 
COPD management and self-management using qualitative methods (individual interviews) 
the following questions: 
a) what are reasons for poor uptake and completion of  SM support programmes amongst 
patients with COPD? 
b) what might be done to make an existing COPD SM programme more appealing and 
applicable to patients with varying levels of COPD severity (including changes to programme 
content and different modes of delivery)?  
c) whether different modes of SM delivery should be considered for patients with different 
degrees of airflow obstruction? 
d) which is the most suitable delivery method for patients with moderate to severe COPD to 
promote uptake and completion?  
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6.3 Research questions  
The main results of the research will help to explain:  
1) Why people with COPD participate in, do not participate in, or fail to complete SM 
support programmes? 
2)  What are the characteristics of people that attend and do not attend SM support 
programmes? (This might help to target programmes towards people who will gain benefits 
from programme attendance) 
3)  Do people with varying levels of COPD severity want different things from SM 
support programmes? 
5)  How should support programmes be delivered to people with different levels of 
severity, and by whom? 
4) How might we make an existing COPD SM programme more appealing, applicable 
and accessible for patients with moderate to severe COPD, or could we deliver SM support to 
these patients in an alternative way? 
 
The findings of the study were intended to help either refine an existing COPD SM 
programme – with the adoption of a new delivery method for patients with moderate to 
severe COPD, or to identify another way to provide SM support to patients with COPD and 
test the new intervention in a small exploratory study (Chapter VII)  
 
6.4 Methods 
6.4.1 Sampling and recruitment  
Key personnel were purposively identified and approached following reading the literature; 
attending a two day workshop in east London on COPD that was aimed at HCPs; and 
discussion with the study supervisor.  
The potential participants were to include:  
• People that develop self-management programmes, including COPD self-management 
programmes  
• People that deliver self-management programmes, including COPD self-management 
programmes 
• Physiotherapists that deliver pulmonary rehabilitation programmes (in hospital, out-
patients and/or at home),  
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• Health care staff and/or researchers involved and interested in promoting SM for 
chronic conditions including COPD in the community.  
The potential participants were invited to participate in this study via an invitation letter 
(Appendix 6.1) and an information sheet (Appendix 6.2) which was either posted or emailed. 
The potential participants were sent one reminder email if no response was received. 
Interested potential participants contacted the researcher directly either by telephone, email or 
a postal reply slip attached to the study invitation letter in a pre-paid envelope.   
The interviews were arranged by the researcher at a time and place convenient to the 
participants, which could be their home, place of work or at the host institution. As a token of 
appreciation for their time and contribution to the study, each participant was given a voucher 
worth £20. 
If the participants (who will be referred to as ‘experts’) were agreeable an interview date was 
arranged and a consent form (Appendix 6.3) was sent to the participant. The participants 
could contact the researcher for further queries. 
 
6.4.2 Interview schedule 
Similar to Chapter V, the semi-structured interview schedule (Appendix 6.4) was developed 
from discussion with the study team and from previous literature122 and the questions were 
framed under the theoretical domains framework.326 The theoretical domains appropriate to 
conduct the interviews with experts were used for example, within the ‘Social influences’, 
‘Emotion’, ‘Environmental context’, ‘Memory’ domains the experts were asked, “In your 
experience what could the reasons be for non-participation by patients with COPD?”.  
 
6.4.3 Interviews 
Pilot interviews were conducted with two HCPs. The preamble for all interviews comprised 
of study introduction, confidentiality, anonymity and permission to record the interview. The 
interview would stop if the expert needed to resume their work, and at the end of the 
interview the expert was thanked for their time and contribution and given a £20 voucher. 
Semi-structured face-to-face interviews explored, experts’ views about their experience of 
involvement in SM generally or specific to COPD patients, whether there was a problem of 
patient participation in SM support programmes and if yes, what were the barriers to 
participation, how participation might be improved in these programmes (a brief summary 
(comprising of one A4 sheet) of an existing COPD SM programme was presented (Appendix 
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5.5) and how patients with COPD, who do not or cannot participate in SM support 
programmes, might be supported with their SM. Data saturation was achieved as no new 
themes emerged from the interviews. The duration of interviews ranged from an hour to an 
hour and a half, were audio-recorded, anonymised, transcribed and imported into Nvivo9 
software for organisation and data analysis.  
 
6.4.4 Data analysis 
See chapter V (section 5.4.4). 
 
6.5 Ethical considerations 
See chapter V (section 5.5) 
 
6.6 Results 
6.6.1 Sample characteristics 
In all 16 interviews (including two pilot interviews) were conducted. Following the two pilot 
interviews 19 experts were approached and 12 agreed to participate. Of those who did not 
participate two no longer worked where the invitation letter was sent and five did not reply. 
In addition to the 12 experts, two experts who had been identified initially as collaborators in 
the development or refinement of the COPD-specific SM programme for COPD patients 
(original study research objective, section 1.1.3) also agreed to take part in the study. So, out 
of the 16 recruited experts, two developed and delivered SM programmes one of whom was a 
health professional, three were lay tutors who delivered SM programmes, one was a policy 
director and three were researchers, one of whom was a health professional who evaluated 
SM programmes, one health professional delivered PR and of the six remaining experts, two 
were health psychologists, two were GPs and two were respiratory consultants within an 
interest in COPD management and/or SM (Table 6.1). 
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Table 6.1 List of the expert interviewees 
No Study ID Title 
1. EP1 – pilot interview Health psychologist 
2. EP2 – pilot interview GP 
3. EP3 Development of SM programme and delivery  
4. EP4 Physiotherapist 
5. EP5 Policy director and evaluation of SM programme  
6.  EP6 Delivery of COPD SM programme  
7 EP7 Researcher 
8. EP8 Health psychologist 
9. EP9 Delivery of SM programmes including condition-specific (diabetes 
and COPD) programmes 
10. EP10 Respiratory consultant 
11. EP11 Delivery of generic EPP and COPD SM programme  
12. EP12 GP with special interest in COPD 
13. EP13 Respiratory consultant 
14. EP14 Health professional/Development of SM programme/COPD SM 
programme and delivery 
15 EP15 Health professional/Researcher 
16 EP16 Researcher 
Key: 
GP –general practitioner; SM – self-management; EPP – expert patient programme; COPD – chronic 
obstructive pulmonary disease  
 
6.6.2 Emergent themes and subthemes 
The study findings comprised of a detailed account of the views of experts who belonged to 
different levels of the health care system and who were involved in the management and/or 
SM of patients with COPD.  
Section 6.6.2.1 describes the emergent overarching themes with subthemes. Additional 
quotes that support the study findings have been placed in Appendix 6.5. Within the patient 
participation definitions, Figure 6.1 illustrates factors that may affect patient participation and 
retention in COPD SM support programmes and Figure 6.2 illustrates suggestions that might 
help to improve patient participation and retention in these programmes.  
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Figure 6.1 Illustration of factors affecting patient participation and retention in COPD SM support programmes 
 
6.6.2.1 (2A) Patient factors 
 do not want or not ready to 
change behaviour 
 not accepted condition or 
taking a long time to accept 
 illness and its consequences 
can lead to lack of 
confidence to go out   
 lack understanding or 
negative beliefs about the 
illness and the programmes  
 physical or practical 
barriers e.g. competing 
commitments 
 
 
 
 
6.6.2.1 (2B) Health system 
factors 
 lack of support from 
primary care/lack of 
integration of SM  
 lack of understanding about 
the role of SM/programmes 
among professionals   
 inefficient health system 
e.g. insufficient training for 
primary care professionals, 
lack of communication 
between different health 
service levels   
 right patients not being 
recruited  
 
 
 
 
6.6.2.1 (2C) Programme 
organisation factors 
 staff unable to explain the 
programme and its benefits 
to patients over the 
telephone 
 long duration of the 
programme 
 absence of a rolling 
programme 
 
 
 
6.6.2.1 (3A) Patient factors 
 unmet expectations/wrong 
expectations from the 
programme 
 instability of the illness or 
not ill enough 
 group dynamic not working 
 physical or practical 
barriers 
 
 
 
 
6.6.2.1 (3B) Programme 
organisation factors 
 inadequate facilitation skills 
 uncomfortable with 
discussing the ‘living wills’ 
section  
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Figure 6.2 Suggestions that might improve patient participation and retention in COPD SM support programmes 
 
                                                                           
 
Provision of 
training and 
support for health 
care professionals 
  
 
 
 
Integration of SM 
into the COPD care 
pathway 
 
 
 
 
Promotion of 
benefits of SM and 
the programmes 
   
 
Health system improvements to improve patient participation 
Identify the right patients for the 
programme e.g.at diagnosis or 
via the patient activation 
measure 
Build relationships with patients 
and identify what patients value 
and if they might be ready to 
self-manage or to participate in 
self-management support 
programme   
Carry out ‘pre-work’ to support 
patients as per their needs e.g. 
support with accepting condition, 
discussion of programme 
benefits   
 
To improve participation 
- offer flexible programme e.g. at different 
times, locations 
- ensure convenient journey and comfortable 
venue 
- programme sessions need to keep patients 
engaged  
Organisational improvements for COPD SM programme 
To improve retention 
- Improve facilitation skills  
- Involve health care professionals to deliver 
the disease-specific elements of the 
programme 
- Include in content e.g. exercise, session of 
depression and COPD to remain, ask  
preference of patients prior to discussion of 
the ‘living wills’ section, cover the ‘what is 
COPD?’ section with patient prior to their 
attendance in the programme 
Pitch patient invite and 
information about the programme 
at the right level of the patient, 
assess and address expectations 
and logistical difficulties  
Use professionals enthusiastic 
about self-management and the 
programmes to refer patients  
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6.6.2.1 Emergent overarching themes 
The experts’ level of engagement in SM was varied perhaps due their professional role, and 
this helped to get a greater understanding from experts about the importance of SM and how 
much SM was embedded in the care of patients with COPD. Some experts were involved in 
the development, delivery and/or evaluation of group-based SM programmes or delivery of 
individual support to patients. These experts believed that SM programmes were about 
engaging patients in their care to reduce hospital admission and improve patient outcomes – 
in line with policy initiatives. A few experts felt that SM education was not delivered in PR 
as intended by the policy guidelines41 while, some experts believed that the educational 
content delivered in PR or during supported discharged all was part of SM. Based on this it 
seemed that COPD patients might only be able to access SM support through SM 
programmes.   
Nonetheless, non-participation and poor retention in PR and SM programmes was 
acknowledged by all experts and explained under five overarching themes:  
(1) Challenges of delivery of SM support programmes – this theme was not directly related to 
the research objectives of this study but informed the findings that explained how 
participation might be improved;  
(2) Reasons for patient non-participation in COPD SM support programmes;  
(3) Reasons for patient dropout;  
(4) Suggestions proposed to improve patient participation and retention (similar to the 
previous chapter were mostly suggested for the COPD-specific SM programme but the 
findings could again be applicable to programmes in development or refinement to help 
improve participation); and  
(5) Supporting patients with their SM in a non-group setting.  
 
(1) Challenges of delivery of SM support programmes 
Several challenges in the recent delivery of SM support programmes were expressed that 
included patients’ not knowing anything about COPD until they came to the programme. This 
lack of knowledge made them angry and reluctant to learn anything or they felt they were 
going to be told to stop smoking; patients’ agreed to participate but then did not attend the 
programme which was frustrating for the experts and created organisational difficulties e.g. 
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an interviewee (SM tutor who did not have COPD) was asked to facilitate a COPD SM 
programme which they found difficult because of insufficient understanding about COPD.     
EP4: Quite a few in the (PR) class I run don’t even know what COPD is, aren’t really sure 
about the condition and how it affects their lungs.  So a lot of them ask about that and 
ask whether actually it’s going to get worse or can it get better sometimes...(on 
further probing why patients do not know what COPD is when they attend 
programmes)… I often wonder whether it’s explained properly when they’re 
diagnosed, or sometimes whether it is formally diagnosed, or whether people (HCP) 
see smoking history or cough, or shortness of breath, and they might just put the two 
and two together, without really explaining what the condition is. 
EP3: ... And someone else came to a course … and she was like, “I’m not giving up 
smoking!” and the tutor just went, “Well, we’re not asking you to give up smoking; 
this isn’t what it’s about!”...“If you want to give up smoking, you can go to a smoking 
place rather than here, because this is about self-management.”...And I think two 
weeks later she went off and joined a non-smoking group!  
EP9:...So we (including the interviewee) aren’t aware of what COPD entails; we’re only 
aware of our specific condition... I don’t know if it’s to do with money.  ... with all the 
change around and turnaround that they’re having at the moment, with all the staff 
that they’ve got rid of …So the first week we would have a drawing of the chest and 
the lungs, and how COPD might occur.  And this is what I found very difficult, 
because I really felt that at this point, it would have been much more sensible to have 
a health professional on board… 
 
i) Uncertainty about the future delivery of SM programmes  
Despite these challenges, the experts who delivered SM support programmes in practice felt 
it was important to deliver these programmes to patients with COPD because patients who 
attended and adhered to these programme had gained benefits. However, several experts who 
did not deliver the programmes were unsure/uncertain because they felt a class-room based 
approach may not be the best way to support patients with cognitive issues, it might not 
change beliefs or because patient-based positive outcomes had not translated into cost savings 
for the health services.   
EP11: Really for any patient, it doesn’t matter who you’re delivering for, you see enormous 
benefit.  If they stick out the course, if they stay with the course and attend most of the 
  268  
 
sessions, it really does help them.  It helps them start to realise they can help 
themselves more, and that actually they don’t have to be dependent on everyone else.  
It helps them realise they can do things again, ... also partly accepting their condition 
more; they see people around them with similar problems, so they’re not alone, which 
is an enormous help to them, they find... 
EP10: Yes, and I think also these patients are elderly, they have other medical problems.  We 
know about psychological co-morbidity, we know about cognitive issues, so I don’t 
know how much sitting in a room listening to somebody talking and pointing at a 
board, whether that’s the right way, whether that’s how they want to find out about 
things, whether there are different ways they want to find out about things.  But I 
don’t think we know the answer to that.  
EP15:…Not very powerful effects on real end outcomes that are of importance to health 
systems that were, for example, trying to decide should we offer this programme.  I do 
think absolutely patients love it.  I mean, it’s really fascinating that it doesn’t have a 
stronger effect on some of these medical outcomes that are subjective!  You know, you 
would think, well, if they really like it, then maybe their health status would go up too, 
but it just doesn’t seem to happen….my gut is that it’s just I think the reasons to be in 
the programme are not so much to change outcomes that are going to be of interest to 
doctors and to health systems… the value of the programme is probably in mostly 
non-medical terms.  
 
One expert mentioned that delivering a clinician programme and a SM programme with 
service improvement would be beneficial all-round 
 
(2) Reasons for patient non-participation in COPD SM support programmes 
All experts agreed that participation in SM support programmes by COPD patients was 
indeed a problem. A few experts had mentioned that as a result of poor uptake they knew of 
some centres that had been closed down. Several experts acknowledged that these 
programme would always be unsuitable for some patients owing to their personalities or 
motivations and mentioned that it would be difficult to engage patients to take part or attend 
these programmes who might be unengaged, unmotivated or uninterested in SM.  
The reasons for patient non-participation were expressed at the level of patients; health 
system and organisational factors.  
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(2A) Patient-related factors 
The following patient-related explanations given by the experts for non-participation matched 
those that were given by the patient stakeholders under the theme ‘resignation or denial’ (in 
Chapter V, section 5.6.2.3).  
  
i) Patient characteristics 
Some explanations given for non-participation were that patients’ might find changing 
behaviour difficult, they might not understand why self-care is important for them or they 
might not want or be ready to self-manage or because they have always been told what to do 
or offered solutions instead of being asked to present solutions. In addition, non-participants 
perhaps might not want to make things better for themselves, some might have accepted their 
condition but they do not ask or want to seek help or some just take time to accept their 
condition or perhaps feel judged because of their smoking. In comparison, patients who 
participated in SM support programmes were those who wanted to learn about their condition 
and management, they have accepted their condition and are already engaged with the 
services.  
EP8:...It’s really difficult to change your behaviour, and I think sometimes we come to work 
and we think, why aren’t these people doing what we know is good for them!  And 
then you knock off at 5 o’clock and go and have a bottle of wine, a kebab and, you 
know, loads of unhealthy behaviours!!! ...  We all have things that we just can’t give 
up and we just have to learn that your patients are just the same as you... And if 
somebody has smoked 50 cigarettes a day for 50 years, it’s not going to be easy to 
just stop smoking, because probably that’s the time when they’re really going to need 
a cigarette! 
EP12: I know some people are able to get to that kind of service whatever the obstacles that 
lie before them, they will get help, they’ll ask somebody, they will get there by 
wheelchair, they’ll crawl!...And there are some people who need a lot of 
encouragement and support to avail the services, even if they are able bodied and 
otherwise fit to do so....So that suggests that there are important psychological 
differences between these people. 
EP13: ...As I say, a lot of people just accept it; it’s just I’m a smoker, I’m still 
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 smoking, I’m breathless, I’m coughing, I get infections: that’s probably just normal 
then, you know, I’ll just live on with it.  And that’s really the attitude in the large 
majority of patients;... 
 
ii) Symptomatic nature of COPD and its consequences 
Many experts suggested that patients’ might not want to join a group because of their 
illness/comorbidities and due to psychological or emotional limitations. Specifically, 
patients’ might be fearful of the unknown, they might not want to discuss their illness with 
strangers, they may be depressed or lack confidence to go out if they live alone and in some 
cases the anticipation of attending the programme may make patients anxious or they might 
remember previous anxiety attacks. The symptomatic nature of COPD and its limitations 
might also make patients feel ashamed because they are dependent on others, they might be 
embarrassed e.g. coughing, about using oxygen in public and these limitations might not be 
acknowledged. 
EP2: My main perceptions?  Fear of a group, if they know it’s a group.  Fear of the 
unknown, that it’s not a normal one-to-one encounter, but you step into a different 
role.  Fear of exposing yourself. 
EP1: I mean, I think there’s a number of people who possibly don’t come on these courses 
because they don’t really know and they’re a bit worried, especially if they’ve had a 
condition for a number of years.  They get to a point where they’re a bit worried to 
admit they’ve really no idea what their condition is. ..And they’re worried that if they 
came on a course they might be shown up for that 
EP9: I think it’s the thing with lots of conditions; you get up in the morning, you don’t really 
feel well.  I mean, nobody is happy with living with their condition, but a lot of people 
aren’t comfortable either.  And so you might feel embarrassed about breathing like 
that, because initially it could just be excessive coughing that you’re getting, so 
you’re embarrassed about being in an environment where you’re just continuously 
coughing.   
 
iii) Lack understanding about COPD and the programmes 
The experts’ mentioned that patients’ might not want to participate because they might have 
no understanding of their condition or they might believe they are not going to get better, 
they might not understand how the programme or exercise would be beneficial to them  
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EP3:  Or it’s not for them…like, I think with COPD, there are people that have become a 
victim of it (the condition), quite often....And so it takes quite a lot of work to think 
about ... they’ve already got this self-belief that if they exercise they’ll become puffed, 
so they don’t exercise.   
EP13: Oh, absolutely!  I think that’s a big barrier, if they have poor understanding about 
what have I actually got and why am I breathless, and what slows me down. 
EP6: In I*** we’ve had like eighteen register, ten turn up and three complete, maybe, or 
four complete.  I would say the biggest reason is that people think, well, I’ve got this, 
it’s not going to get any better, so there’s no point in learning anything how to deal 
with it. 
 
iv) Physical or practical barriers related to participation 
Several physical or practical barriers were suggested that could affect patient participation. 
They were: inconvenient times, difficulties getting to the venue, practicalities of carrying 
oxygen to the venue,  comorbidities that could make it difficult for a patient to sit for a couple 
of hours at a time and competing commitments 
EP11: ...A lot of them (patients) struggle with the travelling; actually getting there, the 
journey is just too much, or it’s public transport.  I often think that’s an area that 
would help; we’ve regularly had requests, “Can you help us get there?” and people 
haven’t, so as a result they didn’t go, or they gave up very quickly.... or they haven’t 
got the money to pay for a taxi.  Or they have to organise it themselves. 
EP7: Generally, it’s (a) getting to the venues, and certainly for people with mobility and 
disability issues, you know, car parking is a huge problem.  You know, if they can’t 
park, even if there’s free car-parking, and sometimes there’s not, if there’s no car 
parking spaces right by the venue, you know, to ask people to walk round the other 
side of the building, that’s going to put people off.  
 
The patient-related factors mentioned here for patient non-participation match the reasons 
that were suggested by the patient stakeholders.  
  
v) Gender differences 
Gender differences were also explored and according to some experts there was not much 
variation in attendance amongst men and women except that men perhaps might not consider 
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participation because they are not joiners like women – a natural social difference or perhaps 
men might feel that being men they are not supposed to ask for help even though they might 
find it hard to adjust to their illness 
EP12: Well, men aren’t joiners in the way that women are.  Men are less social than women.  
Men are less likely to make casual conversation, they’re less good at gossiping, 
they’re less good at sharing than women.  There’s not a tradition of chat and gossip 
between men, it’s not so good, not so old as it is between women, although that’s 
changing.  So there’s probably a natural social difference, which is learnt probably. 
EP8: And I think loss is a big thing; so people not being able to do what they used to do, or 
cope how they used to do.  So a lot of men who were maybe dockers or manual 
workers who have always coped with things by going to work or by going to the pub, 
or going out with their mates, by smoking, and suddenly because of their physical 
limitations, they can’t cope in any of those ways.  So they just feel a whole sense of 
uselessness, a loss of role, and depression, inability to adjust to the illness...And men 
as well; I think sometimes men are sometimes a bit reluctant to go to the groups. 
 
(2B) Health system-related factors 
Various health system factors were suggested that might affect patient participation and they 
included the following: 
 
i) Lack of integration of SM in routine care  
Some experts, who had delivered SM programmes previously, mentioned that problems in 
patient participation or recruitment had occurred because they lacked the support of 
participating primary care trusts and/or GPs despite the SM programme being commissioned 
by them. They explained SM or SM programmes might not have been a priority for health 
professionals possibly because of time constraints, not being involved in the programmes or 
about patient progress or the lack of integration of SM in primary care   
EP14: It (recruitment) is a lot of work, and in fact what we’ve done because we’re 
concentrating on the practices, part of the work that they have to do is they have to do 
the telephone calls; you know, that’s their responsibility...We generate the letters and 
send them out, but the telephone contact has to come from the general practice, 
because we don’t have the facilities to do that.... 
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EP5:  ...The simplest way to put that is a lot of programmes are run off-centre from core 
health services and what have you, they’re not really linked into the care pathway, 
they’re not really linked on what the clinician is doing and so forth, so therefore 
recruitment to them (the programmes) is problematic…  
 
ii) Lack of understanding about SM and programmes among health professionals 
Health professionals’ might not understand the role of SM or SM programmes which might 
make it difficult for them to embed SM in practice or the insufficient evidence of benefit for 
SM might make them reluctant to change their practice including referral to the programmes.  
EP1: … perhaps we don’t spend a lot of time helping other people (clinicians) understand 
it.  Because I know when I was training up, a nurse specialist facilitated the self-
management programmes we ran, ... we… thought of as self-management, and what 
the health care professionals we were training thought of as self-management, were 
quite different…(on further probing)…Because I still think that when I talk about self-
management, I talk about, you know, an approach which is very facilitatory, getting 
patients to be solving problems themselves. Whereas I think the health care 
professionals were talking about it, but still taking a very didactic approach. 
EP16: I think they (GP) didn’t understand it. …and they hated the term ‘expert patient’ – 
that was an absolute anathema to a lot of people, patients and clinicians…I think they 
had this sort of vision that someone out there was doing things and telling things to 
their patients that weren’t safe, that they weren’t in control of them, that they didn’t 
know about.   
EP2: ...I think from my experience it has to do a lot with the culture of the practice; whether 
you’ve got a more traditional paternalistic model, whether you’ve got a more bio 
psycho-social model, which embraces all this and in some practices,  you will have a 
lot of referrals for self-management; in others, none.   
   
iii) Inefficient health system  
Inefficient workings of the health system were also suggested to affect patient participation in 
SM support programmes. They were: primary care staff might lack training to provide 
information about the programmes, lack of communication or sharing of information about 
patient care between primary and secondary care and administrative problems such as 
referrals getting lost or not reaching patients. 
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EP10:  Well, it’s just the system, isn’t it, because they still don’t talk to each other, you 
know?  GP records and hospital electronic records don’t mesh. ...There are people 
working in silos and nobody knows what everyone else is doing!  I think it’s just a 
vastly complex, inefficient lumbering system.  Simply just getting us all to talk 
together and share information effectively is hugely challenging! ...But that is 
changing; you know, social care is now coming into the mix.   
EP4: …So quite often the (PR) referral goes off and they (patients) don’t really know 
anything about it.  A lot of people we ring up and say, “Would you like an              
assessment?” they haven’t got a clue that a referral has even gone off!... we have 
been into GP practices and done lots of education sessions about what our service 
entails...But whether it’s just that the GPs are always changing, there’s locums and 
everything going through, so maybe we don’t always maybe catch everybody... 
 
iv) Right patients might not be recruited 
Some experts mentioned that in previous SM programmes the appropriate patients may have 
not been targeted which could have affected patient participation. For example, targeting 
patients with no understanding about their condition, not asking patients if they would find 
the programme useful and research studies might have used too wide or a narrow inclusion 
criteria.  
EP1: And kind of applying a general everyone is offered this, that might be why we’re 
coming up with some problems.  
EP8:  barrier Yeah.  I think it (COPD) is a really poorly understood condition...And I think 
something really telling happened the other day when I was in a patient’s house and 
she (partner of COPD patient) said, “Yeah, he didn’t tell anybody that he’s HI ... 
COPD!”  And I said, “Were you going to say HIV?”  And she said, “Yeah!”  So to 
her it was just another illness with letters...And it’s really because this man has never 
told anyone that he’s got COPD, and he’s someone that we’re trying to get into group 
programmes, but for him it’s so shaming, that he said that he has asthma... 
 
(2C) Off-putting programme organisational factors 
Several programme organisational issues were mentioned that might have been off-putting to 
patients thus affecting patient participation. They included: place of patient assessment being 
different to the programme venue, programme staff who were unable to explain the service 
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over the telephone, the person who invited patient to the programme not being present at the 
programme, patients who might get tired or might not be able to concentrate for three hours 
and absence of a rolling programme. 
EP4: ...we have our assessments in a different place to where we run the 
programmes....Which often patients find it difficult to get to.  It’s in a hospital setting 
so maybe that puts some of them off...and sometimes they’ve only had a phone call 
from us, and then a letter with some questionnaires, to come along.  So, it’s quite 
difficult to explain the service and why it might be helpful on the phone. 
EP6: And I think with a lot of courses, you can get the contract manager to phone and say 
something, but people will then warm to that person over the phone.  And then they’ll 
say, “So are you going to be there?” and then you have go, “No, actually, sorry, I’m 
not!  I’m going to be sat in behind the desk or ...!”  You know?...And then people go, 
“Oh, well, I’m not coming then.”  
 
(3) Reasons for patient dropout  
(3A) Patient-related factors 
The following patient dropout reasons were suggested by several experts: patients’ might 
have lacked understanding about the programme, they had unmet expectations (e.g. not cured 
or treated or no health improvements seen following attendance at one or two sessions), or 
patients’ lacked understanding that the programme was about SM for the long-term or lacked 
perceived benefits. Other reasons included suffering acute exacerbations or not ill enough; 
and the group dynamic not working e.g. younger or less ill patients could not relate to 
patients who were older or more severe 
EP6: … a lot of people get completely the wrong end of the stick, don’t read the literature 
and what it’s saying, they think they’re going to get a cure by going to this!...You 
know, and then when they come on the first week they realise that actually, no, it’s not 
for them...they don’t really understand the self-management aspect of it.  They think 
that someone’s (doctor is) going to come and it will be a lot more medical than it is.  
EP11: And also it’s introducing things specific to a person’s condition; so with COPD, 
there’s a lot of specific COPD things.  You do find with quite a lot of people coming 
on the courses, they think they’re coming on something to help their specific 
condition, and that’s one of the reasons some people leave, because they see it and 
think, well, this is nothing to do with my condition, so they leave..... And reality is, it is 
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going to help you, it’s just that you have in your mind that you need something 
specific to that. 
EP13: ...Their condition is very variable, so they have exacerbations and drop-out, so 
there’s not the stability you might have with other chronic conditions, you know? 
EP9: ... I had one particular gentleman, who was on the angry course; he was living with 
COPD and he was really worried about his condition because he was saying, “I don’t 
know who to talk to.  I’ve got this, I’ve got that. Blah, blah, blah!”  And he was really 
enjoying the first week that we had delivered, but because of this psychologist 
(another attendee) who wouldn’t stop talking and asking questions …During the 
programme he walked out… 
 
A few experts also suggested that prior commitments such as hospital appointments for other 
comorbidities, holiday plans; problem related to transport or the lack of support from others 
to help patient to get to the programme  
(3B) Organisational factors 
Some experts cited the following organisational factors that could have led patients to drop 
out of the SM programme: the first session of the programme might have been uncomfortable 
for patients because there is a lot to take in, the set-up of the programme seemed to be like 
alcoholics anonymous, classroom-based, poor facilitation skills or the ‘living wills’ section of 
the programme might have been upsetting for patients.  
EP11:  It’s quite hard that first session in that it’s a lot of talking, and whether that’s off-
putting or not, I don’t know...I’m not sure how much they take in as they’re talking 
because it’s heavy stuff like, this is what you’ve got to do in self-management.   
 EP7: Yeah.  And then there’s all the other issues around sometimes the way the course is 
delivered.  If they get a sense that the tutors are ... often this is a common criticism 
and sometimes it’s a reason for dropping out, that tutors are reading from the 
manuals.  And, “We’ve got our own course book.  What’s the point of me going along 
to the course and listening to someone read from that; I could have read it myself!”  
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(4) Suggestions proposed to improve patient participation and retention in SM 
support programmes 
Several improvements were cited for the health system and organisational aspects of the SM 
programme to improve patient participation and improvements to the organisational aspects 
of the SM programme were suggested to improve patient retention.  
(4A) Health system improvements 
i) Identify the right patients and offer the right programme 
Some experts proposed targeting a type of patient such as, symptomatic patients, patients 
with mild, moderate and severe COPD, recently diagnosed patients and younger patients in 
their forties for group-based PR/SM programmes; programmes should be targeted at the right 
time for patients; and use of the patient activation measure (PAM) to ensure consistency 
among professionals to identify the type of support the patient may need.  
EP12: ...if you’re not symptomatic, then it’s not an issue and you probably shouldn’t be 
getting it at the moment, apart from smoking cessation.  
EP9: ... I was just thinking, it is so important to catch them at that right time and... if their 
mindset is that I’m being looked after because I’ve been given X amount of 
medication and that’s how it’s going to have to be, you can’t force them to do 
something they don’t want to do. 
EP6: It (PAM) should be used ... And then if they’re (patients’ are) saying, if they’re very 
confident that they can manage everything ... at the end of it, then just turn round and 
say, “Well, do you know what, I really don’t think that you’ll benefit from attending 
this course.  ...And then to them other people you can say, “Well, judging on the fact 
that you’ve said you’re not confident with that, I think that it would be a really good 
idea for you to come along.” ...And number one, I think it makes it more personal to 
the person; they’re not just turning up having not spoken to anybody...Because I think 
people have to feel very safe in that environment. 
 
ii) Identify from patients what they value  
Following identification of the right patients, many experts mentioned that it might be useful 
to learn where patients were in their illness journey regarding self-management of their 
condition or to participate in SM support programmes however, this might require from 
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professionals communication, discussion and building relationships with the patient to offer 
them interventions suitable to their needs and wants.  
EP8: What you need to do is maybe take a step back and try, first of all, to just build up a 
relationship with that person... it takes more time, but we’re asking people 
(professionals) to be really curious about what that person’s experience of COPD is 
and how it’s affected them.  And then to work with them on seeing what their options 
are...So you’re not just forcing people with our model of what helps, you’re actually 
thinking with them about what do you want in your life, what do you value and what 
do you want to be able to do with COPD, and how can we get you there?....  try and 
understand a bit about why people aren’t doing what we tell them what to do. .. I 
think people don’t do things if you tell them to do it.  We have to present them with 
options and choices, and say, “What do you want to do?” ...“This is what’s available.  
These might be the benefits, these might be the drawbacks.”...“And it’s up to you.”  
And if people hear themselves say it, then they’re more likely to do that. 
EP13: So, I guess if you look at it that way, I think you have to tune into the patient and what 
the patient is really ready for.  That’s where the clinician’s role actually is, you know, 
to get that feel, and it’s about listening to the patient and recognising what their needs 
are, where they are on their journey really.  And then maybe offering ... well, hearing 
what the patients actually want and then having things on offer that are there for 
them, that will just fit, you know?  So it’s not just one thing; I don’t think it’s just one 
course, you know, is the answer. 
 
iii) ‘Pre-work’/ ‘Intermediate step’ to support needs of patients  
Some experts felt that some ‘pre-work’ was needed or an intermediate step was necessary to 
support patients prior to their attendance in SM support programmes so they might consider 
participation. The work could involve: provision of information about the illness, support 
with accepting their condition, making people aware of SM and encouraging patients to 
consider SM and participating in the programmes by relaying the benefits of the programmes 
preferably, in places accessible to patient or within their social environment such as GP 
surgeries, in the community, libraries, place of work, holding an open day comprising of 
health professionals and lay professionals. The following persons were suggested for this 
role, health professionals, people who deliver SM support programmes or previous 
programme attendees.  
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EP2: I often wonder whether a kind of intermediate step is needed, and in our practice we 
now have something for pain and whatever you want to call it medically, I’ll explain 
the symptoms, something in-between where you can have a conversation about what 
is likely to go next before you go on a tailored programme which has some 
prescriptive elements, like COPD, ...And so far the experiences we have are good in 
two aspects: (a) for the practice network to know, and (b) for the patients.  So I think 
it’s not just something which affects the patients, it’s something where the team has to 
be involved as well... 
EP1: … I don’t know whether it’s worth having just some very accessible sort of sessions, 
whether that’s in GPs’ surgeries, where, you know, sort of doing a “what is self-
management?” type of thing. ..for patients. ... a sort of introductory thing running 
however often in GPs surgeries or ...  I mean, you could even do information leaflets, 
...Whether you could do something pre to get people thinking about it (SM), to 
address those things, fears and worries, and expectations and get those more 
appropriate (for programmes).  And then from that, getting people thinking, actually, 
that might work for me. ...Yeah.  So, you know, “Come and find out about free new 
treatment!  Ten minute talk,” or whatever... 
In line with the above, one expert, from their experience, mentioned that providing individual 
support to patients in their homes initially proved successful as it had led some patients to 
come out and attend group-based PR sessions. 
 
iv) Need enthusiastic referrers 
Several experts mentioned various personnel such as GP, nurse, physiotherapist, respiratory 
personnel in COPD clinics, SM tutors or those who were well known and in touch the most 
with patients as suitable to refer patients. Self-referrals were also suggested. However, there 
was some inconsistency among the experts about allowing self-referrals e.g. they may already 
self-managing well or GPs might not refer patients because they might not be interested or 
believe in the treatment enough to refer patients.  
EP3: Well, if it’s referrals then I would say the best people to refer are pulmonary rehab 
and physios to be perfectly honest. ...And for people to self-refer because you’ve got 
in to them to think that they would benefit.   
EP12:  (For a) service (in practice)...I think you need to have enthusiastic referrers. ...So the 
referrers would have to be clinicians, and the practice nurses ... the practice nurses 
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get better attendance rates than GPs...practice nurses who refer patients probably 
have more belief and more interest in COPD, and more belief in the treatment.  ... so I 
think that that might be to do with relationship that the person has, and to do with 
their conviction... 
EP2:  ...I think it would be for these programmes better if only the people who want to, sign 
up for it. ...But it’s an opt-in issue, where people make the first step, instead of being 
passive recipients of a pathway where the system decides something for them… I 
don’t think I have to do outreach for everybody that they really get access, because 
our resources are not endless. 
 
v) Training and support for professionals to support patients 
In order to facilitate the above suggestions about improving participation a few experts 
proposed training for health professionals including lay members such as health trainers or 
health champions; promotion of programme benefits from evidence; and integration of SM 
programmes into routine care to help professionals become aware of the programmes and to 
encourage self-care among their patients based on their action plans that were set up at the 
programme.  
Working with the negative mindset of patients was considered to be a challenge for delivery 
and lack of evidence of benefit of SM programmes was identified as problematic for the 
future delivery of the programmes (see section 6.6.2.1 (1)). So, the promotion of the 
programme benefits from the evidence base mentioned here might help professionals to be 
more accepting of SM for their patients. In addition, arrangements for training and support 
for professionals to work with patients prior to them attending the programmes might also be 
helpful to staff who deliver these programmes as it might make it easier for them to work 
with patients who already had a better understanding about their condition and the 
programmes  
EP5: ...Whereas if they (SM programmes) were fully integrated into the care pathway, so 
that your specialist nurses and things were fully aware of who is more suitable to 
attend, what sort of profile patient, what circumstances, what they need to say to the 
patient around why they think the course would fit, then we see recruitment issues 
beginning to disappear... 
EP12: So it’s complicated. ..I think the more that we encourage GPs to listen and understand 
their patients, and to consider the role of self-management then the more likely you 
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are to achieve control of chronic diseases.  That’s a theoretical position, but that’s 
what I think we should do.  It’s likely to be the case with some diseases on the whole.  
So what should you do?  I think you need to be really clear about where the evidence 
is about self-management; what is it about self-management that works?  What can 
you say to GPs, that this bit works? 
EP4: ...And quite often sometimes it’s the practice nurses that do the referrals, in which 
case I think maybe they could come to understand it (PR service) a little bit better 
maybe. 
 
vi) Improvements to logistics of patient invite to the programme 
Alongside, some experts suggested that a personal approach e.g. face-to-face or by phone or a 
DVD would be beneficial when inviting patients to the programme and that the invitation 
needs to be pitched at the right level of the patient e.g. an anxious patient might need more 
support and would need to feel at ease before they can consider participation; in addition, the 
process of invitation needs to be efficient. Furthermore, it might be useful to identify and 
discuss patient expectations, logistical or practical difficulties and discuss what benefits they 
expect to gain from attendance e.g. increase in confidence, improvement in coping skills. 
There was some inconsistency about allowing patients to bring carers to the programme.  
EP14: No.  A letter is good, but when you send the letter, you need to follow it up with a 
telephone call, because if you get a letter out of the blue and you haven’t a clue what 
people are talking about, then there’s no point....if the practice nurses have given 
information out, then that’s the time when people’s minds are open; they kind of know 
it’s coming.  That’s the time to put it in writing, and that’s the time to do a telephone 
call.  If you can do all three, then you have a better attendance.  We’ve found 
whatever we invite patients to, if you phone them, they will respond better.  Every 
single patient, out of the 21 patients who were coming yesterday (to the SM 
programme), had a telephone call on Tuesday and still we ended up with 13 patients 
yesterday. 
EP7: I think ...So this is where the course needs to be not in isolation; it’s linked up to all 
health and social care...That somehow, how do we get that person supported?  Is it 
they come with their carers? ...Is it somebody, part of the delivery team?  ... 
EP1:  You get two lines of argument, don’t you?  Some people will say, “Oh, I found it 
quite motivating ...!” ...Yeah, and other people will say, “That was scary!”  So, I 
  282  
 
think probably maybe some effort needs to be put in right at the beginning of the 
course, when you’re explaining what the course is and what the expectations are, all 
these difficult issues addressing them head-on, where they’re at, you know? ...I think 
the introductory, setting things up, is worth investment. 
 
(4B) Programme organisational improvements 
i) Improvements to organisational aspects of the SM programme to improve participation 
Several experts gave suggestions to improve the structure of the programme such as the 
programme needs to be flexible - a menu for patients to choose from, e.g. choice of 
programme, location, day, times; the journey to the programme needs to be convenient and 
patients need to feel comfortable in the venue; the duration of the sessions should ensure that 
a patient can concentrate and remain stimulated on a two day course.  
EP12: Yeah.  It (three hours) is a long time.  It is a long time to be talking about these things.  
You probably need to do it in smaller doses, I suppose.  The risk is if you have three 
hours then people will not come back, if they’re not engaged, and if their imagination 
is not stimulated all the time, the risk is that they will not come back 
EP11: So trying to have those courses local to that particular where you’ve done your 
mailing is quite important.  So if you pick a couple of GPs surgeries and do a mailing 
from them, you really want that course to be held locally....I never had a problem with 
the courses actually being held at the GPs surgeries, I think that’s a good idea.  What 
you tend to find then is the patients assume it’s coming from their GP, it’s endorsed 
by their GP and it’s just around the corner, and it’s almost like they’re happy to do 
that.  
Two other experts mentioned that perhaps there should not be any compulsion for patients to 
attend all sessions of a one-off structured SM programme; instead, the programme could 
adopt an informal approach whereby patients could attend sessions of interest to them.  
 
Having a group with mixed severities was mostly a unanimous response amongst the 
participants.  
 
ii) Improvements to the organisational aspects of the programme to improve retention 
Suggestions given to improve patient retention in SM programmes were aimed at the 
organisational aspects of the programme and they included: more training and practice for 
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facilitations skills, involvement of HCPs in the programme e.g. to instil confidence in 
patients, and to show the working together of lay tutors and health professionals. Supporting 
patients with their psychological and emotional limitations by appropriately trained staff was 
highlighted as important.  
EP11: ...The one area I think they (EPP) could do with more help on is how you talk, 
because they (EPP) say they’re not expecting you to be great speakers, which is fine, 
but they talk about paraphrasing the material; the reality is what a lot of the tutors do 
when they go away from the training weekend, they will actually read it out.  And if 
you just read out your text, it is very monotone; it sounds bad, and that, I understand 
from the feedback, is a very negative point on the courses  ....And I really think they 
could do with helping, give the tutors some form of technique to actually put it across 
better, without sounding like they’re reading it out... So I think that’s one thing that 
lets down the course.  .. 
EP1: Yes, (corrects herself) one on stress and one on anxiety and depression (talks given to 
patients in PR).  ..They (patients) liked the ... recognition that emotions were involved 
in dealing with their illness and the validation of that.  It’s (COPD is) quite a difficult 
one to manage though because, with all honesty, if you’re trying to explain the link 
between emotions and symptoms, you have to be careful that patients don’t take away 
the message that what you’re saying is that, in any sense, their symptoms are unreal 
or psychosomatic...Which people do get worried about as soon as you start making 
that link, so you have to be sure whoever is facilitating manages it in a way where 
people don’t take away that message... 
EP4:  So I wonder whether sometimes maybe a fully trained health care professional is 
important because maybe that inspires a bit more confidence in what’s being taught.  
But I definitely think the fact that some of these trainers have COPD is a positive 
thing, because then these people must surely think, well, they know exactly what I’m 
going through. 
EP7: I went to see, at the local (hospital) the respiratory, COPD (team) and they were very 
interested in what the IAPT (staff) can provide because they’re saying that they get 
lots of patients...(and) ...“Oh, we don’t know what to do with them.  We’re not 
trained, and we can sense that some people are incredibly anxious and depressed, 
and we’ve got nowhere to send them, other than go and see your GP.” ……Maybe 
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they’d (IAPT staff would) come in and do a session just on anxiety and 
depression...Depression linked to COPD. 
 
 
Suggestions for the content of the SM programme were also made such as, add an exercise 
component to help patients put their set goals into practice in a more guided way as this will 
increase confidence and reinforce learning; the topic on ‘end of life’, ‘living wills’ or 
‘advanced directive’ might not be well placed in the programme and could be handled at the 
discretion of patients’ preference; the section on ‘Depression and COPD’ was considered 
important and the section ‘What is COPD?’ should be discussed with a patient preferably 
prior to them attending the programme. Retention may improve if patients’ are reassured that 
things important to them will be covered.  
EP12: And these are all elderly people so their attention may well be limited.  I would think 
that what you need to do in something like this is to make sure that exercise is part of 
it...Because I think the exercise itself is what’s going to make them feel better.  So if 
we get the association of feeling better with the learning, then the learning is going to 
be reinforced. ...Exercise is useful when anyone is symptomatic...  
EP6: ... I have a big, big question mark about living wills.  ... but I think that (living wills) 
should perhaps be an add-on for people....And you can say to people, “If you would 
like to talk about future plans for your healthcare,” which is what it is – living wills 
and that, then I think perhaps you should you should just say, “We’re able to do an 
add-on session for 25 minutes (or whatever it is) if you’re interested.  But I’d like to 
only deliver it to people really interested in it, because I realise that at this point in 
your treatment, you might not be ready to talk about that kind of thing.” 
EP3: ....And that is good (What is COPD?)....Yeah, because people really don’t know.  And 
you see, I think they should have learnt that elsewhere!...And also people aren’t able 
to listen to that.  ....  And I always feel like you should just have a little kind of cup of 
tea place at the end, where you can sit down, have a cup of tea and then you can 
actually say to someone, “Well, what does this really mean?”...Or, “Can I come back 
in a week’s time to talk about what this really means to me?”  
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Need for further evaluation  
Some experts mentioned that not a lot was known on this research topic and hence there was 
need for further evaluation. Some others expressed the view that improving participation 
would be a steady process as it would need a cultural shift among patients and health 
professionals - and the working together of various health sectors. Some evaluations were 
underway or were being planned on this topic e.g. having a SM prompt to remind health 
professionals to offer or refer patients to the programme, using previous PR attendees to 
recruit referred patients to PR, getting patients to interact with their referrals, and training for 
health professionals. Certain organisational features were also being addressed e.g. changing 
the current letters that were being sent to patients about the PR service, and introducing a 
taster session prior to the programme 
EP13: ... In my mind, it’s not going to be easy, there’s not a quick answer.  I think it will be a 
steady process of, well, in a way that’s how you do things and how you deliver the 
service.  I think that’s part of that changing of culture process, which applies to not 
just clinicians in the service, but of course the service users as well.  … We always, in 
the service want it all sorted by tomorrow or today; sorry, but that’s totally 
unrealistic, especially if we’re talking about long term processes, very ingrained 
processes and attitudes and beliefs!  ....That’s the problem of course, politically you 
want quick solutions. 
EP2: It’s (SM is) an interesting area (in response to what else can help improve uptake in 
SM programmes) … And what are the problems with that approach with a one-off 
educational intervention, versus a longitudinal relationship. ...And also group 
dynamics; how do you maintain a continuous involvement?  If you involve lay tutors 
in the community, it rests often on individual people to run a group; they’ll move, they 
change so it’s a very fluctuating landscape you’re interacting with. And a lot of 
emails to write and phone calls to have people to speak to...Relationships to build. 
EP15: we’re trying to get a larger grant funded to look at teaching physicians to support 
patient self-efficacy. …You know, ways to improve their confidence that they can 
actually do it and picking a goal that’s realistic.  So it’s really borrowed heavily from 
this (SM), but again, I don’t think it’s meant to be replacing this type of thing, but to 
try to bring the physician into the picture.  So again, if you did have a combined 
programme then the doc would be sort of speaking the same language that the lay 
preachers are.  
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(5) Supporting patients with their SM in a non-group setting   
On exploration, whether a group-based SM programme might be tailored and delivered in an 
individual setting or how else patients with COPD (with emotional/psychological limitations, 
socially isolated, difficult to access including the housebound) could be supported with their 
SM, the responses on this topic were inconsistent. Some experts mentioned there was need 
for more evaluation and some others stated that delivering a programme at home might not be 
feasible because it would mean increased cost, more resource intensive and would take time.  
 
i) Use existing health and social care teams trained in SM support skills to provide initial 
support  
The integration of SM into the health and social care services was offered as a sustainable 
solution by some experts for patients with COPD in general including those who might be 
anxious or fearful, socially isolated, depressed or recently diagnosed, housebound patients 
and even those not ready to change behaviour. Experts’ suggested the use of existing health 
and social care teams involved in caring for a COPD patients to build relationships with 
patients through the provision of SM support skills and this might include visiting patients at 
home initially until patients felt ready to participate in group-based programmes. The use of 
health trainers or health champions was also suggested as a useful resource to support 
patients.   
EP16: I think to focus on nurses, actually.  In primary care, you definitely need validation 
from the GPs that this (SM) is a good thing and it’s worth spending time on.  So it 
won’t work where there’s a culture within the practice where the GPs just think that 
self-management is a load of rubbish, and there are practices like that.  So you need 
that sort of validation that they will support the nursing team and give them the time 
and space to do those sort of more complex consultations…All nurses have to do … 
several training courses during the year to … keep up dated, so the system is there to 
allow that, you’ve just got to make sure the (training) courses are there for them to go 
to. 
EP2: My first idea would be (for anxious people or those who fear groups) a friendly, 
sociable person, who knows about the subject, who builds an individual relationship 
first, visits people at home and so builds a relationship, and then brings them 
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together....And that’s probably easier than also to run the group, just to have different 
relationships to reconcile and to tailor what the group needs. (On further probing) 
EP6: …Well, in an ideal world, … as well as a GPs.  … what I’d like to do is go into a 
COPD clinic within a hospital when people are first diagnosed, or whatever, and 
have a kind of little drop-in table thing there... the consultant sees the person, breaks 
the news to them, but then sends them straight to your table, to say, “OK, go and talk 
to so and so who is sitting out in the waiting room, because they’ll be able to tell you 
ways that you can cope with this a lot better, because I understand that it’s a big thing 
to deal with straight away.”...I think that’s what’s missing in all of that, and I think 
that’s the way to get people interested… 
EP1:  ...Or, you see, I’ve often thought that you’d benefit from a stepped interventional 
model (in response to patients not ready)...What I mean by that is … you’ve got some 
people who would benefit from just the information and that will be enough.  Then 
you’ve got some people which you’d then have a one to one session, and you figure 
out what their beliefs are and then from that (I mean, I’m talking idealistically here, 
obviously!) work on those cognitions to help them be ready for self-management, or 
maybe if they’re ready for a group programme.  So you’re not just saying everybody 
has to, at this point, be ready for this approach; you’re actually seeing the individuals 
as different…Now whether the GP does that, or...there’s COPD clinics where they’re 
seen by the nurses and they make some assessment... 
EP14: A lot of the housebound have to have help to build their confidence because a lot of 
them have become very isolated.   …  They do not believe that they can do things. 
…and if you can encourage them and show them a tiny thing that they can achieve, 
that will inevitably help them onto the next stage... ...So you really need to use the 
teams that are familiar to them (housebound patients)... we have also worked with 
social work carers.... 
 
However, a few experts pointed out that one needs to accept that some patients may not be 
ready to change their behaviour and just reminding patients from time to time about the 
importance of SM would have to suffice.   
EP2: You can’t (change people who are not ready to take responsibility or are scared to 
make a change)....If it would be so easy to change people’s attitudes or lifestyle, then 
we wouldn’t be at the price where we are...Probably accepting that there are people 
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who simply you don’t reach and it’s not made for them....And reminding them from 
time to time, and probably having a less evangelical zeal to get everybody. 
 
Educating family members who are carers was also suggested as another area to explore to 
support housebound patients.  
 
Apart from one participant who because of cost considerations, suggested the evaluation of 
technology such as the internet to provide SM support, several other experts mentioned that 
technology such as internet, DVD or telehealth on its own might not be the best way to 
support COPD patients who were housebound because of the assumption that these patients’ 
lacked internet skills, were not interested or there was a perceived lack of evidence of benefit.  
EP3:  Well, one way (for housebound people) would be to do it internet wise.....But I 
wouldn’t do it on the internet, because I think in (name of area) you’re not going to 
have many people that use it… 
EP1:  And then you’ve got whether you do it via face to face, through workbook, like the 
heart manual, through the internet, which I suspect wouldn’t be very appropriate with 
this group. ...Or a telephone.  You know, my thoughts are that I’m not sure you can 
cover things in quite the same way by telephone. ..That probably works quite well for 
disease management, what you’re talking about ... where there’s a nurse coming in, 
but I’m not sure self-management would work...From all the different options, I think 
you can probably rule out internet and telephone.  I’m not sure about the manual type 
of thing. 
EP16: …I mean the big hope for that (tele-health) is that it’s going to make people much 
more aware of self-management and much more sort of connected in.  … you’re never 
quite sure how people actually think about it in their own home.  Because I think if 
people are linked into it, they think they’re being much more closely monitored than 
they actually are, so there’s that aspect of it.  A lot of people don’t like it because they 
don’t want to be closely monitored because they don’t think they’re ill enough…and if 
they’re told they need it, it makes them feel terrible because everybody wants to think 
that they’re well and managing, everybody does.  And to be told that we now think 
that you need this tele-monitoring, basically they feel it’s awful! 
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In contrast, one expert felt the use of DVD, phone or tele-health would be a useful way to 
support COPD patients.  
EP5:  DVD, work book based, something they could work through…And then of course 
you’ve got telehealth and telemedicine as well, so direct feedback into the home and 
internet in the home and that sort of thing. 
 
6.7 Discussion 
6.7.1 Summary findings 
This study is the first to provide an insight from an expert sample (both HCPs and lay 
experts) of sufficient size to result in data saturation about: reasons for non-participation and 
dropping out of COPD SM support programmes by COPD patients; how participation and 
retention might be improved in these programmes; and how might, patients who do not or 
cannot participate in these group-based programmes, be supported with their SM. However, 
need for further research on this topic was called for by several experts as they felt there was 
yet a lot to learn on this research topic.  
 
Nonetheless, identification of the level of engagement in SM among the experts helped to 
identify that currently patients with COPD might be able to access SM support only from SM 
programmes. There was uncertainty about the delivery of SM programmes in the future either 
because of lack of evidence of benefit or this type of programme was perceived as not being 
the best way to support patients with their SM. Currently, COPD SM programmes are not 
being delivered in practice unless they are commissioned although, PR programmes are still 
very much one of the mainstay treatments for patients with COPD. So, the study findings 
might prove useful to those considering delivery of group-based SM support programmes for 
patients with COPD and want to improve patient participation.  
 
(1) Factors that might lead to patient non-participation and dropout 
Patient non-participation in SM support programmes might be composed of patient, health 
system and programme organisational factors and poor retention in the programmes might 
also be affected by patient factors and programme organisational factors (Figure 6.1).  
Specifically, the patient-related factors that could affect patient participation included: 
patients having accepted their condition but patients might not want to seek help, patients 
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might have not accepted the condition or might take a long time to accept the condition, 
patients might not want or might not be ready to self-manage/change behaviour; the 
symptomatic nature along with psychological and emotional consequences might lead 
patients to lose confidence to go out of the house particularly, among those who live alone or 
patients might be reluctant to try anything outside of their usual care; patients might lack 
understanding about COPD and the programmes including the belief that nothing more can 
be done. Some practical and physical barriers related to participation were also suggested.  
Health system factors that might affect participation included: the lack of support from 
primary care due to SM support programmes either not being a priority or the lack of 
integration of SM into the COPD patient care pathway; HCPs might lack understanding about 
the role of SM or the programmes, the lack of evidence of benefit for SM programmes might 
make professionals reluctant to support the programmes thus affecting patient referral; 
inefficient workings of the health system including not recruiting the appropriate patients for 
the programmes.  
Some programme organisational factors were suggested to affect participation such as, the 
venues for the PR assessment and the programme were not at the same, programme staff 
were not able to explain the purpose of the programme to patients over the telephone 
(insufficient information about the programme was reported by patient stakeholders), a three 
hour duration might not be feasible for patients who might not be able to concentrate for long 
and absence of a rolling programme. 
 
Some patients might have dropped out of SM support programmes because of the following: 
unmet expectations or perhaps they lacked understanding about the purpose of the 
programme, instability of the condition and conversely not perceiving the illness as severe, 
the group dynamic did not work and physical and practical barriers including the lack of 
support to get patients to the programme venue.  
Specific to the SM programme the dropout reasons included: the scripted first session of the 
programme or the classroom-setting might have felt inappropriate, inadequate facilitation 
skills and the ‘living wills’ section of the programme might have made some patients 
uncomfortable.  
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(2) Facilitators to improve patient participation and retention 
The need for further research and evaluation on this topic had been suggested by some of the 
experts. However improvements had been suggested for the health system and programme 
organisational aspects to help improve patient participation and for the organisational aspects 
of the programme to help improve patient retention. 
The proposed health system improvements were: to identify the right patients e.g. at 
diagnosis or by using the PAM for the appropriate intervention; to identify from the patients 
what they want and value through building relationships and if they are ready for SM or 
participation in the programmes; the latter stage might require carrying out some ‘pre-work’ 
prior to patient attendance in the programme e.g. provision of support to help patient accept 
illness, information about the illness, promotion of the programme benefits; to use 
enthusiastic (health and non-health) personnel to refer patients to the programme; and the  
patient invitation and provision of information about the programme would need to be 
pitched at the right level for the patient including identification of patient expectations from 
the programme, and any practical or logistical difficulties related to participation. To support 
these health system improvements several experts had suggested provision of training and 
support for health professionals alongside promotion of the benefits of SM programmes from 
evidence and integration of SM into the care pathway.   
Specific organisational improvements had been suggested for improving participation and 
they were: offer flexibility e.g. a menu of several programmes at various times and locations, 
ensure a convenient journey, a comfortable venue and the programme session should ensure 
patients remain engaged or stimulated. A different option, to delivery of the structured 
programme, was having SM workshops to allow patients to choose the session of interest to 
them and this could result in patients begin to take control of their condition.  
 
The improvements suggested for the SM programme organisational aspects to improve 
patient retention were: more practice for tutors to improve their facilitation skills, 
involvement of HCPs in delivery of the programmes and learning about SM support skills 
and/or psychological skills so professionals could support patients with 
emotional/psychological limitations was perceived as important. The content of the 
programme might benefit from inclusion of exercise, the ‘‘living wills’ section might not be 
appropriate, the section on ‘depression’ should remain and the content ‘what is COPD?’ 
should be covered with patients prior to them attending the programme.  
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Similar to the topic of improving participation, the issue of alternative ways to support 
patients with their SM in a non-group setting was also recognised as needing further 
evaluation. The delivery of the SM programme at an individual level was seen as being 
resource intensive and not cost-effective. However, a solution was proposed, for reaching and 
supporting patients (with emotional/psychological limitations, socially isolated, difficult to 
access including the housebound) and that was integration of SM into the care pathway with 
provision of training and support for all personnel involved in caring for COPD patients in 
SM support skills. The inclusion of lay personnel and family members to support patients 
was also suggested. The suggestions for working with this vulnerable group at an individual 
level matched some of the suggestions that had been given for improving patient 
participation. They were: building relationships, getting patients interested in SM, changing 
their cognitions towards SM, demystifying the group process, building confidence and 
identifying and addressing unrealistic expectations. Support via technology on its own was 
also not considered appropriate by some experts for housebound patients owing to their lack 
of skills, lack of interest in technology and the lack of evidence of benefit for technology in 
COPD. 
 
6.7.2 Comparison with patient stakeholders findings 
It is useful here to compare the views given by experts with views of patients in the previous 
chapter. The commonalities/similarities with regard to factors affecting participation were the 
patient-related factors. Both experts’ and patients’ characterised the participants as people 
with COPD who had accepted their condition, wanted to help themselves or were already 
engaged with the health services – in other words they were activated patients (discussed in 
chapter II). While, the non-participants might still be in denial of their condition or resigned 
to it or were not ready to help themselves or change behaviour as they felt entitled to or were 
reluctant to try anything else other than usual care. Next, the negative beliefs about the illness 
or the psychological/emotional limitations due to the symptomatic nature of COPD might 
lead people with COPD particularly those who live alone, to lose confidence to go out 
unaccompanied and physical/practical barriers related to participation e.g. competing 
commitments were suggested by both patients and experts. On exploration of gender 
differences one male patient said that they had seen more men than women in PR while, a 
few experts said that the numbers who attended the programme were not too dissimilar 
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between men and women. However, one main distinction between men and women emerged 
and that was that men might be too proud or felt uncomfortable to ask for help or men were 
not joiners or sociable in comparison to women.  
One programme organisational factor, insufficient information or explanation given about the 
programme to patients was reported by both to affect patient participation. 
Reasons suggested for dropping out of SM support programmes were illness and lack of 
perceived benefit. In addition, some patients also suggested poor facilitation skills of 
programme staff e.g. tutor lacked knowledge about COPD as a dropout reason. This lack of 
knowledge of COPD or the difficulty to facilitate the COPD elements of the programme had 
been identified as a challenge by one expert interviewee.  
 
The mention of ‘pre-work’ that might be needed e.g. supporting patients with accepting their 
condition or discussion of the programme benefits by several types of personnel in the 
patient’s own environment such as their home or GP practice, to support patients prior to 
patient attendance was similar to patients’ views about provision of motivation and 
encouragement.  
Several organisational improvements were proposed to improve patient participation and/or 
retention by both patients and experts and they were: the patient invitation should be at the 
right level for the patient or the patient should believe in the benefits to enable participation; 
trained staff was important as was the need for improvement in facilitation skills of tutors; 
invite health professionals to give more talks or involve health professionals in the 
programme. With regard to the structure of the programme: the duration of the programme 
needs to ensure patient remains stimulated for the duration, include light exercise/activity, the 
topic on ‘depression and COPD’ was important and the topic on ‘living wills’ might not be 
appropriate.  
 
With regard to supporting patients with COPD (housebound patients, patient who might be 
anxious, depressed, socially isolated or not ready to change behaviour) with their SM, an 
alternative way suggested was supporting patients individually until they felt comfortable to 
attend a group-based programme as delivery of the SM programme at an individual level for 
the long term would be costly and hence not sustainable or use existing health and social care 
teams trained in SM support skills and including family to support patients. Instead of 
offering SM support via technology a better option proposed was either to have SM 
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workshops so patients could choose their session of interest or deliver the sessions in monthly 
Breathe Easy meetings. 
Both patients and experts also recognised that despite all efforts some patients might still not 
want to participate.  
 
One key difference between the patients and experts was that while many patients suggested 
that if people with COPD might be allowed the opportunity to bring a family member, friend 
or carer to the programme to encourage participation, some experts were not sure whether 
involving carers would be useful however, one expert did mention that it could be left to the 
patients to decide.  
 
The comparison of the findings in this chapter with the previous chapter has been informative 
because it has highlighted that the patient-related factors that were reported in this chapter 
were also reported in the previous chapter to affect participation. This suggests that there is a 
need for further involvement of patients with COPD in their care by health professionals and 
working with these patients individually through ‘pre-work’ or provision of ‘motivation and 
encouragement’ by trained professionals in SM support might get patients to participate in 
their care which could help to address some of the patient-related factors and this might 
further help to improve patient participation in SM support programmes.  
 
6.7.3 Comparison with existing literature 
This qualitative study confirmed the findings of quantitative studies85,109 that the problem of 
participation and retention in COPD SM support programmes does exist and some experts 
suggested that this could have contributed to the closing down of some centres that provide 
the programmes. This could explain why currently COPD SM programmes are only delivered 
in practice following their commissioning (EPP CIC link, personal communication) and not 
all CCGs might be commissioning delivery of PR programmes in practice 
http://www.nice.org.uk/guidance/cmg43/chapter/3-Assessing-service-levels-for-people-with-
COPD#benchmark-for-establishing-a-new-pulmonary-rehabilitation-service (accessed 25-8-
14). Until now, an explanation for withdrawal of PR services has been the lack of funding341 
and not poor uptake though both factors could possibly be interdependent. 
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(1) Factors that might lead to patient non-participation and retention 
This study identified some new factors that could affect patient participation in SM support 
programmes and has made a contribution to the limited evidence base.116,124,218 The patient 
factors included that patients with COPD might not be ready or might not want to self-
manage or change behaviour. This was explained in the previous chapter that it could be 
because they might have not to come to terms with their illness or because of loss of 
motivation. In addition, other determinants of behaviour change have been reported as self-
efficacy, SM skills, social support, environmental factors and ongoing support,67 lack of 
which might affect participation. The experts also suggested that patients might take longer to 
accept their illness which could affect participation. Taking time to accept COPD can be 
explained by the slow progressive nature of COPD which may go unnoticed as patients might 
not experience a life disruption caused by their illness331,339 or the symptoms may be ignored 
or ‘explained away’ in less serious terms.331 In addition, the lack of perceived benefits from 
SM support programmes that have been previously reported to affect patient non-attendance 
(Chapter IV), negative treatment beliefs such as, perceived incurability of the condition or 
perceptions that the programme is to be about smoking cessation (also reported in Chapter V) 
and lack of understanding about the condition are also suggested in this study to affect patient 
participation. The lack of knowledge or understanding about COPD and perceptions of the 
programme to be about smoking cessation and as a result being angry or reluctant to learn 
anything was reported as a challenge in delivery of SM support programmes by some experts. 
This negative mindset has been previously attributed to patients only knowledge of 
‘incurable’ COPD coming from GPs and smoking cessation being demanded of them.342 Fear 
of breathlessness and exercise owing to physical and psychological limitations has been 
reported previously as a reason for non-participation in PR,100,116 in this study along with fear 
of breathlessness and other symptoms such as coughing, the fear of the unknown, previous 
anxiety episodes, and the lack of confidence to go out alone particularly among people who 
live alone were also given as non-participation reasons. In contrast, results of a survey 
revealed that patients with high levels of anxiety and depression may be interested to join PR 
– albeit an inpatient PR programme.343 It might be useful to explore the needs of patients who 
might be anxious or depressed with regard to their management. Dislike of a group approach 
has been reported previously by one patient as a reason not to participate in PR 100 however, 
this study identified that it might not be the group setting but being referred somewhere that 
was new or different to the patient’s usual care. The fear of making a change due to being 
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dependent on existing health services has been reported for poor attendance in a COPD SM 
programme previously.122 Different to previous reports,100,114,116,122 some new practical 
barriers were reported to in relation to affecting participation in this study and they included 
that the patient might worry about bringing oxygen to the programme venue and 
comorbidities might make it difficult for patients to sit for the duration of the SM programme. 
Being on long term oxygen therapy was reported recently to influence completion of PR.344  
 
The findings of this study support previously reported findings116,218 that the limited 
knowledge of PR and lack of enthusiasm among primary care professionals while informing 
patients about PR could affect patient referral and thus PR participation. This explains why 
some patients in previous studies100,116 included in Chapter V, may have given, insufficient 
information or inadequate explanation about the programme as a reason for non-participation. 
Additionally, this study found that an inefficient health system e.g. lack of training among 
practice nurses to provide the right information about PR, the lack of communication about 
PR to patients despite being informed to do so, the lack of communication between primary 
and secondary care might also contribute to non-participation. Results of a recent survey345 
suggested the presence of a significant association between low self-efficacy among primary 
care providers and their non-adherence to offering PR to patients with COPD which was not 
identified in this study. This study further identified that the lack of understanding about the 
role of SM or about the programmes among primary care professionals could affect patient 
participation and some experts explained that this might be because of the lack of integration 
of SM and the programmes in the COPD care pathway, SM not being a priority for 
professionals which could be due to the insufficient evidence of benefit for SM programmes 
particularly, the lack of translation of patient benefits into cost savings. In addition, some 
experts were uncertain whether SM programmes could really change patients’ beliefs and 
hence were uncertain about the future delivery of the programmes. These findings can be 
supported by studies that reported the lack of promotion of exercise behaviour change among 
patients with COPD due to professionals lacking understanding about the importance of this 
SM strategy for COPD;218 and poor recruitment in the national evaluation of the generic SM 
programme was because GPs were unable to relate to and conceptualise the benefits of the 
programme;346 and inadequate conclusions from studies on effectiveness of COPD SM 
education on health care utilisation.84 Despite the national roll-out of disease-specific SM 
programmes in the community for patients with chronic conditions including COPD 
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http://www.patient.co.uk/support/expert-patients-programme (accessed 21-9-14 and policy 
focus47 on the provision of an integrated service for COPD patients where collaborative SM 
is a key feature, not much seems to have changed concerning the place of SM in COPD care 
in comparison to other chronic conditions for example diabetes.347 So, until there is a shift 
among HCPs in understanding the role and benefits of SM and applying a collaborative 
approach348 when considering the care of COPD patients the problem of poor participation in 
SM support programmes might possibly remain. One other health system factor that was not 
reported previously to affect patient participation was that the right patients might have not 
been recruited for SM programmes e.g. too wide or stringent criteria was used. The generic 
SM programme has previously received much criticism73 for including a self-selected group 
of patients in research studies as opposed to patients who might benefit most from the 
programme such as, those with poor literacy and those belonging to socio-economically 
deprived groups. In addition, one expert stated that although they received referrals following 
application of the MRC criteria some patients still did not participate perhaps because they 
were not asked if they perceived benefits from attending the programme which suggests that 
identifying the right/appropriate patients solely through use of criteria might not be enough.  
 
Furthermore, the following organisational factors were reported in this study that could have 
affected participation and had not been reported previously: SM support staff unable to 
explain the purpose/benefits of the programme to patients over the telephone – till date the 
lack of information or explanation about the benefits of SM support programmes by health 
professionals has been reported (shown in Chapter IV). However, the programme staff not 
being able to explain the purpose and benefits of the programme itself could further increase 
patient non-participation in SM support; staff that invited patients to programme not being 
present at the programme – this could impact participation among patients who might already 
be nervous or fearful of entering a new environment or meeting strangers or who disliked a 
group setting (Chapter V); and absence of a rolling programme – the lack of flexibility by the 
programme has been reported previously.100  
 
The patient dropout reasons such as unmet expectations, lack of support, instability of the 
condition, physical and practical barriers that were suggested by experts in this study had also 
been reported by patients previously for SM support programmes (Chapter IV). In addition, 
some new dropout reasons suggested in this study were: the lack of understanding about the 
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SM aspect of the programme or that they might not be ready for SM, the group dynamic not 
working either because younger patients could not relate to older patients or some patients 
were disruptive, disliked facilitations skills of the SM tutors and ‘living wills’ session of the 
programme might have been off-putting.  
 
(2) Facilitators to improve patient participation and retention 
In this study, improvements were aimed at the health system and the programme 
organisational aspects to improve patient participation. The following improvements to the 
health system were new findings and they comprised of: identifying the right patients for the 
programme e.g. at diagnosis or via the patient activation measure (PAM) (and patients might 
need another form of support at this point); building relationships with patients to see what 
they want and value and if they might be ready for SM/programmes (and patients might need 
another form of support at this point); carrying out ‘pre-work’ which might include 
supporting patients to accept their condition, addressing treatment beliefs by discussing the 
programme benefits; using enthusiastic personnel about SM and programmes to refer 
patients; pitch the programme at the right level of the patient and assess and address patient 
expectations about the programmes, practical/physical barriers related to participation; and 
these suggestions might need the provision of training and support for HCPs.  
Improving patient referral through improving the information flow was a suggestion given to 
improve participation in PR previously.109,218 This study further suggested that patient referral 
might improve through the provision of positive evidence of SM in COPD among 
professionals and integration of SM programmes into the patient care pathway to help 
professionals encourage SM among their patients. Besides improving patient referrals, the 
remaining proposed suggestions to improve participation in this study have been reported in 
the literature individually in the context of improving patient self-management and not 
participation in SM support programmes. The PAM has been recently used in a study349 
among patients with heart failure whereby targeted tailored interventions based upon a 
patient’s activation levels showed potential of improvement in patient activation towards SM. 
Professional communication and collaboration to build relationships with patients has been 
considered necessary if they want patients to participate in their own health care.350 A recent 
editorial351 has suggested that HCPs should concentrate more on addressing individual 
concerns of COPD patients and help to reduce the emotional burden of living with COPD 
which would be valued more by patients to better manage their illness. Another study352 has 
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suggested building relationships with COPD patients and their families through a ‘dialogue’ 
whereby the nurse can be responsive to patients’ needs and concerns rather than having a 
prescribed agenda about how to make patients perform health-related behaviours. One more 
study205 has emphasized helping patients to understand their illness and its management to 
help them engage with SM and shared-decision making. 
 
A new improvement to the organisational aspect of the SM programme given in this study 
that could be added to the existing evidence base122 to improve patient participation was that 
throughout the duration of the programme it should ensure that patients with COPD can 
remain engaged and stimulated.  
 
Improvements to the programme organisational aspects were also proposed for improving 
retention in this study. The new suggestions were: need for more training for SM tutors to 
improve their facilitation skills, involving HCPs in delivering certain aspects of the 
programme which indeed was always the plan or intention for disease-specific programmes 
(EPP CIC); elicit patient preference prior to discussion of the ‘living wills’ section and cover 
‘what is COPD?’ with patients prior to their attendance in the programme. One study 
reported that patients with COPD might be more interested to learn about living and 
managing with their COPD as opposed to dying with COPD.93  
 
There was some consensus among the experts in this study that the provision of training in 
communication and SM support skills for professionals belonging to various health and social 
care teams who are already involved in the care of COPD patients might be one way to 
support patients with COPD who cannot or do not attend SM support programmes. Working 
in this way initially with patients with COPD could become a starting point for patients to 
start thinking about SM and then possibly participation in SM support programmes. This 
option was preferred by several experts as a better way to support patients with COPD in 
comparison to delivery of a structured COPD programme to patients in an individual setting 
either face-to-face or through technology. However, some experts had realised that the 
provision of SM support in routine care might be a slow and steady process. The slow 
development of integration of SM support into chronic care management among 13 European 
countries including the UK was reported in a recent study.348   
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This study identified some key strategies, not reported previously, to support patients who do 
not want to or cannot participate in group-based PR/SM programmes and these suggestions 
matched those that had been reported by the experts for improving participation for example, 
anxious patients could be supported by building relationships, patients who might not be 
ready to self-manage or participate in programmes would need support with changing their 
negative cognitions towards SM, demystifying the group process. The use of lay experts and 
involving family members was also suggested to support and encourage housebound patients 
with their SM. A non-technological alternative given to delivery of a structured programme 
was to consider delivery of SM workshops in the future to allow patients to participate in the 
session of their choice and which could be a way for patients to begin to take control of their 
condition.  
 
6.7.4 Strengths and limitations of the study 
The study is the first of its kind to explore from lay and HCPs the reasons why patients might 
not participate in SM support programmes moving beyond the exploration of barriers to 
patient referral and facilitators to improve referrals in PR among primary care 
professionals.109,218 The study findings have made some contribution in the field of how to 
support patients with COPD who cannot or do not want to participate in group-based SM 
support programmes and added to the limited evidence that exists on the topic of 
understanding COPD patient non-participation in COPD SM support programmes and how 
participation might be improved in these programmes. However there were some study 
limitations.  
Firstly, the research topic, how patient participation might be improved and how patients 
could be supported in a non-group setting was relatively new, as was acknowledged by 
several experts in this study. Thus, the findings should be applied with caution.  
Secondly, as the previous chapter, reasons for non-participation were not explored from 
patients who might have been non-participants in a study of a SM support programme 
however, the patient-related factors that were suggested to affect patient participation 
matched those that were reported by the patient stakeholders in the previous chapter and 
hence can provide validation to the findings to some extent. Plus the factors identified might 
have been difficult to obtain from the non-participants themselves. Furthermore, this chapter 
was able to demonstrate that besides patient factors and organisational factors several health 
system factors could also affect patient participation in SM support programmes.   
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6.8 Conclusions 
Patient participation in SM support programmes could be affected by a number of patient 
factors e.g. not ready to self-manage, negative consequences of living with COPD; health 
system factors e.g. lack of understanding about the role of SM; and programme 
organisational factors e.g. unable to give sufficient information about the programme. 
Improvements to the health system and programme organisational factors might help to 
address the patient factors and thus increase the potential of improving patient participation in 
these programmes. Specifically, following identification of the right patients, patients need to 
be asked what they value and if they might be ready to self-manage or consider participation 
in SM support programmes through building relationships and provision of appropriate 
support so patients feel motivated and confident to better manage their condition which could 
include participation in SM support programmes. One way of involving and supporting 
patients in their care would require provision of training and support to professionals 
involved in the care of a COPD patient in communication and SM support skills alongside 
the promotion of SM support programmes among HCPs and integration of the SM into the 
COPD care pathway. The process of improving participation could also be used to support 
patients who cannot, or do not want to, attend group-based programmes by involving various 
health and social care teams and those already involved in the care of the COPD patient. This 
might be a more cost-effective, feasible and sustainable option in the long run in comparison 
to delivery of a structured SM programme to patients in an individual setting either face-to-
face or via technology. 
 
Patient dropout reasons suggested were: unmet expectations from the programme or perhaps 
patients’ did not understand or were not ready for self-management; the group dynamic not 
working; severity of illness and not ill enough; and, specific to the SM programme patients, 
might have disliked the facilitation skills of the SM tutors and felt uncomfortable with the 
‘living wills’ section of the programme. Improvement in patient retention could include more 
practice for SM tutors in facilitation skills, involving HCPs in the programme, asking 
patients’ preferences prior to discussion of the ‘living wills’ section in the programme and 
cover ‘what is COPD?’ with patients prior to their attendance in the programme. 
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6.9 Implications 
The study findings suggested that the delivery of SM programmes might be the only way 
patients might have been able to access SM support as this study flagged up that perhaps 
some PR services might still be offering didactic education which has been reported 
elsewhere;342 this lack of provision of best practice30 and the limited implementation of 
COPD SM programmes routinely could limit patients with COPD from acquiring valuable 
SM strategies that are necessary for their long term management. 
Nonetheless, the findings have helped to gain understanding that patient participation in SM 
support programmes might be affected by more than just patient factors or organisational 
factors but also health system factors. In addition, the experts suggested that building 
relationships with patients and providing appropriate support tailored to their needs might 
help to improve patient participation. Building or establishing relationships have mostly been 
suggested as important by patients to help them to participate in their care138,188 and so this 
finding suggested by experts highlights that patients and professionals might be moving 
towards the same goal that is necessary if patients are to take responsibility for their health 
and which includes participation in SM support programmes. To help health professionals 
build relationships with patients and to consider SM for their patients they would need to be 
positive about SM. This might require professionals evaluating their attitudes towards 
patients with COPD,351 assessment of their beliefs about patient SM 
http://www.insigniahealth.com/solutions/clinician-activation-measure (accessed 17-12-13) 
and training in SM support. This might also help integration of SM more into the COPD care 
pathway seen for other chronic conditions.347  
The health system and programme organisational improvements reported in this chapter 
could be used by others involved in the development and delivery of SM support programmes 
for patients with COPD to help improve patient participation.   
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The next chapter describes a non-UK developed model of SM support and its adaptation for 
the UK.  
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Chapter VII. Self-management support for COPD patients – 
the ‘CENTREd’ Model 
 One conclusion from Chapter VI was to offer patients with COPD (including those 
who do not want to or cannot participate in group-based SM support programmes) 
SM support by health care professionals trained in communication and SM support 
skills to help patients start to think/consider SM to better manage their condition.   
 One novel model of health SM support referred to as the ‘CENTREd’ Model, 
developed in Tasmania, Australia, aimed at patients with chronic disease including 
COPD was identified during the course of the doctoral study as another method being 
used to deliver SM support to patients with COPD, other than a group-based SM 
support programme. The model is described briefly and its adaptation for the UK in 
this chapter.   
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7.1 Introduction – The ‘CENTREd’ Model 
The ‘CENTREd’ Model was developed by Dr Helen Cameron-Tucker (HC-T) (senior 
physiotherapist at Hobart, Tasmania, Australia and postdoctoral research fellow at Menzies 
Research Institute, Tasmania, Australia). The training and development programme of this 
doctoral study enabled me to make a two-week research visit to learn more about the model’s 
development and its evaluation in research studies; to observe its implementation in clinical 
practice (by HC-T and a colleague) in different clinical scenarios mainly among patients with 
respiratory disease including COPD (Appendix 7.1); and to undergo the accredited training in 
order to train HCPs to deliver the model.  
 
The ‘CENTREd’ Model draws together and adds to core skills of other evidence-based 
behavioural models www.health.vic.gov.au/pch/downloads/factsheet08.pdf (accessed 14-1-
14),201 including: the Heart Manual;353 the Flinders Chronic Disease Self-management 
Programme; http://www.flinders.edu.au/medicine/sites/fhbhru/self-management.cfm 
(accessed 30-8-14) the Stanford Chronic Disease Self-Management Programme;70 
Motivational Interviewing;354 and health psychology literature;355 in particular that relating to 
health behaviour adoption or maintenance. 
The model aims to equip HCPs to support their patients in developing the confidence and 
capability to take an active role in managing their health, including managing chronic 
conditions such as COPD. The training provides HCPs with practical steps, skills and tools 
immediately applicable to clinical practice.  
The “‘CENTREd’ Steps” are strategies that guide HCPs to offer self-management support in 
a structured format to prevent professionals missing a key ‘Step’ or activity during 
consultation with patients. The Steps with their key aims are presented in Box 7.1. 
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Box 7.1 The ‘CENTREd’ Steps with aims 
The ‘CENTREd’ Steps Aims 
 
Commitment 
 
To ‘Connect’ and agree to work collaboratively 
Engagement To establish a mutually agreed agenda 
Negotiation 
 
To mutually define and decide on goals and link 
these  to health behaviours 
Taking action To set a ‘SMARTIC’ (Specific, Measurable, 
Achievable, Relevant, Timely, Important, 
Confidence) action plan to achieve goals 
Repeating back To clarify mutual understanding. Ensure 
preferences have been met 
Establishing follow-up To mutually agree on time and mode of planned 
follow-up 
 
The “‘CENTREd’ Skills” include: 
 Communication skills (I statements, listening skills);  
 Motivational interviewing skills (open-ended, affirmation, reflective listening, 
summarising, looking Back, envisaging possible future, dealing with resistance, 
dealing with relapse); 
 Problem solving skills; 
 Goal setting skills; and 
 Action planning skills.  
The expected outcomes following implementation of the above listed skills include: 
improved health self-management, adoption or maintenance of health-related behaviours, 
improved satisfaction with the consultation by both patient and health professional and 
improved/reduced health care utilisation.  
 
Embedded in the ‘CENTREd’ Model is the ‘SNAPPS’ Health-Management framework with 
a holistic focus on health. ‘SNAPPS’ is a mnemonic referring to the health related behaviours 
of Smoking, Nutrition, Alcohol, Physical activity, Psychosocial wellbeing and Symptom 
management. The ‘SNAPPS’ Tools can be utilised with patients to engage them and facilitate 
change in the ‘SNAPPS’ health behaviours.  
An illustration of the ‘CENTREd’ Model process is shown in Figure 7.1 and Box 7.2 lists the 
‘SNAPPS’ Tool with their function. Appendix 7.2 gives a more detailed description of the 
‘SNAPPS’ Tools.  
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Figure 7.1 The ‘CENTREd’ Model process 
 
 
 
 
 
Steps 
Commit and Connect 
e.g. use open-ended questions, 
listening skills 
   
‘Tell me what’s happening with 
you? 
How does your breathing affect 
you? (SNAPPS Behaviours) 
Would it be ok if I take notes? 
   
Skills and Tools 
Illicit preferences, 
expectations, identify 
motivation, identify agenda 
through use of SNAPPS 
Guidelines, develop SNAPPS 
summary report and patient 
profile, reflective listening  
   
What are the things you would 
like to work on?  
What are you doing for exercise 
now? (SNAPPS Behaviours)  
What is important to you? 
 
   
Examples 
Affirm positive actions, 
prioritise agreed goals to 
address agenda, provision of 
information, teach skills, use 
behavioural ruler tool to 
affirm behaviour and build 
upon existing behaviour  
What would you like to do about 
it now? Would you like to build 
on your existing exercise/physical 
activity? (SNAPPS Behaviours)  
 
   
Set an action plan (SNAPPS 
Tool, problem solving skills 
   
What will you do exactly? How 
much are you going to do? Is this 
what you want to do? When will 
you do it? How important is this 
plan to you? How confident are 
you that you can achieve this 
plan?  
  
 
   
Tell me what are you going to do when you get 
home? Do you want me to show you once 
more? Would you like me to repeat this 
information?    
   
Mutually agree on 
time and mode of 
follow up  
   
Both patient and health 
professional repeat back what 
was discussed 
   
Given appointment 
card,  
On week 8 we will do a 
review  
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Box 7.2 The ‘SNAPPS’ Tools with its functions 
The ‘SNAPPS’ Tools Function 
 
(1) “‘SNAPPS’ Health behaviours Choices and 
Guidelines’”  
 
Denotes most recent guidelines/recommendation 
on each of the SNAPPS Health behaviours 
(2) “‘SNAPPS’ Health Behaviours Summary 
Report’”  
 
Is utilised with a patient to gain an understanding 
where a patient might be with respect to each of 
the SNAPPS Health behaviours (Tool 1 is used 
with the patient to complete this tool) 
(3) “‘SNAPPS’ Health Behaviour Profile’”  
 
A profile of patient is created after completion of 
Tool 2. This tool affirms what an individual 
currently does to manage their health and 
identifies behaviours to address 
(4) “‘SNAPPS’ Agreed Actions’”  
 
Are mutually determined between patient and 
professional regarding behaviour/s that will be 
adopted or maintained by the patient following 
completion of Tool 2 and 3 
The above tools 2, 3, and 4 can be utilised with a 
new patient or a patient being seen at follow up 
and can be referred to at each consultation to help 
provide the right support to the patient at the right 
time 
 
(5) “‘SNAPPS’ Progress forms’”  
 
Can be utilised to monitor progress in detail of the 
health behaviour/s the patient may have chosen to 
address. There is a progress form for each of the 
‘SNAPPS’ Health Behaviours 
(6) ‘Personal action plan’  
 
A template to set out an action plan with a patient 
(7) ‘Behavioural ruler’  
 
Used to help patients reaffirm what they are 
currently doing regarding a health behaviour/s and 
what they would like to do regarding the health 
behaviour/s prior to identifying a goal and action 
plan 
(8) ‘Steps for Dealing with your concerns’  A visual tool which can be utilised with the patient 
to identify problem solving steps with a patient 
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The ‘CENTREd’ Model has been refined from an approach that has been evaluated in three 
small studies340,356 in Tasmania among practice and community nurses trained in SM support 
(referred to as health mentors) who delivered SM support to patients with COPD by 
telephone.357 Recently the ‘CENTREd’ Model was tested in a feasibility study with nurses in 
Tasmanian General Practice and was found to positively change nurses’ practice.358 
 
7.1.1 Refinement/Adaptation of the ‘CENTREd’ Model for the UK 
The intervention was refined following discussion with a UK respiratory nurse consultant 
(based at St Georges Healthcare NHS Trust and part of the London respiratory team). 
Specifically, one of the tools of the ‘CENTREd’ Model, the ‘SNAPPS’ Health Behaviour 
Choices and Guidelines’ (based on the Australian and Tasmanian government guidelines) 
(Appendix 7.2) following gaining approval from HC-T was adapted and made relevant for 
the UK by referring to the Live Well, NHS Choices website 
http://www.nhs.uk/livewell/Pages/Livewellhub.aspx (accessed 27-12-13). The UK NHS 
health guidelines were adopted for the following ‘SNAPPS’ health behaviours: Smoking, 
Nutrition, Alcohol, Physical activity and Psychosocial wellbeing (Appendix 7.3).  
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The next chapter presents the overall summary and discussion of the study followed by the 
overall conclusions. 
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Chapter VIII. Overall discussion and conclusions 
In Chapter I, the thesis was introduced and the rationale of the study it’s aims and objectives 
were described. The thesis comprised of four stages to meet its aims and objectives, 
following steps proposed in the MRC guidance on developing and evaluating complex 
interventions. These four stages formed Chapters II to VII.  
In Stage 1, Chapters II, III and IV examined existing evidence and applied appropriate theory 
to understand patient participation and completion in SM support programmes. Specifically, 
in Chapter II, the conceptual review explored the origins and meanings of patient 
participation in health care and identified existing studies that had attempted to utilise 
behavioural models to explain participation in health care interventions, including SM 
interventions among patients with chronic disease. Two behavioural models identified in this 
chapter were applied in Chapter IV to the findings of the included qualitative studies in the 
qualitative synthesis in order to better understand participation behaviour of patients with 
COPD in SM support programmes. In Chapter III the quantitative element of the systematic 
review quantified the actual rates of participation and retention in studies of COPD SM 
support programmes.  
In Stage 2, following a new exploration of views from COPD patient stakeholders (Chapter 
V) and from lay providers and professional stakeholders (Chapter VI), a theoretical 
understanding of participation and non-participation behaviour was further developed. This 
work included suggestions around how participation in SM support programmes could be 
improved and how patients, who cannot, or do not want to attend group-based SM support 
programmes, might be supported in their self-management.  
In Stage 3, Chapter VII described a non-UK developed SM support model and its adaptation 
for the UK after carrying out refinements.  
This Chapter (VIII) presents a summary of the principal findings followed by discussion of 
the results in context with other research in the area. The chapter identifies the strengths and 
limitations of the studies in the thesis. Next, the implications for clinicians and policy makers 
are presented followed by research recommendations and finally a summary of the overall 
conclusions are presented.  
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8.1 Summary of principal findings with discussion 
Effective pulmonary rehabilitation42 and self-management interventions359 are expected to 
remain mainstay treatments alongside pharmacological treatments to help patients with 
COPD to better self-manage their condition and to utilise health resources effectively. The 
imperative for this comes not just from the Department of Health, or health care professionals 
(HCPs), but from patients with chronic conditions themselves.360 To help maximise the reach 
of SM support treatments to eligible patients, this mixed-methods study broadly attempted to 
understand the problem of poor participation and retention reported in studies of PR and SM 
support programmes, including programmes for patients with COPD; understand patient non-
participation in SM support programmes and how this could be improved; and to identify 
better ways patients with COPD might access SM support.  
The principal findings of this study are presented under the four stages recommended in the 
MRC guidance for developing and evaluating complex interventions.290 
 
8.1.1 Stage 1: Using existing evidence and application of theory to gain an 
insight into the participation behaviour of patients with chronic disease 
including COPD (Chapters I, II and III) 
 
Existing participation and retention rates in studies of COPD SM support programmes 
(Chapter I) 
In contrast to previous reports,108-112 the quantitative systematic review including 56 studies 
of SM support programmes found high study participation rates (in 43/56 studies only 19% 
had a study participation rate of <50%) and low dropout rates (the study dropout rate and 
intervention dropout rate were <=30% in 93% and 94% of all the studies, respectively) (Table 
3.6)).  
 
Based on the participation definitions adopted in this study and on the calculation of the study 
participation rate (Figure 3.1 and 3.2) endorsed by the extension of the CONSORT statement 
for reporting pragmatic trials226 the calculated proportions were the true estimates of 
participation and retention. Differences between the findings in the systematic review and the 
individual studies108,109,123 and other reviews112 arose from the included studies: 
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(1) reporting the participant flow data incompletely (16% of studies reported ‘potential 
participants identified’, 39% reported ‘numbers assessed for eligibility’ and 77% of studies 
reported ‘numbers eligible’ (Table 3.6));  
(2) adopting their own definitions of what constitutes patient participation in both study and 
the intervention within the study; and  
(3) failing to state the definitions used clearly, which made it difficult to identify whether 
proportions reported referred to the study or to the intervention.  
In addition, based on completeness of the data, the chosen characteristics: year of publication, 
quality score, exercise intervention versus non-exercise intervention and group versus 
individual programme, did not show any evidence of effect on the study participation rate. 
 
Of the 56 studies only 27 studies supplied reasons for patient non-participation, non-
attendance and/or study/intervention dropout. Sixteen studies reported the following reasons 
(Table 3.8) which were common to both patient non-participation and study or intervention 
dropout: physical or external factors; patient-related factors e.g. competing demands or 
priorities, illness, lack of interest; study/intervention factors e.g. inability to contact patients, 
patients failing to comply with the study or intervention or programmes not suitable. Several 
of these reasons had been reported previously in other studies of COPD SM support 
programmes.25,115,117,118 In addition, 11 studies had reported ‘refusal/did not wish to take part’ 
as a reason for study non-participation but did not, or were unable to, elaborate on the reason 
for refusal.  
The incomplete recruitment picture observed among the included studies in the systematic 
review; and the lack of reporting by studies of reasons for patient non-participation, may 
compromise the delivery of SM support programmes in practice as the study findings may 
not be generalisable to the target population; this could lead to exclusion of suitable patients 
who might want to participate and gain benefits from these programmes.361 Several 
studies113,293,344 have highlighted an acute need for qualitative research to understand the 
problem of participation and retention in PR among people with COPD.  
 
Using a qualitative approach, this thesis (in Chapter IV, V and VI) helped in understanding 
why patients with COPD do not attend and/or drop out of SM support programmes; why 
patients with COPD may not want to participate in a SM support programme or may not be 
interested in taking part; how participation may be improved and how else patients with 
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COPD could access or receive SM support - thus making these study findings topical and 
timely. 
 
Before discussion of the summary findings of the qualitative approach specific to COPD the 
conceptual review summary findings (Chapter II), which informed the qualitative approach, 
are presented. 
 
Definitions of patient participation in health care (Chapter II)  
It is clear from the quantitative review that clarity is needed around the definition of the terms 
‘patient participation and ‘non-participation’ in health care. The conceptual review (Chapter 
II) found that the meanings given in the dictionaries (section 2.3.1.1) most closely matched 
the definitions adopted by this study (see glossary page). In addition, the conceptual review 
grouped the various meanings and definitions of ‘patient participation’ into two areas: one 
based on the context of the patient/individual and one at the patient-professional interaction 
level (Figure 2.3).  
 
Patient participation at an individual level meant the individual making the decision to take 
responsibility for their health; and at a patient-professional interaction level (through patient 
partnership/patient collaboration, patient-centred care, patient engagement and 
shared decision-making) it meant involving patients in making decisions about their health 
and health care. Furthermore several studies, through exploration of the meaning of the terms 
from perspectives of patients (mostly with chronic disease) and professionals, found that 
patient participation involved more than just decision-making. Among patients, patient 
participation had meant being confident in one’s self and the HCP, comprehending 
information about illness and its management, and seeking and maintaining a sense of 
control.  Lack of patient participation meant the reverse of these plus a lack of support from 
professionals and not being respected or listened to.  
 
Among nurses, patient participation had meant patients receiving information based on the 
individual needs arising from their condition and non-participation had meant that patients 
did not acknowledge the provision of information. These potentially very important 
differences in meaning for patients and professionals have also recently been reported 
elsewhere.348 To facilitate patient participation in line with the views of patients, 
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professionals, in addition to providing information to patients should ensure that the patient 
has understood the information given. The latter approach performed by the professional may 
also help them to obtain the acknowledgement they want and see as patient participation.  
 
This difference in meaning was a key indication of a barrier for patients to participate in their 
care and likely to extend to participation in SM interventions. The importance of 
professionals changing their practice to work in partnership with the patient at an individual 
level and within the patient’s context (their values, needs, expectations) was a key finding in 
the qualitative study (Chapters V and VI) to help improve patient participation, and is the 
premise of the patient-centred SM support model described in this thesis (Chapter VII) 
(discussed later). Furthermore, the conceptual review showed that not all patients with 
chronic disease may want to participate in their care and that participation may change with 
time, and across different phases of the disease and treatment – demonstrating that patient 
participation is not static but a dynamic process. The dynamic nature of participation was 
explained by two studies in the conceptual review (Chapter II), first148 through a taxonomy 
(Table 2.1) that was developed from the perspectives of patients and professionals and a 
second study136 which developed a conceptual model (Figure 2.2) from the perspective of 
patients and which showed that the process of patient participation was influenced by a mix 
of patient, professional and contextual factors.  
 
Factors affecting participation in studies of SM support interventions among patients with 
chronic disease (Chapter II)  
The conceptual review, which included 25 studies using 11 theoretical models (a socio-
behavioural model/health care utilisation model, attachment/interpersonal theory, social 
theory and health behaviour theories), also suggested (see Figure 2.11) that the main 
influences on patients with chronic disease seeking professional care were increased 
perceived need, or increased perceived severity of symptoms and the need for symptom 
management. In comparison, and in contrast to patients seeking professional care, 
participation in ongoing SM services was not influenced by perceived severity of symptoms; 
instead participation was influenced by patients’ intentions and action planning, the changing 
psychology between motivation and action influenced by increased self-efficacy, positive 
outcome expectations and increased risk perception. Exercise identity was influenced by a 
person’s perceived importance of, and confidence to exercise; the availability of support; and 
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perceived benefits (social and psychological). And in comparison, and in contrast to patients 
who were offered ongoing SM services for the maintenance of their SM behaviours, 
attendance at SM interventions (mostly at outpatients) was influenced by their beliefs 
concerning the intervention and their perceptions of the illness and the intervention in 
response to their health threat.  
 
Specifically, the Self-Regulation Model (SRM) and/or the Self-Regulation Model Necessity-
Concerns Framework (SRM-NCF) model was utilised by studies either prospectively (to 
predict/explain attendance) among patients admitted in hospital, following discharge and 
retrospectively (following attendance/non-attendance behaviour), or in a descriptive way to 
explain patient participation behaviour in SM interventions. The prospective studies reported 
the following illness and intervention perceptions as most predictive of patient attendance: 
increased perceived cure, controllability and necessity for the intervention among 
hospitalised patients; increased perceived disease identity and consequences of the illness 
among patients discharged but prior to programme attendance. The retrospective studies 
reported that the perception that the cause of illness was not related to lifestyle, or that the 
cause was not modifiable, or that the intervention was less necessary, led to patient 
non-attendance whilst increased perceived personal controllability led to attendance. Studies 
that utilised the Theory of Planned Behaviour (TPB) and the Attitude-Social influence-Self-
efficacy (ASE) model found that patient attendance or intention to participate in a SM 
intervention was influenced by an individual’s positive attitude towards the intervention 
(perceived benefits), subjective norm (TPB)/social influence (ASE) (i.e. the perceived 
influence of others such as health professionals, family members  or friends on attending) and 
perceived behavioural control (TPB)/self-efficacy (i.e. reports of fewer external/practical 
barriers to participation). 
 
Factors affecting participation in studies of SM support interventions among patients with 
COPD (Chapter IV) 
Despite the paucity of theoretical models utilised by studies to explain patient participation 
behaviour in SM interventions among patients with chronic disease, and there being only one 
study involving PR,110 the application of the SRM and the adapted ASE model to six 
published studies of SM support programmes (Chapter IV) helped to develop understanding 
of COPD patient participation behaviour (attendance, non-attendance and dropout) (Box 4.1) 
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in studies of SM support programmes beyond the previously reported socio-demographic and 
clinical factors.112,121 The results of the qualitative synthesis (Chapter IV) were consistent 
with the conceptual review findings: the participation behaviour of COPD patients was 
influenced by individuals’ attitude and social influences; and illness and intervention 
perceptions/representations. Attitudes of wanting to help oneself, the perceived influence of 
HCPs, perceptions of the controllability of illness and perceived positive benefits of the 
COPD support programmes, including positive past experiences, were particularly influential 
on attendance behaviour. Non-attendance was influenced by negative attitudes including:  
that improvement in their condition was no longer possible; the perception that the 
programme would not benefit their condition (including negative prior experiences); 
perceived physical or practical concerns related to attendance; and the perceived negativity of 
professionals and family/friends towards the programme. Dropout behaviour was influenced 
by an individual’s attitude and intervention representations that the programme was not 
beneficial after attending a few sessions and by their perceived severity of symptoms. 
 
8.1.2 Stage 2: Further development of theoretical understanding about 
non-participation and participation behaviour of patients with COPD from 
a new qualitative study (Chapters V and VI) 
Besides understanding the problem of participation and retention in SM support programmes 
among COPD patients, exploration and understanding the characteristics of ‘refusers’ in these 
programmes has also been described as vital.322 The findings of the primary qualitative study 
that explored the perspectives of 22 patient stakeholders and 16 experts (comprising of both 
lay and HCPs) (Chapter V and VI), helped to gain understanding of (a) patient non-
participation in COPD SM support programmes; in addition (b) how participation could be 
improved in these programmes; and (c) alternative ways patients might be supported with SM 
other than in a group setting. 
 
a) Reasons for patient non-participation and participation in COPD SM support 
programmes  
The reasons for non-participation in SM support programmes were a combination of patient-
related, programme organisational and health system factors (Figure 5.1 and Figure 6.1).  
In particular, ‘refusers’ might be patients who are not ready to help themselves or to change 
their behaviour; they might have become resigned to their illness; they might be in denial or 
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just taking a long time to accept the nature of their illness; they may be reluctant to try 
anything different to usual care, particularly any physical activity;  they might hold negative 
illness beliefs (e.g. condition is incurable), negative treatment beliefs (e.g. exercise perceived 
as unnecessary, programme preaches about smoking cessation) including perceived increased 
concerns related to participation e.g. cost of transport, difficulties of carrying oxygen to the 
venue and experience negative emotional reactions e.g. fear, anxiety that could result in loss 
of motivation and low self-confidence to go out of the house alone to a programme perceived 
as new/strange. In addition some experts suggested that patients might lack understanding 
about their illness and some patient interviewees, beyond personal factors, said that patients 
might be unaware about the programmes.  
 
Besides cost and lack of perceived benefit from exercise, none of the reasons for non-
participation attributed to patients suggested by the interviewees in this thesis were reported 
in a large qualitative study that explored PR programme non-attendance amongst patients 
who did not attend or complete PR.311 In Keating’s study, the main reasons reported for non-
attendance and non-completion were physical/practical barriers and illness. Furthermore, 
some interviewees added that unmotivated patients being asked to ring up for a PR 
assessment or patients having insufficient information about the programme or having 
inadequate access could lead to non-participation. Some experts had also suggested SM 
support staff being unable to explain the purpose and benefits of the programme over the 
telephone; the absence of rolling programmes; and different venues for PR assessment and 
the programme as reasons for non-participation. Moreover, several expert interviewees 
highlighted health system factors that could affect patient referral and thus participation 
beyond poor information flow about the programmes. Particularly, non-participation could be 
a result of lack of support from primary care due to: the SM programme either not being a 
priority for HCPs; or the lack of integration of SM into the COPD patient care pathway; or a 
lack of understanding among professionals about the role of SM and the programmes - 
possibly owing to insufficient evidence of benefit for SM programmes in COPD. The latter 
findings were directed mainly towards SM programmes however, these findings could be 
applicable to PR programmes since inadequate patient referral to PR programmes and a lack 
of understanding among professionals about how exercise can be beneficial to patients,218 or 
about the importance of PR for COPD management362 have all been reported. Other reasons 
cited for non-participation were the inefficient working of the health service e.g. a lack of 
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trained primary care staff to provide the right information about programmes, lack of 
communication between professionals at various levels, and administrative problems (e.g. 
referrals getting lost), and failure to target the right patients for SM programmes.   
The health system factors cited above could explain why some patients might be unaware 
about the programmes. These factors, and the programme organisational factors, could not 
have been foreseen by patient stakeholders. Thus gaining the perspectives from both patients 
and professionals helped in understanding non-participation beyond understanding the 
characteristics of ‘refusers’. 
 
Dropout reasons included: poor communication and facilitations skills of SM tutors, PR staff 
not being able to focus much attention on new patients, inappropriate venue; illness; inability 
to keep up with the exercises and embarrassment to ask for help, and unmet expectations 
from the programme – this latter finding was also reported in the qualitative synthesis 
(Chapter IV).  
 
b) Suggestions for improving patient participation in SM support programmes 
This thesis, and particularly the qualitative study (Chapter IV and V), has made a contribution 
to the limited evidence base that exists regarding improving patient participation in SM 
support programmes for COPD (Figure 5.1 and Figure 6.2) however, several patient 
interviewees also suggested that despite all efforts to improve participation some patients 
may still be reluctant to participate, and some experts suggested that this topic would benefit 
from further research.  
The patient interviewees suggested the following to help improve patient participation: 
provide encouragement, motivation, and support in things patients might be doing well; 
encourage participation by discussing the programme, or their benefits using a one-to-one 
approach e.g. through GP, PR staff in a GP practice, invite patients to a trial session, visit 
patients at home or use a DVD to inform about the programme; help patients accept their 
condition and build confidence so they feel a “sense of worth”; and allow patients to bring a 
family member, friend or carer to at least one programme session. In addition, lack of 
awareness of SM support programmes could be addressed by creating awareness of COPD 
among the general public – better recognition that COPD is a disabling disease might prompt 
patients to seek help and support.  
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The interviewees suggested promotion of SM programmes through adverts in several 
locations e.g. health website, in GP surgeries, day surgeries (patient admitted and discharged 
on the same day), hospitals, pharmacies and also suggested using the familiar and trusted 
staff in these locations to discuss the benefits of the programmes with patients. Using 
volunteers to promote the programmes was also proposed.  
 
The experts similarly stated that much initial work needed to be done with patients at an 
individual level to improve participation. Several suggestions were made; professionals 
should identify the appropriate patients for the programme e.g. at diagnosis, or using the 
Patient Activation Measure (PAM). The PAM scores could then be used to provide tailored 
support to individuals – this action was recently reported as a key message within the King’s 
Fund report of ‘supporting people to manage their health’.195 Building relationships with 
patients was recognised as important to identify what patients’ value in their illness journey 
and exploring their readiness to self-manage and to participate in SM support programmes. 
This is different to administering the PAM because the measure identifies patients’ ability to 
self-manage and how likely they may be to engage in healthy behaviours.195 However, only 
through building relationships would one be able to understand the reasons why a patient may 
not be ready to self-manage or engage in health behaviours and only then could appropriate 
and tailored support be provided or offered to the patient. This support could take the form of 
supporting patients to accept their condition, provision of information about the illness, 
promoting benefits of the programme and was referred to as ‘pre-work’ or an intermediate 
step prior to patients attending SM support  programmes. The suggestions given by patient 
interviewees above e.g. provision of motivation and encouragement to patients could be 
included within this ‘pre-work’ stage.   
Subsequently, the experts also suggested that, ideally, referral should be made by 
professionals interested and enthusiastic in SM and SM support programmes; the 
programmes should be pitched at the right level for the patient; and practical and logistical 
issues would need to be assessed and addressed. In addition, the experts recognised that for 
these suggestions to take place there was need for provision of training and support for 
professionals, integration of SM support into the routine patient care pathway and the 
promotion of evidence on the benefit of SM in COPD.   
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This alliance of patients and professionals working together, and the importance of building 
good relationships, mentioned in the qualitative study was also identified in the conceptual 
review chapter (Chapter II) as a key aspect of patient-centred care in a clinical setting, i.e. to 
encourage patient participation or encourage patients to become active by identifying their 
needs and preferences so they can participate in the management of their health and health 
care.55 Activated patients are more likely to engage in healthy behaviours e.g. taking regular 
exercise.195 Established relationships with professionals was what patients with chronic 
disease understood as patient participation in health care.188 This suggests that the role of SM 
support programmes  to teach patients skills to take greater responsibility for their health153 
might have to be the role of health professionals also, through the process of creating 
partnerships and building relationships with patients, to help them consider participation in 
these programmes. However, the latter may require a positive attitude and the acquisition of 
appropriate skills among professionals.363  
 
Moreover, there were several suggestions from both patients and experts to help improve 
uptake of the novel COPD-specific SM programme previously evaluated by the author.85 
Some of these suggestions could also be applied to improve patient uptake in PR. Patients 
suggested: where self-referral is not available it should be GPs who refer patients; use of a 
personal approach to invite and inform about the programme; use of trained staff to facilitate 
the programme; introduce talks by several experts e.g. smoking cessation experts could 
educate about the lungs, health psychologists could explain the importance of adopting health 
behaviours for the long term; the content should continue to include the topic ‘depression and 
COPD’ and omit the ‘living wills’ topic; reduce waiting time between invitation and 
attendance from two to four weeks; hold the programme outside of the ‘rush hour’; keep in 
mind that the concentration of a patient with COPD mainly lasts an hour or two; include light 
exercise with music; refer patients to PR or Breathe Easy at the end of the programme. 
 
The experts similarly felt that the programme should ensure patients remain engaged and 
stimulated; in addition, the programme should be flexible e.g. offer patients several 
programmes at various times and locations, and the journey to the programme should not be a 
challenge.  
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These findings above were not used to refine the existing COPD SM programme in this study 
because (a) organisational changes within the EPP CIC had led to redundancies including the 
lay tutor who had agreed to help with refinements of the programme; (b) the EPP CIC had 
stopped delivering COPD-specific programmes in the community unless they were 
specifically commissioned (c) and, most importantly,  the findings of all the work in the 
thesis to date suggested that  there needed to be radical changes to many aspects of the 
original programme, including recruitment, content and delivery, in order to improve 
participation.  
 
c) Other/Better ways patients with COPD could be supported to access SM 
Most patient interviewees felt that a group-based programme was still the best way to offer 
SM support to patients with COPD including housebound patients. This view mostly seemed 
to originate from their own positive experience of participating in group-based SM support 
programmes. In addition, apart from one interviewee who suggested use of ‘skype,’ most 
interviewees were not keen to see delivery of the programme over the phone, via a manual or 
technology e.g. DVD, internet - perhaps because of their own disinterest in, or dislike of, 
such approaches.  
The participants did recognise the importance of provision of individual support for 
housebound patients, who cannot, or do not want to, attend group-based programmes; 
however, they mentioned that offering the SM programme on an individual basis would be 
costly and felt it would not be sustainable in the NHS. Instead, some participants suggested 
that more efforts could be directed to get housebound patients out of the house so they could 
gain benefits from the programme; the resources e.g. one-to-one/a personalised approach 
could be focused upon introducing the programme and their benefits to patients and taking 
care of any practicalities. Few interviewees mentioned the use of existing services e.g. the 
REDS team to deliver support to housebound patients. The recent British Thoracic Society 
guidelines42 made a recommendation that housebound patients should not routinely be 
offered PR within their home due to insufficient evidence of benefit. Two non-technological 
options had been offered by other patient interviewees and they included have a 
person/specialist based in a GP practice that patients could regularly access for COPD-related 
queries and deliver sections of the COPD SM programme in Breathe Easy meetings. 
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Several experts were also either unsure or did not think the SM programme would be feasible 
or cost-effective to deliver to patients in an individual setting. They too felt provision of SM 
support via technology was not appropriate owing to patients’ lack of skills, lack of interest 
and insufficient evidence of benefit. Experts stated that identifying the best way to support 
patients with SM in a non-group setting needed further exploration and evaluation and 
perhaps it could mean spending more resources in the short term to see long term benefits e.g. 
professionals would need to be trained in communication and SM skills. The suggestions 
given to support housebound patients were similar to those given for improving patient 
participation e.g. there is need to ask about patients’ needs and beliefs, build relationships 
with them, get patients interested and relay the importance of SM, build confidence, and 
address unrealistic expectations about the programmes. A small number of participants also 
suggested linking SM services with smoking cessation services to sustain SM; and that 
integration of SM support into both health and social care services was important. Training in 
communication and SM support skills for all HCPs involved in COPD care and involving 
family members to support patients with COPD was suggested. This finding can be supported 
by studies24,356,364 that reported the majority of patients with COPD might be able to access 
improved SM support through delivery by their regular HCPs trained in communication and 
SM support skills. 
 
8.1.3 Stage 3: Adapting a non-UK developed SM support model for the UK 
(Chapter VII) 
A model of SM support, the ‘CENTREd’ Model was refined by Dr Helen Cameron-Tucker 
(H-CT) in Tasmania Australia, from an approach that had been evaluated in three studies by 
Walters340,356,357 (a colleague of H-CT). The three studies340,356,357 had evaluated a patient-
centred model that provided health mentor training to practice and community nurses that 
enabled provision of SM support to patients with COPD by telephone. The refinement and 
the uniqueness of the ‘CENTREd’ Model was the addition of the ‘SNAPPS’ Health-
Management framework with a holistic focus on health. The delivery of this SM support 
model in routine clinical practice by H-CT and colleague was observed. Following training, 
this model was refined and adapted for the UK (Chapter VII).  Specifically, the guidance for 
the ‘SNAPPS’ behaviours were replaced with the guidance from the Live Well, NHS Choices 
website 
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http://www.nhs.uk/livewell/Pages/Livewellhub.aspx (accessed 27-12-13) following 
discussion with a UK respiratory nurse consultant (based at St Georges Healthcare NHS 
Trust and part of the London Respiratory Team), and a COPD action plan developed and 
designed in the UK365 and recommended for practical use was added to the training manual.  
 
8.2 Strengths and Limitations of this thesis 
8.2.1 Strengths 
Patient participation in COPD SM support programmes is problematic and there was limited 
evidence to help understand the reasoning behind the problem and much less evidence on 
how it might be improved. Application of the MRC framework, to develop and evaluate 
complex interventions, in this thesis helped to gain further understanding about the problem 
of poor participation and how it might be improved. The balance of approaches used in this 
thesis may have been more towards developing a complex intervention (three reviews – 
Chapter II, III, IV and a primary qualitative study – Chapter V, VI) and not on evaluation of 
the intervention though, the approaches used were conducted in-depth and helped to inform 
the aims and objectives of this thesis.  
This doctoral thesis is original as it has shed light into an important but easily neglected topic.  
The conceptual review (Chapter II) led to the meticulous examination of the meaning of the 
term patient participation from different perspectives and for the first time the meanings have 
been subsumed broadly into an individual/patient level and a professional-patient interaction 
level. In addition, the review through use of health behaviour theories, helped understanding 
of the different behavioural factors that influence participation in ongoing SM services, the 
maintenance of SM behaviours, and participation in SM interventions (normally held in 
outpatients) among patients with chronic disease.  
A comprehensive quantitative systematic review (Chapter III) identified a ‘true’ estimate of 
study participation and completion rates in studies of COPD SM support by adopting 
definitions of patient participation. This exposed problems with previous work in the area. 
The definitions helped to clearly delineate the differences between the terms ‘participation’ 
and ‘attendance’; ‘non-participation’ and ‘non-attendance’ and these distinctions were 
followed where possible throughout this thesis. In addition, the lack of recording or reporting 
of participant flow data, including reasons for patient refusal, highlighted the scope for 
further understanding on the topic and this was achieved by the qualitative study (Chapter V 
and VI) in this thesis. 
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Use of the ‘best fit’ thematic ‘framework synthesis (Chapter IV) with application of theory 
(from Chapter II) as a ‘lens’ to view patient reasons for participation (attendance, non-
attendance, dropout behaviour) in the published studies of COPD SM support, suggested for 
the first time that the participation behaviour of patients with COPD was influenced by their 
beliefs or perceptions of their illness and treatment – these findings are novel and go beyond 
previous reports of socio-demographic or clinical factors. 
An original qualitative primary study (Chapter V and VI) was conducted to explore the topic 
of non-participation and how it might be reduced – a topic which has been suggested as a 
priority322 but which has received little research attention in terms of increasing 
understanding. In addition a health behaviour theory and a social theory (discussed in Chapter 
II) were used to explain some of the findings that were proposed to influence non-
participation in COPD SM support programmes (Chapter V). Furthermore, the suggestions 
given to improve participation went beyond the improvement of information flows about 
referrals to programmes among HCPs. 
The triangulation of findings around patient participation from these different sources led to a 
comprehensive, thorough, and considered examination of the research topic with extensive 
recommendations for improvement grounded in the findings of this thesis and support the 
research literature. 
The identification of a novel model of SM support, the ‘CENTREd’ Model, and its adaptation 
to the NHS suggest there is merit in conducting a further evaluation in the future with the 
possibility of implementation in the UK clinical practice.  
 
8.2.2 Limitations 
The initial intention of the systematic review (Chapter III) had been to calculate the 
participation and completion rates in studies of SM support programmes among patients with 
asthma and heart failure in addition to COPD however, the limited time to complete the 
review within the wider doctoral study led to the decision to focus only on COPD. In 
addition, the review calculated the participation proportions from effectiveness studies of 
COPD SM support programmes. In addition, while the data extraction included, ‘numbers of 
potential participants identified’ and ‘numbers assessed for eligibility’, the letter (Appendix 
3.1) sent to the authors of the included studies to obtain further information on the participant 
flow data had not included these two outcomes which may have contributed to the 
incompleteness of the data. However, the likelihood of receiving this additional information 
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was probably low as only 51% of the authors had responded to the request for more 
information and not all their responses included the participant flow data requested. 
Using a less structured approach to conduct a conceptual review (Chapter II) and lack of 
regular discussion with experts in the methodological/topic area could have led to omission 
of some key articles. In addition, the review focused mainly on health behaviour theories to 
help explain patient participation in SM interventions and little attention was given to social 
theories to help explain the research topic. Furthermore, the included studies had utilised 
either older or newer versions of the theoretical models and this might have limited the 
consistency of the findings to explain patient participation.  
In the qualitative synthesis (Chapter IV), the contribution of the six studies was unbalanced 
as none of the studies had individually explored reasons for attendance, non-attendance and 
dropout and none of the studies were underpinned by theory. The limited verbatim data in 
some of the included qualitative studies or the data being outside of the remit of the two 
theories, prevented the mapping of four subthemes onto the ‘best fit’ theoretical frameworks. 
Another limitation was that under the ‘best fit’ framework approach302 the health behaviour 
theories (adapted ASE model, the SRM-NCF) applied in the qualitative synthesis was the 
earlier/ or original version of the model that were used by Lemaigre184 and Keib181 in their 
study. Both these models have been further developed since the 1980s/90s and include 
several more theoretical constructs.13,316  
Exploring the topic of non-participation amongst patient stakeholders (Chapter V) mostly 
with good previous attendance in a SM support programme and with professionals (Chapter 
VI), instead of with patients who had refused to participate in the programme might limit the 
transferability of the findings to non-participants in a study of a SM intervention or the 
intervention itself. In addition, several expert interviewees felt that there was still a lot to 
learn about the topic of how participation might be improved, or how patients with COPD 
might be supported to access SM support other than in a group-based setting and voiced the 
need for further evaluation. Due to the limited evidence on these topics in COPD, efforts 
should be made to evaluate the suggestions given to improve patient participation in this 
thesis to build the evidence base.  
 
8.3 Results in context of other studies 
Comparison with other literature about patient participation (attendance, non-attendance, 
dropout) behaviour 
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Only one other study366 was identified that applied the MRC framework. This study aimed to 
improve the low attendance rates reported in studies of cardiac rehabilitation (CR) 
programmes among coronary heart disease patients (where fewer than 35% of eligible 
patients take part). Mosleh367 developed and piloted a theoretically worded patient letter 
(based on the Self-Regulation (SRM) and the Theory of Planned Behaviour (TPB)) among 
patients approached in hospital wards. The letter was targeted in response to patient 
behaviour i.e. patients failing to attend after invitation, and patients’ negative illness beliefs. 
Sixty eight per cent of patients (n=375) were recruited into the study. The study findings 
demonstrated that the letter significantly increased patient attendance to 84%, in comparison 
to 74% in a control group receiving a standard letter (odds ratio 2.93, 95% CI 1.56-5.56). The 
number needed to treat was 9 (95% CI 7-12). The attendance rate was acknowledged as being 
higher than usual for CR. On assessing the patients’ illness perceptions, among the 
programme attenders, a patient’s increased perceived ‘identity’ (attributing symptoms to the 
illness) was also significantly associated with attendance. The latter has been reported 
previously to influence CR attendance among hospitalised patients.177  
 
In addition to Mosleh’s study, several studies173,174,177,179,180 have utilised the SRM and the 
SRM-NCF (Necessity-Concerns Framework) to predict/explain attendance and non-
attendance in cardiac rehabilitation among coronary heart disease patients (Chapter II). This 
thesis, on application of the SRM and the SRM-NCF behaviour change theories in the 
qualitative synthesis (Chapter IV), consistent with the findings of studies of cardiac 
rehabilitation in the conceptual review (Chapter II), identified that particular COPD illness 
perceptions (‘perceived controllability’, ‘perceived consequences’, ‘perceived identity’) and 
treatment perceptions including ‘perceived necessity or concerns’ were associated with the 
full range of participation behaviour (attendance, non-attendance and dropout behaviour) in 
COPD SM support programmes. And On application of the adapted Attitude-Social 
influence-External barriers (ASE) model, again in line with Lemaigre’s study,184 participation 
behaviour was shown to be influenced by a patient’s ‘attitude’ and perceived ‘social 
influences’. As a result, assessment of beliefs/perceptions about the illness and intervention 
among patients with COPD could prove helpful when predicting attendance at SM support 
programmes.  
However, the time of assessment of patient perceptions in their illness journey may also be 
important in predicting attendance in SM support interventions. This thesis (in Chapter II) 
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identified that while illness perceptions predicted attendance in outpatient cardiac 
rehabilitation programmes offered to patients in hospital or following hospital 
discharge,174,177,182 patient perceptions did not predict attendance in maintenance 
programmes;170 Sniehotta170 suggested  one explanation for the latter was that patient 
perceptions may change over time. A recent study368 also found that patients with coronary 
heart disease who had been invited to participate in the EPP, a year after their cardiovascular 
event, refused to participate - perhaps because they were in better physical condition (or 
perceived fewer ‘consequences’ from their illness). However, this may not be the same for 
patients with COPD due to the progressive and deteriorating nature of their condition and 
regular assessment of perceptions of patients with COPD has been suggested by other studies. 
318,319 This thesis further proposes targeting the negative patient perceptions (as they are 
amenable to change)13 with a view to improving patient participation. Therefore adaptation of 
the existing illness and intervention questionnaire13,180 for COPD might be useful. 
In this thesis, exploration of patient stakeholders’ reasons for attendance and drop out at SM 
support programmes (Chapter V) were consistent with reasons reported in previously 
published qualitative studies122,304,305,309 (Chapter IV). A novel reason given by one 
participant for attending the SM programme was to remind oneself of skills they had learned 
in PR over a year ago and forgotten over time. A recent study reported that COPD patients 
with a diagnosis of more than five years are at an increased risk of mild cognitive decline369 
and so would benefit from having more regular follow up with regard to their management.370 
 
Regarding dropout behaviour, another new reason proposed by a few patient interviewees 
was poor communication and facilitation skills in those leading the groups. Although having 
good programme facilitation has been cited previously as important for SM programme 
engagement and adherence by patients with chronic disease.371 While, a new reason proposed 
for drop-out from PR in this thesis was staff being too busy to give sufficient individual 
attention to participants. These participants, according to expert interviewees, could be those 
who lacked understanding about what the programme entails or might not be ready to self-
manage or could not perceive any benefits. Hence, these patients might benefit particularly 
from individual attention, at least initially, as staff supervision and support has previously 
been reported as a reason for patient adherence and completion of PR.305 Another drop-out 
reason cited in the study (Chapter V and VI) in this thesis was inappropriate PR venues, a 
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previous study115 has reported transport difficulties and longer travel time to get to the 
programme as reasons for PR non-completion. 
 
The new suggestions identified in this thesis mentioned above could also be explained by the 
SRM, SRM-NCF and the adapted ASE model. The behavioural constructs of the SRM and 
the TPB (particularly the attitude and subjective norm constructs of the TPB) that were used 
by Mosleh to create the letter that improved attendance in CR367 helped to explain both 
attendance and dropout behaviour among COPD patients in this thesis (Chapter IV). As a 
result, there may be scope to target the letter (following refinements) to improve patient 
retention in SM support programmes. For patients with COPD, Mosleh’s letter367 may also 
need to incorporate the SRM in relation to ‘intervention representations’ e.g. lack of 
perceived benefits and the SRM-NCF ‘perceived necessity’ and ‘perceived concerns’ 
constructs e.g. prior commitments or lack of transport because these constructs influenced the 
attendance and dropout behaviour of COPD patients in this thesis. Physical/practical barriers 
are recognised problems of attendance among patients with chronic disease including COPD 
in SM interventions.220,311 These barriers were included among the reasons that had been 
suggested in this thesis for non-participation in SM support programmes. Understanding 
barriers to participation and how it might be improved was also a focus of this thesis and is 
discussed next.  
 
Comparison with other literature about patient non-participation 
Mosleh367 had a high study participation rate (68%). The participants were approached about 
the study in hospital wards by nurses/physiotherapists and interested participants were 
provided with written and oral study information by the research team. This approach is 
likely to have contributed to the high participation rate; telephone or face-to-face as 
recruitment has been reported previously to improve participation in behaviour change 
interventions.372,373 In comparison, the systematic review in this thesis also found high study 
participation rates in studies of SM support programmes and in over 40% of the studies 
(where reported) the mode of invitation had been verbal/face-to-face. However, this may 
differ in routine care on the ground. Patients with COPD are normally referred to PR by 
professionals based in secondary or primary care via a letter with, or without, prior discussion 
when their condition is stable116 or immediately after hospital discharge following  an acute 
exacerbation.317 On receiving the letter patients with COPD are requested to ring up for an 
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appointment to attend PR assessment but many do not even make an assessment 
appointment113 and (Timi Ogunlowo. Lead Respiratory Physiotherapist. Personal 
communication 2013). The requirement to ring up for an assessment was cited in the 
qualitative study in this thesis as a factor that might predispose to non-participation in a SM 
support programme.  
Mosleh’s367 theoretically constructed invitation letter could be used to recruit patients in 
COPD SM support programmes and for some individuals the letter (without any prior 
discussion) may be enough to address negative beliefs, reassure and motivate them to 
consider participation. However for some the letter on its own may not be enough to boost 
participation.  
 
One explanation for potential differences in response between patients with coronary heart 
disease and those with COPD is the socio-demographic differences between patients with 
these two conditions, for example, in Mosleh’s study,367 the mean age of the study 
participants was 62.5 years; 69% were male; 72% had suffered a myocardial infarction and 
only 10% lived in the most deprived areas. The CR programme attenders were younger, 
employed and less likely to have hypertension. In comparison, COPD tends to be a disease of 
the elderly374 with low socio-economic status375 and widely reported to have poor literacy and 
health literacy.376 Secondly, the patient non-participation reasons in COPD SM support 
programmes cited by both patient and expert stakeholders in this thesis suggest that these 
individuals might benefit more from interaction and discussion with a HCP rather than 
receiving a (theoretically constructed) letter. Key patient-related reasons for non-participation 
identified in this thesis included: patient not ready to help themselves, self-manage or change 
behaviour; in denial of their illness or just resigned to living with the illness; reluctance to try 
anything different to usual care or feel entitled to be a burden; prolonged inactivity due to the 
nature of the condition and hence reluctance to try anything new; negative illness beliefs, 
including negative emotional reactions, result in loss of motivation to do anything 
particularly any physical activity and loss of confidence to venture out alone to a programme 
considered new/strange; negative treatment beliefs or lacked understanding about COPD and 
its treatments – all of which may not be easily addressed by a letter alone.   
 
Before discussing how non-participation could be addressed it was useful to compare the 
above non-participation findings with patient reasons cited for non-participation in previous 
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studies of SM support programmes. Sanders338 explored barriers to participation in a study of 
tele-health services among patients with chronic disease including COPD. Non-participation 
reasons included many patients being uncomfortable, or not knowing how, to use the 
technology and the finding that some would have preferred to speak to someone in person 
supports the findings of this thesis. Bower377 explored refusal to participate in a study of the 
EPP, the reasons given comprised of: not wanting to  receive the intervention; having 
received it previously; and the intervention being unsuitable or inconvenient. Reasons for 
refusing to participate in a study of PR114 included lack of perceived benefits of exercise, and 
physical and practical barriers. In addition, two studies224,377 also explored reasons for 
participation in studies of SM support programmes and altruism was the dominant theme in 
both studies. The latter has been reported as a major reason why people take part in 
research.378 Willis224 explained that some patients with COPD participated in the study of SM 
support because although they believed they could not make their own life better they wanted 
to help others. Hence, the same author suggested that potential participants should be 
encouraged to believe that participation would be not only of direct benefit to them but also 
future generations. Discussion about the benefits of SM support programmes was suggested 
in this thesis to help improve participation or address non-participation in SM support 
programmes. Some studies have suggested that patient recruitment for SM interventions may 
benefit if recruitment is conducted face-to-face in routine consultations by HCPs.85,368 
 
Comparison with other literature about improving patient participation 
In this thesis the findings around improving participation include suggestions on what could 
be done now to boost patient participation. To avoid duplication, these practical suggestions 
are compared with other relevant literature, and denoted by an arrow symbol, in this section 
rather than being discussed in the implications section of this chapter (section 8.5).  
 
Both patient and professional participants in this study suggested methods or processes to 
help improve patient participation aimed at HCPs. These involved: identification of the right 
patients e.g. through use of the PAM or at the right time e.g. at diagnosis; building 
relationships with eligible patients, identifying what they value and exploring whether they 
are ready for SM or ready to participate in SM support programmes in their illness journey; 
carrying out ‘pre-work’ among patients not yet ready e.g. supporting patients to accept their 
condition, providing information about their illness; building confidence, motivating and 
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encouraging participation in programmes by discussion of programme benefits e.g. via 
professionals, peers, home visits, DVD, or by invitation to a trial session. 
 In a recent report195 assessing the activation level of patients via the PAM measure it 
has been suggested that this measure helps identify patients who might or might not 
be receptive to SM, or even to shared decision-making.195 The PAM score could then 
be used to provide individualised and appropriate support195, for example, a patient 
with a low activation score (less than level 2, see page 93) may not want to/may not 
be ready to participate in a SM support programme - in this case the health 
professional may have to work with the patient one-to-one on an issue important to 
the patient and provide support and follow up until goal achievement before moving 
to the next step.  
 
According to a recent study152 ‘SM is a process of continuing learning within the life context 
of a patient living with chronic disease’. 
 This might require all HCPs to support patients holistically to address how patients 
live and reduce limitations as a result of living with the chronic condition.152 
One study214 reported that patients with chronic disease are most keen to learn about their 
condition and its management, and are receptive to SM education soon after diagnosis. 
Similarly, in COPD, it has been suggested30 that patients may be more receptive to ‘teachable 
moments’ and accept SM education, PR and smoking cessation strategies soon after suffering 
an acute exacerbation. In the qualitative study in this thesis one recently diagnosed patient 
was very keen to participate in a COPD SM programme despite having completed PR 
previously and would have liked to receive the SM programme soon after diagnosis. This 
eagerness/interest to learn about the condition and management soon after diagnosis has been 
explained by patients becoming overwhelmed by the many changes that they be asked to 
make soon after diagnosis.214 Another study53 has proposed three patient characteristics 
which make them suitable for referral to SM programmes: low health-related quality of life, 
active engagement in life (e.g. plans to do enjoyable things) and low self-efficacy, as an 
improvement in health-related quality of life and self-efficacy were seen among these patients 
following completion of the programme.53 However the same author acknowledged that 
people who are disempowered, have worse health and fewer resources were more likely be 
less engaged and not referring these patients could increase health or social inequalities.  
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 This suggests that perhaps more efforts might need to be made with less engaged 
patients prior to programme attendance through building relationships. 
 
Building relationships with patients,350 concentrating on the individual concerns of patients 
with COPD,351 and being responsive to patient-family needs352 have so far been suggested in 
studies to engage patients in self-management per se, but have not previously been proposed 
for promoting engagement in SM interventions. However, one aspect of patient self-
management may include making the decision to participate in SM interventions.198  
 
To improve participation, patients’ concerns or needs might need to be addressed which 
could take the form of professionals’ ‘pre-work’:  
 prioritising discussion of COPD and its treatment with patients379 prior to patient 
referral,379 or when considering patient referral, during consultation with the patient;  
 supporting patients to accept their condition which may involve helping patients to 
understand their limitations or losses as a result of their condition and adjusting their 
expectations of what is realistic and achievable;380 and/or  
 motivating and building confidence which might involve using a holistic approach to 
identify what is important to patients, helping them set realistic/specific goals using 
goal-setting skills and developing action plans by using action planning and problem 
solving skills to achieve the set goals (premise of the ‘CENTREd’ Model, Chapter 
VII).  
 
Motivating patients to encourage participation with pamphlets or during home visits has been 
suggested to improve participation in CR220 and the use of lay health workers to support 
patients following patient referral has been suggested for PR100 while in this thesis,  
 the opportunity to bring a friend, family member, informal or formal carer to at least 
the first session of the programme was also suggested as an avenue to encourage 
participation. The latter might be particularly helpful to patients who are fearful, 
nervous, lack confidence to leave the house on their own, or might be uncomfortable 
to go into a new environment and meet strangers.122 
 
Actions which might be useful to conduct prior to, or during patient referral to improve 
patient participation are discussed above, however it remains necessary for HCPs to:  
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 consider referring eligible people to COPD SM support programmes in the first place. 
 
Lack of referral to SM interventions has been identified as a problem in the literature367 and 
was also cited as one of the health system factors influencing patient participation in this 
thesis. Factors that could affect patient referral identified in this thesis were:  
(1) lack of enthusiasm/support for SM among HCPs including lack of integration of SM into 
the COPD patient care pathway;  
(2) lack of understanding about the role of SM and programmes e.g. due to insufficient 
evidence for SM in COPD;  
(3) lack of communication between professionals in primary and secondary care and between 
programme staff and professionals; and  
(4) organisational/administrative problems.  
 
Some of these findings are consistent with findings from other studies116,218 that explored the 
barriers to PR referral among primary care professionals. In summary, the barriers identified 
by these other studies were: limited knowledge of PR; lack of understanding about how 
promotion of exercise can be beneficial or the importance of PR for COPD management; and 
lack of enthusiasm while informing patients about PR.116,218,362 Compared to PR, the 
usefulness or importance of SM programmes for COPD has been given little regard, or even 
rejected, in primary care.368 In particular, reports of inconclusive evidence of benefit for 
COPD SM programmes,84 reported by several expert interviewees in this study, and a study 
suggesting harm50 based on negative findings of two studies105,381 presumed to be of SM 
programmes (but in actuality disease management interventions51) could have created further 
disinterest among primary care professionals. Furthermore, some experts in this thesis 
(Chapter VI) cited that programme staff find it difficult to discuss the benefits of SM support 
programmes with patients over the telephone which could also lead to patient non-
participation.  
 
 To increase patient referrals to SM support programmes, particularly from primary 
care this thesis suggested utilising professionals interested in and enthusiastic about 
SM; pitching the programme at the appropriate patient level and assessing patients, 
and trying to address any practical and logistical difficulties that might impact 
attendance. Other suggestions included: provision of information about the 
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programme benefits to professionals and training for professionals to improve 
referrals; SM needs to be integrated into the patient care pathway; and evidence of 
benefit for SM in COPD needs to be promoted. Previous studies116,218 have proposed 
improving information flow about referrals and services and a recent Australian 
study suggested making PR part of standard care through financial incentives to 
enhance PR referrals.218  
 
PR has been reported to be one of the least implemented guideline recommendations for 
COPD management in primary care.382 In the UK, PR is considered a mainstay treatment for 
patients with COPD in health policy guidelines42,43 and research studies100 but it is principally 
recognised as standard care for patients with COPD by secondary care professionals rather 
than by primary care professionals.30,218,311 The Quality and Outcomes Framework (QOF) 
includes a COPD indicator that records “The percentage of patients with COPD with a 
record of FEV1 in the previous 15 months (COPD 10)”, to help GPs identify potential 
patients who could benefit from PR. There was a plan in 2013/2014 to have a new indictor 
for direct recording of percentage of PR referrals by primary care; however, this plan has now 
been deferred for another year http://www.nhsemployers.org/your-workforce/primary-care-
contacts/general-medical-services/quality-and-outcomes-framework/changes-to-qof-201415 
(accessed 13-5-14). This could further impact patient participation in PR with already poor 
patient referral to PR observed in primary care (Stephanie Taylor, Personal Communication, 
2014). 
 Instead, perhaps the following support among professionals could help to address 
some of the referral problems cited above: education to create awareness about the 
importance of SM in COPD;85 promote the recent evidence of benefit for SM in 
COPD;359 reiterate the positive evidence of PR to help professionals become aware of 
its benefits218; recognise the importance of PR in COPD;30 and stress that patients 
who do participate in SM support programmes do attend and complete these 
programmes.361  
 One study participant also cited that professionals need to ‘believe’ in the benefits of 
SM support programmes so they can positively influence patients to participate in the 
programmes which could help to improve patient participation. This may be achieved 
if professional peers or local commissioners championed the benefits of SM in 
COPD through discussion, education and perhaps even drafting suitable local 
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policies. Using local commissioners to stress PR referrals in primary care has been 
suggested previously.100 
 It is important to note that stressing the benefits of programmes to improve patient 
referrals may be futile if HCPs remain unaware of service provision.341 A survey341 
examined the extent of PR programmes across the UK and revealed that about 58% 
of acute units had access to PR for eligible patients. The units lacked access due to 
several funding and organisational issues (e.g. no funding, unit not being aware of a 
PR service, programmes not running due to lack of staff, PR not available for all 
postcodes, patients get PR if referred from hospital but not from GP). If all 
professionals involved in patient referral could be provided with a list of all locally-
based SM support programmes, and if they are made aware of any changes to 
availability (e.g. services closing down) this could help to improve the information 
flow about referrals and services for both primary and secondary care. In addition, 
involving the referring health professional in the programme may increase 
understanding about patient eligibility and lead to confidence in wider referral to the 
programme85,220 and could also help to improve communication between programme 
staff and HCPs as the latter was identified as a barrier to participation in this thesis.  
 Moreover, that the venue of SM support programmes needs to be local to the patient 
cannot be emphasised enough. The cost of transport was cited as a concern by some 
of the patient interviewees. The burdensome journey to PR previously reported100,114 
was also identified in this thesis (Chapter V and VI). 
 
 Wider awareness of COPD SM support programmes among the general public was 
also suggested by several patient interviewees so that more people with COPD could 
consider seeking help and possibly participate in these programmes. The 
interviewees proposed for example, putting posters in hospitals and GP surgeries, 
using a health website, TV and also involving people in places that patients with 
COPD normally frequent and trust such as, GP surgeries, hospital, day centres and 
pharmacies. To date, the lack of awareness about COPD and PR programmes has 
only been reported by professionals116,218 as a barrier to communication about the 
benefits of the programmes. Johnston218 suggested media e.g. YouTube to promote 
awareness of COPD and PR. A recent editorial374 also suggested directing patients to 
the British Lung Foundation website to find out more about PR. 
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 The qualitative section of this thesis also recommends several components to help 
improve patient attendance and retention to the existing COPD SM programmes as 
(section 8.1.2; Chapter V, Chapter VI) additions to previously proposed 
suggestions.122  
 
Comparison with other literature about supporting patients with their SM other than in a 
group-based setting  
Despite all efforts to improve participation, both expert and patient interviewees 
acknowledged that some patients with COPD might still not want to participate in 
group-based programmes. Both patients and experts felt it was important to support 
housebound patients at home however, delivery of the SM programme at an individual level 
either through technology e.g. internet, DVD, telehealth, video or face-to-face was not the 
answer according to most interviewees because it would be costly to the NHS and hence 
would not be sustainable.  
 
In comparison, Beswick220 reported that home-based programmes should only be aimed at 
patients who are motivated and unable to access group-based programmes; these programmes 
should not be a substitute for patients with low motivation or who lack interest. Hopkinson374 
advised caution in relying too much on internet-based strategies as these may exclude many 
patients with COPD due to lack of use/access. Jaglal,383 on evaluation of a tele-chronic 
disease SM programme among patients in rural and remote communities, found 
improvements in self-efficacy, health behaviours and health status similar to the traditional 
group-based programme and thus advocated this approach for patients unable to access 
group-based programmes. Fairbrother384 suggested that professionals saw SM only as patient 
compliance in the context of telemonitoring and the study called this ‘compliant self-
management’. Dinesen’s study 385 of tele-rehabilitation among patients with advanced COPD 
identified that although patients had initially committed to learn about the new technology 
and perform exercises at home, the performance of exercises varied as a result of the physical 
and emotional limitations felt daily due to changes in their illness As a result, Dinesen 
suggested that these patients would benefit from regular assessment to help identify the right 
intervention or support and also who will most benefit from tele-rehabilitation. Perhaps 
patients with advanced COPD might benefit from, or would be more suited to, receiving one-
to-one support.  
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 Both patients (from their positive experience of SM support programmes) and 
professional interviewees in this thesis suggested that a better use of resources might 
be to support housebound patients individually initially so appropriate support could 
be provided, or until they felt comfortable or ready to self-manage and, that at this 
point they might even consider participation in group-based SM support programmes.  
This view of working with patients individually to improve participation has been discussed 
in the earlier section and could be applied to housebound patients as well. Some experts in 
this thesis further suggested that, instead of offering a one-off group-based programme to 
support patients with their SM (also reported elsewhere,85,386):  
 SM needs to be integrated into the existing health and social care services to “make 
every contact count”. Others felt that integration of SM into existing services might 
be a slow and gradual process, and costly in the first instance, as this would require 
professionals to work with patients more intensely, in particular with those who might 
be anxious, disinterested or not ready, recently diagnosed or housebound.  
In addition, a few experts mentioned that provision of training in patient engagement, 
communication, and SM support for all professionals who care for patients’ with COPD 
would be a sustainable option in the long-term. 
 
Currently, the provision of SM support for patients with COPD other than in a group-setting 
is aimed at or is the responsibility of nurses within chronic disease management.16,152,387  
 However, the role of facilitating SM and being supportive152 can be difficult for 
nurses without appropriate training.387,388  
Very limited evidence exists on interventions at the level of HCP220,367 to improve patient 
participation in SM interventions. Mosleh367 identified health system factors to affect 
participation in CR however, they chose to improve patient attendance by placing focus on 
patient-related factors and devised a simple and inexpensive intervention (theoretically-
constructed letter). Based on the findings of this thesis, the letter would have not have been 
sufficient to improve patient participation in COPD SM support programmes. In contrast this 
thesis suggests intervening at the level of HCPs particularly by exploring the acceptability 
and feasibility of the ‘CENTREd’ Model of SM support among both UK respiratory nurses 
and patients with COPD. Reasons being, the evaluation of the ‘CENTREd’ approach in study 
by Walters356 showed that primary care professionals recognised that the model was about 
involving patients in decision-making, identifying patient agenda through effective 
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communication and prioritising patient choice and this approach of partnership working and 
supporting patients with COPD is a key suggestion given in this thesis to improve patient 
participation in COPD SM support programmes. However, recognising the importance of 
partnership working might not be enough for its routine implementation because this thesis 
also identified several health system factors e.g. the lack of integration of SM into the COPD 
patient care pathway that would need to be addressed, also reported elsewhere,389 to facilitate 
the partnership style of working, to help improve participation in SM support programmes. 
This might require: 
 creating a wider, general awareness of principles of chronic disease management390 
that includes SM support among different levels of the health system. 
 The practice culture may also need to recognise that change takes time391 for example, 
allowances need to be made initially for the new style of working between patient and 
professional or until the delivery of SM support becomes routine. 
 
8.4 Overall conclusions 
Poor participation and retention rates in PR programmes have been well documented in the 
literature however, this doctoral study arose as a result of poor study participation rates in a 
study of COPD-specific SM programme. Thus, understanding the problem of participation in 
COPD SM support programmes with a view to improving participation in these programmes 
and identifying other suitable ways patients with COPD could access SM support was the 
focus of this thesis. Key findings from each chapter have been drawn together to produce an 
explanatory model of barriers to participation and how it might be improved (Figure 8.1). 
 
In conclusion, non-participation and other related aspects of participation (attendance, non-
attendance and dropout behaviour) in COPD SM support programmes could be influenced 
by: 
 socio-behavioural patient factors e.g. resignation to illness, negative illness beliefs 
which may change over time due to changes within the illness journey of a patient; 
 organisational issues e.g. provision of insufficient information about the programme, 
poor facilitator skills, an inaccessible location; and  
 health system factors e.g. lack of support from primary care/lack of integration of SM 
in to the patient care pathway, lack of understanding about the role of 
SM/programmes among professionals  
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Patient participation in COPD SM support programmes could be improved by addressing the 
patient socio-behavioural factors through carrying out improvements in the health system and 
the programme organisation. Addressing health system factors would help patients to 
participate in their care (become ‘activated’ or ‘engaged’) which could include making a 
decision to participate in a SM support programme.  
Specifically, at the level of the patient-professional interaction this would involve: 
 identifying the right/eligible patients for the programmes; 
 building relationships with patients to identify what they value or need and to assess if 
they might be ready to participate in their care including participation in a SM support 
programme or another type of intervention; 
 carrying out ‘pre-work’, among patients who might not be ready to self-manage or 
participate in the programme, to help them get ready to participate in their care and in 
a SM support programme. Here the ‘pre-work’ could involve supporting patients to 
accept their illness, providing more information about the illness, encouraging 
participation by motivation, building patient confidence and discussing the benefits of 
SM and the programme. This stage would also be useful for patients who cannot or do 
not want to access SM support in a group-setting.  
 making appropriate referrals to the programme which could involve pitching 
information about the programme at the right patient level, addressing any unrealistic 
expectations about the programme and assessing and addressing any practical or 
logistical difficulties. Referrals would likely improve if they were made by 
professionals who were aware of the benefits of SM and the programmes for their 
patients. 
To facilitate the above patient-professional interaction wider health system improvements 
would need to made such as: 
 provision of training to change the practice style of professionals to include 
communication and SM support skills (through the ‘CENTREd’ Model) to help with 
patient engagement, negotiation and carrying out ‘pre-work’ in accordance with 
patients’ needs. Plus provision of follow up support for trained professionals to enable 
the implementation of the learnt skills in routine care with confidence; 
 better communication to HCPs about the availability of the programmes and the 
referral process involved;  
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 better communication between various professionals at different levels of the health 
system including with programme staff; and 
 wider promotion of SM support programmes and their benefits among HCPs and 
integration of SM into the patient care pathway 
 wider awareness of COPD among the general public including the medical profession 
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Figure 8.1 Explanatory model of barriers to patient participation and how it might be improved 
 
A
t th
e lev
el o
f p
atien
t-p
ro
fessio
n
al in
teractio
n
 
Non-participation could be influenced by 
patients’: 
- resignation of illness and in denial of illness; 
- negative illness and treatment beliefs 
including negative emotional reactions  
- health system factors 
- programme organisational issues 
Participation (attendance, non-
attendance, dropout) can be influenced 
by patients’: 
- attitude and social influence 
- illness and intervention perceptions  
But patients’ beliefs or 
perceptions may change over 
time due to changes in the 
illness journey    
Can result in patient 
participating in their 
care 
Record and report the participant flow data to calculate participation and completion rates 
T
o
 im
p
ro
v
e p
atien
t p
articip
atio
n
 
Professionals 
enthusiastic about SM to 
refer patients 
Carry out ‘pre-work’ to 
support patients with 
their SM so patients 
consider participation 
in care including in the 
SM support programme 
Build relationships to 
identify patients’ values, 
wants and needs and if 
they are ready to 
participate in SM and 
programmes 
Identify the right/eligible 
patients e.g. at diagnosis   
Pitch patient invitation 
at the right level of 
patient, assess and 
address programme 
expectations, 
practical/logistical 
difficulties, and offer 
patient to bring a family 
member or carer to the 
programme 
F
acilitatio
n
 o
f a p
artn
ersh
ip
/p
atien
t-cen
tred
 ap
p
ro
ach
 w
ith
 in
clu
sio
n
 o
f S
M
 su
p
p
o
rt 
Provision of 
training and 
ongoing 
support for 
professionals 
to facilitate 
partnership 
approach 
 
Integration 
of SM into 
the COPD 
patient care 
pathway 
 
Promotion of 
SM and their 
benefits for 
patients with 
COPD 
 
Better 
communicati
on between 
professionals 
including 
programme 
staff  
 
W
id
e h
ealth
 sy
stem
 im
p
ro
v
em
en
ts P
L
U
S
 W
id
er aw
aren
ess o
f C
O
P
D
 am
o
n
g
 th
e p
u
b
lic an
d
 p
ro
fessio
n
als 
p
u
b
lic ah
 
Programme organisational 
improvements e.g. structure, 
content, trained staff 
Best way to support 
patients with their 
SM other than in a 
group setting 
through use of 
trained staff 
- Programme organisational 
factors e.g. inadequate 
facilitation skills insufficient 
support 
Key: Barrier to participation Facilitator to participation 
Wider 
awareness of 
COPD  
  343  
 
8.5 Implications for clinicians and policymakers 
8.5.1 Implications for clinicians 
Understanding the reasoning behind the participation and non-participation behaviour of 
patients with COPD in SM support programmes has important clinical implications. In 
addition, this thesis provides HCPs with insights into the process that is needed to support 
patients with COPD to improve their participation behaviour. This process has been 
discussed at length in section 8.3 (denoted by the arrow symbol).  
Based on these findings, to improve participation, patients with COPD need to be supported 
in coming to terms with their illness, they need to understand that their condition can be 
controlled and managed and that they can still achieve things important to them. They need to 
understand the importance of and the benefits of SM support programmes for the 
management of their condition. Alongside, practical/logistical difficulties related to 
attendance need to be addressed where possible.  
To achieve this, clinicians should promote patient-centred care or encourage patients with 
COPD to participate in their care by showing commitment and engaging patients (through 
use of communication/motivational interviewing techniques and listening skills) and 
identifying what patients’ value, want or need to better manage their condition and overall 
health and assess if they might be ready to manage their condition or to participate in a SM 
support programme (the patient activation measure could be used to assess if patients might 
be ready to self-manage). Health care professionals should relate patients’ wants and needs to 
target key health or SM behaviours and discuss with them where they are with these 
behaviours and what if any they would like to address or build upon. 
If a patient is ready to participate in the SM support programme, information about the 
programme should be pitched at the right level of the patient and assess and address, where 
possible, practical or logistical difficulties (e.g. if anxious reassure and make patient feel 
comfortable, allow them to bring a family member, friend or carer to at least the first session 
of the programme) and make appropriate referrals. If a patient is not ready to self-manage or 
to participate in a SM programme, identify the reasons, address the negative beliefs towards 
the illness and the programme, negotiate and support the patient (through use of motivational 
techniques and SM support skills) with their SM by linking to things that is important to the 
patient and that they would like to and realistically could achieve. This should be followed 
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until the patient feels ready to participate in the SM support programme and make appropriate 
referrals. 
In addition, clinicians should recognise that patients’ perceptions of their illness including 
treatments may change over time owing to the progressive nature of their condition and its 
impact which might affect day-to-day management. As a result, these patients might benefit 
from regular assessment so the appropriate support can be provided which may include 
referral to a SM support programme or another intervention. 
 
To enable HCPs to provide patient-centred care including SM support, provision of training, 
ongoing supervision and support should be made available. To ensure smooth patient 
referrals to SM support programmes there needs to be wider promotion of benefits of SM and 
SM support programmes, integration of SM into the patient care pathway and better 
communication between clinicians working at different levels of the health system including 
programme staff.  
Lastly, the SM support programme would need to be available and accessible to patients with 
COPD and be delivered by trained staff.  
 
Regarding improvement of participation rates in clinical services – for example, a study113 
that evaluated the effectiveness of a clinical PR service, 27% of eligible patients failed to 
attend (declined/did not attend) a PR assessment, nearly half (47%) of patients assessed for 
PR did not attend PR and 60% of those referred failed to complete the treatment. Clinical and 
socio-demographics factors could only explain a small proportion of the variance in 
attendance and completion. The study highlighted the need to gain patients’ perspective and 
explore how patients were prepared for PR.  
Based on the findings of this thesis, understanding the reasons why eligible patients might 
decline or not attend a PR assessment and then addressing those reasons through professional 
innovations and indeed the wider health system making changes towards a patient-centred 
care approach with inclusion of SM support could begin to make a difference in the 
participation and completion rates of the PR service. However, this can only be assessed in a 
future evaluation. 
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8.5.2 Implications for policy makers 
Policy makers may be encouraged that HCPs have begun to recognise the importance of 
patient-centred care and provision of SM support for patients with COPD. However, policy 
makers need to be aware that without health system improvements suggested in this study the 
routine implementation of patient-centred care including SM support may remain the 
exception rather than the rule348 Supporting professionals to support patients is essential as 
this study has shown that patient participation in their care can be influenced by a variety of 
patient, professional and health system factors. 
While the recent BTS guidelines42 for PR have recommended clinical PR services to 
calculate patient uptake, adherence and completion rates, the guidelines could further 
recommend adoption of patient participation definitions to help calculation of the 
participation rates. The clinical services could either adopt their own definitions or the ones 
used in this thesis.  
The adoption of rigorous definitions and application of quantitative methods helped to 
identify high study participation and completion rates in studies of SM support in this thesis – 
this encouraging finding should be helpful in continuing the commissioning of SM support 
programmes for COPD patients.361  
Commissioners involved in setting up local polices could help improve patient referral to 
COPD SM support programmes by altering health professional beliefs towards SM, stress the 
importance of SM and SM support programmes for their patients through education and 
clinical guidance; setting up decision and reminder prompts to refer eligible patients; and 
motivating professionals through evaluative feedback and comparing individual GP practice 
performance relative to peers also based locally. This approach was proved successful for 
increasing appropriate prescribing and reducing inappropriate prescribing among GPs in a 
recent study.392 Financial incentives could also be used to support and improve patient 
referrals.392 
 
8.6 Future research recommendations 
Future research studies should provide clear and rigorous definitions when reporting patient 
participation, enabling a ‘true’ estimate of patient ‘participation rates’ and avoiding confusion 
amongst readers. To calculate ‘participation rates’, it is important for research studies of SM 
support programmes to record and report detailed participant flow data. It is essential for 
studies to report these data to help HCPs interpret the study results and to decide if the results 
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could be applied to their patients.285,286 A recent study393 has also recommended research 
studies have an a priori definition of a programme completer with explanation for the number 
of sessions chosen as a pre-determined dose to help clinical services that might be developing 
or delivering exercise-based programmes for patients with COPD. 
Studies, until now, have only used psychological/behavioural theories to understand 
participation behaviour in SM interventions however, as participation can be also be affected 
by a person’s external environment167 future research should include exploring and 
understanding this behaviour from a societal or sociological perspective204,213 to help improve 
this behaviour. 
In COPD, application of health behaviour theories in this thesis was useful to understand 
participation behaviour and hence, assessment of patient perceptions towards their illness and 
treatment may help to predict attendance in COPD SM support programmes;110 in addition, 
the negative perceptions identified would need to be understood and acknowledged by HCPs 
and could be targeted by behaviour change interventions,177,180,318 and the practical aspects 
related to attendance could be considered in the design of the programmes.320 This thesis 
proposes adaptation of the illness13 and the intervention perception questionnaire, targeted at 
patients with coronary heart disease,180 for COPD. This thesis has made a start towards the 
development of an intervention (namely, for the PR programme) perception questionnaire. 
Using the Necessity-Concerns Framework as a conceptual guide, the findings of the 
qualitative approach in this thesis (from Chapter IV, V and VI) helped to generate a list of 
draft statements (Appendix 8.1). These statements have undergone face validity assessment 
among experts (three clinicians, ST (principal study supervisor), PW and RF; and three health 
psychologists, AC, EE and LS). The responses from experts were generally positive and that 
the questionnaire largely had face validity. In a future study, efforts will be made to continue 
the development of the draft questionnaire by following the recommendations suggested by 
Streiner and Norman394 for developing a screening instrument and piloting it among patients 
with COPD. 
Additionally, this thesis proposes an evaluation of the feasibility and acceptability of the 
‘CENTREd’ Model of SM support among patients with COPD and UK respiratory nurse 
specialists working in the field of COPD management. Rationale being, respiratory nurses 
have insufficient knowledge of evidence-based strategies to help promote SM among patients 
with COPD and mostly owing to lack of training in specific communication techniques;395 
the nurses would benefit from training and education to manage patients with respiratory 
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disease;396 and training for professionals in communication and SM support skills was 
identified as one strategy to better support patients with their self-management which in turn 
could help to improve participation in SM support programmes. The aims of the feasibility 
study will assess: 
1) the acceptability of the training in the ‘CENTREd’ Model among health professionals  
2) the feasibility of delivery of the newly learnt skills among patients with COPD in routine 
practice by the trained professionals 
3) the acceptability to patients with COPD of receiving SM support in routine practice and 
the potential to adopt SM health-related behaviours including participation in SM support 
interventions 
 
The research objectives will comprise: 
1) Identification, recruitment and training of health professionals in the ‘CENTREd’ Model 
and the assessment of acceptability and feasibility of the training.  
2) Assessment of the trained professionals’ adoption of the ‘CENTREd’ Steps, Skills and 
Tools and their implementation in routine practice among patients with COPD over a study 
period of 4 months. 
3) Among patients with COPD, assessment of the acceptability of receiving SM support in 
routine practice and their potential in the context of this support to improve or maintain 
lifestyle/health-related behaviours including participation in SM support interventions. 
 
The proposed methodology will include a before-after study design with qualitative 
methodology (through video recording of clinical consultations and post-consultation 
interviews). This methodology can be supported by a similar methodology that was proposed 
in a recent study397 within a wider pragmatic cluster RCT design whereby the implementation 
of a complex intervention (focus on osteoarthritis consultation between patient and nurse) 
was to be documented through interviews and observation (unspecified how) of clinics and 
feedback meetings.  
 
Lastly, researchers need to recognise that reasons for participation in a SM intervention might 
be different to a study of a SM intervention. Chapter II and Chapter IV helped to understand 
patient participation behaviour in studies of SM interventions and Chapter V and VI helped to 
understand participation and non-participation behaviour in SM support interventions. So, 
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patient participation in the proposed feasibility study or another study of SM support might 
improve by: keeping the patient reasons in mind when developing the study eligibility 
criteria; inviting and informing eligible patients about the study using a one-to-one or 
personalised approach preferably by health professionals and passing details of the interested 
patients to the study researcher; the study researcher ensuring that the interested eligible 
patients have understood the purpose of the study and the intervention, assessing patient 
expectations, practical or physical barriers related to participation and addressing where 
possible any unrealistic expectations, practical or physical barriers. It might also be useful to 
assess if the eligible patients are ready or capable of self-management. Finally, the study 
should record and report reasons for study non-participation, intervention non-attendance 
non-completion and study non-completion. 
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Appendices 
The appendices from every chapter have been saved in a CD enclosed with this thesis. 
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